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Abstract 
 
Genome-wide association studies (GWAS) have successfully identified common obesity-
associated variants. These have been primarily conducted using populations of European 
ancestry and the relevance of these loci in other populations remains to be determined. The 
aims of this study were multi-fold, in both corroborating the role of these variants in Asians 
and in unravelling new obesity-associated variants.  
 
In my first study, I examined the relevance of specific variants, initially identified in 
Europeans, with obesity in Asian populations from Singapore (Chinese, Malays and South-
Asians). This confirmed the role of several novel obesity loci and suggested that common 
variants obesity-associated variants were relevant across ethnic groups.   
 
To identify additional obesity-associated loci in East-Asians, a hypothesis-free GWAS 
approach was adopted in the next study. These studies were initially carried out in 
Singaporean datasets and subsequently, expanded to consortia levels to increase power in the 
study. These efforts successfully identified novel BMI-associated variants in East-Asians and 
highlighted that insulin-associated processes may be involved in obesity susceptibility. 
 
In the third study I extended the findings of a possible role for insulin-associated processes in 
obesity by aiming to understand the relevance of type 2 diabetes risk loci with obesity 
predisposition in adults and in childhood and birth among East-Asian datasets. Data from this 
study revealed a possible ethnic-specific association at a HHEX locus among adult East-
Asians and identified another HHEX variant at which the effects on childhood BMI interacted 
with birth weight. 
 
In the final study, I assessed an inflammtory phenotype, serum C-reactive protein levels, for 
novel associations in East-Asian datasets using GWAS with a focus on identifying any 
obesity interactions. I further sought to clarify on the causality between CRP with vascular 
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disease in this study. Although no novel variants were detected in this study, several initial 
findings from earlier GWAS were replicated in the East-Asian populations. Furthermore, it 
was determined that CRP was not causally associated with macrovascular and microvascular 
disease. 
 
Primary results from these studies served to replicate several novel obesity loci in Asian 
populations and revealed novel risk variants. Nevertheless, it is striking that much of the 
genetic variation in obesity levels remains unidentified.  Additional research is necessary to 
pin-point causal location and mechanisms for the already identified loci and it would be 
important to address the role of non-SNP genetic variations in obesity susceptibility.  
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panels for Europeans  (CEU, pink dots), Han Chinese (CHB, yellow dots), 
Japanese (JPT, turquoise dots) and Yorubans  (YRI, black dots) used to detect 
outliers with discordant ethnic membership from reported ethnicity or admixed 
220 
xiv 
 
samples.  
Appendix I Figure 7 
Principle Component Analysis (PCA) of Chinese adults from  SP2 (turquoise dots) 
genotyped on Illumina 550 chips with Singapore Genome Variation Project 
(SGVP) reference panels for Chinese (CHS, red dots), Malay (MAS, blue dots) 
and Asian-Indian samples (INS, green dots) used to detect outliers with discordant 
ethnic membership from reported ethnicity or admixed samples.   
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Appendix I Figure 8 
Principle Component Analysis (PCA) of Chinese adults from  SP2 (red dots) 
genotyped on Illumina 550 chips with HapMap reference panels for Europeans  
(CEU, pink dots), Han Chinese (CHB, yellow dots), Japanese (JPT, turquoise dots) 
and Yorubans  (YRI, black dots) used to detect outliers with discordant ethnic 
membership from reported ethnicity or admixed samples  
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Appendix I Figure 9 
Principle Component Analysis (PCA) of Chinese adults from  SCES (black dots) 
genotyped on Illumina 550 chips with Singapore Genome Variation Project 
(SGVP) reference panels for Chinese (CHS, red dots) and Malay (MAS, green 
dots) used to detect outliers with discordant ethnic membership from reported 
ethnicity or admixed samples.   
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Appendix I Figure 10 
Principle Component Analysis (PCA) of Chinese adults from  SCES (black dots) 
genotyped on Illumina 610 chips with HapMap reference panels for Europeans  
(CEU, blue dots), Han Chinese (CHB, red dots), Japanese (JPT, green dots) and 
Yorubans  (YRI, pink dots) used to detect outliers with discordant ethnic 
membership from reported ethnicity or admixed samples.   
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Appendix I Figure 11 
Principle Component Analysis (PCA) of Malay adults from  SiMES (black dots) 
genotyped on Illumina 610 chips with Singapore Genome Variation Project 
(SGVP) reference panels for Chinese (CHS, red dots), Malay (MAS, green dots) 
and Asian-Indian samples (INS, blue dots) used to detect outliers with discordant 
ethnic membership from reported ethnicity or admixed samples.   
225 
Appendix I Figure 12 
Principle Component Analysis (PCA) of Malay adults from  SiMES (black dots) 
genotyped on Illumina 610 chips with HapMap reference panels for Europeans  
(CEU, red dots), Han Chinese (CHB, turquoise dots), Japanese (JPT, blue dots) 
and Yorubans  (YRI, green dots) used to detect outliers with discordant ethnic 
membership from reported ethnicity or admixed samples.   
226 
Appendix I Figure 13 
 Principle Component Analysis (PCA) of Asian-Indian adults from  SINDI (black 
dots) genotyped on Illumina 610 chips with Singapore Genome Variation Project 
(SGVP) reference panels for Chinese (CHS, red dots), Malay (MAS, green dots) 
and Asian-Indian samples (INS, blue dots) used to detect outliers with discordant 
ethnic membership from reported ethnicity or admixed samples.  
227 
Appendix I Figure 14 
Principle Component Analysis (PCA) of Asian-Indian adults from  SINDI (black 
dots) genotyped on Illumina 610 chips with HapMap reference panels for 
Europeans  (red dots), Han Chinese (CHB, turquoise dots), Japanese (JPT, blue 
dots) and Yorubans  (YRI, green dots) used to detect outliers with discordant 
ethnic membership from reported ethnicity or admixed samples.   
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Appendix II Figure1 
Regional plots of 9 previously detected obesity loci which did not have index SNP 
information in any of the Singaporean datasets, using Z-BMI association p-values 
after meta-analysis.  
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Appendix III Figure 1 
QQ plots comparing p-values in the gene–gene interaction analysis. Genome-wide      
gene–gene interaction analyses were conducted between the landmark SNP of the 
each of the BMI-associated loci (SEC16B, CDKAL1, KLF9, BDNF, FTO, MC4R, 
and GIPR loci) and genome-wide SNPs (2,178,018 SNPs).  
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1. Introduction 
 
1.1 Global obesity epidemic 
 
Obesity is a medical condition in which excess body fat has accumulated to a point that it 
may adversely affect health and/or reduce life expectancy [1].  Common obesity is complex 
in nature and is caused by a combination of inherent genetic and external environmental 
forces [2-3].  It has tremendous medical and social impacts and is threatening to overwhelm 
both developed and developing nations [4].  
 
Global obesity levels have escalated in recent years, hovering at epidemic proportions [1-3].  
Over the past 20 years, global obesity estimates in adults, clinically defined as a body-mass 
index (BMI) > 30 kg/m
2
, have more than doubled to 475 million and a further one billion 
adults are currently overweight (25 kg/m² ≤ BMI < 30 kg/m2) [5].  Escalating obesity trends 
show little signs of slowing [1-3] and studies warn that over a billion people worldwide 
would be classified as clinically obese within 20 years, resulting in tremendous medical and 
public health burdens [6].   
 
Trends in childhood obesity levels paint a similarly ominous outlook, with present estimates 
highlighting that approximately 200 million school-aged children are overweight [5].  Studies 
indicate that obesity and related metabolic complications in young track into adulthood and 
predispose individuals to increased risks of prematurely developing illness that have 
previously been thought to be a problem of older age (such as adult-onset type 2 diabetes 
mellitus) [7-9].  With no well-established or safe treatments available for obesity [10-11] and 
diet and physical activity modifications deemed as short-term modifiers [12], there is a great 
need for a better appreciation of disease aetiology to manage the current global obesity crisis. 
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1.2 Health impact of obesity 
 
Fundamentally, obesity results from a chronic imbalance between energy intake and 
expenditure, which leads to excessive storage of energy in the body [13].  Obesity is a well-
established key contributor to a myriad of health complications, as highlighted in figure 1.1 
below (adapted from Malnick SD and Knobler H, 2006 [14]), and in certain countries, such 
as the United States of America, it is considered the greatest preventable contributor to 
morbidity and mortality [15-16].  In recent years, the escalating obesity epidemic has been 
blamed for the world-wide explosion in rates of other non-communicable diseases, 
particularly type 2 diabetes (T2D), evolving into a global burden of ‘diabesity’ [17-18]. 
 
Figure 1.1: List of major complications associated with obesity (adapted from Malnick SD and 
Knobler H, 2006 [14]. 
 
 
 
The psychological impacts related with obesity status are also plentiful and being overweight 
is associated with body dissatisfaction and unhealthy weight control behaviours, often leading 
to low self-esteem, affecting social relationships and reducing quality of life of the affected 
person [19-20].  Moreover, obese individuals face biasness at every facet of society and are 
often undeservedly typecast as being lazy and unmotivated [20].  
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1.2.1 Obesity and inflammation 
 
It has become recognized that obesity often gives rise to a heightened state of inflammation 
in the body [21] and this link between inflammation and obesity has been illustrated by 
increased serum inflammatory biomarkers, such as C-reactive protein (CRP), among obese 
patients [22-23].  Adipose tissues are not merely amorphous energy depots, but rather, serve 
as an essential endocrine and metabolic organ that express and secrete several factors, 
collectively known as adipokines that can have considerable effects on the physiology of 
other tissues and organs [24].  These adipokines include non-esterified fatty acids and 
inflammatory cytokines, such as tumour necrosis factor α (TNFα) and interleukin-6 (IL-6) 
[21, 24].  Studies indicate that obese individuals display elevated production and secretion of 
these harmful adipokines as well as increased infiltration of macrophages into adipose 
tissues, which results in an overall chronic pro-inflammatory and pro-atherogenic profile [21, 
24]. 
 
The primary medical problems associated with obesity, such as insulin resistance, liver 
steaosis and artherogenic progression, are believed to stem from increased inflammation 
among obese individuals [21, 24].  Targeting the inflammatory component in obesity may, 
therefore, prove useful in developing strategies to slow down progression of obesity related 
health complications.  
 
1.3 Obesity in Asia 
 
Increasing adult and childhood obesity trends are ubiquitously prevalent in almost all Asian 
countries, especially in those that have experienced rapid urbanisation and modern 
developments in recent years [25-27].  Several Asian countries are also faced with managing 
a dual burden of both escalating obesity levels as well as malnutrition among their 
populations [28].  Nevertheless, there is a trend of shifting from energy deficiency to excess 
nutrition as these countries increasingly urbanise [29-30].   
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Singapore, where much of the data was collected for this PhD study, is a country that has 
experienced tremendous socio-economic boom since gaining independence in the 1960s and 
has emerged as one the world’s most prosperous nations [31].  It was one of the few Asian 
countries to recognise the increasing obesity trends and the related impact to public health in 
its population at a relatively early stage (during the late 1980s and early 1990s).  This 
prompted widespread government led initiatives such as, the National Healthy Lifestyle 
programme to promote healthier eating habits and encourage physical activity [32].  
Nevertheless, obesity and overweight levels have continued to rise in all three major ethnic 
groups of the Singaporean population (Chinese, Malays and Asian-Indians), both among 
adults and children [33]. 
 
It is also of particular concern that there are strong evidences that individuals of Asian 
ancestry have higher percentage of body adiposity as compared to Europeans at a similar 
BMI level [34-35].   This results in elevated health risks among Asians, even among those 
with lower BMI levels who would not be clinically categorised as being obese or overweight 
using traditional clinical cut-offs (obesity defined as a BMI > 30 kg/m
2
 and overweight 
defined as 25 kg/m² ≤ BMI < 30 kg/m2) [36].  As such, it is likely that estimates of obesity 
prevalence among Asians using traditional cut-offs would have underestimated the true 
magnitude of the problem in Asia [34-36].   
 
Recently, this has led to an expert review by the World Health Organization (WHO), 
convening to address the appropriateness of “global” BMI cut-offs in Asian populations.  As 
a result, additional BMI cut-offs at 23 kg/m
2
 and 27.5 kg/m
2
 have been identified for public 
health action in Asian populations [37].  In view of these additional criteria and taking into 
account the ill-preparedness of most developing Asian countries, where serious initiatives to 
curb obesity levels are not widespread, the burden of the obesity epidemic is likely to be even 
greater in Asia [38].  
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1.4 Measures of obesity 
 
Health impacts of obesity are primarily due to the excess fat that is stored in the body.  
Measures that accurately differentiate between various body composition (such as fat mass 
and muscle mass) and directly measure the percentage of body fat include dual energy x-ray 
absorptiometry (DXA) and air-displacement plethysmography.  However, these are often 
impractical to be utilised in large-scale epidemiological studies due to higher costs and time 
required for assessments [39].  
 
Common surrogate measures of obesity widely used in large-scale epidemiological studies 
include BMI, waist-hip ratio (WHR) and waist circumference (WC).  BMI is defined as an 
individual’s weight (in kilograms, kg) divided by the square of the individual’s height (in 
meters squared, m
2
) [40].  It is an easily derived and a non-invasive measure for overall 
adiposity [41] in adults as well as in children [42] and strongly correlates with related 
comorbidities such as cardiovascular disease (CVD) and T2D [40].   Nevertheless it should 
be noted that BMI does not differentiate between fat, muscle and bone mass distributions and 
this could result in misclassifications of individuals [43], (i.e. body-builders could be wrongly 
classified as being overweight or obese due to higher muscle mass).   
 
WHR and WC are measures of central or abdominal adiposity, which is associated with 
increased health risks due to increased visceral fat storage near the major organs [44].  
Substantial differences in body fat patterning exist between males and females and thus cut-
offs for central obesity measures differ; abdominal obesity is defined by a WC ≥ 94 cm in 
males and  ≥ 80 cm in females or WHR  ≥ 0.90 in males and WHR  ≥ 0.85 in females, as 
defined by the WHO [45]. 
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1.5 Causes of the obesity crisis 
 
The explosion in worldwide obesity levels has taken place over a relatively short period of 
time [1-3, 46].  This coincides with the establishment of the modern ‘obesogenic’ 
environment [46], especially in developed and developing nations, where there is easy access 
to highly appetizing and energy-dense food with a reduced need for physical activity and 
energy expenditure.  Thus, there is no doubt that rapid changes in the living environment are 
to blame for the current obesity epidemic.   
 
Nevertheless, not every individual exposed to this ‘obesogenic’ environment becomes 
overweight or obese and within a population, the ease and extent of weight gain or weight 
loss is probably determined largely by inherent genetic factors [2-3, 47].  In the following 
sections I discuss evidence for the role of genetics in susceptibility to obesity. 
 
1.5.1 Evidence for a genetic basis in obesity 
 
Epidemiology studies for obesity highlight that concordance in obesity levels decrease with 
reduced relatedness [48].  Twin studies further indicate that monozygotic (MZ) twin pairs 
have greater correlation with obesity levels than dizygotic (DZ) pairs [49] and adoption 
studies [50], reveal stronger correspondence of BMI with biological parents.  As such there is 
long-established evidence for the importance of genetics in obesity.  More significantly, 
recent twin studies examining children born in the face of the current widespread 
‘obesogenic’ environment have indicated prominent genetic influences for overall and central 
obesity measures and heritability estimates of BMI and WC can be higher than 70% [51].   
 
Furthermore, elucidation of defects in single genes that result in monogenic or Mendelian 
forms of obesity have provided direct evidence for the importance of genetic factors in the 
development of obesity [52].  Moreover, it is evident that severity of obesity levels tends to 
correlate with ethnicity [53] and certain ethnic groups are more predisposed to weight gain 
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than others living in similar ‘obesogenic’ environments [54].  The ‘thrifty gene hypothesis’ 
has been proposed explain these observations [55].  Different evolutionary histories (i.e. 
episodes of famines and food shortage) of various ethnic groups could have led to different 
degrees of selection of genetic factors that promote weight gain.  However, in modern times, 
these ethnic populations are now exposed to an environment of plenty and are, therefore, 
even more predisposed to storing energy in the body.   
 
The thrifty gene hypothesis is however highly controversial.  Other epidemiologists such as 
John Speakman argue that there must have been insufficient time for enrichment of ‘thrifty 
genes’ if selection had only begun acting since the invention of agricultural processes or 
conversely, obesity levels should be much severely widespread if famines (and therefore 
selection pressures) were ubiquitously present since the age of man [56].  As such a more 
probable hypothesis, the ‘predator release hypothesis’, has been proposed to explain the 
distribution of obese individuals in the population [56].  In this hypothesis it is proposed that 
the effective removal of predation risks for ancestral man had removed a negative selection 
pressure on genetic variants that would limit body size, allowing genetic drifts among genes 
regulating the upper limit on body size [56]. 
 
1.6 Genetic architecture of obesity  
 
Human obesity can be grouped into three distinct classes based on the suspected (or 
diagnosed) aetiology of disease.  Monogenic obesity occurs due to a single gene defect [52].  
Variation in the leptin (LEP) gene was identified as the first single-gene defect causing severe 
obesity in the late 1990s, from analysis of a highly consanguineous Pakistani family [57].  
Subsequent success in reversing obesity phenotypes by treatment of leptin-deficient 
individuals with recombinant leptin was of paramount significance as it indicated that 
successful therapeutic intervention for obesity could be achieved through detailed molecular 
discernment of the affected individuals [58].   
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Since the discovery of LEP, about 20 single-gene disorders have been identified [52], all of 
which are involved in the central control of energy homeostasis [52].  Although these 
mutations often have very strong biological effects and obesity is observed from a very early 
age in childhood, these monogenic gene disorders are rare and insufficient to explain the 
current explosion in obesity levels seen in the population [52].  Recent review articles have 
summarised findings from studies on monogenic forms of obesity and these are indicated in 
Table 1.1 (adapted from O'Rahilly S, 2009 [52] and Chung WK, 2011 [59]).  All genes 
implicated with monogenic obesity play a role in the leptin-melanocortin pathway which, 
controls overall energy homeostasis in the body and figure 1.2 (adapted from Zanella and 
Ribero-Filho [60]) provides a simplified diagram of position of genes involved in this 
pathway that bring about a catabolic effect.  Increased energy intake results in higher leptin 
release from adipose stores which, signals to neurons in the brain, resulting in the promotion 
of catabolic processes in the body. 
 
 
Another class of obesity is syndromic obesity and this occurs when obesity arises together 
with a distinct set of clinical features, such as mental-retardation and organ-specific 
abnormalities [48, 59].  Around 25 syndromic forms of obesity have been recognized and the 
genetic bases for several of these have been elucidated [59].  Details of main syndromic 
obesity are highlighted in table 1.2.  Similar to monogenic defects, syndromic forms of 
obesity are rare, for example the Prader Willi Syndrome (PWS) occurs once in approximately 
20,000 live births [59]. 
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Figure 1.2: Simplified leptin-melanocortin pathway indicating signalling of peripheral adipose tissue to the brain through leptin to bring about a catabolic 
effect in the body (adapted from Walley Zanella and Ribero Filho [60]). LEP: leptin, LEPR: leptin receptor, POMC: Pro-opiomelanocortin, PCSK1: 
Proprotein convertase 1, α- MSH: alpha- Melanocyte stimulating hormone, MC4R: Melanocortin 4 Receptor, BDNF: Brain-derived neurotropic factor. 
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Table 1.1: Details of main monogenic forms of human obesity [(adapted from O'Rahilly S, 2009 (52) and Chung WK, 2011 (59)].  
 
Gene  Comment  Known mutations Phenotype  
Leptin (LEP)  Adipocyte derived hormone  ∆G133, Arg105Trp  Extreme, early-onset obesity, hyperphagia, 
delayed puberty, T-cell abnormalities  
Leptin Receptor (LEPR)  Receptor for adipocyte-
derived hormone  
Exon 16 splice donor 
G =>A  
Extreme, early-onset obesity, short stature, 
hyperphagia, delayed puberty  
Pro-opiomelanocortin 
(POMC)  
Hypothalamic neuropeptide  G7013T, 7133delC, C3804A, 
A6851T, 6906delC, 6996del, 
7100insGG, 7134delG  
Early-onset obesity, adrenal insufficiency, 
red hair  
Proprotein convertase 1 
(PCSK1)  
Processes pro-peptides 
(including POMC) to active 
compounds  
Gly483Arg, A = >C + 4 
intron 5 donor splice site, 
Glu250Stop, Del213Ala  
Early-onset obesity, elevated proinsulin, 
hypocortisolemia, depressed POMC, reactive 
hypoglycaemia, hypogonadotrophic 
hypogonadism  
Melanocortin 4 Receptor 
(MC4R)  
Receptor for POMC 
products αMSH and βMSH  
Over 20 mutations  Early-onset obesity, hyperphagia, increased 
fat mass, increased lean mass, increased bone 
mineral density and bone mineral content, 
increased linear growth, and 
hyperinsulinemia  
Homologue of Drosophila 
single minded 1 (SIM1)  
Transcription factor 
necessary for hypothalamic 
development  
Translocation between 
chromosomes 1p22.1 and 
6q16.2  
Early-onset obesity, hyperphagia, increased 
linear growth  
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Table 1.2: Details of main syndromic forms of human obesity [(adapted from O'Rahilly S, 2009 (52) and Chung WK, 2011 (59)]. 
Syndrome  Implicated gene  Possible mode of inheritance  Phenotypes 
Prader Willi syndrome  Contiguous gene disorder in 
15q11-13 
Imprinting defect with loss of 
paternally expressed genes  
Neonatal hypotonia, poor feeding, evolving into 
extreme hyperphagia, central obesity, decreased 
lean body mass, short stature, hypothalamic 
hypogonadism, mild mental retardation, 
obsessive compulsive behaviour  
Bardet-Biedl syndrome  Numerous gene loci leading 
to Bardet-Biedl syndrome 1-
15 (BBS1-BBS12)  
Autosomal recessive  Progressive rod-cone dystrophy, post axial 
polydactyl, renal cysts, progressive renal 
disease, dyslexia, learning disabilities, 
hypogonadism, occasional congenital heart 
disease, and progressive late childhood obesity  
Alstrom syndrome  Alstrom syndrome 1 
(ALMS1)  
Autosomal recessive  Mild truncal obesity, short stature, type 2 
diabetes, retinopathy, sensor neural hearing 
loss, nephropathy, dilated cardiomyopathy  
Wilms tumour, Aniridia, 
Genitourinary anomalies 
and mental Retardation 
(WAGR) syndrome  
Brain-derived neurotropic 
factor (BDNF)  
Autosomal dominant  Obesity, Wilms’ tumour, aniridia, genitourinary 
anomalies, mental retardation  
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The third subgroup of obesity is known as polygenic or common obesity, which affects the 
majority of obese cases in the general population [2-3, 48] and is the main phenotype of 
interest in my PhD study.  Polygenic obesity is complex in nature and involves a combination 
of environmental factors as well as numerous gene variations, each with effect sizes that are 
expected to be modest (as compared to large effect sizes seen in Mendelian forms of obesity) 
[2-3, 48].  
 
1.6.1 Hypotheses for genetic architecture of complex disease 
 
One hypothesis that attempts to explain the genetic aetiology of common diseases (such as 
common obesity) is the common disease-common variant (CDCV) hypothesis.  This suggests 
that common complex diseases, such as obesity, may be a result of a number of common 
genetic variants, where disease causing alleles have become prevalent in the population [61-
62], as seen in the ε4 apolipoprotein E (APOE) allele with Alzheimer’s disease.  This 
hypothesis has been the scientific model for genome-wide association studies (GWAS, 
discussed below) that have been conducted for several common diseases and traits.  
Nevertheless, the CDCV hypothesis is controversial and has been challenged by the notion 
that natural selection should, in fact, keep deleterious mutations in the human genome at low 
levels [62-63].   
 
An alternative hypothesis to the CDCV is the common disease-rare variant (CDRV) 
hypothesis which posits that the major proportion of genetic variance underlying complex 
diseases could be due to loci where risk alleles are deleterious and are thus, at lower 
frequencies in the population [63].  In reality, these hypotheses may not be mutually 
exclusive and a combination of both common and rarer variants may predispose to complex 
diseases. 
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1.7 Identifying genetic loci for common obesity 
 
Genome-wide linkage studies and candidate gene studies have been successful in identifying 
loci associated with monogenic or syndromic obesity [64].  Until recently, studies 
interrogating the genetic basis of common obesity have also relied on similar strategies [64].  
In this section I discuss traditional and subsequently, more modern methodologies used to 
identify obesity associated genetic variants and highlight key findings from these studies. 
 
1.7.1 Traditional methods to detect common obesity 
 
Genome-wide linkage analysis is a hypothesis-free approach that utilizes polymorphic 
genetic markers or microsatellites spaced throughout the genome to identify novel genomic 
segments that co-segregate with the disease or related phenotype, among related individuals 
[65].  Identified segments are subsequently interrogated further to pin-point the causative 
gene or variant.  Although this approach has proved fruitful for other common diseases, as in 
the case of identification of variants near the transcription factor 7-like 2 (TCF7L2) 
associated with T2D [66], a recent large-scale meta-analysis of genome-wide linkage studies 
for common obesity of over 30,000 individuals did not identify any strong associations [67].   
Failure of linkage analysis to detect genetic loci associated with common obesity could lie in 
the fact that this approach is best powered to detect variants that are highly penetrant and 
possess large effect sizes; features that are not expected to contribute significantly to common 
forms of obesity [48]. 
 
Alternative to the hypothesis-free approach, research was also based on extending findings 
from in vitro and in vivo studies to assess the contribution of biologically plausible candidate 
genes for obesity association, using a candidate gene approach.  Early candidate studies 
compared frequencies of one or a few carefully selected variants at candidate genes among 
unrelated obese patients (cases) relative to non-obese individuals (controls) [48].  Although 
numerous candidate genes have been identified in this manner, the majority of these loci are 
not supported by confirmatory replications in independent datasets [64].   
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Several factors have been proposed for the inconsistencies of early candidate gene studies.  
The original findings were likely to be false positive results arising from multiple testing in 
often small and underpowered datasets [48].  Moreover, the fundamental difficulty in 
choosing plausible candidate genes when knowledge on molecular mechanisms of common 
obesity was limited has hampered gene discovery for common obesity through the candidate 
gene approach [48].   
 
1.7.2 Key findings for common obesity from large-scale candidate gene studies 
 
In an effort to increase power in the study, more recent candidate gene analyses have 
however, utilised larger cohorts or combined data as meta-analyses and have successfully 
detected strong associations with variants at five different gene loci, namely melanocortin 4 
receptor (MC4R), adrenergic β3 receptor (ADRB3), proprotein convertase 1 (PCSK1), brain 
derived neurotropic factor (BDNF) and endocannabinoid receptor 1 (CNR1) [68].   
 
The CNR1 locus was assessed for obesity association due to evidence that therapeutic 
modulations of cannabinoid receptors could modify obesity phenotypes [69].  A large-scale 
study of over 5,000 individuals identified variants at the CNR1 to be strongly associated with 
obesity among populations of European ancestry [39].  
 
Variants at MC4R, PCSK1 and BDNF gene loci have previously been associated with 
monogenic forms of obesity and represent excellent biological candidates due to their role in 
the central control of energy homeostasis [52].  Association of variants at these loci with 
common obesity was inconsistent or unknown until recent large scale population studies and 
meta-analyses efforts detected robust associations with obesity or BMI.  For MC4R, gain-of-
function variants (I251L and V103I) have been identified, which protect from obesity [70-
73].  Similarly large scale meta-analyses have firmly confirmed two non-synonymous 
mutations at PCSK1 (N221D and Q665E-S690T pair) [74] and the V66M polymorphism at 
BDNF to be associated with common obesity [75]. 
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Additionally, large scale population studies or meta-analyses have also proved useful in 
providing evidence to rule out inconsistent associations at candidate loci with common 
obesity. This has been seen in the case of ectoenzyme nucleotide pyrophosphate / 
phosphodiesterase (ENPP1) [76] and interleukin 6 (IL6) [77] where large-scale studies were 
unable to detect significant associations with obesity levels.  Moreover, large-scale candidate 
studies have also indicated ethnic-specific obesity effects at some gene loci, such as the 
W64R variant at ADRB3 where meta-analysis results of over 44,000 indicated associations 
with obesity in only East-Asian samples but not among Europeans, [78].   
 
1.8 Genome-wide association studies (GWAS) 
 
In more recent times, GWAS have emerged as the method of choice for detecting common 
genetic variants associated with obesity and other common diseases. This methodology has 
successfully identified approximately 50 variants associated with obesity and obesity-
associated phenotypes [48, 65, and 79].  
 
Similar to genome-wide linkage studies, GWAS is a hypothesis free approach, which does 
not require, a priori, a detailed mechanistic understanding on disease aetiology.  This has 
shed light on the discernment of molecular regulation of obesity levels with several novel and 
unexpected loci that have been identified [65, 79].  GWAS further entails assessing unrelated 
individuals and utilises several hundred thousands of single-nucleotide polymorphisms 
(SNPs) at the same time, enabling the genome to be interrogated at a greater resolution than 
that possible with genome-wide linkage studies [65].   Additionally, as it does not require the 
analysis of related samples, GWAS enables larger cohorts to be assembled, which in turn, 
improves power in detecting true variants that may have more modest effect sizes [65, 79].   
 
GWAS are often carried out in two stages [79]: stage 1 or the discovery stage involves initial 
analysis for a trait or disease and the identification of top associated signals and stage 2 or the 
replication stage involves confirming association results from the discovery stage using 
additional independent samples.  In order to maximise likelihood of replication, sample size 
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in the latter should be ideally larger than the discovery cohort to enhance power and similar 
in terms of phenotype classification and ethnicity as power may be lost due to miss-classified 
samples and inter-ethnic variability in genetic structure or LD, respectively.  Subsequently, 
association signals from the two stages are normally combined using meta-analysis 
procedures.  As numerous association tests are conducted in a GWAS study, the numbers of 
type 1 errors or false positives tend to be inflated and therefore, very stringent levels of 
significance are required [79].  Generally, a genetic signal is considered to be significantly 
associated with a trait or disease when replication is achieved in an independently collected 
dataset and association levels reach a p-value of less than 5 x 10
-8
 (considering that one 
million tests have been performed). 
 
1.8.1 Factors that facilitated the development of GWAS approach 
 
Over the past few years, rapid advancements in genetic knowledge and genotyping 
technology, coupled with economic feasibility have made GWAS a powerful tool for gene 
discovery [80].  
 
During the late 1990s and early 2000, improvements in sequencing technology and 
international efforts to sequence the human genome were instrumental in providing 
researchers with a catalogue of SNP variations [81], such as dbSNP [82].  Subsequent large-
scale efforts, such as the International HapMap Consortium [83], facilitated the compilation 
of detailed correlations or linkage disequilibrium (LD) patterns between neighbouring SNPs 
among various major world populations.   
 
These efforts highlighted that in non-African populations extensive LD exists between 
neighbouring SNPs [48], such that regional SNPs are transmitted across generations in 
correlated blocks due to close proximity.  Such findings were instrumental in allowing for a 
‘tagging SNP’ approach to interrogate the entire genome and it has been estimated that as few 
as 500,000 ‘tagging‘ or even random SNPs across the genome would sufficiently capture the 
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majority of common SNP variations [i.e. with a minor allele frequency (MAF) ≥ 5%] in non-
African populations [65, 84].   
 
These significant advancements in the knowledge of the human genome had also been 
paralleled with technological breakthroughs in genotyping methodology, which made cost-
effective and precise whole genome genotyping a possibility [85].  These together have 
brought about the advent of the era of GWAS [79] and this methodology has been 
extensively used over recent years resulting in over 950 publications, highlighting 
unprecedented numbers of gene loci associated with more than 200 diseases or quantitative 
traits [86].  In the following sections, I discuss the major breakthroughs in GWAS conducted 
for obesity and obesity related quantitative traits.  
 
1.8.2 Key findings from GWAS for overall obesity 
 
Detection of variants for overall obesity has been mainly conducted by analysing BMI as a 
quantitative trait in population samples or by analysing case-control studies where obese 
subjects are defined as those with a BMI > 30 kg/m
2
. 
 
A low-density GWAS for obesity in 2006 (assessing approximately 116,000 SNPs), reported 
an association at a common SNP near the insulin induced gene 2 (INSIG2) for both adult and 
childhood obesity [87].  However, subsequent attempts to replicate this finding, even in large-
scale studies, have been unsuccessful [88-90].  
 
Common variants at intron 1 of the fat mass and obesity associated gene (FTO) were the first 
genetic locus to be irrefutably associated with common forms of overall obesity in 2007 [91].  
This locus was initially identified in a GWAS for T2D (approximately 2,000 cases and 3,000 
controls) using populations of European ancestry, where it was observed that the association 
with T2D was lost when participants’ BMI was taken into consideration [91].  The 
associations with BMI were subsequently replicated in 30,000 adults and children of 
18 
 
European ancestry [91].  At around the same time studies reported similar findings at this 
gene locus for associations with BMI and early-onset obesity [92-94].  These findings in 
populations of European ancestry provided robust validation for the associations observed at 
FTO with overall obesity.   
 
The power in a GWAS to detect true associations is primarily dependent on two factors – the 
effect size and the frequency of the allele [65, 79].  In the case of FTO, the high frequency of 
risk variants (approximate 40% in European populations) enabled the discovery of this locus 
to be identified among Europeans in moderately sized datasets.  Another major finding from 
the discovery of FTO was that effect sizes for variants involved in common obesity was more 
modest than expected.  Therefore, discovery of additional variants of similar or even smaller 
effects than the FTO locus (in European populations) would require larger sample sets to 
increase power for detecting associations in the study [79].   
 
The perceived limitation in power prompted large-scale collaborative research with the aim to 
detect other obesity associated variants.  Initial efforts of such collaborative work, using a 
discovery set of 16,876 samples of European ancestry, proved fruitful in the detection of 
another locus, approximately 200 kb upstream of the MC4R gene [95].  The association at 
this gene locus was also confirmed in over 65,000 adults and children of similar European 
ancestry.  As expected, the effect size of the variant near the MC4R locus was observed to be 
smaller than that of the FTO variants (0.23 kg/m
2
 and 0.39 kg/m
2
 increase in BMI per risk 
allele at the near MC4R and FTO loci, respectively [79]) and therefore, required a larger 
sample size for identification. 
 
In parallel, another study identified the same locus in a GWAS for BMI in a much smaller 
number of Asian-Indian samples (2,684 samples) which, was subsequently replicated among 
approximately 12,000 Asian-Indian and European samples [96].  Although the effect size at 
this locus among Europeans and Asian-Indians were similar, the discovery of the locus near 
MC4R with obesity was possible in a smaller dataset as the allele frequency of the implicated 
variant was higher among Asian-Indians (36% compared to 27% in Europeans) [96], thus 
enhancing the power of this study. 
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Subsequently, even larger and multi-centre collaborative meta-analyses studies of GWAS for 
BMI associations in mainly populations of European ancestry have been conducted by the 
deCODE and the Genetic Investigation of ANthropometric Traits (GIANT) consortia and 
these have successfully identified up to 32 genetic loci (including previously identified loci, 
which were confirmed in this study) [97-99].  All gene loci detected from GWAS for BMI 
associations have been highlighted in table 1.3.  Importantly, the new loci detected from these 
efforts generally had smaller effect sizes and/or had lower allele frequencies than previously 
identified loci [97-99].  Furthermore, even in combination, these loci only explain a fraction 
of the overall inter-individual BMI variation (about 2%) [99-100], which suggest that 
perhaps, several other genetic variants remain to be discovered [99].  
 
GWAS of overall obesity have detected an extraordinary number of genetic loci in a very 
short period of time.  However, determining the causal variant or the causal gene from 
GWAS data alone may often prove to be complicated [98-99].  It is important to note that the 
association signals detected from GWAS are unlikely to be causal but instead, have been 
detected due to the LD relationships with the causal mutation that could lie in any of the 
regional genes or even reflect long-range interactions as seen in colon cancer [101].  As 
several of these association signals are not directly located within genes (such as the locus 
near MC4R) but rather, in intergenic regions, researchers can only postulate on the best 
implicated gene based on characterised functions of regional genes that lie close to the 
identified variant.  On the other hand, intergenic signals may also indicate that a portion of 
genetic control in common overall obesity may not always involve mutations in protein 
structure, which are more likely to be more severe in nature, but influences regulation of gene 
expression levels [101].   
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Table 1.3: 32 loci associated with BMI in recent large-scale GWAS. Index SNPs, risk allele, per risk allele increase in BMI and risk allele 
frequency derived from most recent and largest GWAS (Speliotes et al., 2010 [99]). Loci ranked according to date of initial discovery and then 
by effect size. 
 
Implicated gene Position Index SNP 
Risk 
allele 
Per risk allele increase 
in BMI (kg/m
2
) 
Risk allele frequency 
in Europeans (%) 
GWAS Reference 
FTO 16q22.2 rs1558902 A 0.39 42 
Frayling et al. (2007), Scuteri et al. (2007), 
Dina et al. (2007) 
Near MC4R 18q22 rs571312 A 0.23 24 Loos et al. (2008), Chambers et al. (2008) 
Near TMEM18 2p25 rs2867125 C 0.31 83 
Willer et al. (2009), Thorliefson et al. 
(2009) 
Near GNPDA2 4p13 rs10938397 G 0.18 43 Willer et al. (2009) 
SH2B1* 16p11.2 rs7359397 T 0.15 40 
Willer et al. (2009), Thorliefson et al. 
(2009) 
Near NEGR1 1p31 rs2815752 A 0.13 61 
Willer et al. (2009), Thorliefson et al. 
(2009) 
MTCH2/NDUFS3/CUGBP1 11p11.2 rs3817334 T 0.06 41 Willer et al. (2009) 
Near KCTD15 19q13.11 rs29941 G 0.06 67 
Willer et al. (2009), Thorliefson et al. 
(2009) 
SEC16B 1q25 rs543874 G 0.22 19 Thorliefson et al. (2009) 
BDNF 11p14 rs10767664 A 0.19 78 Thorliefson et al. (2009) 
Near ETV5 3q27 rs9816226 T 0.14 82 Thorliefson et al. (2009) 
SLC39A8 4q24 rs13107325 T 0.19 7 Speliotes et al. (2010) 
Near PRKD1 14q12 rs11847697 T 0.17 4 Speliotes et al. (2010) 
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Near GPRC5B/IQCK 16p12.3 rs12444979 C 0.17 87 Speliotes et al. (2010) 
QPCTL/GIPR 19q13.32 rs2287019 C 0.15 80 Speliotes et al. (2010) 
Near RBJ/POMC/ADCY3 2p23.3 rs713586 C 0.14 47 Speliotes et al. (2010) 
TFAP2B 6p12 rs987237 G 0.13 18 Speliotes et al. (2010) 
MAP2K5/SKOR1 15q23 rs2241423 G 0.13 78 Speliotes et al. (2010) 
NRXN3 14q31 rs10150332 C 0.13 21 Speliotes et al. (2010) 
FAIM2 12q13 rs7138803 A 0.12 38 Speliotes et al. (2010) 
LRRN6C 9q21.3 rs10968576 G 0.11 31 Speliotes et al. (2010) 
Near FLJ35779/HMGCR 5q13.3 rs2112347 T 0.10 63 Speliotes et al. (2010) 
Near FANCL 2p16.1 rs887912 T 0.10 29 Speliotes et al. (2010) 
CADM2 3p21.1 rs13078807 G 0.10 20 Speliotes et al. (2010) 
Near TMEM160/ZC3H4 19q13.32 rs3810291 A 0.09 67 Speliotes et al. (2010) 
Near LRP1B 2q22.2 rs2890652 C 0.09 18 Speliotes et al. (2010) 
MTIF3/GTF3A 13q12.2 rs4771122 G 0.09 24 Speliotes et al. (2010) 
TNNI3K 1p31.1 rs1514175 A 0.07 43 Speliotes et al. (2010) 
Near ZNF608 5q23.2 rs4836133 A 0.07 48 Speliotes et al. (2010) 
Near PTBP2 1p21.3 rs1555543 C 0.06 59 Speliotes et al. (2010) 
Near RPL27A/TUB 11p15.4 rs4929949 C 0.06 52 Speliotes et al. (2010) 
NUDT3/HMGA1 6p21.31 rs206936 G 0.06 21 Speliotes et al. (2010) 
* Gene rich region with SH2B1 believed to be the most likely casual gene.
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A primary goal of GWAS is in hypothesis generation and providing insights in disease 
aetiology and these studies for overall obesity have successfully highlighted possible 
molecular pathways of disease.  Several of the postulated causal genes detected from these 
GWAS are known to be strongly expressed in brain tissues [98, 102].  Furthermore, variants 
in or near at least three genes (MC4R, BDNF, POMC) that have key functions in central 
control of energy homeostasis and in which, mutations are known to result in severe 
monogenic forms of obesity have also been identified with common overall obesity [102].  
These findings may implicate a major role for the central nervous system (CNS) in the 
control of common obesity and also, indicates that overall obesity is probably due to errors in 
molecular control of satiety rather than defects in peripheral storage of energy [100, 102].  
However, other discoveries such as variants at the gastric inhibitory polypeptide receptor 
(GIPR), implicates different mechanisms, such as incretin response at the gut, in common 
obesity [103]. 
 
GWAS for extreme, early-onset obesity and morbid obesity [104-105] have also been 
conducted on the premise that the affected patients would be enriched for variants associated 
with common obesity [106].  These efforts have identified five additional gene loci associated 
with obesity [104-105] (table 1.4) and have confirmed several genetic loci previously 
associated with BMI [104-106].   
 
Although these novel loci detected from early-onset or morbid obesity were observed to have 
relatively larger effect sizes (table 1.4) than those detected from population studies [104-106], 
the failure to replicate the identified loci, even in very large population datasets however, 
questions their relevance to common forms of obesity [99]. 
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  Table 1.4: Details of five novel loci detected from GWAS of early-onset and/or morbid obesity. 
 
Implicated 
gene 
Position Index SNP 
Risk 
allele 
Effect size 
Risk allele frequency 
in Europeans (%) 
Reference 
NPC1 18q11 rs1805081 A 
0.062 kg/m
2
 increase in BMI per risk allele 
(dominant effect) 
53 Meyre et al., (2009) 
MAF 16q22 rs1424233 A 
0.030 kg/m
2
 increase in BMI per risk allele 
(additive effect) 
91 Meyre et al., (2009) 
PTER 10p12 rs10508503 C 
0.017 kg/m
2
 increase in BMI per risk allele 
(additive effect) 
91 Meyre et al., (2009) 
SDCCAG8 4q43 rs10926984 T 
NS for BMI change in population samples but 
significant for adult obesity odds-ratio = 1.19 
89 Scherag et al., (2010) 
TNKS/MSRA 8q23.1 rs17150703 A 
NS in BMI change in population samples and 
adult obesity but significant for early-onset 
obesity odds-ratio = 1.10 
19 Scherag et al., (2010) 
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1.8.3 Key findings from GWAS for central obesity 
 
Common measures of central or abdominal obesity such as waist circumference (WC) and 
waist-hip ratio (WHR) correlate well with intra-abdominal fat and reflect patterns of fat 
deposition in the body, which is independent of overall obesity levels or BMI status [107].   
 
Three large-scale GWAS studies using samples of European ancestry have been conducted in 
an attempt to unravel common variants associated with central obesity [108-110], using 
central obesity measures as a quantitative trait.  These studies have identified, in total, 19 loci 
associated with either WC or WHR.  Similar to the GWAS of overall obesity, detection of 
these variants were only possible after large-scale collaborative meta-analysis efforts due to 
the modest effect sizes of the variants identified.   
 
Findings from these GWAS have offered valuable insights into the mechanism of central 
obesity.  At five of these loci [FTO, MC4R, methionine sulfoxide reductase A (MSRA), 
transcription factor AP-2 beta (TFAP2B) and neurexin 3 (NRXN3)] associations with overall 
obesity (tables 3 and 4) has also been identified, indicating that the strong positive correlation 
between BMI and central obesity measures [107] had driven these associations.  The 
remaining 14 variants (table 1.5) however, remained robustly associated with WHR even 
after correction for BMI levels and indicate association with processes that are involved with 
body fat patterning independent of overall obesity.   
   
Unlike studies for overall obesity where several of the implicated genes were observed to be 
highly expressed in the hypothalamus or brain tissues and have possible roles in central 
control of satiety [98, 100], many loci identified to be associated with central obesity have 
putative functions in peripheral storage and distribution of adipocytes [48, 68].  Furthermore, 
GWAS for central obesity measures have also indicated considerable heterogeneity between 
males and females at several of the detected loci, with larger effects observed in females 
[110] (table 5).  These findings may help explain sex-specific variations in fat distribution 
and body composition [111].  
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Table 1.5: Details of 14 loci associated with WHR independent of overall obesity.  Index SNPs, risk allele, per risk allele increase in WHR and risk 
allele frequency derived from Heid et al., 2010 [110]. Loci ranked according to effect size. 
 
Implicated gene Position Index SNP 
Risk 
allele 
Per risk allele 
increase in WHR 
Risk allele frequency 
in Europeans (%) 
Significantly larger 
effects in females 
Reference 
RSPO3 6q22.33 rs9491696 G 0.045 52 Yes Heid et al., (2010) 
Near NFE2L3 7p15.2 rs1055144 T 0.043 21 No Heid et al., (2010) 
Near VEGFA 6p21.1 rs6905288 A 0.039 56 Yes Heid et al., (2010) 
Near GRB14 2q24.3 rs10195252 T 0.036 60 Yes Heid et al., (2010) 
TBX15-WARS2 1p12 rs984222 G 0.031 37 No Heid et al., (2010) 
NISCH-STAB1 3p21.1 rs6784615 T 0.036 94 No Heid et al., (2010) 
Near LYPLAL1 1q41 rs4846567 G 0.032 28 Yes Heid et al., (2010) 
Near ITPR2-
SSPN 
12p21.1 rs718314 G 0.030 74 Yes Heid et al., (2010) 
Near HOXC13 12q13.13 rs1443512 A 0.030 24 Yes Heid et al., (2010) 
Near LY86 6p25.1 rs1294421 G 0.028 39 No Heid et al., (2010) 
Near ADAMTS9 3p14.1 rs6795735 C 0.026 41 Yes Heid et al., (2010) 
DNM3-PIGC 1q24.3 rs1011731 G 0.026 57 No Heid et al., (2010) 
ZNRF3-
KREMEN1 
22q12.1 rs4823006 A 0.019 57 Yes Heid et al., (2010) 
CPEB4 5q35.2 rs6861681 A 0.019 34 No Heid et al., (2010) 
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1.8.4 Key findings from GWAS for body fat percentage 
 
Although BMI is a widely-used, effective correlate for determining overweight and obesity 
levels, it does not distinguish between lean-mass, bone-mass or fat-mass [48].  Furthermore, 
as indicated above, it is well documented that different populations, such as in Asians, 
percentage adiposity can be drastically different as compared to Europeans with the same 
BMI level [34-35].  Researchers have very recently begun analysing the genetic control of 
percentage body fat with the assumption that this would be a more direct measure of 
adiposity levels in the body [112]. 
 
One large-scale GWAS has been conducted for body fat percentage using a discovery dataset 
that consisted of 29,069 European and 7,557 Asian-Indian individuals [112].  In addition to 
the variants at the FTO gene locus, this study identified two new loci [near insulin receptor 
substrate 1(IRS1) and another near sprouty homolog 2 (SPRY2)].  The percentage body fat 
decreasing allele at the IRS1 locus was, perhaps ironically, also seen to correlate with a 
poorer metabolic profile.  This was however, determined to be due to the fact that the same 
IRS1 allele was associated with reduced subcutaneous fat rather than the more detrimental 
visceral fat [112].   
 
1.8.5 Key findings from GWAS of birth weight (BW) 
 
High and low birth weights (BW) are associated with metabolic defects later in life [113].  
Recent GWAS studies have identified two loci, adenylate cyclase 5 (ADCY5) and cyclin L1 
(CCNL1) associated with reduced BW in predominantly European populations [114].  
Interestingly, the ADCY5 is also known to affect blood glucose levels and risks of T2D in 
adults, providing a genetic basis for the associations between BW and adult metabolic 
defects. 
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Other genetic studies have further explored this impact of known T2D variants (identified 
from GWAS of adult population) on childhood phenotypes and have successfully detected 
associations at the CDK5 regulatory subunit associated protein 1 (CDKAL1) and 
hematopoietically expressed homeobox (HHEX) in European populations with BW as well as 
childhood obesity [115-117].  Conversely however, variants detected from adult obesity do 
not seem to be associated with BW and thus, are not expected to affect growth in utero [118].    
 
1.9 Justifications for analysis of obesity in non-European populations 
 
There is no doubt that recent GWAS has improved our knowledge on the genetic basis of 
obesity.  However, all large-scale GWAS performed to unravel novel obesity loci, have been 
primarily conducted analysing populations of European ancestry (except 2 studies [96, 98]) 
and it is unclear if these same genetic variants also cause obesity susceptibility in other ethnic 
groups.   
 
Extending findings from these initial GWAS to other ethnic groups would be key in 
corroborating initial results and would determine if the associations observed with specific 
variants are transferable across ethnic groups (suggesting that the increase in obesity levels 
worldwide are largely governed by defects in similar molecular pathways).  Furthermore, 
examining inter-ethnic differences in LD structure at risk loci in such studies could prove to 
be useful in narrowing down the causal loci in the genetic regions that have been identified 
[119]. 
 
The FTO locus has been most extensively studied in non-European populations and although, 
initial attempts at replicating these findings in non-European ethnic groups were inconsistent 
[120-121], results from this PhD project as well as in other studies [119, 122-126] were key 
in extending and corroborating the role of variants in FTO in obesity predisposition among 
populations of other ancestry, such as East-Asians, South-Asians and African ethnic groups.  
These studies have indicated that although the effect sizes of risk variants at FTO seem to be 
comparable among different populations, frequencies of risk alleles were lower than those 
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seen in European populations and thus, the contribution of variants in FTO to obesity 
predisposition would vary among different ethnic groups [79].   
 
Replication of other risk loci identified have been more limited, although evidence exists that 
common variants associated with obesity risk (first identified in Europeans) are mainly 
transferable, at least among samples of East-Asian [123, 127-128] and African [97] ancestry.   
 
The heritability of obesity measures such as BMI, WHR and WC among non-European 
populations, such as those in Asians, is similarly high [129-130].  Furthermore, the 
contribution of all obesity loci detected so far (in predominantly European studies), even in 
combination, is minute in explaining the inter-individual variation in obesity levels [99].  
This highlights that several common variants may have remained uncovered [102] and 
conducting GWAS studies in non-European subjects may help to unravel novel variants 
associated with obesity.  As highlighted by the locus near MC4R, which was observed to be 
associated with BMI in a smaller set of Asian-Indians samples [96] as compared to the study 
using subjects of European ancestry [95], it may be possible to exploit differences in allele 
frequencies between populations to enhance power to detect novel variants associated with 
obesity.  An additional example of exploiting inter-ethnic differences in allele frequency to 
detect novel loci using GWAS is seen in the potassium voltage-gated channel, KQT-like 
subfamily 1 (KCNQ1) locus with T2D [131-133], where the variant identified had similar 
effects in East-Asians and Europeans but was detected first in East-Asians due to a larger 
allele frequency. 
 
Furthermore, examples of ethnic-specific obesity gene loci exist, as seen in a recent GWAS 
in Pima Indians where RNA binding protein, fox-1 homolog (RBFOX1) was seen to be 
associated with adiposity levels [109] and in ADRB3 mutations [78] in East-Asians.  As such 
ethnic-specific variants may have been totally missed in studies conducted exclusively in 
European populations and conducting GWAS in non-European populations may help to 
unearth these genetic mutations. 
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1.10 Aims of study 
 
This study was primarily based in Singapore, a relatively small city-state that has experienced 
rapid modernisation over the past 50 years and consists of approximately five million 
residents [135].  The population of Singapore is a multi-ethnic mix of three main ethnic 
groups, namely Chinese, Malays and Asian-Indians. These ethnic populations represent the 
major portion of populations in Asia, wherein a dramatic increase in obesity and related 
metabolic health complications are expected over the next few decades [136-137].  The 
primary aims of this study were to – 1) corroborate and assess the role of novel obesity loci, 
first detected in European populations, among Asian populations and 2) unravel novel obesity 
loci among Asian populations.  
 
With prior knowledge of findings from recent GWAS for obesity conducted mainly in 
populations of European ancestry, the initial result chapter (chapter 3) of my thesis is focused 
on a hypothesis-driven approach for assessing candidate loci.  Here, I aimed: 
 
1. To conduct a thorough assessment of previously identified obesity loci, detected first 
in European GWAS scans, among Singaporean Asian populations to corroborate and 
confirm initial obesity findings. 
2. To assess transferability or relevance of associations between obesity and common 
variants identified in populations of European ancestry, in other non-European ethnic 
groups (East-Asian and South-Asians).  
3. To extend these obesity findings to a Chinese childhood dataset. 
4. To assess the role of physical activity at the FTO locus for modulation of obesity 
risks. 
5. To identify possible mechanistic roles for novel loci using pathway-based analyses. 
 
In chapter 4, I present results of an alternative approach, hypothesis-free GWAS for obesity 
among East-Asian populations.  On the principle that inter-population genetic differences, 
such as allele frequencies or ethnic-specific loci, may exist, my aims were: 
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1. To perform GWAS scans for obesity (BMI levels) associations in adult East-Asian 
populations (Chinese and Malay ethnic groups) as well as in a Chinese childhood 
cohort resident in Singapore. 
2. To identify promising SNPs for further examination and confirmation in additional 
independent East-Asian datasets. 
3. To expand these obesity GWAS studies to consortia levels, in a collaborative exercise 
with several additional groups, to assess if augmented sample size and power would 
enable detection of novel variants associated with BMI in East-Asian populations and 
provide new insights in obesity regulation. 
 
Chapter 5 of my thesis discusses extensions I have made from obesity GWAS studies 
conducted using East-Asians samples, which highlighted a strong role of insulin-related 
pathways in obesity.  The main motivations were: 
 
1. To determine obesity risks among variants previously associated with T2D, several of 
which are known to be associated with insulin secretion, using GWAS data from all 
available adult Singaporean East-Asian datasets.   
2. To confirm any significant association by further replication in additional adult East-
Asian and European datasets and to further determine any ethnic specific roles at 
detected loci.   
3. To examine recent reports of birth weight and childhood obesity association at loci, 
first detected for T2D risks in Europeans, in a Chinese childhood datasets and further 
identify if these loci act interactively to modify BMI levels at a later paediatric age. 
 
 
In Chapter 6, I have carried out a GWAS study for a related trait, serum C-reactive protein 
(CRP), which is a well-characterised marker for systemic inflammation [138], among the 
Singaporean populations. Specifically, the aims of this study were:  
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1. To unravel novel variants associated with CRP in East-Asian samples from Singapore 
and to validate and assess transferability of these known loci to East-Asians. 
2. To assess if known risk factors for cardiovascular disease, such as obesity levels, 
affect associations at CRP- associated genetic loci. 
3. To assess causality of a serum CRP associated gene variant with vascular disease.  
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2. Methodology 
 
Description of study cohorts and main methodologies used in my PhD study are discussed in 
this chapter.  Precise study-specific details are further highlighted in the appropriate results 
chapters. 
 
2.1 Study samples 
 
Various datasets were genotyped and analysed for obesity and related phenotype associations 
during the course of the study, depending on the dates they had become available.  These 
datasets have been split into: 1) those in which I was involved in the GWAS scans and/or 
analyses of genome-wide data (eight datasets) and 2) cohorts that were used for de novo 
genotyping of specific SNPs (seven datasets), as indicated in figure 2.1.   
 
Figure 2.1: 8 cohorts with GWAS data and 7 cohorts used for de novo genotyping in this project. 
Number and ethnicity of samples genotyped are indicated in brackets. Datasets of samples with 
European ancestry, BMES and NFBC1966, were used only for replication of loci discovered in Asian 
cohorts.  
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2.1.1 Datasets with genome-wide data 
 
Study methodologies and relevant traits from cohorts in which genotyping was carried out in 
a genome-wide scale are detailed below.   
 
2.1.1.1 Singapore Prospective Study Program (SP2) 
 
SP2 is a population-based, cross-sectional study of adult Singaporean Chinese, Malay and 
Asian-Indians, aged between 24 and 95 years and this study that was specifically designed to 
examine the pathogenesis of cardiovascular and metabolic diseases.  Individuals who 
participated in previous surveys, the Thyroid and Heart Study 1982–1984 [139], National 
Health Survey 1992 [140], National University of Singapore Heart Study 1993–1995 [141] or 
National Health Survey 1998 [142], were invited to participate in this larger study. 
Disproportionate stratified sampling was used to select individuals from the population with 
over sampling of the minority groups to ensure that prevalence estimates for the minority 
groups were reliable and to allow statistical comparison between ethnic groups.  5,499 
Chinese, 1,405 Malays and 1,138 Asian-Indians samples were available in this study and 
subjects provided informed consent.  Genome-wide genotyping in SP2 was only carried out 
in 3066 adult Chinese samples and detailed methodology of SP2 has been previously 
published [143]. 
 
Anthropometric measurements were performed by trained professionals at the clinics.  
Weight and height were measured in light clothing with no shoes.  BMI was calculated as 
weight (in kg) over height (in m) squared.  Waist circumference (in cm) was measured at 
midpoint between the last rib and the iliac crest and hip circumference (in cm) was measured 
at trochanter of the femur. An average of at least two systolic blood pressures (SBP) and 
diastolic blood pressures (DBP) measurements were taken and hypertension was defined as a 
history of hypertension or SBP > 140 mmHg or DBP > 90 mmHg. 
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Interviewer-administered questionnaires were used to gather demographic and socio-
economic characteristics, lifestyle factors and medical history of participants.  Age was 
defined as the age at the time of clinical examination and sex and ethnicity was recorded as 
indicated in the participant’s National Registration Identity Card (NRIC).  A combination of 
questionnaires was used to gather information on status and frequency of tobacco smoking 
and alcohol consumption as well as to estimate leisure time, transportation, occupational and 
household physical activity levels and dietary intake of food choices.  Total activity level per 
week (METhr/week) was subsequently calculated from light, moderate and vigorous physical 
activity each individual was involved in, using estimated Metabolic Equivalent Task (MET) 
hours per week.  
 
After a 10 hour overnight fast, fasting blood samples were drawn in the morning for 
measurement of serum lipids, glucose, and insulin and CRP levels.  Serum lipid and glucose 
concentrations were measured using kits from Boehringer Mannheim Systems (Mannheim, 
Germany) and read on a BM/Hitachi 747 analyser (Roche Diagnostics, Corp. Indianapolis, 
IN).  Insulin levels were measured using immunoassay (Abbott ASYM Abbott Laboratories, 
Chicago, IL).  Subjects were diagnosed to have T2D if participants presented with a history 
of diabetes mellitus or fasting glucose levels ≥7.0 mmol/l.  Serum CRP was assayed in SP2 
using a particle-enhanced immunoturbidimetric method implemented on a Roche/Integra 400 
Analyser (Roche Diagnostics, Rotkreuz, Switzerland). 
 
Intermediate traits of vascular disease, retinal micro-vascular calibre - central retinal vein 
equivalent (CRVE) and central retinal artery equivalent (CRAE) [144-145] were taken during 
eye examination and so far have been assessed in a subset of the SP2 participants (N = 
1,413).  Digital fundus photography was taken using a retinal camera (Canon CRDGi with a 
10D SLR back; Canon, Tokyo, Japan) after pupil dilation.  Two retinal images were taken, 
according to the Early Treatment for Diabetic Retinopathy Study (ETDRS) standard field 1 
and ETDRS standard field 2, cantered on the optic disc and fovea, respectively [146].  Retinal 
vascular calibre was measured with computer-assisted software (IVAN, University of 
Wisconsin, Madison, WI) according to standardized protocols [147-148].  Vessel 
measurements in each study were carried out by trained graders, masked to study subjects’ 
characteristics.  Image of the right eye was used for measurements and when this was 
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unavailable or un-gradable (due to disease or when at least 6 measurements of arterioles or 
venules could not be measured), the left eye image was examined.  All arterioles and venules 
crossing through a specified zone (0.5 – 1 disc diameter away from the optic disc margin) 
were measured and summarised as the CRAE or CRVE, respectively. 
 
2.1.1.2 Singapore Malay Eye Study (SiMES) 
 
The SiMES study is a population-based, cross-sectional study of Malay adults residing in 
Singapore, aimed to principlely quantify the risk factors for major eye diseases in the general 
adult Malay population and methodology has been previously described [143].  Age-stratified 
random sampling of all Malay adults aged 40 to 80 years residing in 15 residential districts in 
the south-western part of Singapore was performed and of the 4,168 eligible participants 
invited, 3,280 participated in the study (participation rate of 78.7%).   This region had been 
selected due to close proximity of public transport facilities with study clinics and they were 
representative of the distribution of age, house-type and socio-economic status in Singapore.  
Genome-wide genotyping was performed for 3072 adult Malay participants from SiMES. 
 
Participants were invited to clinics where they provided study consent and details on 
demographic and socio-economic characteristics and medical history were obtained.  Height 
and weight were measured and used to derive BMI, as detailed above.  Blood pressure 
measurements and definition of hypertension patients were similar to the to the SP2 study.  
CRVE and CRAE measures were obtained using the same protocol as indicated above. 
 
A 40ml non-fasting venous blood was collected for all SiMES participants.  Plasma glucose, 
serum lipids and acetylated haemoglobin (HbA1c) were measured using enzymatic methods 
implemented in the Advia 2400 Chemistry System (Siemens Medical Solutions Diagnostics, 
Deerfield, IL, USA).  T2D was defined as participants with a history of diabetes mellitus or 
HbA1c levels ≥ 6.5% in non-fasting blood samples.  Serum CRP measures were obtained 
using a similar protocol described in the SP2 study. 
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2.1.1.3 Singapore Diabetes Cohort Study (SDCS) 
 
SDCS comprises of adult Singaporean Chinese, Malay and Asian-Indian individuals with 
T2D, between the ages of 19 and 92, and has been previously published [149].  The primary 
aim of this study was to identify genetic and environmental risk factors for diabetic 
complications and to develop novel biomarkers for tracking disease progression.  Since 2004, 
participants from SDCS were recruited from primary health-care facilities in Singapore, 
namely, National Healthcare Group Polyclinics, National University Hospital Singapore and 
the Tan Tock Seng Hospital, and the study now includes over 5,000 T2D patients with a 
participation response rate of 90%.  Whole genome genotyping was performed in only adult 
Chinese T2D patients (N = 2,210). 
 
Informed consent was obtained for each patient and demographic characteristics and 
measurement of height and weight and derivation of BMI were similar as indicated above. 
 
2.1.1.4 Singapore Indian Eye Study (SINDI) 
 
SINDI is a population-based, cross-sectional study of Asian-Indian adults (N = 3,400), aged 
over 40 years, residing in the south-western part of Singapore and forms half of the Singapore 
Indian Chinese Cohort Eye Study [150].  Genome-wide scans were performed in 2,953 
participants from SINDI.   
 
BMI was determined as indicated above from measured height and weight.  CRVE, CRAE, 
SBP, DBP and definition of hypertension were similar to SP2 and SiMES.   Non-fasting 
blood was drawn from SINDI patients and HbA1c and serum lipids were measured with 
turbidimetric inhibition immono assays using the Roche-Cobas® CE analyser (Roche 
Diagnostics, Germany).  T2D patients were defined as in SiMES. 
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2.1.1.5 Singapore Chinese Eye Study (SCES) 
 
SCES is a population-based, cross-sectional study of about 3,300 Chinese subjects over 40 
years, residing in the south-western part of Singapore.  Together with the SINDI cohort, 
SCES forms the second component in the Singapore Indian Chinese Cohort Eye Study and 
details on study methodology have been previously described [150].   Genome-wide 
association scans have been performed in 1,949 adult Chinese participants from the SCES 
study. 
 
Non-fasting blood was collected in all SCES patients and derivation of BMI and 
measurements of SBP, DBP, non-fasting HbA1c and serum lipids were conducted as 
indicated for SINDI.  T2D patients and hypertensive patients were also defined similarly as in 
indicated in SiMES. 
 
2.1.1.6 Singapore Cohort study Of the Risk factors for Myopia (SCORM) 
 
SCORM [151] is a prospective study consisting of 1,979 children from grades 1-3 (age 7 to 9 
years) who were recruited from three schools in Singapore (located in the Eastern, Western 
and Northern regions).  The primary aim of SCORM was in assessing risk factors for myopia 
in children and since 1999, the SCORM children have been followed up yearly.  Data and 
samples were collected only after informed consent was given by the participants’ parents or 
guardians. 
 
Buccal and saliva DNA samples were collected from children in this cohort and genome-
wide genotyping has been conducted in 1,155 Chinese children from SCORM.  Height and 
weight were measured using standard protocols and BMI was derived in a similar fashion as 
indicated above.  BMI measures taken at the visits when the children were nine years of age 
were used in this study, to ensure maximal sample size and minimise pubertal effects of older 
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paediatric age.  Birth weight measures were obtained from subject health booklets, completed 
by qualified professionals at birth. 
 
2.1.1.7 Blue Mountain Eye Study (BMES) 
 
The BMES [152] is a population-based prospective cohort of a representative Australian 
community (aged between 49 and 97) from areas including Katoomba, Leura, Medlow Bath 
and Wentworth Falls, with an aim to study common eye diseases among older Australians.  
This area was chosen as its demography is similar to the overall Australian population of this 
age. 3,654 residents were recruited between 1992 and 1994 and follow-up evaluations were 
conducted after 5, 10 and 15 years.  
 
At each examination, detailed assessment for eye disease and other general health measures 
was conducted.  Data from the second time-point were used in this study as it represented the 
largest sample size.  BMI was derived from self-reported height and weight measures.  
Venous blood after an overnight fast was collected at the clinics and diabetic patients were 
identified as those who gave a history of diabetes mellitus or if their fasting glucose ≥ 7.0 
mmol/l at the study examinations.  In total, 2,761 BMES participants were whole-genome 
genotyped. 
 
2.1.1.8 Northern Finland Birth Cohort 1966 (NFBC1966) 
 
The NFBC1966 dataset has been described in detail previously [153].  Mothers who were due 
to give birth in 1966 in two Northern provinces of Finland (Oulu and Lapland) in 1966 were 
enrolled in the NFBC1966 cohort (N=12,058).  Primary clinical data collection on parents 
and the child occurred prenatally and at birth.  Data collection on the child continued at ages 
six months, one year, 14 years and 31 years.  This study utilised data collected from 
individuals at age 31, where 5,923 participants still living in the Helsinki area or Northern 
Finland were invited to participate in a detailed biological and medical examination. 
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Height and body weight were measured using a standardised protocols and BMI was derived 
as indicated above.  Weight was not measured for pregnant women.  Blood samples were 
drawn after overnight fasting in the morning and used to measure fasting insulin and fasting 
glucose levels.  Diabetic patients were identified as those who gave a history of diabetes 
mellitus or if their fasting glucose ≥ 7.0 mmol/l.  4,936 samples from NFBC1966 had GWAS 
data. 
 
2.1.2 Datasets used for de novo genotyping 
 
De novo genotyping procedures were carried out using the Sequenom massArray
®
 platform 
(Sequenom, San Diego, CA, USA).  Main methodologies of cohorts and relevant traits used 
in my project are indicated below. 
 
2.1.2.1 1998 Singapore National Health Survey (NHS98) 
 
The NHS98 dataset is a population-based, cross-sectional study of 4,723 Singaporean 
Chinese, Malay and Asian-Indian participants aged between 18 and 69 years. Detailed 
methodology of this survey has been previously reported [142].  This study was 
subsequently, during the course of this PhD project, combined with other cohorts to make up 
the larger SP2 study (see 2.1.1.1).   De novo genotyping was performed in 2,919 Chinese, 785 
Malay and 594 Asian-Indians from NHS98.   
 
Study participants provided informed consent and an interviewer-administered questionnaire 
was used to capture data on socio-demographic factors, smoking, and alcohol consumption.  
In this study, the level of physical activity was categorized into three groups: those who 
regularly exercised defined as participation in any form of sports for at least 20 minutes for 3 
or more days per week; those who occasionally exercised (less than 3 days per week) and 
those who did not exercise.   
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BMI, WC, WHR and blood pressure were measured for all subjects similar to SP2 study.  
Fasting blood samples were drawn after an overnight fast for measurement of serum lipids, 
glucose and insulin.  Serum lipid and glucose concentrations were measured using kits from 
Boehringer Mannheim Systems (Mannheim, Germany) and read on a BM/Hitachi 747 
analyser (Roche Diagnostics, Corp. Indianapolis, IN).  Patients with T2D and hypertension 
were defined in a similar way as in SP2. Total cholesterol, triglyceride and glucose were 
measured using enzymatic colorimetric assays.  High-density lipoprotein (HDL-C) was 
measured using a homogenous colorimetric assay while low-density lipoprotein (LDL-C) was 
measured using a homogenous turbidimetric assay.  
 
2.1.2.2 Singapore Malay Eye Study (SiMES) 
 
The SiMES study has been described above (see 2.1.1.2).  Before a GWAS was conducted in 
this study population, de novo genotyping was performed on 2,996 adult Malays from 
SiMES. 
 
2.1.2.3 Da Qing children cohort study 
 
The Da Qing children cohort study is a prospective study of 425 Chinese children from the 
city of Da Qing, China and has been described previously [154].   These children were 
recruited at the age of five and followed up yearly for five years and the main aim of this 
study was to investigate factors associated with longitudinal changes in weight during 
childhood and the development of metabolic disease risk factors.   
 
Height and weight were measured using standard protocols and used to derive BMI as 
described above.  In this study de novo genotyping was carried out in 420 Chinese children 
from Da Qing. 
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2.1.2.4 Singaporean early-onset obese study 
 
141 Singaporean Chinese and 97 Singaporean Malay unrelated early-onset severely obese 
children with inclusion criteria of percentage ideal weight for height greater than 140% and 
onset of obesity before six years of age were recruited after a nationwide assessment by the 
School Health Service.  Methodology of this study has been previously reported [155].  De 
novo genotyping of these samples were carried out together with 332 Chinese and 227 Malay 
controls drawn from cord blood stores as a case-control study. 
 
2.1.2.5 Singapore Cardiovascular Cohort Study (SCCS2) 
 
The SCCS2 is a Singaporean adult (between ages 24 and 95) population-based prospective 
study combining two previous surveys – the 1992 National Health Survey [140] and the 
National University of Singapore Heart Study (1993–1995) [141] and has been previously 
described [156].  Although the SP2 study also recruited samples from these two surveys, 
samples genotyped were not overlapping between SCCS2 and SP2.  The SCCS2 has 4,453 
participants and genotyping was carried out in a subset of these patients (583 Chinese and 
197 Malay adults), as recruitment was on-going.  
 
Height and weight were measured and derivation of BMI was performed as indicated above 
in the SP2 dataset. Fasting blood was taken from patients and used to measure serum glucose 
and lipids in a similar protocol as SP2. 
 
2.1.2.6 Singapore Prospective Study Program (SP2) 
 
The SP2 dataset has been described above (see 2.1.1.1) and de novo genotyping was 
performed in 721 adult Malay samples.  
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2.1.2.7 Multi-ethnic cohort (MEC) 
 
The MEC is a population-based prospective cohort that is part of the Singapore Consortium 
of Cohort Studies and consist of approximately 9,000 Singaporean adults between the ages 21 
and 75 years.  BMI was derived similarly as described above from measured heights and 
weights of participants.  Non-fasting blood was taken from participants for measurement of 
serum glucose and lipid.  As recruitment was on-going, only adult Malay subjects (N=1,200) 
were genotyped during this PhD study.  
 
2.2 Main study variables 
 
Details of main phenotypes from available datasets used in this study are indicated in tables 
2.1 and 2.2, below.  For obesity analyses among Asian populations, BMI as a continuous 
measure was chosen as the primary outcome variable to be studied for several reasons: 
 
1) BMI is a widely-used correlate to determine overweight and obesity levels, even 
among children [41-42]  
2) This trait was available in all datasets.   
3) To prevent loss of study power by dichotomising or categorising a continuous 
variable [although this was done in certain analyses (analyses of extremes of BMI 
distribution) and to confirm specific results]. 
 
Other study variables were analysed as secondary traits, used to adjust obesity association 
levels and for assessment in specific studies.  These are detailed in individual results chapters.  
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Table 2.1:  Relevant clinical measures from datasets with GWAS data used in this PhD study. 
 
SP2 SiMES SDCS SINDI SCES SCORM BMES NFBC1966 
Ethnicity Chinese Malay Chinese Asian-Indian Chinese Chinese Australian Finns 
N 3,066 3,072 2,210 2,953 1,949 1,155 2,761 4,936 
% Males 46.6 49.5 50.2 51.1 49.9 51.0 56.8 49.8 
Mean age (SD) 48.0 (11.25) 59.1 (11.04) 64.4 (10.21) 58.0 (10.07) 59.4 (9.52) 9 66.7 (9.03) 31 
BMI (kg/m2)  [N / Mean (SD)] 
2,431 /              
22.9 (3.39) 
2,522 /            
26.4 (5.11) 
1,992 /           
25.3 (3.87) 
2,531 /           
26.2 (5.03) 
1,861 /       
23.8 (3.52) 
1,006 /        
17.14 (2.93) 
2,110 /         
27.54 (4.93) 
4,582 /          
24.7 (4.12) 
WHR  [N / Mean (SD)] 
2,429 /               
0.8 (0.08) 
- - - - - - - 
WC (cm) [N / Mean (SD)] 
2,429 /             
81.4 (11.40) 
- - - - - - - 
BW (kg) [N / Mean (SD)] - - - - - 
956 /               
3.2 (0.43) 
- - 
LDL-C  (mmol/L) [N / Mean (SD)] 
2,431 /               
3.1 (0.83) 
2,541 /              
3.5 (1.01) 
- 
2,538 /           
3.3 (0.94) 
- - - - 
HDL-C (mmol/L)  [N / Mean (SD)] 
2,432 /                 
1.5 (0.36) 
2,541 /              
1.4 (0.33) 
- 
2,537 /           
1.1 (0.30) 
- - - - 
CRP (mg/L)  [N / Mean (SD)] 
2,198 /               
1.5 (1.62) 
2,275 /               
2.5 (1.7) 
- - - - - - 
CRVE (µm) [N /Mean (SD)] 
1,411 /           
218.9 (20.3) 
2,230 /           
219.2 (22.61) 
- 
2,390 /       
208.2 (19.93) 
- - - - 
CRAE (µm) [N / Mean (SD)] 
1,413 /           
144.8 (14.54) 
2,181 /           
141.3 (16.64) 
- 
2,390 /        
144.6 (14.46) 
- - - - 
% obese 3.8 18.9 10.6 17.1 4.8 - 24.9 8.9 
% overweight 19.6 36.8 41.1 39.4 25.8 - 44.5 31.5 
% diabetes 5.4 24.6 100 33.5 9.02 - 0.7 11.4 
% hypertension 34.7 68.5 - 78.7 - - - - 
Obesity defined as BMI ≥ 30 kg/m2 and overweight defined as 25 kg/m² ≤ BMI < 30 kg/m2.  Diabetes defined as participants with a history of T2D or fasting glucose levels ≥7.0 mmol/l in SP2, 
NFBC1966 and BMES or HbA1c levels ≥ 6.5% in non-fasting blood samples in SiMES, SINDI and SCES. Only diabetic samples recruited in SDCS dataset.  Hypertension defined as history of 
hypertension or SBP > 140mmHg or DBP > 90mmHg.   
BMI: Body-mass index, WHR: waist-hip ratio, WC: waist circumference, BW: birth weight, LDL-C: Low-density lipoprotein cholesterol, HDL-C: High-density lipoprotein cholesterol, CRP: 
C-reactive protein, CRVE: Central retinal vein equivalent, CRAE: Central retinal artery equivalent.
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Table 2.2: Relevant clinical measures from cohorts used for de novo genotyping in this PhD study. 
 
NHS98 SiMES Da Qing SCCS2 MEC SP2 Singaporean early-onset obese study 
Ethnicity Chinese Malay Indian Malay Chinese* Chinese Malay Malay Malay Chinese Malay 
N 2,919 785 594 2,996 420 582 197 1,200 721 141 cases / 332 controls 97 cases / 227 controls 
% Males 45.6 47.9 47.8 48.1 49.8 50.1 53.3 36.3 45.5 
65.9 in cases / 50.6 in 
controls 
61.9 in cases / 54.6 in 
controls 
Age (years) 
37.9    
(12.23) 
38.9 
(12.48) 
40.6 
(11.87) 
58.6 
(11.03) 8 
57.8 
(10.62) 
55.4 
(11.14) 
44.7 
(13.52) 
46.9 
(11.87) - - 
BMI (kg/m2) 
22.7      
(3.71) 
25.5    
(4.96) 
25.1 
(4.60) 
26.3 
(5.11) 
16.2 
(2.88) 
23.4 
(3.52) 
26.7 
(4.76) 
26.7 
(5.28) 
25.9 
(4.86) - - 
WHR 
0.8        
(0.07) 
0.8     
(0.07) 
0.9 
(0.07) - - - - - - - - 
WC (cm) 
78.1      
(10.6) 
82.6    
(11.9) 
85.1 
(11.5) - - - - - - - - 
HDL-C (mmol/L) 
1.4        
(0.37) 
1.3     
(0.33) 
1.1 
(0.30) 
1.4 
(0.33) - - - - - - - 
LDL-C (mmol/L) 
3.4        
(0.95) 
3.9      
(1.08) 
3.7 
(1.03) 
3.5 
(1.00) - - - - - - - 
% obese 3.9 16.6 13.5 18.7 - 4.7 19.7 23.2 19.3 - - 
% overweight 20.1 33.3 28.4 36.5 - 25.6 40.7 35.8 34.6 - - 
% hypertension  18.6 25.9 20.2 68.5 - 41.5 53.5 34.5 38.4 - - 
% diabetes 7.7 14.1 19.2 23.6 - 9.8 20.1 13.4 13.8 - - 
Data are mean (SD). * Chinese children from China. 
Obesity defined as BMI ≥ 30 kg/m2 and overweight defined as 25 kg/m² ≤ BMI < 30 kg/m2. Diabetes defined as participants with a history of T2D or fasting glucose levels ≥7.0 mmol/l in 
NHS98, SCCS2 and SP2 or HbA1c levels ≥ 6.5% in non-fasting blood samples in SiMES and MEC. Hypertension defined as history of hypertension or SBP > 140mmHg or DBP > 90mmHg.   
BMI: Body-mass index, WHR: waist-hip ratio, WC: waist circumference, LDL-C: Low-density lipoprotein cholesterol, HDL-C: High-density lipoprotein cholesterol. 
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2.3 De novo genotyping methodology 
 
De novo genotyping was conducted using the Sequenom MassARRAY
®
 platform 
(Sequenom, San Diego, CA, USA), which allows pools of SNPs (approximately 30 SNP 
assays each time) to be assayed together.   
 
A flow chart on de novo genotyping using the Sequenom platform that I had adopted during 
the PhD study is provided in figure 2.2.  DNA preparation and genotyping procedures were 
conducted together with colleagues of the Human Genetics genotyping team at the Genome 
Institute of Singapore (GIS).    
 
Figure 2.2: Sequenom genotyping procedures conducted before statistical analysis. WGA: whole-
genome amplification, HWE: Hardy-Weinberg equilibrium. 
 
 
Before actual genotyping, SNPs were selected and designed into multiplex assays using the 
MassARRAY
®
 designer software and DNA of samples from available cohorts were prepared 
and adjusted to between 5 ng/µl and 15 ng/µl.  Quantification and quality of DNA was 
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assessed through ratio of the absorbance at 260nm and 280nm (A260/280) in a NanoDrop 
spectrophotometer, pico-green serial dilution assays and by assessing DNA bands in agarose 
gel.   
 
In one dataset, the Da Qing children cohort, DNA concentrations and volume were observed 
to be low and inadequate for genotyping and therefore, whole-genome amplification (WGA) 
of DNA was carried out using illustra™ GenomiPhi™ V2 DNA amplification kits.  This 
involved an initial digesting step, followed by amplification (Phi29 DNA polymerase) to 
produce approximately 4 µg of DNA (> 10 kb product length) for each sample.  DNA 
samples were subsequently adjusted to suitable concentrations for Sequenom genotyping 
(between 5 ng/µl and 15 ng/µl).   
 
Adjusted samples of DNA were then brought forward for genotyping using the Sequenom 
MassARRAY
®
 platform.  In brief, this involved amplification of the region containing the 
SNP of interest using polymerase chain reaction (PCR).  Next, SNP-specific primers, which 
anneal next to the polymorphic site of interest, were added to the PCR product together with 
the MassEXTEND
®
 mix (Sequenom Inc) to allow extension of the primers.  Subsequently, 
mass-assisted laser desorption ionization time of flight mass spectrometry was used for allelic 
discrimination of the extended primers.   
 
Several quality control (QC) measures were performed to ensure high quality of genotyped 
data.  Firstly, genotype cluster plots of every SNP genotyped using Sequenom was analysed 
to ensure appropriate clustering.  SNPs with low call-rates (< 90%) or significant departures 
(p-value < 0.05) from Hardy-Weinberg equilibrium (HWE) were excluded from further 
analyses as these may indicate inefficient assays and misclassification of genotypes, 
respectively.  Low call rates were confirmed among negative controls (water samples plated 
out together with sample DNA in assay plates) and high concordance in call rates and 
genotype counts were sought among duplicate samples.  Breakdown on genotyping efficiency 
of SNPs are detailed in appropriate results chapters. 
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2.4 GWAS genotyping methodology 
 
Genome-wide genotyping of all Singaporean Asian datasets (SP2, SiMES, SDCS, SINDI and 
SCES) were carried out at the GIS with assistance from the Human Genetics genotyping 
team.  I had prepared and adjusted DNA samples for the BMES and genotyping was carried 
out by the Welcome Trust Case-Control Consortium (WTCCC) while the NFBC1966 dataset 
was genotyped by the North-Finnish Birth Cohort group (NFBC).   
 
All genome-wide scans were performed using various Illumina
®
 SNP-arrays (Illumina Inc., 
San Diego, CA, USA) and the Infinium
®
 assay.  A total of 1,155 Chinese children from 
SCORM were genotyped using the Illumina Hap550 (N=418) and Hap550Duo arrays 
(N=737).  3,066 Chinese adults from SP2 were genotyped using the Illumina 1Mduo 
(N=1,016), HumanHap 610Quad (N=1,467) and Hap550 arrays (N=583). Chinese adult 
diabetic patients from SDCS were genotyped using the Illumina 1Mduov3 (N=1,015) and 
HumanHap 610Quad arrays (N=1,195).   All SCES Chinese samples (N=1,949, SiMES 
Malay adults (N=3,072) and SINDI Asian-Indian samples (N=2,953) were genotyped using 
HumanHap 610Quad arrays.  2,761 BMES samples were genotyped using the Illumina 
Human 670Quad array and a total of 4,936 NFBC1966 samples were genotyped using the 
Illumina 370Duo array.  When more than one SNP-array was used for genotyping, duplicate 
samples were genotyped to assess quality of genotyping. 
 
Figure 2.3 indicates main procedures that were undertaken during GWAS genotyping.   DNA 
of samples from datasets were quantified and adjusted to between 30 ng/µl and 80 ng/µl, in a 
similar manner as indicated above.  Subsequently, samples of DNA were brought through the 
Illumina
®
 whole-genome genotyping work-flow.  Briefly, this involves a whole-genome 
amplification step, after which fragmented and amplified DNA were hybridised to bead-chips 
lined with 50-mer complementary probes.  Subsequently an enzymatic single-base extension 
of labelled bases was carried out for allelic discrimination. 
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Figure 2.3:  Schematic of GWAS methodology adopted and key processes. WGA: whole-genome amplification, QC: quality control, HWE: Hardy-Weinberg 
equilibrium. 
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2.4.1 Quality control (QC) procedures after genome-wide genotyping 
 
Extensive QC measures were carried out to ensure SNPs and samples with poorly performing 
assays were removed before statistical analysis.  Detailed breakdown on SNP and sample QC 
filters for each study are indicated in table 2.3 and table 2.4, respectively. 
 
QC for the GWAS datasets of European ancestry populations, BMES and NFBC1966, were 
carried out by BMES/WTCCC groups and NFBC, respectively.  Subsequent sample and SNP 
exclusions and adjustments during statistical analyses for these European datasets were 
performed as recommended by these groups (Tables 7 and 8).  QC procedures for the 
Singaporean Asian GWAS datasets (SCORM, SP2, SDCS, SiMES, SINDI and SCES) were 
carried out in Singapore together with colleagues from the Centre for Molecular 
Epidemiology, National University of Singapore (CME/NUS), Singapore Eye Research 
Institute (SERI) and GIS.   
 
QC measures for the Singaporean datasets were conducted similarly and performed in a chip-
wise manner, where data from each SNP-chip was assessed separately when more than one 
SNP-chip was used in the study (except for SCORM, where I had previously combined 
genotyped data from the Illumina Hap550 and Hap550duo chips).  I had performed these 
procedures for SCORM using PLINK (version 1.02) [157].  Similar R scripts were utilised 
for these procedures, developed by colleagues at CME/NUS and GIS, to standardise QC 
methodology for GWAS data from cohorts that were genotyped subsequently. 
 
For QC of genotyped SNPs from GWAS, sex-linked and mitochondrial SNPs were removed 
before analyses, together with CNV detection probes in the SNP arrays.  Remaining 
autosomal SNPs were QCed based on extremes in HWE (p-value < 10
-4
), which could 
indicate sample contaminations.  SNPs that were monomorphic or rare (MAF < 1%) were 
also excluded as GWAS were not powered to detect associations at low frequency SNPs and 
SNPs with low call-rates (< 95%) were also excluded as these may indicate poor SNP assays.  
In datasets where more than one chip was used for genotyping, Mantel-extension tests were
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carried out to test for differences in allele frequencies [158].  Quantile-quantile (QQ) plots of 
the test statistics were then analysed to detect SNPs that gave highly discrepant genotype 
calls and were removed.  SNPs were re-coded in the forward strand on NCBI build36 in all 
datasets to enable efficient comparisons in subsequent analyses.   
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Table2.3: Detailed SNP QC thresholds utilised for GWAS datasets. 
 SP2 SiMES SDCS SINDI SCES SCORM BMES NFBC1966 
Illumina SNP chip 1M Duo 610 Quad 550 610 Quad 1M Duo 610 Quad 610 Quad 610 Quad 550
*
 670 Quad 370 Duo 
No. of genotyped only SNPs 1,185,068 620,881 561,466 620,881 1,185,068 620,881 620,881 538,429 561,466 594,224 339,629 
No. of imputed only SNPs 1,231,463 1,795,716 1,855,129 1,313,443 1,231,463 1,795,716 1,348,697 1,926,240 1,917,800 4,116,699 2,225,712 
Total Imputed and genotyped 
SNPS 
2,416,531 2,416,597 2,416,595 1,934,324 2,416,531 2,416,597 1,969,578 2,464,669 2,479,266 4,710,923 2,565,341 
SNPs with allelic 
discrepancies 
62 - 69 - - 45 - - 
SNPs with positional 
discrepancies between 
observed data and HapMap 
reference panels 
79 13 15 13 79 13 - 12 15 - - 
SNPs with MAF < 1% 153,908 189,571 197,610 49,165 155,612 190,799 27,882 265,554 189,643 560,518 212,008 
SNPs with call-rate < 95% 225,135 392,044 404,878 424,293 226,643 395,613 502,323 424,924 402,499 1439,825 616,914 
HWE outliers (p-value < 10
-4
) 761 1,668 275 4,481 825 1,593 5,868 648 432 25,249 16,190 
SNPs with poor imputation 
information score < 0.5 
4 6 81 1 4 5 0 5 4 1 10 
No. of SNPs that pass QC 
filters 
2,071,812 1,834,625 1,810,065 1,560,745 2,069,054 1,829,742 1,527,744 1,773,537 1,816,934 2,685,330 1,720,219 
λ† 1.008 1.018 1.002 1.046 1.002 1.007 1.022 1.016 1.022 1.052 1.032 
* Data from 550 and 550 duo SNP chips.  † Genomic inflation factor after BMI Z-score analysis.
52 
 
Table 2.4: Detailed sample QC thresholds utilised for GWAS datasets.  Sample QC of SP2 and SDCS were done together as these datasets were part of an 
original T2D GWAS study.  QC of BMES and NFBC1966 not performed in Singapore. 
 SP2 and SDCS SiMES SINDI SCES SCORM BMES NFBC1966 
Illumina SNP-Chip 
1M Duo 610 Quad 550 610 Quad 610 Quad 610 Quad 550* 670 Quad 370 Duo 
Ethnicity 
Chinese Malay Asian-Indian Chinese Chinese Australian Finn 
Total samples genotyped 2,031 2,662 583 3,072 2,953 1,949 1,155 2,761 4,936 
Extreme heterozygous samples and/or 
samples with low call-rate
†
 
32 17 0 37 34 11 39 91 0 
Related samples and/or 
duplicates/contaminations 
58 229 13 279 326 41 56 195 58 
Discordant ethnic membership
‡
 20 26 7 170 39 6 13 125 0 
Gender discrepancies 31 24 1 44 16 2 28 23 15 
Other filters
¥
  - - - - - - - 28 14 
Remaining samples 1,890 2,366 562 2,542 2,538 1,889 1,019 2,299 4,849 
Samples with BMI information 1,868 2,220 335 2,522 2,531 1,866 1,006 2,114 4,594 
* Data from 550 and 550 duo SNP chips.  † Low call-rate defined as < 95% call-rate and extreme heterozygosity defined as < 0.25 or > 0.35.  ‡ Discordant ethnic membership detected from 
Eigenstrat PCA program only in the SCORM dataset and by analyzing PCA plots in all other datasets.  ¥ 14 samples from NFBC1966 withdrew consent, 26 samples excluded from BMES due to 
poor concordance rate with de novo genotyping results from 30 selected SNPs and 2 other samples from BMES removed as they were considered as extreme XY intensity outliers. 
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Sample QC procedures for Chinese adults in SP2 and SDCS were carried out together as 
these were part of an original T2D case-control study, while sample QC in all other datasets 
were performed individually.  In these two studies where more than one SNP-chip was used, 
concordance rates of overlapping samples were high (> 95%) (figure 2.4).   
 
Figure 2.4: Concordance levels of duplicate samples genotyped in 550, 610 and 1M chips in the SP2 
and SDCS studies. 
  
 
 
In all datasets, samples were excluded based on sample call-rates (< 95%) and extreme 
heterozygosities (< 0.25 or > 0.35), which could indicate sample contaminations and 
inaccurate genotype calls (table 2.4).  Estimated identity-by-descent measures were 
calculated by pair-wise comparison of sample genotypes to detect cryptic relatedness such as 
monozygotic twins and first-degree relatives (full-sibling pairs and parent-offspring pairs) 
(table 2.4).  One sample from each of these relationships was excluded from further analysis 
and where duplicate samples had been genotyped in different SNP-arrays, samples from the 
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denser array was retained.  Samples with gender discrepancies between genetically-inferred 
gender from genotype data and clinical reported gender were also excluded. 
 
Population structure ascertainment to prevent confounding of study results, was done using 
principle component analysis (PCA) [159] with and analysing plots with four reference 
panels from International HapMap [83] and Singaporean Chinese, Malay and Asian-Indian 
reference samples from the Singapore Genome Variation Project (SGVP)  [160].  Outliers 
with discordant ethnic membership from reported ethnicities and possible admixed samples 
were subsequently detected and removed.  In the SCORM dataset, the Eigenstrat PCA 
program [159] with a threshold set at eight standard deviations was used to remove samples 
that were possible outliers.   
 
We observed that the SiMES Malays and Asian-Indian samples from SINDI did not cluster 
tightly even after exclusion of outliers in the populations and that Malays and Chinese 
samples often clustered very closely with each other [figure 2.5 and 2.6, details of PCA 
analyses for all Singaporean GWAS datasets (SCORM, SP2, SDCS and SCES) with SGVP 
and HapMap reference panels are provided in the Appendix I].  It was therefore decided that 
further adjustments during statistical analyses were required to adjust for population 
stratification in these datasets (first 2 principle components for SiMES and first 3 principle 
components in SINDI). 
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Figure 2.5: Plots of the first three principle components to identify the admixed samples or samples 
with miss-specified ethnic memberships in the SiMES dataset (black dots) with Singapore Genome 
Variation Project (SGVP) reference panels of Chinese (CHS, red dots), Malay (MAS, green dots) and 
Indians (INS, blue dots).  Identified outliers from reported ethnicity indicated by pink dots. A) PC1 vs 
PC2. B) PC1 vs PC3. 
 
 
 
 
 
 
A) 
B) 
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Figure 2.6: Plots of the first three principle components to identify the admixed samples or samples 
with miss-specified ethnic memberships in the SINDI dataset (black dots) with Singapore Genome 
Variation Project reference panels of Chinese (CHS, red dots), Malay (MAS, green dots) and Indians 
(INS, blue dots). Identified outliers from reported ethnicity indicated by pink dots. A) PC1 vs PC2. B) 
PC1 vs PC3. 
 
 
 
 
A) 
B) 
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2.4.2 Imputation procedures after GWAS genotyping 
 
Since different genotyping platforms were used in the genome-wide scans, imputation for 
additional autosomal SNPs was carried out to increase coverage and to facilitate subsequent 
combination of data.  Imputation procedures for all Singaporean GWAS datasets (SP2, 
SDCS, SiMES, SINDI, SCES and SCORM) were carried out using the IMPUTE program 
(version 0.2.1) [161].  Imputed genotype calls were based on HapMap Phase 1 and 2 East-
Asian samples (CHB and JPT) of NCBI build 36 and dbSNP 126 for all Chinese samples 
(SP2, SDCS, SCES and SCORM).  As no specific reference panels were available for the 
Malay (SiMES) and Asian-Indian (SINDI) datasets, all HapMap samples (CEU, YRI and 
JPT+CHB) on NCBI build 36, release 22 dbSNP 126 were used as reference for imputation, 
to better capture local patterns of haplotype variations [162-163].  A posterior probability of 
at least 0.90 and a call-rate of at least 95% were required for all imputed SNPs (Table 2.3).  
SNPs were also checked for any allelic and positional discrepancies with data from HapMap 
(Table 2.3).  These procedures were performed by a colleague at the NUS/CME to 
standardise data from all Singaporean GWAS datasets.   
 
Imputation for the NFBC1966 dataset was performed using the HapMap European panel 
(CEU) as reference and in the BMES dataset, the European (CEU) reference panel from the 
1,000 Genomes Project NCBI build 36 was used for imputation and these were conducted 
independently by the NFBC and BMES/WTCCC groups, respectively.  
 
Before statistical analyses of datasets, I had replaced actual genotyped information for SNPs 
(when both imputed calls and actual genotype information was available) into files and re-
coded all genotypes to the forward strand. 
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2.5 Statistical analysis 
 
All skewed study variables were normalised prior to analyses, either by logarithmic or 
inverse normal transformations in all study populations and used as the dependent variable in 
the analyses.  These transformations were performed in STATA (version 8.2).   
 
Association tests conducted for single SNP analyses were performed in STATA (version 8.2) 
in an additive genetic model.  For quantitative measures, linear regression analyses were 
performed to study the associations between individual SNPs with traits of interest and 
logistic regression was used to examine the association between SNPs and categorical 
outcomes.  Heterogeneity in results between sexes was determined before (methods for 
heterogeneity discussed below) decisions were made to perform association analyses with 
males and females combined.  All analyses were conducted stratified for ethnicity and further 
adjustments were made for additional covariates (which was dependent on outcome variable 
analysed) such as age, sex, smoking status, alcohol consumption, physical activity levels, 
lipid levels, T2D status, hypertension status, and BMI or obesity status (when SNP 
associations with outcome variables that were independent of obesity status were sought).  
Adjustments of relevant covariates during analyses are detailed precisely in appropriate 
results chapters.   
 
2.5.1 Statistical analysis in GWAS 
 
SNP-based trend tests for Z-scores of quantitative trait (e.g. Z-BMI, Z-WHR and Z-WC) in 
individual genome-wide studies were carried out in a chip-wise manner, where data was 
analysed separately for each SNP-chip when more than one SNP-chip was used in a study. 
All association tests were carried out using the genome association toolset, SNPTEST 
(version 1.1.5) [161] in an additive genetic model, with appropriate adjustments made for 
sex, age (or age
2
 to account for non-linear relationship of BMI in later age), population 
stratification and BMI (when associations independent of overall obesity levels were sought).  
For analyses of imputed SNPs, the –proper option was included in SNPTEST to account for 
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uncertainties in the imputation calls and only SNPs with imputation information scores that 
were at least 0.5 were accepted.  For individual SNPs, the association for each genotype was 
quantified by the regression slope (β), the standard error of β (se) and the association p-value 
for the outcome variable. Data from chip-wise analyses of datasets which were genotyped on 
more than one SNP-chip (SP2 and SDCS) were subsequently meta-analysed (detailed below, 
section 2.5.2). 
 
Genomic inflation factors (λ) [164] were calculated after analyses, as the median of observed 
χ2 statistics divided by the median of the central χ2 distribution with 1 degree of freedom 
(0.456).  A genomic correction was further applied to association results from each chip, to 
control for possible residual inflations.  Similar procedures using logistic regression were 
adopted when GWAS were conducted for categorical outcomes.  Inflation factors in the 
Singaporean datasets were observed to be low (1.002 – 1.046, table 2.3), indicating that most 
poorly performing samples and SNPs had been excluded effectively during QC procedures. 
 
2.5.2 Meta-analysis procedures 
 
To increase sample size and power of study to detect associations, summary statistics of SNP 
associations from individual studies (study-specific β and se) were pooled together in meta-
analyses procedures.  Similarly, in GWAS studies, all overlapping SNPs were pooled in 
global meta-analyses.  These procedures were carried out using the meta package in STATA 
(version 8.2) using the general inverse variance-weighted method to derive overall pooled 
estimates and two-sided p-values, where the pooled effect estimate was defined as the sum of 
inverse variance-weighted betas of all studies divided by the sum of inverse-variance weights 
of all studies, [ ∑(w x β) / ∑w, (w = study-specific inverse-variance weight and β = effect 
estimate of each study)].   Forest plots were subsequently inspected to visualise and compare 
effect estimates from meta-analysis and individual study data. 
 
In global meta-analyses of GWAS results, studies were pooled assuming a fixed-effect model 
as the principle aim was in locus discovery and not in precise estimation of effect sizes.  In 
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meta-analysis of specific loci or SNPs however, meta-analyses were also carried out using a 
random-effects model when between-study heterogeneity measures (detailed below) were 
observed to be large.  
 
2.5.3 Heterogeneity measures 
 
Heterogeneity measures, Cochran’s Q and I2 were calculated using the meta and heterogi 
packages in STATA (version 8.2) to assess between-study heterogeneity of data being 
combined.  I had defined significant between-study heterogeneity as a Cochran’s Qp-value < 0.1 
[165] or I
2
 greater than 40% [166].   
 
2.5.4 Defining levels of significance 
 
In the GWAS studies, a significant association was defined as a p-value of less than 5 x 10
-8
 
(genome-wide significance level).  However, when bringing forward promisingly-associated 
SNPs from the discovery stage for further follow-up in the replication stage,  a less stringent 
p-value cut-offs (p-value ≤ 10-5) was adopted as it was observed that the studies, individually 
or in combination, were often underpowered. 
 
During candidate loci studies in which replication of well-established loci were sought among 
the Singaporean Asian population, a less stringent p-value cut-off of < 0.05 was used to 
define significant associations.  In these analyses, consistency of beta directions (from studies 
in which variant was detected) was ensured and association levels were adjusted using 
Bonferonni corrections, dependent on the number of independent tests that had been 
performed.  Binomial tests were used to assess for an over-representation of significant 
signals in the study (compared to the expected at α = 0.05) and for over-representation of 
directional consistency (compared to the expected at α = 0.5). 
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2.5.4 Conditional probability analysis 
 
Conditional probability analysis was performed after initial GWAS to identify any region-
specific signals that were independent of previously identified index variants.  These analyses 
were performed by repeating GWAS association steps in SNPTEST (version 1.1.5), with 
additional adjustments made for the genotypes of index SNPs at the region.  Regional plots of 
association signals were assessed before and after conditional probability analysis to identify 
any SNPs with independent associations.  Regional diagrams were plotted using Locus Zoom 
[167], 
 
2.5.5 Combined gene-risk score analysis (GRS) 
 
GRS analyses were conducted, to assess the combined contribution of selected SNPs on 
outcome variables, specifically BMI and CRP measures, among the Singaporean Asian 
populations.  To account for the differing effect sizes of these variants, the GRS was 
weighted by SNP-specific betas obtained from initial GWAS analyses.  The GRS was 
subsequently divided by the mean effect size to rescale the score to the possible range of total 
combined risk alleles for an individual. 
 
The dependent variable of interest was regressed on the GRS and the variance explained was 
identified as the difference in r
2
 with and without inclusion of the GRS in regression models.  
These analyses were performed using STATA (version 8.2). 
 
2.5.6 Interaction analysis 
 
Interaction analyses were performed to test if effects of genetic variants may not only act 
additively, but interactively with specific factors.  Genome-wide interaction analysis was 
done in one study to assess if BMI levels could modulate SNP associations with serum CRP.  
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These analyses were performed using PLINK (version 1.02) [157] with the inclusion of the –
GxE function and BMI used as a continuous variable, using only actually genotyped SNPs. 
 
In candidate loci studies, interactions at specific loci were assessed to test the hypothesis that: 
 
1) Exercise levels [categorized into three groups in the NHS98 cohort- those who 
regularly exercised defined as participation in any form of sports for at least 20 
minutes for 3 or more days per week, those who occasionally exercised (less than 3 
days per week) and those who did not exercise] can modulate obesity effects of FTO 
variants. 
2) BW status [categorized according to percentile BW in SCORM - low BW (<10th 
percentile), high BW (>90th percentile) and average BW (between 10th and 90th 
percentile)] could interact with HHEX variation to modulate BMI at a later paediatric 
age.  
3) BMI, blood glucose or age (linear variables in SP2 and SiMES) could modify effects 
of CRP-associated variants. 
 
The likelihood ratio test in STATA (version 8.2) was used to test for significant interaction at 
these specific genetic loci, by comparing regression models with and without the cross-
product interaction variable.  For interaction analyses with categorical outcomes, dummy 
variables were created during regressions using the xi function in STATA (version 8.2). 
 
2.6 Power calculations 
 
Quanto power calculator [168] was used to estimate power in the study to detect associations 
of specific loci among the Singaporean datasets using observed allele frequencies in 
Singaporean populations and effect estimates from studies in which these loci were originally 
discovered.  Estimated sample sizes in the Singaporean datasets needed for an 80% power for 
detecting these associations were also calculated. 
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2.7 Pathway-based analysis 
 
Ingenuity Pathway Analysis (IPA) (version 8.7) was used to detect for any involvement of 
known canonical pathways among implicated genes at loci that were significantly associated 
with outcome variables.  Significant pathways were only determined after a Benjamini-
Horchberg correction for multiple tests, implanted in IPA.  
 
2.8 Linkage Disequilibrium (LD) calculations 
 
Calculation of LD and visualization of LD plots between specific SNPs among the 
Singaporean datasets were carried out using Haploview [169]. 
 
Quantification of inter-population differences in LD patterns were also calculated using the 
varLD program [170] using reference samples from HapMap [83] and SGVP [160].  This 
program tests the null hypothesis that the regional pattern of correlation between SNP pairs is 
identical across any two populations.  Raw varLD scores were subsequently normalized to 
standard scores using population specific means and standard deviations. 
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3. Replication of known obesity loci in Singaporean Asian populations 
 
3A.1 Introduction 
 
When this PhD project was initialised, common variants at intron 1 of the FTO gene had 
recently been identified to predispose to obesity risks [91-94] in populations of European 
ancestry.  However, these variants had shown no associations in non-European ethnic groups 
such as Polynesians [120] and African Americans [92].  An initial study in Asians (Chinese 
Hans) [121] had further suggested that common FTO variants do not affect BMI or alter the 
risk of obesity.  A lower frequency of the variant alleles, first found to be associated in 
European populations, and potential differences in local linkage disequilibrium (LD) 
structure had been cited to explain these discrepancies [121].  It was therefore important to 
substantiate these novel findings with attempted replications and to characterise the 
contribution (if any) of common variants in this gene to obesity in Asia.  
 
The initial phase of this results chapter (chapter 3A) details findings from hypothesis-driven 
candidate loci analysis of FTO variants among Singaporean Asians.  10 common SNPs 
(rs9939609, rs8050136, rs1421085, rs17817449, rs7193144, rs1121980, rs9940128, 
rs9939973, rs9926289 and rs9930506) at intron 1 of the FTO gene, first discovered from 
European GWAS studies [91-94], were selected for de novo genotyping using Sequenom
®
 in 
two Singaporean populations that were available during the initial stage of my project – 
NHS98 (consisting of 2919 Chinese, 785 Malays and 594 Asian-Indian samples) and SiMES 
(consisting of 2996 Malays).  I had primarily aimed to: 
 
1. Investigate the contribution of common FTO variants to obesity-related traits [BMI, 
waist circumference (WC) and waist-hip ratio (WHR)] and type 2 diabetes (T2D) in 
Singaporean Chinese, Malay and Asian-Indian populations.  
2. As recent studies have suggested that exercise may attenuate the obesity effects of 
FTO [171], I examined for interaction between FTO and physical activity levels from 
data available from the NHS98 Chinese population (N = 2,279). 
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3. Examine for possible differences in LD between common SNPs at the FTO locus 
between Europeans, East-Asians (Chinese and Malays) and South-Asians (Asian-
Indians). 
 
 
3A.2 Sequenom genotyping results of FTO SNPs in NHS98 and SiMES 
Out of the 10 common FTO SNPs selected for genotyping, one SNP (rs9930506) failed assay 
design and was excluded.  Minor allele frequencies (MAF) (also the risk alleles, as determined 
from initial European studies) for the nine genotyped SNPs, tests for HWE deviation and 
genotyping call-rates are listed in table 3A.1.  The minor allele frequencies (MAFs) for all 
nine SNPs were higher in Asian-Indians (0.33-0.43) than in Malays (0.28-0.33) or Chinese 
(0.12-0.18).  None of the SNPs showed significant deviation from HWE. 
 
 
3A.3 Assessment of linkage disequilibrium (LD) at the FTO locus 
 
Figure 3A.1 below illustrates high degree of LD (r
2
) observed between the FTO SNPs, with 
similar patterns in all three Singaporean Asian ethnic groups; Singaporean Chinese (r
2 
= 0.60-
0.99 in NHS98), Malay (r
2 
= 0.77-0.99 in NHS98 and r
2 
= 0.80-0.99 in SiMES) and Asian-
Indian (r
2 
= 0.64-0.99 in NHS98) samples.  Furthermore, the LD (r
2
) structure of common 
SNPs at this region in Europeans (HapMap CEU panel, r
2 
= 0.83-0.96) (figure 3A.2) was 
highly similar to that in the Singaporean populations.   
66 
 
Table 3A.1: Details of Hardy-Weinberg (HWE) tests, minor allele frequency and genotyping rates for FTO SNPs assessed in the study. 
SNP 
NHS98 SiMES 
HWE p-value MAF 
Call-rate (%) 
HWE p-value MAF 
Call-rate (%) 
Chinese Malay Asian Indians Chinese Malay Asian Indians Malay 
rs9939973 0.572 0.826 0.128 0.175 0.314 0.426 97.9 0.882 0.32
6 
99.7 
rs9940128 0.527 0.785 0.121 0.175 0.315 0.425 98.1 0.882 0.32
6 
99.5 
rs1421085 0.653 0.303 0.270 0.123 0.278 0.345 97.5 0.962 0.29
4 
99.5 
rs1121980 0.328 0.443 0.044 0.168 0.311 0.421 98.9 0.951 0.32
7 
99.2 
rs7193144 0.525 0.709 0.204 0.121 0.291 0.337 97.6 0.634 0.30
5 
99.5 
rs17817449 0.648 0.786 0.362 0.119 0.283 0.335 96.0 0.990 0.29
6 
99.4 
rs8050136 0.718 0.868 0.283 0.119 0.282 0.332 97.7 0.990 0.29
5 
99.6 
rs9926289 0.625 0.893 0.275 0.12 0.284 0.335 97.9 0.999 0.29
6 
99.5 
rs9939609 0.652 0.586 0.2324 0.118 0.282 0.333 97.7 0.780 0.29
5 
99.7 
HWE: Hardy-Weinberg equilibrium, MAF: minor allele frequency.  
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Figure 3A.1: Linkage disequilibrium (r
2
) between the nine FTO SNPs in the NHS98 and SiMES populations. 
 
 
 
Figure 3A.2: Linkage disequilibrium (r
2
) between 8 out of the 9 FTO SNPs genotyped (based on CEU population from HapMap. No data was available on 
rs9926289 on NCBI Build36). 
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3A.4 Association results of FTO SNPs with obesity and diabetes in NHS98 and SiMES 
 
Table 3A.2 shows associations between the nine FTO SNPs with BMI and T2D in NHS98 
and SiMES.  BMI values were normalised by natural log transformation during analyses and 
back transformed in tables.   No heterogeneity due to sex was observed (p-value > 0.1) and 
data from analyses with both sexes combined are presented.  Assessments for associations 
with BMI and T2D were initially performed correcting for age and sex and subsequently, 
association levels were further assessed with additional adjustments for smoking status, 
alcohol consumption, education status, physical activity levels and BMI (during T2D 
analysis).  Corrections for multiple tests during statistical analyses were not performed as 
these SNPs showed strong LD in all the Singaporean populations (figure 3A.1) and thus, 
represent one test. 
 
As this was the initial study I was involved in during my project, several of these statistical 
analyses (associations with T2D and secondary traits, including central obesity measures, 
lipids and blood pressure and interaction analyses) were performed together with a colleague 
(Jonathan Tan) from the National University of Singapore, Centre for Molecular 
Epidemiology (NUS/CME). 
 
All nine FTO SNPs showed BMI associations with an effect size, per risk allele, of 0.42 - 
0.68 kg/m
2
 (p-value < 0.0001) in NHS98 Chinese, 0.65 - 0.91 kg/m
2
 (p-value < 0.02) in 
NHS98 Malays, and 0.52 - 0.64 kg/m
2
 (p-value < 0.0001) among SiMES Malays.  These 
effect sizes were comparable to that observed in European populations (approximately 
0.40kg/m
2 
[91]).  No statistically significant associations were observed among Asian-Indians 
from NHS98.  Meta-analysis (fixed-effects) of BMI association between the index FTO SNP 
[91], rs9939609, in all four populations in this study however, showed no significant 
heterogeneity (Cochran’s Qp-value < 0.1) and had a pooled effect size of 0.62 kg/m
2
 change in 
BMI (p-value = 2 x 10
-12
).  
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FTO variants were also associated with an increased risk of T2D in the NHS98 Chinese (OR: 
1.32 - 1.42, p-value ≤ 0.049), NHS98 Malays (OR: 1.52 - 1.63, p-value ≤ 0.028) and SiMES 
Malays (OR: 1.20 - 1.24, p-value ≤ 0.007).  However, these associations were abolished after 
adjustment for BMI, except in the SiMES Malays (OR: 1.17 - 1.22, p-value ≤ 0.026).   
 
 
Table 3A.3 summarises the association between rs9939609, the index FTO SNP [91], with 
obesity-related quantitative traits.  These quantitative measures were similarly natural log 
transformed before analyses and estimated means were back transformed in tables.  
Rs9939609 showed highly significant associations with WC in both NHS98 Chinese (p-value 
< 0.0001) and NHS98 Malays (p-value = 0.001).  Borderline associations were also observed 
with low-density lipoprotein cholesterol (LDL-C) and triglyceride, the latter only after 
adjustment for BMI, in NHS98 Chinese samples.   
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Table 3A.2: Association results of nine FTO SNPs with BMI and T2D examined in NHS98 and SiMES populations. Significant results (p-value < 0.05) 
indicated in bold. 
SNP rs9939973 rs9940128 rs1421085 rs1121980 rs7193144 rs17817449 rs8050136 rs9926289 rs9939609 
NHS98 Chinese (N=2,919)          
∆BMI (kg/m2) 0.43 0.42 0.68 0.43 0.63 0.67 0.68 0.68 0.66 
    p-value*/p-value† <0.0001/<0.0001 0.001/<0.0001 <0.0001/<0.0001 <0.0001/<0.0001 <0.0001/<0.0001 <0.0001/<0.0001 <0.0001/<0.0001 <0.0001/<0.0001 <0.0001/<0.0001 
T2D OR  1.33  1.32  1.42  1.19  1.42 1.39  1.40  1.40  1.37  
    p-value*/p-value† 0.036/0.132 0.043/0.15 0.024/0.128 0.187/0.434 0.025/0.102 0.039/0.178 0.036/0.168 0.035/0.163 0.049/0.212 
NHS98 Malay (N=785)          
∆BMI (kg/m2) 0.83 0.82 0.90 0.65 0.82 0.91 0.86 0.88 0.89 
    p-value*/p-value† 0.001/0.002 0.002/0.002 0.001/0.001 0.011/0.015 0.002/0.002 0.001/0.001 0.001/0.002 0.001/0.001 0.001/0.001 
T2D OR  1.61 1.60 1.59 1.57 1.52 1.63 1.53  1.60  1.57  
   p-value*/p-value† 0.013/0.082 0.014/0.084 0.016/0.095 0.016/0.071 0.027/0.12 0.011/0.074 0.028/0.129 0.015/0.092 0.018/0.104 
NHS98 Asian-Indians (N=594)          
∆BMI (kg/m2) 0.24 0.23 0.03 0.28 0.12 0.10 0.04 0.11 0.10 
    p-value*/p-value† 0.352/0.333 0.36/0.347 0.913/0.781 0.267/0.247 0.658/0.458 0.715/0.527 0.877/0.719 0.674/0.487 0.7/0.532 
T2D OR  0.84  0.85  0.87  0.94  0.93  0.85  0.87  0.88  0.96  
    p-value*/p-value† 0.341/0.356 0.349/0.365 0.467/0.564 0.711/0.74 0.677/0.766 0.393/0.438 0.445/0.53 0.51/0.543 0.84/0.914 
SiMES Malay (N=2,996)          
∆BMI (kg/m2) 0.55 0.55 0.64 0.52 0.62 0.64 0.63 0.61 0.64 
    p-value*/p-value† <0.0001/<0.0001 0.001/<0.0001 <0.0001/<0.0001 <0.0001/<0.0001 <0.0001/<0.0001 <0.0001/<0.0001 <0.0001/<0.0001 <0.0001/<0.0001 <0.0001/<0.0001 
T2D OR  1.23  1.24  1.20  1.24  1.21  1.20  1.20  1.20  1.21  
    p-value*/p-value† 0.001/0.004 0.001/0.004 0.007/0.025 0.001/0.003 0.005/0.019 0.007/0.026 0.007/0.023 0.006/0.021 0.005/0.019 
∆: change, T2D defined as participants with a history of T2D or fasting glucose levels ≥7.0 mmol/l in NHS98 or HbA1c levels ≥ 6.5% in non-fasting blood samples in SiMES.  
*Adjusted for age and sex;†Adjusted for age, sex, current smoking, exercise (except in SiMES population), BMI (for risk of T2D), education and alcohol consumption. 
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Table 3A.3: Association of FTO SNP rs9939609 with obesity related traits in the NHS98 and SiMES populations. Significant results (p-value<0.05) 
indicated in bold. Means are adjusted for age and sex only. 
 
 NHS98 SiMES 
 Chinese (N=2,919) 
P* P† 
Malay (N=785) 
P* P† 
Asian-Indians 
(N=594) P* P† 
Malay (N=2,996) 
P* P† 
Genotype 0 1 2 0 1 2 0 1 2 0 1 2 
HDL-C (mmol/L) 1.42 1.42 1.42 0.735 0.127 1.31 1.29 1.27 0.244 0.792 1.15 1.14 1.14 0.832 0.741 1.36 1.34 1.33 0.164 0.785 
LDL-C (mmol/L) 3.36 3.44 3.52 0.024 0.298 3.87 3.86 3.84 0.787 0.248 3.70 3.70 3.70 0.787 0.939 3.52 3.55 3.58 0.251 0.508 
Triglycerides (mmol/L) 1.18 1.18 1.17 0.813 0.037 1.37 1.44 1.52 0.062 0.522 1.42 1.43 1.44 0.876 0.833 1.25 1.26 1.27 0.752 0.955 
Waist (cm) 77.84 79.09 80.35 <0.0001 <0.0001 81.70 83.56 85.42 0.001 0.002 84.97 85.17 85.38 0.74 0.775 - - - 
Waist-Hip Ratio 0.82 0.83 0.83 0.184 0.174 0.83 0.83 0.84 0.198 0.202 0.86 0.85 0.85 0.584 0.597 - - - 
Systolic BP (mmHG) 120.6 121.0 121.4 0.49 0.641 124.3 125.4 126.5 0.236 0.835 120.6 121.7 122.9 0.194 0.175 147.0 147.4 147.7 0.541 0.949 
Diastolic BP (mmHG) 73.6 74.2 74.7 0.179 0.79 75.7 76.7 77.7 0.108 0.995 72.7 74.1 75.6 0.039 0.027 79.9 79.8 79.6 0.56 0.308 
P: p-value, *Adjusted for age and sex, † Adjusted for age, sex, current smoking, exercise (except in SiMES), BMI, education and alcohol consumption. No central obesity measures available in 
SiMES. 
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3A.5 Modulation of obesity risk of FTO by physical activity level in NHS98 Chinese  
 
Interaction between rs9939609 and exercise in relation to BMI was examined in the Chinese 
samples of NHS98, where physical activity measures were available (regular exercise defined 
as participation in any form of sports for at least 20 minutes ≥ 3 days per week, occasional 
exercise defined as participation < 3 days per week and no exercise as non-participation in 
sports) and since this ethnic group represented the largest sample size.  Although it appeared 
that rs9939609 had a smaller effect on BMI in those who exercised regularly (figure 3A.3), 
this interaction was not statistically significant (likelihood ratio test p-value=0.248).   
 
Figure 3A.3: Interaction between rs9939609 with physical activity in relation to BMI in NHS98 
Chinese. Regular exercise defined as participation in any form of sports for at least 20 minutes ≥ 3 
days per week, occasional exercise defined as participation < 3 days per week and no exercise as non-
participation in sports. Allele A = risk allele for obesity. 
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3B.1 Introduction 
 
During the course of my project, further large-scale GWAS studies had identified up to 32 
loci associated with BMI [95-99] and five loci with early-onset and morbid obesity [104-
105], including the FTO locus.  All these GWAS had been primarily conducted with 
populations of European ancestry and the relevance or transferability of most of these 
variants in other ethnic groups was unknown.   
 
The second phase of this chapter (chapter 3B) specifies results from in silico replication of all 
recently identified obesity loci (from European GWAS studies) in Singaporean Asian GWAS 
datasets. These included data from Chinese children [SCORM (N = 1,006)], Chinese adults 
[SP2 (N = 2,431) and SCES (N = 1,861)], Chinese adult diabetics [SDCS (N = 1,992)], adult 
Malays [SiMES (N = 2,522)] and Asian-Indians [SINDI (N = 2,531)].  My aims here were to: 
 
1. Examine whether novel obesity-associated variants identified in European populations 
were relevant in Chinese, Malay and Asian-Indian ethnic groups, the three major 
ethnic groups in Asia. 
2. Re-examine association of FTO with BMI in a larger Asian-Indian dataset (SINDI,    
N = 2,531) to exclude the possibility of non-replication due to poor power in my 
previous study using a smaller Asian-Indian dataset (NHS98 Asian-Indians, N = 594). 
3. Identify possible mechanistic roles for novel loci using pathway-based analyses. 
 
3B.1 Loci selection for in silico validation in Singaporean GWAS datasets 
 
32 index SNPs from a recent European GWAS for BMI [99] and nine SNPs from five other 
loci discovered from GWAS that utilized European early-onset or extreme obesity samples 
[104-105] were studied.  Table 3B.1 below provides details of MAF and quality control (QC) 
issues for these SNPs among the Singaporean datasets.  Previously reported proxy SNPs [97], 
rs10913469 and rs7647305 were evaluated at the SEC16 homolog B (SEC16B) and ETS 
variant 5 (ETV5) regions, respectively as index SNPs [99] had poor call-rates among the 
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Singaporean datasets (table 3B.1).  These proxy SNPs were in strong LD (r
2
 > 0.9 in HapMap 
CEU) with index SNPs reported in the more recent GWAS [99].   
 
Two SNPs, rs13107325 [solute carrier family 39 (zinc transporter), member 8 (SLC39A8) at 
chromosome 4] and rs10508503 [phosphotriesterase related (PTER) at chromosome 10], 
were seen to be rare (MAF < 0.01) or monomorphic among the Singaporean populations and 
were excluded from my analysis (table 3.1).  Seven other loci, from mitochondrial 
translational initiation factor 3 (MTIF3) and general transcription factor IIIA (GTF3A) at 
chromosome 13, neurexin 3 (NRXN3) at chromosome 14, protein kinase D1 (PRKD1) at 
chromosome 14, G protein-coupled receptor, family C, group 5, member B (GPRC5B) and 
IQ motif containing K (IQCK) at chromosome 16, low density lipoprotein receptor-related 
protein 1B (LRP1B) at chromosome 2, zinc finger protein 608 (ZNF608) at chromosome 5, 
Fanconi anemia, complementation group L (FANCL) at chromosome 2 respectively, were 
dropped as index SNPs were not genotyped or not captured after imputation procedures and 
there were no suitable proxies. 
 
Thus, in total, I brought forward 30 index SNPs from 28 obesity loci, corresponding to FTO 
at chromosome 16, melanocortin 4 receptor (MC4R) at chromosome 18, glucosamine-6-
phosphate deaminase 2 (GNPDA2) at chromosome 4, transmembrane protein 18 (TMEM18) 
at chromosome 2, glutaminyl-peptide cyclotransferase-like (QPCTL) and gastric inhibitory 
polypeptide receptor (GIPR) at chromosome 19, brain-derived neurotrophic factor (BDNF) at 
chromosome 11, ETV5 at chromosome 3, mitogen-activated protein kinase kinase 5 
(MAP2K5) and SKI family transcriptional corepressor 1 (SKOR1) at chromosome 15, 
SEC16B at chromosome 1, neuronal growth regulator 1 (NEGR1) at chromosome 1, 
transcription factor AP-2β (TFAPB2) at chromosome 6, FLJ35779 and 3-hydroxy-3-
methylglutaryl-CoA reductase (HMGCR) at chromosome 5, nudix (nucleoside diphosphate 
linked moiety X)-type motif 3 (NUDT3) and high mobility group AT-hook 1 (HMGA1) at 
chromosome 6, rab and DnaJ domain containing (RBJ), adenylate cyclase 3 (ADCY3) and 
proopiomelanocortin (POMC) at chromosome 2, Fas apoptotic inhibitory molecule 2 
(FAIM2) at chromosome 12, TNNI3 interacting kinase (TNNI3K) at chromosome 1, 
potassium channel tetramerisation domain containing 15 (KCTD15) at chromosome 19, 
75 
 
mitochondrial carrier homolog 2 (MTCH2), NADH dehydrogenase (ubiquinone) Fe-S protein 
3 (NDUFS3) and CUG triplet repeat, RNA binding protein 1 (CUGBP1) at chromosome 11, 
leucine rich repeat neuronal 6C (LRRN6C) at chromosome 9, polypyrimidine tract binding 
protein 2 (PTBP2) at chromosome 1, cell adhesion molecule 2 (CADM2) at chromosome 3, 
SH2B adaptor protein 1 (SH2B1), apolipoprotein B48. receptor (APOB48R), sulfotransferase 
family, cytosolic, 1A, phenol-preferring, member 2 (SULT1A2), AC138894.2, ataxin 2-like 
(ATXN2L) and Tu translation elongation factor, mitochondrial (TUFM) at chromosome 16, 
transmembrane protein 160 (TMEM160) and zinc finger CCCH-type containing (ZC3H4) at 
chromosome 19, ribosomal protein L27a (RPL27A) and tubby (TUB) at chromosome 11,  
tankyrase (TNKS) and methionine sulfoxide reductase A (MSRA) at chromosome 8, v-maf 
musculoaponeurotic fibrosarcoma oncogene homolog (MAF) at chromosome 16, Niemann 
Pick type C1 (NPC1) at chromosome 18 and serologically defined colon cancer antigen 8 
(SDCCA8) at chromosome 1, for  in silico assessment among the Singaporean GWAS 
datasets (table 3B.1). 
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Table 3B.1: Details of QC issues and comparison of allele frequencies from reported loci associated with obesity and allele frequencies in Singaporean 
populations. SNPs in bold selected for in silico validation among the Singaporean datasets. 
rsid Chr Position Reported genes 
ΔBMI 
(kg/m
2
) 
Risk 
allele 
Reported 
AF 
MA 
Eu 
MAF 
Eu 
MA 
Chi 
*Ave 
MAF Chi 
MA 
Mly 
MAF 
Mly 
MA 
Ind 
MAF 
Ind 
QC comments 
rs1558902 16 52361075 FTO 0.39 A 0.42 A 0.42 A 0.13 A 0.30 A 0.33 
 
rs10938397 4 44877284 GNPDA2 0.18 G 0.43 G 0.43 G 0.27 G 0.23 G 0.38 
 
rs2867125 2 612827 TMEM18 0.31 C 0.83 T 0.17 T 0.07 T 0.09 T 0.20 
 
rs7647305
¥
 3 187316984 ETV5 0.23 C 0.80 T 0.20 T 0.09 T 0.14 T 0.19 
 
rs571312 18 55990749 MC4R 0.23 A 0.24 A 0.24 A 0.17 A 0.13 A 0.33 
 
rs2287019 19 50894012 QPCTL,GIPR 0.15 C 0.80 T 0.20 T 0.19 T 0.17 T 0.14 
 
rs2815752 1 72585028 NEGRI 0.13 A 0.61 G 0.39 G 0.08 G 0.13 G 0.38 
 
rs2241423 15 65873892 MAP2K5,SKOR1 0.13 G 0.78 A 0.22 G 0.42 G 0.37 A 0.38 
 
rs7138803 12 48533735 FAIM2 0.12 A 0.38 A 0.38 A 0.26 A 0.17 A 0.36 
 
rs1555543 1 96717385 PTBP2 0.06 C 0.59 A 0.41 A 0.11 A 0.10 A 0.43 
 
rs1514175 1 74764232 TNNI3K 0.07 A 0.43 A 0.43 G 0.25 G 0.46 G 0.45 
 
rs10913469
‡
 1 176180142 SEC16B 0.17 C 0.20 C 0.20 C 0.19 C 0.09 C 0.17 
 
rs2112347 5 75050998 FLJ35779, HMGCR 0.10 T 0.63 G 0.37 T 0.43 T 0.45 T 0.43 
 
rs713586 2 25011512 RBJ, ADCY3,POMC 0.14 C 0.47 C 0.47 C 0.46 C 0.42 C 0.46 
 
rs10767664 11 27682562 BDNF 0.19 A 0.78 T 0.22 T 0.49 T 0.49 T 0.31 
 
rs987237 6 50911009 TFAP2B 0.13 G 0.18 G 0.18 G 0.13 G 0.22 G 0.21 
 
rs206936 6 34410847 NUDT3, HMGA1 0.06 G 0.21 G 0.21 G 0.46 G 0.42 G 0.41 
 
rs7359397 16 28793160 
SH2B1, APOB48R, 
SULT1A2, AC138894.2, 
ATXN2L, TUFM 
0.15 T 0.40 T 0.40 T 0.08 T 0.08 T 0.16 
Low call-rate in SiMES and 
SINDI 
rs3817334 11 47607569 
MTCH2, NDUFS3, 
CUGBP1 
0.06 T 0.41 T 0.41 T 0.28 T 0.23 T 0.32 
 
rs10968576 9 28404339 LRRN6C 0.11 G 0.31 G 0.31 G 0.17 G 0.06 G 0.18 
 
rs29941 19 39001372 KCTD15 0.06 G 0.67 A 0.33 G 0.20 G 0.35 A 0.44 
 
rs13078807 3 85966840 CADM2 0.1 G 0.20 G 0.20 G <0.01 G 0.03 G 0.09 Rare in SP2 
rs9816226 3 187317193 ETV5 0.14 T 0.82 A 0.18 A <0.01 A <0.01 A 0.15 
Low call-rate, rare in SP2, 
SDCS, SCORM and SiMES 
rs543874 1 176156103 SEC16B 0.22 G 0.19 G 0.19 G 0.15 G 0.02 G 0.14 
Low call-rate in SCORM, 
SP2, SDCS and SiMES 
rs3810291 19 52260843 TMEM160,ZC3H4 0.09 A 0.67 G 0.33 A 0.21 A 0.38 A 0.32 
Low call-rate in SP2, 
SINDI and SiMES 
rs4929949 11 8561169 RPL27A,TUB 0.06 C 0.52 T 0.48 C 0.18 - 
 
- - 
Low call-rate in SCORM 
and SP2 and not available 
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in SiMES and SINDI 
rs4771122 13 26918180 MTIF3, GTF3A 0.09 G 0.24 G 0.24 - 
 
- 
 
- - Not available 
rs13107325 4 103407732 SLC39A8 0.19 T 0.07 T 0.07 - mono T <0.01 T <0.01 
Rare in SINDI and SiMES 
and mono in Chinese 
rs10150332 14 79006717 NRXN3 0.13 C 0.21 C 0.21 - 
 
- 
 
- - Not available 
rs11847697 14 29584863 PRKD1 0.17 T 0.04 T 0.04 - 
 
- 
 
- - Not available 
rs12444979 16 19841101 GPRC5B, IQCK 0.17 C 0.87 T 0.13 - 
 
- 
 
- - Not available 
rs2890652 2 142676401 LRP1B 0.09 C 0.18 C 0.18 - 
 
- 
 
- - Not available 
rs4836133 5 124360002 ZNF608 0.07 A 0.48 A 0.48 - 
 
- 
 
- - Not available 
rs887912 2 59156381 FANCL 0.10 T 0.29 T 0.29 - 
 
- 
 
- - Not available 
rs516175 8 9806983 TNKS,MSRA -0.04 A 0.11
†
 A 0.11 A 0.18 A 0.21 A 0.13 
 
rs17150703 8 9783208 TNKS,MSRA -0.10 A 0.11
†
 A 0.11 A 0.16 - 
 
- - 
Low call-rate in SiMES and 
SINDI 
rs1424233 16 78240252 MAF 0.03 A 0.91 C 0.09 C 0.36 C 0.43 C 0.30 
 
rs1805081 18 19394430 NPC1 0.06 A 0.53 C 0.47 C 0.25 C 0.23 C 0.24 
 
rs12145833 1 241550377 SDCCAG8 0.05 T 0.87
†
 G 0.13 G 0.06 G 0.03 G 0.08 Low call-rate in SINDI 
rs10926984 1 241528776 SDCCAG8 0.02 T 0.89
†
 G 0.11 G 0.06 - 
 
- - 
Not available in SiMES and 
SINDI 
rs10508503 10 16339956 PTER 0.02 C 0.91 T 0.09 - mono - mono - mono Mono in all datasets 
rs13278851 8 9788282 TNKS,MSRA -0.10 A 0.11
†
 A 0.11 - 
 
- 
 
- - Not available 
MA: Minor allele, MAF: minor allele frequency, AF: allele frequency, MA: minor allele,  Chi: Chinese,  Mly: Malay,  Ind: Asian-Indian, Eu: European. ¥ Proxy SNP for  ETV5 region, ‡ proxy SNP for SEC16B region, *Average MAF of all Chinese 
datasets (SCORM, SP2, SDCS, SINDI); † allele frequency reported from HapMap. Not available under QC issues indicates that SNP was not genotyped or imputed,  mono: monomorphic SNP, low call-rate: < 0.95, rare: MAF < 0.01. 
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3B.2 BMI Z-score (Z-BMI) associations of index SNPs in Singaporean datasets 
 
In all datasets, association analyses were performed with Z-BMI as the dependent variable, 
with adjustments made for sex, age
 
(except SCORM as all samples were nine years of age) 
and population stratification (first two principle components in SiMES and first three 
principle components in SINDI only).   
 
Tables 1 and 2 in Appendix II provide association details for all SNPs examined in individual 
Singaporean dataset.  Out of the 30 index SNPs, 23 were successfully genotyped or imputed 
in all five Singaporean GWAS datasets (SCORM, SP2, SDCS, SiMES and SINDI) and thus 
subjected to meta-analysis (table 3B.2) to improve sample size and power.  Heterogeneity 
measures did not indicate significant between-study heterogeneity for SNPs tested (slight 
heterogeneity was detected at rs571312 near the MC4R gene) and thus results assuming a 
fixed-effect model are presented.   
 
Rs1558902 from the FTO locus showed the strongest association after meta-analysis (meta p-
value = 1.44 x 10
-7
) (table 3B.2).  Examination of forest plot for this SNP indicated that 
effects were stronger in the SCORM childhood dataset as compared to the adult datasets 
(figure 3B.1).   In the larger SINDI Asian-Indian dataset (N=2,538 as compared to the 
NHS98 Asian Indians, N=594, in my previous study), the FTO index SNP, rs1558902, was 
associated with Z-BMI (p-value = 0.0182, Table 2 in Appendix II).  There was greater power 
to detect associations at the FTO locus among the SINDI samples as compared to the NHS98 
Asian-Indians (78% power as compared to 32% power in NHS98 to detect effect sizes 
reported in Europeans [99] (0.39 kg/m
2, table 3B.1), α = 0.05) and the FTO variant tested 
here was in perfect LD with the SNP tested in the earlier FTO replication study (r
2 
= 1.00 
between rs1558902 and rs9939609 in SINDI Asian-Indians). 
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Table 3B.2: Z-BMI association for obesity loci first detected among Europeans, among combined Singaporean GWAS datasets. Data from 23 index SNPs 
were available after combination of all GWAS and significant findings are in bold 
    All GWAS meta-analysis (N=10,482) 
rsid Chr Position Reported genes Test allele Ref allele Comment Power P-value Beta SE I
2 
(%) Q p-value 
SNPs previously detected from GWAS using BMI as a quantitative trait 
rs1558902 16 52361075 FTO T A imputed 0.95 - 0.99 1.44x10
-7
 -0.090 0.017 0 0.736 
rs10938397 4 44877284 GNPDA2 G A imputed 0.57 - 0.69 3.58x10
-4
 0.054 0.015 0 0.487 
rs571312 18 55990749 MC4R C A genotyped 0.59 - 0.87 1.79x10
-3
 -0.054 0.017 43 0.092 
rs2867125 2 612827 TMEM18 T C genotyped 0.57 - 0.93 2.80x10
-3
 -0.067 0.022 0 0.729 
rs2287019 19 50894012 QPCTL,GIPR T C genotyped 0.32 - 0.40 3.46x10
-3
 -0.052 0.018 0 0.920 
rs10767664 11 27682562 BDNF T A imputed 0.70 - 0.77 4.95x10
-3
 -0.039 0.014 0 0.501 
rs7647305 3 187316984 ETV5 T C genotyped 0.47 - 0.73 1.67x10
-2
 -0.049 0.020 20 0.272 
rs2241423 15 65873892 MAP2K5,SKOR1 G A genotyped 0.43 - 0.44 3.43x10
-2
 0.029 0.014 0 0.798 
rs10913469 1 176180142 SEC16B T C genotyped 0.28 - 0.47 3.71x10
-2
 -0.039 0.018 29 0.203 
rs2815752 1 72585028 NEGRI G A genotyped 0.17 - 0.43 9.18x10
-2
 -0.033 0.020 0 0.989 
rs987237 6 50911009 TFAP2B G A genotyped 0.24 - 0.34 0.106 0.029 0.018 0 0.999 
rs2112347 5 75050998 FLJ35779, HMGCR T G imputed 0.29 - 0.29 0.122 0.021 0.014 0 0.900 
rs206936 6 34410847 NUDT3, HMGA1 G A genotyped 0.13 - 0.14 0.167 0.019 0.014 0 0.544 
rs713586 2 25011512 RBJ, ADCY3,POMC T C imputed 0.50 - 0.51 0.237 -0.016 0.014 0 0.926 
rs7138803 12 48533735 FAIM2 G A genotyped 0.25 - 0.37 0.237 -0.019 0.016 29 0.203 
rs1514175 1 74764232 TNNI3K G A genotyped 0.14 - 0.17 0.388 -0.013 0.015 0 0.929 
rs29941 19 39001372 KCTD15 G A genotyped 0.10 - 0.13 0.406 0.013 0.015 0 0.970 
rs3817334 11 47607569 
MTCH2, 
NDUFS3,CUGBP1 
T C genotyped 0.11 - 0.12 0.509 0.010 0.015 0 0.792 
rs10968576 9 28404339 LRRN6C G A genotyped 0.11 - 0.22 0.745 
-
0.006* 
0.019 0 0.737 
rs1555543 1 96717385 PTBP2 C A imputed 0.08 - 0.13 0.840 0.004 0.019 7 0.377 
SNPs previously detected from GWAS using extreme obese or early-onset obese cases 
rs516175 8 9806983 TNKS,MSRA G A imputed - 1.28x10
-2
 0.044 0.018 0 0.691 
rs1424233 16 78240252 MAF T C genotyped - 0.444 0.011 0.014 0 0.451 
rs1805081 18 19394430 NPC1 T C genotyped - 0.855 0.003 0.016 0 1.000 
Power of study (α = 0.05) using reported changes in BMI. Ranges of power were due to varied minor allele frequencies among Singaporean datasets. Power for studies carried out in extreme and early-
onset obesity not performed in quantitative BMI analyses in Singaporean datasets. 
* Inconsistent direction of beta as compared to original study in European populations. 
Q (Cochran’s Q, significant Qp-value<0.1) and I
2
 indices used to measure between-study heterogeneity. Genotyped: SNP genotyped in at least 1 dataset. Imputed: imputed SNP. 
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Figure 3B.1: Forest plot of effect sizes detected at the rs1558902 variant at intron 1 in the FTO gene, 
among the Singaporean GWAS datasets tested. 
 
 
Nine additional index variants near or at MC4R, GNPDA2, TMEM18, QPCTL/GIPR, BDNF, 
ETV5, MAP2K5/SKOR1, SEC16B and TNKS/MSRA loci also showed significant associations 
(meta p-value between 0.037 and  3.58 x 10
-4
, table 3B.2).  SNPs for which there was greater 
power to detect an association at α < 0.05, showed statistically significant associations (upper 
range 47% - 99%), while those for which power was lower (upper range 12% - 51%) failed to 
replicate (table 3B.2).   
 
There was an over-representation of significant signals (Binomial-test p-value < 0.001 for 
over-representation of association signals compared to the expected at α = 0.05) (table 3B.2) 
in the meta-analysis data.  I further tested the hypothesis that SNPs were directionally 
consistent with original studies. The direction of effects of all except one index SNP 
(rs10968576 at LRRNC) (table 3B.2) were similar to original European GWAS results 
(Binomial-test p-value<0.001, assuming the consistency of direction is 0.5 under the null).  
 
Three other index SNPs were significantly associated with Z-BMI in at least one Singaporean 
study (table 1 and 2 in Appendix II).  Rs13078807 (CADM2) was significant (p-value = 
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0.0418) only among Asian-Indians and was observed at a lower allele frequency, with 
opposite effects among the SiMES Malay population and was monomorphic among all 
Chinese datasets.  Rs1555543 (PTBP2) was significant in the Chinese diabetic cohort only 
(p-value = 0.0103) and rs7138803 (FAIM2) was associated with BMI in the Chinese diabetic 
cases (p-value = 0.0250) and SCORM Chinese children (p-value = 0.0310) while effect 
directions and allele frequencies were variable between datasets and ethnic groups.    
 
3B.3 Further examination of index SNP, rs571312, near the MC4R locus 
 
For most variants, between-study heterogeneity of effects was negligible, except for rs571312 
at the MC4R locus where slight heterogeneity was observed (I
2 
= 42% and Qp-value = 0.092) 
(table 3B.2).  Although direction of effects were consistent in all datasets, the forest plot for 
this SNP indicated that effect sizes were greater in Chinese children (SCORM, β = -0.171) 
and Asian-Indians (SINDI, β = -0.101) than in the other datasets (figure 3B.1).  
 
Figure 3B.2: Forest plot of effects for the near MC4R index SNP (rs571312), which showed 
suggestive significant between-study heterogeneity among the Singapore GWAS datasets (I2 = 42% 
and Qp-value= 0.092).   
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3B.4 Assessment of regional SNPs at nine loci  
 
At nine loci where I could not directly assess effects of index SNPs (see section 3B.1 and 
table 3B.1, examination of regional SNPs within a recombination block (between 
recombination peaks of at least 20Cm/Mb) containing the index SNPs, were carried out. 
Figure 1 in Appendix II, details association levels of regional SNPs from all nine loci.  At 
eight loci (table 3B.3) surrounding SNPs had significant associations with Z-BMI, however 
only the top regional SNP at SLC39A8 (rs10014145) remained significant (corrected meta p-
value = 0.045, table 3B.3) after multiple tests adjustments (assuming 9 independent tests).   
LD between this SNP and the index SNP however, was low among Asians reference 
populations (table 3B.3). 
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Table 3B.3:  Details of top regional SNPs at which, index SNPs were not assessed directly in the Singaporean datasets. LD (r
2
) was drawn from Chinese, 
Malay and Asian-Indian reference panels from the SGVP and Han Chinese (CHB) from HapMap phase 2 and Gujarati Indians (GIH) from HapMap Phase 3. 
Chr 
Reported 
genes 
Top regional 
SNP 
Regional SNP 
meta p-value 
regional SNPs with 
meta p-value < 0.05 
Corrected 
meta p-value* 
Index SNP 
Distance between index 
and regional SNP (bp) 
LD between index and top regional SNP (r2) 
2 FANCL rs10210132 0.006 9 0.051 rs887912 168421 No info in SGVP / No info in HapMap CHB and GIH 
2 LRP1B rs17832932 0.009 1 0.081 rs2890652 17136 No info in SGVP / No info in HapMap CHB and GIH 
4 SLC39A8 rs10014145 0.005 2 0.045 rs13107325 11868 
CHS=0.001, MAS=NA, INS=0.009 / CHB=NA, 
GIH=NA 
5 ZNF608 rs6595571 0.173 0 1 rs4836133 46682 No info in SGVP / No info in HapMap CHB and GIH 
13 
MTIF3, 
GTF3A 
rs7334690 0.036 2 0.324 rs4771122 61355 No info in SGVP / CHB=0.034, GIH=NA 
14 PRKD1 rs4357843 0.006 2 0.054 rs11847697 324463 No info in SGVP / No info in HapMap CHB and GIH 
14 NRXN3 rs2543575 0.006 10 0.054 rs10150332 135175 No info in SGVP / No info in HapMap CHB and GIH 
16 
GPRC5B, 
IQCK 
rs1350380 0.006 3 0.051 rs12444979 101396 No info in SGVP / No info in HapMap CHB and GIH 
10 PTER rs11253892 0.044 1 1 rs10508503 32832 
CHS=NA, MAS=0.000, INS=0.003 / CHB=NA, 
GIH=0.010 
* Bonferroni correction assuming 9 independent tests. 
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3B.5 Pathway-based assessment of all significant loci 
 
Test for involvement in known canonical pathways using 13 implicated genes at 10 loci that 
showed an association after meta-analysis of all Singaporean GWAS datasets, identified the 
neurotrophin/tyrosine kinase (TRK) signalling pathway.  This signal remained significant 
after adjustments for multiple testing implemented in Ingenuity Pathway Analysis (IPA) 
(Benjamini-Horchberg corrected p-value=0.029) (figure 3B.2A).  Examination of the 
neurotrophin/tyrosine kinase (TRK) signalling pathway highlighted that two obesity loci, 
BDNF (extracellular neurotrophin binding) and MAP2K5 (downstream intra-cellular kinase) 
act on the same pathway, affecting neuronal growth (figure 3B.2B). 
 
Figure 3B.3: Ingenuity Pathway Analysis (IPA) results of top canonical pathways identified with 
implicated genes at 13 replicating obesity loci. A) The neurotrophin/TRK signalling pathway remains 
significant (adjusted p-value = 0.029) after adjusting for multiple testing (Benjamini-Hochberg, 
threshold line). B) The neurotrophin/TRK signalling pathway involving neurotrophins (BDNF, red) 
binding membrane-bound tyrosine kinase (TRK) receptors that invoke an intracellular signalling 
cascade which subsequently activate mitogen activated / ERK kinase (MAP2K5, green). 
 
A) 
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3B.6 Gene risk score (GRS) assessment of 10 significant loci in SCES dataset 
 
Using an independent GWAS dataset, Chinese adults from SCES, the role of these 10 index 
SNPs with obesity was tested in a combined gene risk score (GRS) analysis (weighted by 
effect estimates from meta-analysis of Singaporean GWAS datasets, table 3B.2).  The GRS 
was significantly associated with BMI in SCES (β = 0.125 kg/m2, p-value = 0.011), although 
the variance explained was small (0.4% variation in BMI).  The distribution of the GRS and 
cumulative effects of risk alleles on BMI is indicated in figure 3B.3.  
 
B) 
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Figure 3B.4: Cumulative effects of 10 obesity associated variants that were significant in meta-
analysis of Singaporean GWAS datasets (SCORM, SP2, SDCS, SiMES and SINDI) on BMI in SCES 
Chinese adults (N=1,861). GRS was weighted by effect sizes of variants obtained from meta-analysis 
of SCORM, SP2, SDCS, SiMES and SINDI (table 3B.2). 
 
 
 
3B.7 Additional phenotype assessments of 10 loci associated with Z-BMI 
 
Associations with additional quantitative measures, Z-scores of birth weight (BW) in 
SCORM and central obesity measures [waist circumference (WC) and waist-hip ratio 
(WHR)] from SP2 were tested for the 10 loci that showed a significant association with Z-
BMI.  Initial assessments did not indicate heterogeneity between sexes (p-value > 0.1) and 
data from genders combined in the datasets are presented in table 3B.4 below.  None of these 
SNPs showed a significant association with birth weight or central obesity measures. 
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Table 3B.4: Association levels with Z-scores of birth weight (BW) in SCORM and Z-scores of waist circumference (WC) and waist-hip ratio (WHR) for 10 
SNPs that were associated with Z-BMI in the meta-analysis of all Singaporean GWAS datasets. 
      SCORM Z-BW SP2 Z-WC SP2 Z-WHR SP2 Z-WHR* 
N 956 2,431 2,431 2,431 
rsid Chr Position 
Reported 
genes 
Test 
allele 
Comment Beta SE p-value Beta SE p-value Beta SE p-value Beta SE p-value 
rs1558902 16 52361075 FTO T imputed -0.042 0.068 0.539 -0.062 0.037 0.091 -0.023 0.035 0.510 0.008 0.031 0.807 
rs10938397 4 44877284 GNPDA2 G imputed 0.036 0.052 0.492 0.058 0.031 0.051 0.044 0.025 0.084 0.016 0.023 0.488 
rs10767664 11 27682562 BDNF T imputed -0.028 0.046 0.539 -0.025 0.023 0.273 -0.033 0.023 0.149 -0.013 0.020 0.517 
rs2867125 2 612827 TMEM18 T genotyped -0.021 0.083 0.801 -0.066 0.044 0.132 -0.048 0.042 0.255 -0.017 0.038 0.657 
rs7647305 3 187316984 ETV5 T genotyped -0.026 0.078 0.737 -0.060 0.040 0.133 -0.007 0.038 0.860 0.046 0.034 0.183 
rs571312 18 55990749 MC4R C genotyped 0.065 0.059 0.272 -0.023 0.032 0.456 -0.034 0.031 0.260 -0.024 0.027 0.379 
rs2287019 19 50894012 
QPCTL, 
GIPR 
T genotyped 0.049 0.058 0.394 -0.053 0.030 0.054 -0.020 0.029 0.484 0.007 0.025 0.785 
rs2241423 15 65873892 
MAP2K5, 
SKOR1 
G genotyped -0.034 0.046 0.467 0.022 0.024 0.358 0.013 0.023 0.568 0.005 0.021 0.806 
rs10913469 1 176180142 SEC16B T genotyped -0.043 0.058 0.458 0.009 0.030 0.750 0.003 0.029 0.924 -0.008 0.026 0.746 
rs516175 8 9806983 
TNKS, 
MSRA 
G imputed -0.015 0.060 0.796 0.020 0.030 0.494 0.002 0.029 0.954 -0.006 0.026 0.818 
* Analysis performed with additional adjustment for BMI. Genotyped: SNP genotyped in at least 1 dataset. Imputed: imputed SNP. 
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3.2 Discussion 
 
The FTO gene was first associated with obesity in Europeans [91-94] and this spawned a 
series of replication and characterization studies.  Associations of common FTO variants with 
obesity and related secondary metabolic traits replicated well in European populations [172-
173], but initial results from other ethnic groups were inconclusive [92, 120-121].  Thus, the 
first phase of my project involved a detailed candidate locus analysis of FTO in populations 
of Asian ancestry living in Singapore.  As additional novel variants associated with obesity in 
large-scale studies using European populations were discovered in more recent times [95-99, 
104-105], I have further assessed their transferability to Asian populations in the second 
phase of this study.   
 
Replication efforts of known FTO variants, first detected among Europeans, revealed clear 
associations with obesity and T2D in Chinese and Malays living in Singapore.  Furthermore, 
effect sizes obtained in my initial study were similar to that seen in European populations 
(approximately 0.40 kg/m
2
).  Similar effects were not observed in Asian-Indian samples from 
the NHS98 cohort.  This was due to low power in the study (40% power to detect changes in 
BMI of 0.5 kg/m
2 
[91], α = 0.05) and re-examination of FTO in the larger SINDI Asian-
Indian dataset, showed significant associations with Z-BMI.  Associations with BMI in the 
FTO locus were observed despite smaller risk allele frequencies of FTO SNPs in Asians (as 
compared to European allele frequencies) especially evident among the East-Asians samples 
(Singaporean Chinese and Malays). 
 
Comparisons of LD patterns of common SNPs at FTO between the Singaporean datasets and 
Europeans (CEU) samples from HapMap revealed no major differences in this region.  
Common FTO SNPs were correspondingly in strong LD with each other in all datasets.  Thus 
inconsistencies in obesity associations for FTO variants, as seen in non-European replication 
efforts, such as the initial replication study in Asians by Li et al. (2008) [121] using Han 
Chinese samples from Beijing and Shanghai, were unlikely to be due to lower frequency of 
risk alleles and differences in genetic architecture.  Importantly, two of the three SNPs tested 
by Li et al. (2008) [121] in Chinese Hans (rs8050136 and rs9939609) were also genotyped in 
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the Singaporean samples and both of these showed similarly low MAFs [approximately 0.12 
in NHS98 Chinese and Han Chinese in the Li et al. (2008) [121] study], yet strong obesity 
associations were observed in the Singaporean Chinese. 
 
The common form of obesity is a multi-factorial condition, thought to develop from a 
complex interplay of genes and environmental factors such as dietary habits and levels of 
physical activity.  Studies have indicated attenuation of the effects of FTO variants on obesity 
by physical activity [171]. Similarly, possible explanations for the differences in associations 
seen in Singaporeans but not in the study by Li et al. (2008) [121], could lie in different 
exposures to environmental and/or lifestyle factors.  This may be relevant, given that surveys 
in Shanghai Chinese [174-175] have reported that an average of 35% of subjects exercised 
regularly.  Although direct comparisons cannot be made as specific definitions of exercise 
levels may be different between NHS98 and the Chinese surveys, it is possible that Chinese 
living in China have a greater level of physical activity than Singaporean Chinese (14.7% 
regularly exercised in NHS98).  An attenuation of effects of FTO variants were seen among 
the NHS98 Chinese who exercised more, but this gene-exercise interaction was not 
significant.  It is however, likely that this study was underpowered to detect such interactions 
(assuming a MAF of 0.12 there was only 40% power at α-level = 0.05).  However, in a more 
recent meta-analysis of over 200,000 adults, in which the same NHS98 and SiMES 
populations were involved in, the interaction between FTO and physical activity has been 
firmly established [176].   
 
Age-gene interactions may also affect validation efforts and result in non-replication [177].  It 
has been suggested that FTO variants may have stronger associations in children and 
teenagers than in adults [178].  Furthermore at the rs1558902 FTO SNP, larger effect 
estimates were observed in the SCORM childhood dataset as compared to the Singaporean 
adult datasets.  Therefore, the differences in average age between the two Chinese 
populations (37.9 ± 12.2 in NHS98 Chinese compared to 58.6 ± 6.0 in the Han Chinese) 
could have further contributed to the discrepancies seen in association with obesity risks.   
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Candidate FTO variants were also associated with T2D among Singaporean Chinese 
(NHS98) and Malays (NHS98 and SiMES).  Adjustment for BMI diminished, but did not 
abolish the association in the SiMES Malay dataset raising the possibility of a direct effect of 
FTO with T2D, which has not been observed in other studies.  However, this could also 
highlight residual confounding by obesity.  It is well-established that compared to Europeans 
of similar BMI, Asians have different levels of adiposity and thus, risks of T2D [35-36].  
Consequently, adjusting for BMI may not fully account for the confounding effects of 
adiposity on the risk of T2D in the SiMES Malays. 
 
FTO SNPs also showed associations with obesity-related traits in the NHS98 and SiMES 
datasets.  Other than a strong association with waist circumference (p-value < 0.0001 in 
NHS98 Chinese and p-value = 0.001 in NHS98 Malays), borderline associations were 
observed with LDL-C and triglycerides (p-value = 0.024 and p-value = 0.037 in NHS98 
Chinese).  However, given the multiple associations tested, it is possible that these could 
represent false positive findings and repeating analyses for central obesity measures in the 
larger SP2 dataset did not indicate any significant associations. 
 
It is noteworthy that the adult Singaporean datasets (SP2, SDCS, SiMES and SINDI) were 
involved in a more recent meta-analysis of 96,551 East and South Asian samples to assess 
associations with obesity and T2D [124].  Findings from this large-scale study confirmed my 
study results that: 
1. Despite a lower risk allele frequency FTO is associated with obesity risks in East and 
South Asian populations, with similar effect sizes as those seen among Europeans.  
2. There were no discrepancies due to sex for FTO associations with obesity risks.  
3. There was a possible direct association of FTO with T2D among Asians. 
 
In the second phase of this study, besides the FTO locus, I detected significant associations 
for nine additional obesity loci among meta-analysis data of all Singaporean GWAS cohorts 
(SCORM, SP2, SDCS, SiMES and SINDI).   The GRS of these variants further showed clear 
cumulative associations in an independent Singaporean dataset (SCES) although the variance 
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explained was small (0.4%).  This is perhaps not too surprising given that all 32 BMI-
associated loci identified to date only explain less than 2% of variance of BMI in European 
populations [99] and may indicate that several additional loci associated with common 
obesity remain unravelled.  
 
Associations detected for Z-BMI with SNPs at the GNPDA2, MC4R, SEC16B, TMEM18, 
ETV5 and the BDNF loci were in line with previous replication attempts among Asian 
populations [127-128], corroborating their role in common obesity predisposition.  
Replication of index SNPs at QPCTL/GIPR, MAP2K5/SKOR1 and TNKS/MSRA represent 
novel findings in Asians.  In addition, three loci showed significant associations in sub-
groups, including rs13078807 at the CADM2 (Asian-Indians only); rs1555543 at PTBP2 
(Chinese T2D cohort only); and rs7138803 at FAIM2 (Chinese children and Chinese T2D 
patients).  Replication of the FAIM2 locus in only children and diabetics is consistent with a 
previous validation study that studied Han Chinese individuals [128].   
 
It has been emphasized that several of these variants, initially detected from European GWAS 
studies for BMI association, are primarily expressed in the brain [98].  The detection of the 
neurotrophin/TRK signalling pathway, where both BDNF and MAP2K5 were involved in 
neuronal development [179] further emphasizes a central role for neuronal development in 
determining obesity risks in Asians. Conversely, as also detected among Europeans [99], 
replication of the GIPR locus implicates a control of appetite by the gut among Asians as well 
[103].   
 
The validated variants were not associated with birth phenotype (birth weight) or abdominal 
obesity among Asian populations tested in the study.  This was consistent with findings from 
European data that indicate that BMI variants have a limited role in determining foetal 
growth and that molecular pathways involved in fat patterning or distribution in the body is 
varied with those involved with overall obesity [79].  Together, these findings and replication 
efforts indicate that at least some genetic predisposition to overall obesity risks might be 
shared among Asians and Europeans.   
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For 14 obesity loci identified through European GWAS for obesity, no association with BMI 
among the Singaporean Asian populations were detected.  One possibility is that there are 
significant genetic heterogeneity at these loci between Asians and Europeans.  However, 
index SNPs are unlikely to be causal and differences in allele frequencies and LD between 
populations may have masked associations.  At some loci where I was unable to directly 
assess index SNPs, regional SNPs indicated associations with BMI in the Singaporean 
datasets however, corrections for multiple tests abolished these associations except at the 
SLC39A8 locus.  Nevertheless, LD of regional signal and the index SNP at SLC39A8 was 
observed to be low among Asian populations and thus, it is unlikely that this regional signal 
represent an adequate proxy. 
 
It is important to note that several of these novel variants identified from European GWAS 
studies have modest effect sizes and were only discovered after analyses of over 200,000 
study samples [99].  Consequently, the sample size in my analyses of Singaporean GWAS 
datasets, even after meta-analysis (N = 10,482), may not have been adequately powered to 
detect all true associations.  Associations with variants at NEGR1, SH2B1 and KCTD15 that 
have previously replicated in Han Chinese populations [128] were not detected in this study 
of Singaporean populations.  These SNPs tended to be those for which power was lower in 
this study and approximately 30,000, 40,000 and 90,000 SP2 Chinese samples would have 
been required for an 80% power (α = 0.05) to detect BMI changes similar to Europeans at 
reported index SNPs at NEGR1, SH2B1 and KCTD15, respectively.  Furthermore, as 
indicated above, the common form of obesity is considered a multi-factorial condition and, 
therefore, population specific gene-environment factors [180] may have further attenuated 
true genetic signals among the Singaporean cohorts. 
 
Although I attempted to increase power to detect associations by combining datasets in the 
meta-analysis, the diverse nature of the populations, including a childhood dataset and a 
diabetic cohort, may have contributed to a degree of heterogeneity.  Loci associated with 
paediatric obesity may differ from adult obesity and there may have been a degree of 
confounding among the diabetic cases, even though, at these specific obesity loci that were 
tested (with the exception of MC4R) strong between-study heterogeneity was not detected.   
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Nonetheless, I repeated meta-analyses of the Singaporean datasets by excluding SCORM and 
SDCS to assess any changes in Z-BMI association levels and these are detailed in table 3 of 
Appendix II.  Excluding the diabetic cohort from the meta-analysis abolished significant 
association at only one variant - rs10913469 at the SEC16B locus (meta p-value = 0.223, 
table 3 in Appendix II).  However the direction of beta at this locus among the SDCS 
diabetics (β = -0.11, table 2 in Appendix II) was consistent with the meta-analysis of all 
datasets and the meta-analysis done after excluding the SDCS diabetics.   
 
Restricting meta-analyses to only adult datasets (excluding SCORM) showed that at two loci 
(rs516175 at the TNKS/MSRA locus and rs2241423 at the MAP2K5/SKOR1 locus) significant 
associations were lost (table 3 in Appendix II).  However at these loci, directions of effects in 
SCORM children were also similar (rs2241423 β = 0.08 and rs516175 β = 0.15, table 1 in 
Appendix II) with that of the meta-analysis of all datasets and meta-analysis after excluding 
the SCORM dataset (table 3 in Appendix II).  Limiting the analysis to only adults, did 
improve between-study heterogeneity at the MC4R locus (Qp-value = 0.160), but it has been 
reported that associations at this locus are stronger among children and in certain ethnic 
groups (Asian-Indians) [95-96], consistent with findings in my study.  Additionally, another 
significant locus, rs206936 at the NUDT3/HMGA1 region, was identified after removing the 
SCORM children and may represent a late-onset obesity loci. Nevertheless, association at this 
locus in the meta-analysis of adult samples was very marginal (meta p-value = 0.0479, table 3 
in Appendix II) and thus would warrant further confirmation in large-scale independent 
studies.   
 
These additional analyses however, do not affect the principle findings from the second phase 
of this study which confirms that diverse ethnic groups share some degree of genetic 
predisposition to obesity risks and common variants associated with overall obesity, first 
detected in Europeans, are transferable across ethnic groups (at least in East-Asian and South-
Asian populations). 
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4. Detection of novel obesity loci 
 
4A.1 Introduction 
 
To date, all genome-wide association studies (GWAS) for obesity associations, have been 
primarily conducted with populations of European ancestry.  Moreover, all known genetic 
variants for BMI together only explain a small proportion of the overall variance in obesity 
[99].  Thus, it is likely that several novel genetic loci associated with obesity risks remain to 
be unearthed.  The genetic contribution to obesity measures such as BMI, waist-hip ratio 
(WHR) and waist circumference (WC) among Asians is as high as that in Europeans [129-
130].  Furthermore, certain gene regions, such as ADRB3, may be uniquely associated with 
obesity among Asians and not in European populations [78].  It is, therefore, possible that 
GWAS carried out with only European samples might have missed variants that may be more 
relevant in other ethnic groups.  
 
Exploiting population differences in allele frequencies could be an important strategy for 
detecting new obesity-associated variants.  This has been highlighted in the discovery of the 
188kb upstream region of the MC4R gene at chromosome 18, where  the association could be 
detected using fewer Asian-Indian samples (2,684 samples) than required for European 
studies (16,876 samples) because of the higher frequency of the variant allele among Asian-
Indians (36% compared to 27% in Europeans) [95-96].  In the initial section of this chapter 
(chapter 4A), I discuss results from my analysis of GWAS for obesity among Singaporean 
East-Asian (Chinese and Malays) populations.  Here I seek to: 
 
1. Detect novel variants that have an effect on both Singaporean East-Asian paediatric 
and adult Z-BMI with a meta-analysis of 7,951 samples from a discovery stage of 
GWAS data consisting of SCORM Chinese children (N = 1,006), SP2 Chinese adults 
(N = 2,431), SDCS adult Chinese diabetics (N = 1,992) and SiMES adult Malays (N = 
2,522). 
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2. Follow-up top Z-BMI hits (p-value ≤ 10-5) from the discovery stage with additional de 
novo genotyping in 3,920 adult and paediatric East-Asian samples (MEC, SP2 and 
SCCS2 adult Singaporean Malays, SCCS2 adult Singaporean Chinese, Da Qing 
childhood population from China and Singaporean early-onset extreme obese 
samples) and in silico assessment in an additional East-Asian adult GWAS datasets 
(1,831 adult Singaporean Chinese in SCES). 
3. I also discuss results from Singaporean GWAS studies where I examined for central 
obesity associations (Z-scores of WC and WHR in SP2 only) and associations using a 
case-control design - extremes in the population (obesity, defined as a BMI ≥ 30 
kg/m
2
) as compared to normal controls (defined as 18.5 kg/m
2
 ≤ BMI < 23 kg/m2). 
 
4A.2 Association results of Z-BMI in discovery GWAS datasets 
 
Strength of association signals after genomic control (GC) with BMI Z-scores (Z-BMI) in 
each GWAS dataset was visualized using QQ-plots. This enabled the comparison of observed 
p-value associations with the null expectation in the study.  Figure 4A.1 illustrates individual 
QQ-plots for Z-BMI association in the four discovery GWAS datasets.  Association results 
from individual datasets were relatively weak, with observed p-values of top hits (top most 
end of observed p-value plots) often dipping below expected association values.  This 
indicated that individually, the studies were inadequately powered to detect variants 
associated with BMI.  Therefore, to increase sample sizes and power, summary statistics from 
individual datasets were combined using meta-analyses, assuming a fixed effects model.  The 
relatively close clusters of Chinese and Malay samples from PCA analyses (see 2.4.1 in 
Chapter 2) further justified the combination of the Chinese and Malay datasets. Table 4A.1 
below details on the three meta-analyses performed during the discovery stage of this GWAS 
and figure 4A.2 shows the QQ-plots for Z-BMI association p-values after meta-analyses. 
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Figure 4A.1: QQ-plots of BMI Z-score association p-values after GC correction (imputed and 
genotyped SNPs) from individual datasets used in discovery GWAS. Negative log of observed p-
values (blue dots) were compared with the negative log of expected p-values (diagonal). Analyses for 
SP2 and SDCS performed chip-wise and subsequently combined to get overall study estimates.  A) 
QQ-plot of BMI Z-score association p-values in SCORM (N = 1,006, λ=1.022). B) QQ-plot of BMI 
Z-score association p-values in SP2 (N = 2,431, λ= 1.010 -1.016). C) QQ-plot of BMI Z-score 
association p-values in SDCS (N = 1,992, λ = 1.005 – 1.012). D) QQ-plot of BMI Z-score association 
p-values in SiMES (N = 2,531, λ=1.046). 
 
 
 
 
 
A) B) 
C) D) 
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Table 4A.1:  Details of three meta-analyses carried out in discovery GWAS for Z-BMI. 
Meta-analysis Studies combined 
Combined sample 
size 
Overlapping SNPs 
All GWAS SCORM, SP2, SiMES, SDCS 7,951 1,397,222 
All Chinese SCORM, SP2, SDCS 5,429 1,710,771 
All Adults SP2, SDCS, SiMES 6,854 1,404,015 
 
Figure 4A.2: QQ-plots of BMI Z-score association p-values (imputed and genotyped SNPs) from combined datasets after meta-analysis in discovery GWAS.  
Negative log of observed p-values (blue dots) were compared with the negative log of expected p-values (diagonal). A) QQ-plot of BMI Z-score association p-
values in All GWAS meta-analysis (N = 7,951). B) QQ-plot of BMI Z-score association p-values in All Adult meta-analysis (N = 6,854. C) QQ-plot of BMI Z-
score association p-values in All Chinese meta-analysis (N = 5,429).  
  
B)   A)   C) 
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The QQ-plot of association p-values from the All Chinese meta-analysis still adhered closely 
to the null expectation at the top most end of the plot (figure 4A.2C).  In the All Adult meta-
analysis, observed p-values of top hits were seen to dip below the expected null, indicating 
that even after combining data from 6,854 samples from SP2, SDCS and SiMES, overall 
study results were under-powered to detect Z-BMI associated variants among East-Asian 
Chinese and Malay adults (figure 4A.2B).  The QQ-plot of the All GWAS meta-analysis 
however, showed an upward deflection from expected values at the topmost end, indicating 
that observed p-values of top SNPs were stronger than association levels that would be 
expected (due to chance) in the study (figure 4A.2A).  Figure 4A.3 below shows a Manhattan 
plot of results from the All GWAS meta-analysis. The most strongly associated SNPs were 
from chromosome 16 and corresponded to intron 1 of the FTO gene, a true positive for BMI 
predisposition in the Singaporean Chinese and Malay populations (detailed in chapter 3). The 
next best hit was detected at chromosome 5, downstream of the neurolysin gene (NLN).   
 
Figure 4A.3: Manhattan plot showing negative log p-values of BMI Z-score association from the All 
GWAS meta-analysis against corresponding chromosomes. Top SNPs were detected at intron 1 of the 
FTO locus at chromosome 16 (green circle) and second best hits were at chromosome 5 
corresponding to the NLN locus. Black line indicates threshold p-value 10
-5
 line and SNPs with p-
values above this threshold were looked at more closely for subsequent replication. 
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4A.3 Selection of top SNPs for further follow-up in replication stage 
 
258 SNPs from the All GWAS meta-analysis had meta-analysis p-values ≤ 10-5.  Top 15 
SNPs (ranked according to meta-analysis p-values) were observed from the well-
characterized intron 1 region at FTO in chromosome 16 (meta-analysis p-value between 5.22 
x 10
-7
 and 1.05 x 10
-6
).  As it was not feasible to bring forward all 258 SNPs from replication, 
I prioritized SNPs based on strength of associations and if they were actually genotyped (as 
opposed to imputed SNPs)  
 
In selecting SNPs for follow-up, I included only two FTO SNPs – rs8050136 (genotyped) 
and rs7185735 (imputed) to serve as positive-controls for the replication stage.  Three SNPs 
[rs10443943 and rs10443942 at the paladin (PALD) gene in chromosome 10 and rs16829328 
in chromosome 2] were excluded due to significant between-study heterogeneity (Cochran’s 
Qp-value < 0.1).  I subsequently grouped the remaining top SNPs into one Mb regions and 
prioritized actually genotyped SNPs over imputed ones; imputed SNPs were only included 
for replication when the association p-values were stronger than the most significant 
genotyped SNP in the same one Mb region.  Details of all 75 SNPs (58 genotyped and 17 
imputed) selected for follow-up in the replication stage are provided in Table 1 of Appendix 
III, while details of top 10 Z-BMI associated tagging SNPs (r
2
 > 0.8 in HapMap CHB and 
JPT at each one Mb region) is indicated below in table 4A.2.  
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Table 4A.2: Association results from individual studies and meta-analysis summary statistics for top 10 Z-BMI associated tagging SNPs (r
2
 > 0.8 in 
HapMap CHB and JPT at each one Mb region) selected from discovery GWAS of four Singaporean datasets (SCORM, SP2, SDCS, SiMES) brought 
forward to the replication stage. Details of all 75 SNPs selected for replication is available in Table 1 of Appendix III.  
     
SCORM               
(N=1,006) 
SP2                          
(N=2,431) 
SiMES                   
(N=2,531) 
SDCS                      
(N=1,992) 
Meta-analysis                    
(N=7,951)  
rsid Chr Position 
Test 
allele 
Ref MAF Beta p-value MAF* Beta p-value MAF Beta p-value MAF* Beta p-value Beta p-value Gene‡ 
rs7185735 16 52380152 G imp 0.125 0.220 1.17x10
-3
 0.123 0.090 3.93x10
-2
 0.293 0.101 8.56x10
-4
 0.147 0.082 5.97x10
-2
 0.105 3.15x10
-7
 FTO 
rs7711329 5 65161785 T typed 0.188 0.169 3.48x10
-3
 0.186 0.095 8.08x10
-3
 0.327 0.085 3.88 x10
-3
 0.198 0.071 7.09x10
-2
 0.093 5.61x10
-7
 NLN 
rs11221723 11 128860611 G imp 0.416 0.098 3.30x10
-2
 0.414 0.069 1.61x10
-2
 0.472 0.062 2.29x10
-2
 0.405 0.081 1.16x10
-2
 0.073 3.82x10
-6
 
 
rs777294 2 195844481 G typed 0.270 0.068 1.84x10
-2
 0.256 0.123 1.23x10
-4
 0.112 0.067 0.122 0.249 0.067 5.89x10
-2
 0.088 5.81x10
-6
 
 
rs2341849 2 151632344 T typed 0.246 -0.087 9.20x10
-2
 0.249 -0.025 0.444 0.265 -0.089 4.32x10
-3
 0.245 -0.138 1.76x10
-4
 -0.081 6.83x10
-6
 
 
rs573264 11 113597792 G typed 0.308 0.064 0.178 0.300 0.084 6.51x10
-3
 0.439 0.069 1.09x10
-2
 0.303 0.066 5.39x10
-2
 0.072 1.18x10
-5
 ZBTB16 
rs422084 9 107030743 T typed 0.111 -0.158 2.80 x10
-2
 0.113 -0.106 1.38x10
-2
 0.110 -0.103 1.94x10
-2
 0.103 -0.092 6.56x10
-2
 -0.108 1.21x10
-5
 
 
rs7502947 17 54584498 G typed 0.328 -0.033 0.501 0.320 -0.064 3.44x10
-2
 0.370 -0.068 1.64x10
-2
 0.314 -0.103 1.70x10
-3
 -0.072 1.36x10
-5
 PRR11 
rs3778812 7 137097938 G typed 0.321 -0.082 8.66x10
-2
 0.331 -0.112 1.44x10
-4
 0.304 -0.057 5.83x10
-2
 0.326 -0.036 0.207 -0.072 1.37x10
-5
 DGKI 
rs7136193 12 57603148 T typed 0.055 -0.211 2.94x10
-2
 0.055 -0.194 1.57x10
-3
 0.061 -0.074 0.202 0.050 -0.161 2.45 x10
-2
 -0.148 1.45 x10
-5
 LRIG3 
typed: SNP genotyped in at least 1 SNP-chip; imp: SNP not genotyped in any SNP-chip; MAF: minor allele frequency. 
* Average MAF for SP2 and SDCS derived from data from 3 and 2 SNP-chips used for genotyping, respectively. ‡ Nearest implicated gene in 500kb region surrounding SNP position. 
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4A.4 Z-BMI association results for top hits in replication stage 
 
75 SNP were de novo genotyped using the Sequenom massArray platform in 3,920 adult and 
paediatric samples (MEC, SP2 and SCCS2 adult Malays, SCCS2 adult Chinese, Da Qing 
childhood population from China and Singaporean early-onset extreme obese samples).  
Details of minor allele frequencies (MAF), call-rates and HWE p-values for all 75 SNPs are 
provided in table 2 in Appendix III.  11 SNPs (rs7814835, rs4923728, rs573264, rs11221725, 
rs8077052, rs6715902, rs2341849, rs11671664, rs10930471, rs651748 and rs9291848) that 
had significant deviation from HWE (p-value < 0.05) or call-rates < 0.90 in at least one 
replication cohort were excluded from statistical analyses.   
 
Z-BMI associations for this same set of SNPs were also looked-up, in silico, in an additional 
GWAS dataset (SCES adult Singaporean Chinese cohort).  Association for Z-BMI in 
individual dataset and combined meta-analysis of all replication cohorts is provided in table 3 
in Appendix III.   Eight SNPs were observed to have p-values < 0.05 and consistent beta 
directions for Z-BMI in the combined replication data, with strongest associations at 
rs8050136 and rs7185735 at the FTO locus in chromosome 16 and rs4507392 near the 
LIMCH1 gene in chromosome 4 (table 3 in Appendix III). 
 
Results of top replicating tagging SNPs, r
2
 > 0.8 in CHB and JPT HapMap samples, (with 
similar direction of effects in discovery GWAS and overall meta-analysis p-value ≤ 10-6), 
after linear regression analysis with additional datasets for Z-BMI, are provided in table 4A.3 
(see table 4 in appendix III for complete table of all SNPs that were followed-up).  FTO SNPs 
(rs7185375 and rs8050136) reached genome-wide levels of significance (p-value between 
1.76 x 10
-9
 and 2.55 x 10
-9
).  The second best hit from the initial discovery GWAS, SNPs 
near NLN, failed to replicate (Table 3 in Appendix III) and a regional plot in figure 4A.4 
indicates reduced overall association levels after the replication stage of the GWAS for these 
SNPs.  SNPs from several other genetic loci such as LIMCH1, SLC44A1, LACE1, COL2A1 
and gene desert regions at Chromosome 8 (closest genes SLC39A10 and DNAH7) had 
improved associations after replication stage, but reached only nominal levels of significance 
(overall meta-analysis p-value between 1.87 x 10
-7 
and 8.92 x 10
-6
).   
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Table 4A.3: Individual stage results for top Z-BMI associated tagging SNPs (r
2
 > 0.8 in CHB and JPT HapMap samples and overall meta-analysis p-value ≤ 
10
-6
).  Only the FTO SNP (rs7185735) reached genome-wide levels of significance (p-value < 5 x 10
-8
). See see table 4 in appendix III for complete table of 
all SNPs that were followed-up. 
  
    
Combined de novo 
replication cohorts 
SCES                              
(in silico replication) 
Discovery GWAS Overall meta-analysis 
 
N 3,120 1,861 7,951 12,932 
rsid Chr Position Test allele Beta SE p-value Beta SE p-value Beta SE p-value Beta SE p-value Qp-value Gene* 
rs7185735 16 52380152 G 0.073 0.029 0.013 0.099 0.049 0.044 0.105 0.020 3.15x10
-7
 0.095 0.016 1.76x10
-9
 0.837 FTO 
rs4507392 4 41157169 T 0.092 0.036 0.010 0.090 0.056 0.105 0.100 0.024 3.20x10
-5
 0.097 0.019 1.87x10
-7
 0.703 LIMCH1 
rs328012 9 107077538 C 0.086 0.035 0.013 0.049 0.050 0.322 0.097 0.022 1.93x10
-5
 0.088 0.017 4.08x10
-7
 0.891 SLC44A1 
rs2167065 8 76723009 T 0.039 0.026 0.138 0.099 0.035 0.005 0.066 0.016 4.98x10
-5
 0.064 0.013 4.74x10
-7
 0.104  
rs12526579 6 108922246 G 0.041 0.027 0.120 0.060 0.035 0.087 0.065 0.016 9.89x10
-5
 0.059 0.013 4.71x10
-6
 0.704 LACE1 
rs6447084 4 41226161 T 0.050 0.037 0.181 0.088 0.056 0.113 0.101 0.025 4.99x10
-5
 0.086 0.019 7.90x10
-6
 0.610  
rs2038143 6 56312934 T 0.056 0.034 0.105 0.044 0.043 0.307 0.087 0.021 5.03x10
-5
 0.073 0.017 8.92x10
-6
 0.639 COL21A1 
* Nearest implicated gene in 500kb region surrounding SNP position 
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Figure 4A.4: Chromosomal plot of the NLN region in chromosome 5. Plots show negative log p-value association levels plotted against chromosomal 
position. Red squares: imputed SNPs at discovery GWAS, blue diamonds: genotyped SNPs at discovery GWAS and green triangles: association for overall 
meta-analysis (discovery and replication stages of GWAS).  Six NLN SNPs (circled) were selected for further validation. Rs9291848 was discarded after QC 
procedures. All 5 remaining NLN SNPs had weaker associations after replication. 
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4A.5 Early-onset and extreme obesity association results of top hits in replication stage 
 
Sequenom genotyping results for all SNPs followed up from initial discovery GWAS in the 
Singaporean early-onset and extreme obese cohort is provided in table 4 in Appendix III.  Six 
SNPs (rs11671664, rs651748, rs1729788, rs6894548, rs12526579 and rs16894435) had 
significant deviations from HWE (p-value < 0.05) or low call-rates (< 0.90) in at least one 
replication cohort and thus, were excluded from logistic regression analyses. 
 
There was an overrepresentation of significant loci (p-value < 0.05 at either the Chinese or 
Malay cohorts) that showed directional inconsistencies between the Chinese and Malay 
cohorts (7 out of 8 significant SNPs, Binomial test p-value < 0.001, α = 0.5), including those 
at the FTO locus and thus, individual study results were not combined in a meta-analysis 
(table 5 in Appendix III).   Among the eight SNPs that showed association with Z-BMI in the 
replication stage of the GWAS (table 3 in Appendix III) only the FTO SNPs strongly 
replicated but in only the Singaporean Chinese early-onset cohort (table 4A.4 below, table 5 
in Appendix III provides association details of all SNPs). 
 
Table 4A.4: Association of SNPs with early-onset and extreme obesity that had showed an 
association with Z-BMI in replication stage of GWAS. Rs12526579 was not assessed due to 
significant HWE deviation. 
    
 141 Chinese early-onset obese cases 
and 332 controls 
97 Malay early-onset obese cases 
and 227 controls 
rsid Chr Position 
Test 
allele 
Gene OR (95% CI) p-value OR (95% CI) p-value 
rs8050136 16 52373776 C FTO 0.32 (0.22 – 0.47) 3.72 x 10-9 1.29 (0.88 – 1.88) 0.200 
rs7185735 16 52380152 G FTO 3.08 (2.09 - 4.53) 9.35 x 10
-9
 0.78 (0.54 – 1.14) 0.213 
rs6447084 4 41226161 T  1.07 (0.66 – 1.73) 0.831 0.73 (0.42 – 1.26) 0.242 
rs4507392 4 41157169 T LIMCH1 1.19 (0.76 – 1.88) 0.474 0.74 (0.45 – 1.21) 0.268 
rs328018 9 107073397 T SLC44A1 1.07 (0.67 – 1.71) 0.697 0.95 (0.53 – 1.71) 0.893 
rs328012 9 107077538 C SLC44A1 1.08 (0.69 – 1.69) 0.630 0.98 (0.61 – 1.58) 0.930 
rs2167065 8 76723009 T  1.21 (0.91 – 1.62) 0.271 0.99 (0.70 – 1.40) 0.955 
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4A.6 GWAS of extremes of BMI as compared to normal controls in East-Asian populations 
 
With a hypothesis that individuals at the extremes of BMI spectrum would be enriched for obesity 
predisposing variants I performed GWAS analysis in all adult East-Asian datasets from Singapore 
(SP2, SDCS, SiMES and SCES), defining obese cases as those with a BMI > 30 kg/m
2 
and normal 
controls as individuals with a BMI between 18.5 kg/m
2 
and 23.5 kg/m
2
.  QQ plots of observed p-
values as compared to expected levels after GC adjustment in each dataset are provided in figure 
4A.5.  Even after meta-analysis of all datasets (929 obese cases and 3,232 normal controls) top 
observed p-values were not greater than expected (figure A5.5). 
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Figure 4A.5: QQ plots comparing negative log observed Z-BMI p-value associations in y-axis and negative log expected associations in x-axis. P-values in 
individual datasets have been adjusted for genomic inflation. Analyses for SP2 and SDCS performed chip-wise and subsequently combined to get overall study 
estimates. A) QQ plot for SP2 (90 obese cases and 1,283 normal controls, λ=1.010 – 1.024). B) QQ plot in SDCS (210 obese cases and 610 normal controls, 
λ=1.015 – 1.029). C) QQ plot in SiMES (529 obese cases and 631 normal controls, λ=1.014). D) QQ plot in SCES (99 obese cases and 708 normal controls, 
λ=1.002). E) QQ plot after meta-analysis (fixed effects) (929 obese cases and 3,232 normal controls). Obese cases defined as BMI > 30 kg/m2 and normal controls 
defined as BMI between 18.5 kg/m2 and 23.5kg/m
2
. 
 
 
A) B) C) 
D) E) 
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4A.7 GWAS of central obesity measures in SP2 adult Chinese dataset 
 
Linear regression was performed for Z-WHR and Z-WC associations in SP2.  Figure 4A.6 details 
QQ plots of observed associations as compared to expected levels in the study.  These analyses 
were further adjusted for overall adiposity (BMI) to detect any independent associations (figure 
4A.6) and as there is strong evidence for sexual dimorphism in fat distribution [110], analyses were 
repeated stratifying for sex (figure 4A.7).  In all analyses, top observed association p-values were 
weaker than expected values, except in SP2 female associations with WHR (before and after BMI 
adjustments) and in WC after adjustment for BMI (figure 4A.7A, B and D).  Nevertheless these top 
SNPs did not reach genome-wide levels of significance and details of top SNPs (p-value ≤ 10-7) for 
WC and WHR associations in females are provided in table 6 of Appendix III. 
 
Figure 4A.6: QQ plots comparing negative log observed p-value association in y-axis and negative log 
expected associations in x-axis for Z-WHR and Z-WC association in SP2 (male and females combined).  
Analyses were conducted chip-wise (3 chips) in SP2 and combined in a meta-analysis. P-values have been 
adjusted for genomic inflation. A) QQ plot for Z-WHR in SP2 (N=2,429, λ=1.001 – 1.002). B) QQ plot Z-
WC in SP2 (N=2,429, λ=1.016 – 1.027). C) QQ plot for Z-WHR in SP2 adjusted for BMI (N=2,429, 
λ=1.001 – 1.002). D) QQ plot for Z-WC in SP2 adjusted for BMI (N=2,429, λ=1.011 – 1.016). 
A) B) 
C) D) 
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Figure 4A.7: QQ plots comparing negative log observed p-value association in y-axis and negative log expected associations in x-axis for Z-WHR and Z-WC 
association in SP2 stratified for sex.  Analyses were conducted chip-wise (3 chips) in SP2 and combined in a meta-analysis. P-values have been adjusted for 
genomic inflation. A) QQ plot for Z-WHR in SP2 females (N=1,298, λ=1.007 – 1.022). B) QQ plot Z-WHR in SP2 females adjusted for BMI (N=1,298, λ=1.006 – 
1.027). C) QQ plot for Z-WC in SP2 females (N=1,298, λ=1.004 – 1.009). D) QQ plot for Z-WC in SP2 females adjusted for BMI (N=1,298, λ=1.008 – 1.026).    
E) QQ plot for Z-WHR in SP2 males (N=1,131, λ=1.004 – 1.016). F) QQ plot for Z-WHR in SP2 males adjusted for BMI (N=1,131, λ=1.008 – 1.013). G) QQ plot 
for Z-WC in SP2 males (N=1,131, λ=1.002 – 1.003). H) QQ plot for Z-WC in SP2 males adjusted for BMI (N=1,131, λ=1.002 – 1.006). 
 
A) B) 
E) F) H) G) 
D) C) 
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4B.1 Introduction 
 
Even after assessing close to 13,000 East-Asian samples, GWAS analyses using the 
Singaporean datasets alone did not unravel novel loci associated with obesity, besides the 
FTO locus.  Increasing sample size in the discovery GWAS stage would therefore, be 
necessary to further increase power to detect true variants associated with obesity among 
East-Asians.  In this section, I provide results from two East-Asian consortia-based GWAS 
that I was involved in, which led to discoveries of novel obesity loci.  The principle 
motivation for this collaborative work was to drastically increase sample size and improve 
power by pulling together summary statistics from several GWAS studies.   
 
The main consortium that I worked closely with was the Asian Genetic Epidemiology 
Network (AGEN) and we had aimed to assess for Z-BMI associations among East-Asians.  
This involved, in total, 82,048 samples from 21 datasets using a 3-stage study design.  Figure 
4B.1 details all datasets used in this study.  Singaporean cohorts were analysed at all three 
stages (SP2, SDCS and SiMES in initial discovery stage, SCORM in in silico replication 
stage and SCCS2, MEC and SP2 samples were used for de novo replication) as indicated in 
figure 4B.1.  We decided that all sites would perform analyses (using genotyped and imputed 
SNPs) for datasets individually and submit GC-adjusted summary statistics to a central site 
(Vanderbilt University), for meta-analyses to be performed (assuming a fixed effect model).  
For this study, I re-analysed all the Singaporean datasets as we had decided to further include 
age-squared as a covariate in linear regressions to adjust for the non-linear relationship 
between BMI and age.  We further examined all previously identified obesity loci (from 
initial European GWAS studies [99]) among East-Asians and carried out secondary analyses, 
namely sex and population stratified and conditional probability analyses to confirm and 
further characterise novel loci that were identified. 
 
The second consortium-based analysis was led by the RIKEN group in Japan.  The discovery 
stage of the study included only Japanese participants in this study.  Singapore datasets (SP2, 
SDCS and SiMES only) were involved in the second replication stage of this study (with an 
initial replication using Japanese subjects only).  Statistical methodology for Z-BMI 
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association was similar as in AGEN.  The RIKEN group also performed a genome-wide gene 
x gene interaction analysis during the discovery stage and replications of this interaction were 
sought in additional East-Asian samples. 
 
Figure 4B.1: Study design of the Asian Genetic Epidemiology Network (AGEN) consortium for 
analysis of Z-BMI in East-Asians. Singapore datasets are indicated in bold 
 
 
Figure 4B.2: Study design of the RIKEN analysis of Z-BMI in East-Asians. Singapore datasets are 
indicated in bold. 
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4B.2 Association levels with Z-BMI at discovery stage of AGEN study 
 
Figure 4B.3, indicates top SNPs identified from stage 1 (discovery stage) of the AGEN study 
and location of replicating index obesity SNPs (from initial European studies).  798 SNPs had 
p-values < 1 x 10
-4
 from the combined meta-analysis data of eight GWAS studies included in 
stage 1 and these were brought forward for additional follow-up.  Previously identified index 
SNPs at FTO (rs17817449, p-value = 6.13 x 10
-12
) and SEC16B (rs574367, p-value = 2.38 x 
10
-11
) reached genome-wide levels of significance in stage 1 data.  Index SNPs at seven other 
obesity loci (MC4R, MAP2K5, ADCY3, TFAP2B, BDNF, GIPR and GNPDA2) reached more 
nominal levels of significance (p-value between 0.015 and 6.18 x 10
-8
) with Z-BMI among 
the East-Asian stage 1 samples.   
 
Figure 4B.3: Manhattan plot of negative log meta-analysis p-value after combining results from eight 
datasets used in stage 1 of the AGEN study. Blue threshold line indicates p-value = 0.05. Index SNPs 
from nine previously identified obesity loci (indicated in red), first identified in Europeans replicated 
among the East-Asian samples. SNPs above orange threshold line (p-value = 1x10
-4
) were selected for 
replication in additional datasets in replication stage (stage 2) of the study. Loci indicated in blue 
eventually reached or were close to genome-wide levels of significance (green threshold line) in the 
AGEN study. 
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4B.3 Replication results of top hits in AGEN study 
 
We meta-analysed association levels from stage 1 and 2 for the 798 SNPs that were followed-
up.  SNPs from the same nine previously identified obesity loci (from European GWAS 
studies, detailed above) that were seen to replicate in stage 1 and SNPs in or near four 
additional novel loci [CDK5 regulatory subunit associated protein 1 (CDKAL1), prohormone 
convertase 1 (PCSK1), glycoprotein 2 (GP2) and paired box 6 (PAX6)] reached or were close 
to genome-wide levels of significance (stage 1 and 2 meta-analysis p-values between 4.6 x 
10
-27 
and 2.24 x 10
-7
).  Table 4B.1 below details association levels at each stage of the AGEN 
study for top SNPs at these 13 loci.  
 
Additional de novo replication was performed in stage 3 samples for novel loci identified in 
our study.  Top SNPs from GIPR, ADCY3 and MAP2K5 were included in stage 3 although 
they had been identified in the most recent European GWAS for BMI association [99] as at 
the time our study was conducted these loci had not yet been identified as obesity risk loci.  
The direction of associations were consistent for all four novel loci identified in this study 
although, only the CDKAL1 SNP (rs9356744) was significantly associated with Z-BMI in the 
stage 3 East-Asian samples (p-value = 3.02 x 10
-3
) (table 4B.1).  Meta-analyses results from 
all three stages showed that SNPs in or near CDKAL1, PCSK1 and GP2 reached genome-
wide levels of significance (overall p-value ≤ 1.02 x 10-8), while the SNP near PAX6 was 
close to genome-wide levels (overall p-value = 7.65 x 10
-8
) (table 4B.1). 
 
No significant heterogeneity due to sex or populations (Chinese, Japanese, Korean and Malay 
populations) were detected in this study (Qp-value > 0.1) for the newly identified loci.  We 
further performed analyses after excluding subjects with chronic disease (cancer or diabetes) 
and also conducted a case-control study (dichotomizing samples at BMI = 27.5 kg/m
2
 [37]), 
to assess if these loci could still be detected. Similar associations were detected from these 
analyses, although significance levels were decreased due to reduced sample size (table 7 in 
Appendix III).   
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Table 4B.1: Association levels at each stage of the AGEN study for loci identified to be associated with East-Asian individuals in the AGEN study. 
Association for these SNPs in only the Singapore studies (meta-analysis of all GWAS and de novo replication datasets) are included for these SNPs for 
comparison. Genome-wide significant loci (p-value < 5x10
-8
) indicated in bold. 
      
p-value* 
 
Nearest 
gene 
Chr rsid 
Risk 
allele 
RAF Beta (SE)
†
 
Stage 1 
(N=27,715) 
Stage 2 
(N=36,691) 
Meta-analysis 
Stage 1 and 2 
(N=64,406) 
Stage 3 
(N=17,642) 
Meta-analysis 
Stage 1, 2 and 3 
(N=82,048) 
Singapore
‡ 
 
(N=10,652) 
Explained 
Variance 
(%)
 †
 
Previously identified BMI loci 
FTO 16 rs17817449 G 0.17 7.92(1.06) 6.13x10
-12
 8.18x10
-14
 4.60x10
-27
 
 
4.60x10
-27
 
 
0.18 
SEC16B 1 rs574367 T 0.20 5.93(0.92) 2.38 x10
-11
 1.28x10
-10
 9.47x10
-20
 
 
9.47x10
-20
 
 
0.11 
MC4R 18 rs6567160 C 0.21 5.51(0.93) 6.92x10
-8
 3.35 x10
-9
 2.76x10
-15
 
 
2.76x10
-15
 
 
0.10 
GIPR 19 rs11671664 G 0.50 4.22(0.76) 1.29x10
-5
 2.57x10
-8
 2.80x10
-12
 0.003 5.93x10
-14
 7.69x10
-4
 0.09 
ADCY3 2 rs6545814 G 0.45 3.26(0.76) 1.20x10
-5
 1.62x10
-5
 1.62x10
-9
 1.05x10
-5
 1.35x10
-13
 0.007 0.05 
BDNF 11 rs6265 C 0.44 4.97(0.83) 1.18x10
-5
 2.72x10
-9
 3.56x10
-13
 
 
3.56x10
-13
 
 
0.12 
MAP2K5 15 rs4776970 A 0.22 2.55(0.90) 1.10x10
-6
 4.63x10
-3
 2.24x10
-7
 0.003 2.33x10
-9
 0.006 0.02 
GNPDA2 4 rs10938397 G 0.29 3.72(0.85) 1.60x10
-3
 1.30x10
-5
 9.69x10
-8
 
 
9.69x10
-8
 
 
0.06 
TFAP2B 6 rs4715210 T 0.21 3.05(0.91) 1.12x10
-5
 7.64x10
-4
 1.61x10
-7
 
 
1.61x10
-7
 
 
0.03 
Newly identified BMI loci 
CDKAL1 6 rs9356744 T 0.58 3.39(0.76) 3.21x10
-5
 7.67x10
-6
 8.01x10
-9
 0.003 2.00x10
-11
 0.005 0.06 
PCSK1 5 rs261967 C 0.41 3.77(0.77) 1.22x10
-5
 9.36x10
-7
 8.76 x10
-10
 0.856 5.13x10
-9
 0.006 0.07 
GP2 16 rs12597579 C 0.80 4.09(0.96) 7.13x10
-5
 2.07 x10
-5
 4.76 x10
-8
 0.145 1.02x10
-8
 3.36x10
-4
 0.05 
PAX6 11 rs652722 C 0.61 2.75(0.77) 2.84x10
-5
 3.70 x10
-4
 5.30x10
-8
 0.189 7.65x10
-8
 0.002 0.04 
*p-value adjusted for GC in individual studies and after meta-analysis.  † from stage 2 data only. ‡meta-analysis of all Singaporean GWAS datasets (SP2, SDCS, SiMES, SCORM) and de novo 
replication cohorts (SCCS2, MEC and SP2). RAF: Risk allele frequency. Beta expressed as % deviation of BMI in study. 
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Although still statistically significant, association levels for the newly identified loci in only 
the Singaporean datasets (meta-analysis of all Singaporean GWAS and de novo replication 
cohorts used in the AGEN study) were drastically weaker (p-values between 3.36 x 10
-4
 and 
0.002) as compared to the full AGEN association results (table 4B.1).  We had approximately 
85% and 62% power to detect variants with effect sizes of at least 3% of the standard 
deviation (SD) of BMI (approximate effect sizes of novel variants identified in the stage 2 of 
the AGEN study) and MAF of 0.20 at α = 0.05 in stage 1 and 2 of the AGEN study, 
respectively, while power to detect BMI-associated variants of similar effect sizes and allele 
frequencies using only the Singaporean datasets used in this study was 40% (α = 0.05).   
 
4B.4 Conditional analysis at ADCY3, MAP2K5 and GIPR loci 
 
At the ADCY3, MAP2K5 and GIPR loci where we had detected loci with genome-wide levels 
of associations in AGEN in parallel to the GWAS study in Europeans [99], we assessed the 
possibility of independent associations at these loci for index SNPs from each other.  
Association analyses at these specific loci were repeated for index SNPs detected in AGEN 
with further adjustments for the genotypes of index SNPs detected in Europeans (and vice 
versa).  Table 4B.2 details association levels in AGEN (meta-analysis of stage 1 and 2) 
before and after adjustments for index SNPs at these three loci.   
 
At the ADCY3 and MAP2K5 loci, index SNPs identified in East-Asians and Europeans 
showed a moderate degree of LD (r
2
 > 0.53, table 4B.2).  However the LD of index SNPs 
(rs11671664 in East-Asians and rs2287019 in Europeans) were poor at the GIPR locus        
(r
2
 = 0.03 and 0.26 in East-Asians and Europeans, respectively) and conditional probability 
analysis at the SNP identified in AGEN (rs11671664) indicated genome-wide significance 
even after adjustments for the European index SNP (rs2287019) (table 4B.2). 
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Table 4B.2: Z-BMI association of index SNPs at ADCY3, MAP2K5 and GIPR in AGEN meta-analysis of stage 1 and 2 before and after conditional 
probability analyses. Conditional probability analyses for AGEN index SNPs performed by adjustment of genotypes of index SNPs from European study. 
   
Association for SNP without 
adjustment for genotypes 
Association for SNP after adjustment 
for genotype of index SNP 
Risk allele frequency 
LD between           
index SNPs (r
2
) 
Locus Index SNPs Risk allele Beta p-value Beta p-value East-Asian European East-Asian European 
ADCY3 
rs6545814
*
 G 3.66 1.62x10
-9
 3.81 0.002 0.45 0.42 
0.742 0.683 
rs713586
†
 C 2.72 3.82x10
-5
 0.96 0.484 0.50 0.47 
MAP2K5 
rs4776970
*
 A 3.91 2.24x10
-7
 3.64 0.001 0.22 0.62 
0.533 0.536 
rs2241423
†
 G 3.06 8.28x10
-7
 1.41 0.185 0.38 0.80 
GIPR 
rs11671664
*
 G 4.78 2.80x10
-12
 4.38 2.41x10
-10
 0.50 0.92 
0.026 0.264 
rs2287019
†
 C 1.86 0.034 0.53 0.638 0.79 0.83 
* Index SNP identified from AGEN study. † Index SNP identified in Europeans [99]. Allele frequencies and LD from HapMap samples. Beta expressed as % deviation of BMI in study 
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4B.5 Associations of SNPs with Z-BMI in the discovery and replication stages of the 
RIKEN study 
 
11 SNPs with p-values < 1 x 10
-5
 after meta-analysis of Japanese samples from discovery 
GWAS stage and replication stage 1 (N = 30, 383) were brought forward for further 
assessment by the RIKEN group.  These SNPs were, in silico, assessed in replication stage 2 
which included data from three Singaporean GWAS studies (SP2, SDCS and SiMES).  Table 
4B.3 details Z-BMI association results of all SNPs with significant associations in the 
replication phase of the RIKEN study that reached overall genome-wide levels of 
significance.  
 
SNPs from five previously identified loci (FTO, BDNF, GIPR, MC4R and SEC16B) reached 
genome-wide levels of significance (meta-analysis p-value between 4.8 x 10
-22
 and 3.9 x 10
-9
, 
table 4B.3) in the RIKEN study.  Two novel loci in or near CDKAL1 (rs2206734, meta-
analysis             p-value = 1.4 x 10
-11
) and Kruppel-like factor 9 (KLF9) (rs11142387, meta-
analysis p-value = 1.3 x 10
-11
) were also identified with genome-wide levels of significance 
in this study (table 4B.3).  The CDKAL1 locus was the same locus that was also detected for 
Z-BMI association in AGEN and the index SNP identified in RIKEN (rs2206734) and the 
index SNP from AGEN (rs9356744) were in strong LD in East-Asian populations (HapMap 
CHB and JPT reference panels, r
2
 > 0.90). 
 
The RIKEN group had also performed genome-wide (using 2,178,018 imputed and 
genotyped SNPs) gene-gene interaction analyses at the seven index SNPs that reached 
genome-wide levels of significance, assuming additive × additive effects of two SNPs.  QQ 
plots of observed interaction p-values as compared to expected levels are provided in figure 1 
of Appendix III.  At only the KLF9 locus were there marginally stronger interaction p-values 
than expected.   
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Table 4B.3: Z-BMI association levels at discovery and replication stages for SNPs that reached genome-wide levels of significance in the RIKEN study. 
Genome-wide significant associations in bold. 
     
Discovery GWAS           
(N = 26,620) 
Combined replication stages 
(N=35,625) 
Overall meta-analysis 
(N=62,245) 
Explained 
variance
*
 
rsid Position 
Implicated 
Gene 
Risk 
allele 
RAF Beta (SE) p-value Beta (SE) p-value Beta (SE) p-value 
rs12149832 16q12 FTO A 0.20 0.056 (0.011) 3.2×10
-7
 0.090 (0.011) 5.1×10
-17
 0.073 (0.008) 4.8×10
-22
 0.20 
rs2030323 11p14 BDNF C 0.60 0.054 (0.008) 1.3×10
-9
 0.040 (0.008) 1.8×10
-7
 0.046 (0.006) 3.8×10
-16
 0.08 
rs11671664 19q13 GIPR G 0.45 0.051 (0.008) 7.4×10
-9
 0.041 (0.009) 5.6×10
-6
 0.046 (0.006) 6.8×10
-14
 0.08 
rs2206734 6p22 CDKAL1 C 0.59 0.043 (0.008) 8.3×10
-7
 0.035 (0.008) 6.2×10
-6
 0.039 (0.006) 1.4×10
-11
 0.06 
rs2331841 18q21 MC4R A 0.25 0.045 (0.011) 1.2×10
-5
 0.047 (0.009) 1.9×10
-7
 0.046 (0.007) 1.8×10
-11
 0.08 
rs11142387 9q21 KLF9 C 0.46 0.048 (0.008) 4.6×10
-8
 0.028 (0.011) 0.0084 0.040 (0.007) 1.3×10
-9
 0.04 
rs516636 1q25 SEC16B A 0.22 0.053 (0.011) 4.2×10
-7
 0.044 (0.014) 0.0014 0.050 (0.008) 3.4×10
-9
 0.07 
* Estimated BMI variance explained from combined replication samples.  Combined replication stages include stage 1 replication (3,763 Japanese from BioBank) and stage 2 
replication (31,862 East-Asians from nine GWAS).  
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4B.6 Replication of gene-gene interaction association in replication studies 
 
The top interaction term in the discovery stage of the RIKEN study, was observed between 
the KLF9 index SNP (rs11142387) and a SNP (rs13034723) at the myostatin gene (MSTN) 
(rs11142387 x rs13034723, interaction p-value = 1.0 x 10
-6
, table 4B.4).   These analyses 
were performed by including the two SNPs as well as the interaction term in linear regression 
models.  Single SNP associations in the RIKEN study for the MSTN SNP (rs13034723) did 
not reach genome-wide levels of significance, however the interaction with KLF9 was 
replicated in additional East-Asian samples, reaching an overall genome-wide interaction p-
value (1.7 x 10
-8
, table 4B.4).   
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Table 4B.4: Gene–gene interaction association for Z-BMI between index SNPs at KLF9 and MSTN loci at discovery GWAS and replication stages. Linear 
regression model included rs11142387 (KLF9), rs13034723 (MSTN) and rs11142387xrs13034723 terms in each stage of study. Singaporean subjects included 
East-Asian populations from SiMES, SP2 and SDCS. 
    
Discovery GWAS                               
(N = 26,620) 
Replication in additional 
Japanese subjects                            
(N=7,910) 
Replication in Singaporean 
subjects *                           
(N=6,875) 
Overall meta-analysis 
(N=34,530) 
rsid Position Gene 
Risk 
allele 
Beta (SE) p-value Beta (SE) p-value Beta (SE) p-value Beta (SE) p-value 
rs11142387 9q21 KLF9 C 0.09 (0.012) 8.3×10
-14
 0.12 (0.027) 1.7×10
-5
 0.05 (0.030) 0.095 0.09 (0.010) 3.6×10
-17
 
rs13034723 2q32 MSTN A -0.07 (0.015) 2.8×10
-5
 -0.07 (0.029) 0.018 -0.02 (0.013) 0.128 -0.044 (0.010) 1.8×10
-6
 
rs11142387 
× 
rs13034723 
- - - 0.06 (0.013) 1.7×10
-6
 0.07 (0.025) 0.003 0.04 (0.029) 0.083 0.06 (0.012) 1.7×10
-8
 
* Meta-analysis results from SiMES, SP2 and SDCS Singaporean East-Asian datasets. 
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4B.7 Evaluation of novel loci in European samples 
 
Transferability of obesity loci (identified to be associated with BMI in East-Asians from the 
AGEN and RIKEN study) among populations of European ancestry were subsequently 
analysed, in silico, utilizing GWAS data from the GIANT consortium (table 4B.5).  
Significant (p-value < 0.05) and directionally consistent associations were observed at index 
East-Asian SNPs of PCSK1 and GP2 loci among the European samples.  At the CDKAL1 
locus, significant associations were observed for the SNP identified in the RIKEN study 
(rs2206734, p-value = 0.005) but not for the SNP identified from AGEN (rs9356744,           
p-value = 0.186).  Although these CDKAL1 SNPs were in strong LD in East-Asians              
(r
2
 > 0.90, HapMap CHP and JPT populations) correlation was poor in Europeans (r
2
 = 0.39, 
HapMap CEU) and thus, the different LD pattern index SNPs and the unidentified causal 
SNP in Europeans could have brought about the varied associations (as compared to East-
Asians).  At the KLF9 index SNP, association in Europeans was not statistically significant 
(table 4B.3). 
 
Table 4B.5: Association of novel BMI associated SNPs (at genome-wide significance levels) among 
the GIANT European population.  
    
 European samples from GIANT consortium                   
(N=123,864) 
Gene Chr rsid Test allele RAF Beta (SE) p-value 
Explained Variance 
(%) 
Index SNPs detected from AGEN study 
CDKAL1 6 rs9356744 T 0.64 0.67 (0.51) 0.186 0.00 
PCSK1 5 rs261967 C 0.43 1.50 (0.47) 0.002 0.01 
GP2 16 rs12597579 C 0.90 2.86 (1.10) 0.009 0.01 
Index SNPs detected from RIKEN study 
CDKAL1 6 rs2206734 C 0.80 1.12 (0.47) 0.005 0.02 
KLF9 9 rs11142387 C 0.47 0.41 (0.52) 0.500 0.00 
  Beta expressed as % deviation of BMI in study 
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4.2 Discussion 
 
In my initial evaluation for novel loci pre-disposing to obesity among East-Asians I had 
utilized cohorts that were only available in Singapore.  In the discovery stage, high resolution 
GWA scans were performed on pediatric and adult Singaporean Chinese and Malay samples 
to detect genetic regions associated with BMI and top hits were followed-up in additional 
independent East-Asian childhood and adult samples for validation.  Data from these efforts 
highlighted a strong association at the FTO region in all datasets, reaching robust genome-
wide significance (p-value < 5 x 10
-8
) in the combined meta-analysis.  These results serve to 
corroborate the role of FTO with obesity from youth through to adulthood among East-Asian 
populations. 
 
Variants downstream of the NLN gene on chromosome 5 were detected as the second best hit 
at the discovery GWAS stage.  NLN encodes the metallopeptidase, neurolysin, which is a 
known regulator of neurotensin.  Neurotensin is a neuropeptide involved with appetite control 
[181] and therefore, NLN was a strong candidate for biological relevance to obesity.  
However, all NLN SNPs selected for follow-up in the replication stage of the Singaporean 
GWAS study failed to replicate and overall association levels (meta-analysis of discovery and 
replication results) weakened.  Therefore, although NLN represented a plausible candidate, 
the failure to replicate suggests that these variants were probably false-positive findings, 
generated by multiple-testing during the discovery stage of the GWAS [182] and this 
highlights the importance of validating and confirming initial leads during GWAS. 
 
Nevertheless, variants from several novel regions that were followed up in additional samples 
replicated with more suggestive overall association levels (overall meta-analysis p-value 
approximately 10
-7 
- 10
-6
) and further studies would be needed to confirm these new findings.  
These included variants in or near LIMCH1, SLC44A1 and a gene desert region at 
Chromosome 8.  Unlike NLN, the relationship of LIMCH1 and SLC44A1 with obesity is not 
obvious.  LIMCH1 has not been extensively characterised and SLC44A1 is a choline 
transporter involved in cholinergic neuron development [183].  None of these variants were 
associated with early-onset and extreme obesity in the Singaporean case-control study and it 
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may be possible that biological mechanisms of early-onset obesity could be highly different 
to those of common obesity [99].    
 
Despite analysing a relatively large (but still modest) number of samples (approximately 
13,000 in total) for Z-BMI associations in my initial GWAS study, I was unable to detect 
additional obesity associated loci, besides the FTO region.  While I was limited by issues of 
time and completion of genotyping in the Singaporean datasets, one possibility for the lack of 
robust signals could lie in the study design that I had adopted.  While the combination of 
Chinese and Malay samples was necessary to increase power, this strategy may have 
introduced heterogeneity in the combined results (although genetically these populations 
were determined to be highly similar, see section 2.4.1 in Chapter 2).  Inclusion of the 
SCORM paediatric cohort together with adults in the discovery stage could have further 
brought about additional heterogeneity in the study as genetic basis of paediatric and adult 
obesity differs [99].  Nevertheless, common obesity loci identified in adults have replicated 
well in younger populations, including the SCORM cohort [123].  Furthermore several loci, 
such as FTO and MC4R are known to have stronger effects in childhood datasets and it may 
be possible that the reduced environmental exposure in younger samples may, in fact, 
improve power to detect genetic associations [123]. 
 
Another possibility for the lack of robust associations in my initial GWAS study could be that 
there remain no additional variants or aptly named ‘low-hanging fruits’, with sufficiently 
large enough effect sizes and allele frequencies among East-Asian populations that would 
have enabled detection in a moderately sized study.  It has to be acknowledged that I was 
considerably underpowered to detect variants with modest effect sizes in my initial study.  
For example, I had approximately 42% power to detect variants with half the effect sizes of 
index FTO SNPs (approximate change in BMI of 0.2 kg/m
2 
seen in both Europeans and 
Asians) and minor allele frequency of 0.1, at α = 0.05 in the discovery stage of the 
Singaporean GWAS study for BMI association. 
 
Assessments for obesity loci using an alternative study design (obese cases compared to 
normal controls) in all available Singaporean GWAS datasets did not indicate any robust 
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signals for further follow-up.  Assessments for abdominal obesity traits available in only the 
SP2 adult Singaporean Chinese dataset indicated similarly sobering results, although 
preliminary data identified stronger associations with WHR and WC in females, consistent 
with previous studies [110].   
 
From my initial Singaporean GWAS analysis for obesity, it was clear that identifying 
common variants associated with BMI in East-Asians would require substantially larger 
sample sizes to improve power for detecting variants that were likely to have modest to small 
effect sizes, similar to those that have been detected from consortium-based efforts using 
European population GWAS data [97-99].  Augmenting sample size was the primary goal for 
collaborating in the AGEN and RIKEN consortium-based studies that were aimed at 
detecting BMI associated loci in East-Asians.  In the discovery stage of these East-Asian 
consortia, we had over 88% power to detect variants with half the effect sizes of index FTO 
variants (approximate change in BMI of 0.2 kg/m
2) and minor allele frequency of 0.1, at α = 
0.05. 
 
With the substantial increase in sample size, the AGEN and RIKEN consortium-based efforts 
successfully identified and confirmed BMI associations at five index SNPs from four novel 
genomic regions (in or near CDKAL1, PCSK1, GP2, KLF9) in East-Asian populations.  An 
additional locus near PAX6 showed suggestive associations but did not reach robust genome-
wide levels in the AGEN study.   Our conditional probability analyses at the GIPR locus 
(detected in parallel to European GWAS) further highlighted an additional robust association 
that was independent of the index SNP detected in European populations. 
 
Leveraging on the genome-wide data, we further observed nine previously identified loci 
from European GWAS studies (in or near FTO, SEC16B, MC4R, GIPR, ADCY3, BDNF, 
MAP2K5, GNPDA2 and TFAP2B) that reached or were close to genome-wide levels of 
significance among the East-Asian populations.  These replications serve to firmly 
corroborate the role of these loci as obesity risk variants among populations that were not 
European.   
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As expected, all novel loci identified from the AGEN and RIKEN studies were observed to 
have very modest effect sizes (explaining between 0.04% and 0.07% of BMI variation 
individually) and in combination only explain approximately 0.22% of BMI variation in East-
Asians (about the same variance explained by the FTO locus alone in East-Asians).  This 
further confirms that the lack of robust associations in my initial GWAS study using 
Singaporean datasets alone was primarily due to inadequate power to detect such modest 
associations.   
 
Three of the four novel loci (CDKAL1, PCSK1 and GP2) identified from AGEN and RIKEN 
were seen to be transferable to non-East-Asian populations and replicated among European 
samples available in the GIANT consortium.  However the effect sizes of these variants 
tended to be smaller and the variance in BMI explained were lower in Europeans as 
compared to East-Asians (between 0.01% and 0.02% in Europeans), highlighting why these 
variants were not identified in large-scale European GWAS [99].  Only the index CDKAL1 
SNPs detected in RIKEN (rs2206734) replicated in Europeans.  However, ethnic specific 
differences in LD structure (from HapMap CEU, CHB and JPT data) were determined 
between the two index CDKAL1 SNPs in Europeans (r
2
 = 0.39) and East-Asians (r
2
 > 0.90), 
indicating that the true functional SNP encoding risk for obesity at this region is in LD with 
both rs9356744 and rs2206734 in East-Asians but only with rs2206734 in populations of 
European ancestry.   
 
The KLF9 SNP (rs11142387) however did not replicate among the European samples tested 
despite similar risk allele frequencies in East-Asians and Europeans (0.47 in East-Asians and 
0.48 in Europeans) and despite being adequately powered (99% power to detect associations 
at rs1114238 with effect sizes observed in the RIKEN study and MAF seen among 
Europeans, at α = 0.05) and therefore, may represent a loci specific for obesity predisposition 
in only East-Asians.  
 
Although the precise causal genes (or variants) could not be determined with GWAS data 
alone from the East-Asian studies, putative genes observed near or at the chromosomal 
positions of identified SNPs were interesting.  The most strongly associated novel genomic 
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region for Z-BMI in both the AGEN and RIKEN studies was observed at the CDKAL1 gene, 
which is a well-characterised locus for T2D risk [184], and is known to be involved with 
insulin secretion [185].  Given the strong link between T2D and obesity, one concern was a 
possibility of confounding of association results due to the inclusion of diabetic patients in 
the study.  However, re-analyses after exclusion of diabetic cohorts still indicated a robust 
association with Z-BMI at the CDKAL1 locus (rs9356744, p-value = 4.01 x 10
-8
 in AGEN, 
table 6 in Appendix III) and therefore the association at the CDKAL1 locus with BMI in East-
Asians was unlikely to be driven by patients with diabetes.    
 
The nearest gene from the novel SNP (rs261967) identified in chromosome 5 was PCSK1 
(81.3 kb away).  The PCSK1 gene is a type I pro-insulin processing enzyme that plays a key 
role in regulating insulin biosynthesis [186] and rare mutations at this gene cause severe 
Mendelian forms of obesity [52, 59].  More recently, a candidate-gene study in Europeans 
reported two common non-synonymous coding variants (rs6234, rs6235) in PCSK1 that were 
associated with obesity [187].  These SNPs however, were not associated with obesity among 
East-Asians in the AGEN study (p-value = 0.151 and 0.189 for rs6234 and rs6235, 
respectively) and were not correlated with the SNP that was identified in our study (r
2
 = 0 in 
CHB and CEU of HapMap).  Therefore the SNP near PCSK1 identified in this study 
represents a novel locus for common obesity. 
 
The nearest gene to rs12597579 on chromosome 16 was GP2 (63.9 kb away).  The role of the 
protein encoded by this locus in the pathogenesis of obesity is unclear and mutations at GP2 
have been known to cause pancreatitis [187].  An interesting observation from the putative 
novel obesity genes detected from the East-Asian consortia studies was that most of these 
genes seemed to implicate insulin associated processes (CDKAL1 is involved with insulin 
secretion at the pancreas, PCSK1 is known to process pro-insulin and GP2 is involved in 
pancreatitis), suggesting the importance of insulin-associated pathways in common obesity 
predisposition, especially among East-Asian populations.  
 
The rs11142387 variant located just upstream of the KLF9 gene (1 kb away), represents 
another plausible biological candidate for obesity and highlights an alternative mechanism for 
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common obesity at the adipocyte level.  This gene is a member of zinc-finger transcription 
factors involved in the regulation of various physiological processes and a recent study 
indicated KLF9 as a pro-adipogenic transcription factor, acting through the trans-activation of 
peroxisome proliferator-activated receptor gamma (PPARγ) [188].  In the RIKEN study, we 
further detected a gene-gene interaction between the KLF9 locus and a SNP at the MSTN 
gene (rs13034723).  MSTN is a member of the transforming growth factor-beta (TGFβ) 
superfamily and is involved in the maintenance of muscle mass [189-190].  Thus, this 
interaction implicates a role for the homeostatic balance of muscle and fat mass regulation in 
common obesity predisposition among East-Asians. 
 
To conclude, my initial GWAS analyses for obesity associated loci using available 
Singaporean datasets, detected robust associations at only the FTO locus.  This highlighted 
the need for larger sample sizes to be adequately powered to detect obesity risk variants that 
were likely to have modest to small effect sizes.  The consortia-based (AGEN and RIKEN) 
GWAS for BMI association among East-Asian populations addressed this power issue and 
signified the value of performing such studies in non-European populations.  With improved 
sample sizes, we were able to identify novel obesity loci at four genomic regions (CDKAL1, 
PCSK1, GP2 and KLF9).  The majority of these novel loci highlighted an importance for 
insulin-associated processes in obesity risks and were transferrable to populations of 
European ancestry (CDKAL1, PCSK1 and GP2).  The KLF9 loci did not replicate in 
Europeans and may represent an East-Asian specific obesity locus.  All the novel loci 
identified however, were observed with very modest effect sizes in East-Asians (and even 
smaller effects among European samples) and do not explain a major proportion of overall 
variation in BMI.  This suggests that several other obesity risk loci remain to be unravelled. 
 
 
 
 
 
 
127 
 
5. Evaluation of type 2 diabetes variants for adult and childhood obesity in East-Asians 
 
5.1 Introduction 
 
The relationship between body mass index (BMI) and risk for type 2 diabetes (T2D) is 
intricate as shown by the impact of variants at the FTO locus that are associated with 
susceptibility to both obesity and T2D [91].  Moreover, variants at HHEX and CDKAL1 gene 
regions, first detected as loci associated with T2D [184], have been recently identified as 
childhood obesity [115-116] and birth weight (BW) loci [115, 117] among paediatric samples 
of European ancestry.   Our consortium-based GWAS efforts for BMI in East-Asians (chapter 
4B) have further identified variants at the CDKAL1 and PCSK1 loci to be associated with 
obesity and indicated that insulin-associated processes may be involved in common obesity 
predisposition.  
 
Insulin is an essential metabolic hormone that not only controls glucose values but also 
regulates several central and peripheral metabolic processes and insulin resistance plays an 
important part in the pathophysiology resulting from obesity [191-192].  Insulin may also 
directly contribute to the aetiology of obesity through a putative impact on the control of 
energy balance [193].  Long-term intra-cerebral infusion of insulin in the third ventricle of 
the hypothalamus in animal studies, results in reduced caloric intake and body weight [194], 
while disruption of insulin signalling in the central nervous system causes increased food 
intake and diet-induced obesity [195].  
 
To date, genetic studies have revealed over 40 variants associated with T2D or 
hyperglycemia [196-201], the majority of which are known to have an effect on pancreatic 
beta-cell function and insulin secretion [202].  Despite evidence of a central role for insulin in 
feeding behaviour [194-195], the influence of most T2D susceptibility loci (with the 
exception of FTO and CDKAL1) on the pathogenesis of common adult obesity in East-Asians 
is unknown.  Furthermore, as studies that have implicated the HHEX and CDKAL1 regions as 
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childhood obesity and BW loci, were conducted using samples of European ancestry, their 
relevance to other ethnic groups remains unclear.  In this study my dual aims were to 1) 
evaluate the role of variants, first identified as T2D susceptibility loci, for obesity association 
among adult East-Asian populations and 2) replicate initial findings of HHEX and CDKAL1 
as BW and childhood obesity loci in Singaporean Chinese children. 
 
In the first part of this chapter I present results of adult obesity associations for T2D risk 
variants.  As an initial stage, I assessed, in silico, associations of these variants for Z-BMI in 
adult Singaporean Chinese GWAS studies [SP2 (N = 2,431), SCES (N = 1,861) and SDCS 
(N = 1,992)].  Assessments were repeated after excluding diabetes patients from the datasets 
to exclude the possibility of confounding in association results.  Subsequently, validation of 
any significant association was sought in additional adult East-Asian populations.  These 
cohorts included GWAS data from adult Singaporean Malays, SiMES (N = 2,534) as well as 
from another group that had joined this study - adult Koreans from the Korea Association 
Resource (KARE) project (N = 8,814).  Transferability of association was also assessed in 
GWAS data of adult populations of European ancestry – the Australian Blue Mountain Eye 
Study, BMES (N = 2,110) and the North-Finnish Birth Cohort 1966, NFBC96 (N = 4,582).   
 
As initial study results suggested a possibility of inter-ethnic differences (East-Asian as 
compared to European) in BMI associations at an identified genomic locus, I looked for 
differences in LD and evidence of positive selection between East-Asians and Europeans.  
The varLD programme [170] was used to quantify inter-ethnic LD differences at the genomic 
region to assess for significant variation in genetic structure between East-Asian and 
European populations.  Additionally, I assessed for evidence of interaction between the 
significant variant identified with diet or physical activity from data available in the SP2 adult 
Chinese dataset.   
 
Subsequently, with assistance from colleagues at the Centre for Molecular Epidemiology 
(CME) in Singapore, we assessed for evidence of positive selection at the identified region 
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among the different ethnic groups.  Briefly, this selection analysis was performed using the 
integrated haplotype score method (iHS) (http://hgdp.uchicago.edu/Software/) [203] using 
phased haplotypes of Singaporean Chinese and Malays from SP2 and SiMES, respectively.  
To derive empirical p-values, the genome was divided into non-overlapping 200 kb windows 
with at least 20 SNPs in each window.  In each window, the proportion of SNPs with |iHS| > 
2 SD was determined as the test statistic.  These windows were further binned into 
increments of 20 SNPs (i).  For each of these window and bin, the empirical p-value was the 
number of windows with a test statistic greater than that of in i [204].  
 
In the second part of this chapter, I provide details from replication analyses of childhood 
obesity (BMI at age 9) and BW at the HHEX and CDKAL1 loci in the SCORM Singaporean 
Chinese paediatric cohort (N = 1,006).  At loci that were observed to replicate in the SCORM 
samples, I also tested the hypothesis that extreme BW may influence BMI at later childhood 
[115]. 
 
All GWAS analyses (Z-BMI and Z-BW) in this study were corrected for sex, age, age-
squared (except in SCORM and NFBC96 as all SCORM samples were at age 9, while all 
NFBC96 samples were at age 31) and population stratification (first two principle 
components in SiMES and NFBC96 only).  A genomic control correction was further applied 
to adjust study results in all datasets. 
 
5.2 Selection of T2D risk loci for assessment of obesity in adult Singaporean Chinese 
 
I selected 33 SNPs that had showed associations with T2D in East-Asians from a recent 
GWAS study [200], in which the Singaporean datasets had also been utilized (SP2, SDCS 
and SiMES datasets).  Selected variants included eight novel loci for T2D susceptibility in 
East-Asians and 25 SNPs (initially identified in predominantly European GWAS for T2D) 
that were seen to replicate among East-Asian populations [200].  
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Minor allele frequencies (MAF), call-rates and Hardy-Weinberg equilibrium (HWE) p-values 
for these SNPs in the Singaporean adult Chinese datasets (SCES, SP2 and SDCS) are 
provided in Table 1 of Appendix IV.  None of these SNPs failed QC thresholds (MAF < 0.01, 
call-rate < 0.95 and HWE p-value < 10
-5
).  However, one SNP (rs8042680) was not available 
(not genotyped or captured after imputation) in all three datasets.  Rs10811661 was not 
available in both SCES and SDCS while another SNP (rs6815464) was not available in the 
SP2 study.  These SNPs were excluded from subsequent meta-analysis procedures. 
 
5.3 Z-BMI association results in adult Singaporean Chinese adults 
 
Table 5.1, below, details Z-BMI association levels (individual dataset and combined results) 
for all SNPs that were combined in a meta-analysis of SP2, SCES and SDCS Singaporean 
Chinese adults (see table 2 in Appendix IV for full association results).  Meta-analysis results 
indicated significant associations (corrected meta-analysis p-value between 0.035 and 0.006) 
at three SNPs [rs7754840 (in CDKAL1), rs9939690 (in FTO) and rs1111875 (near HHEX)], 
after a Bonferronni correction for multiple testing (assuming 30 independent tests).   
 
At only the CDKAL1 SNP (rs7754840) significant between-study heterogeneity was detected                    
(Qp-value = 0.073) and strongest association was seen in the SDCS adult Singaporean Chinese 
diabetic cohort.  This CDKAL1 SNP was in LD (r
2
 > 0.82 in CHB and JPT panel in HapMap) 
with index CDKAL1 SNPs (rs2206734 and rs9356744) detected to be associated with obesity 
in our East-Asian consortia-based GWAS (chapter 4B) and therefore represents the same 
obesity risk locus.  The FTO SNP (rs9939609) also represented a true positive that has been 
well-replicated in the Singaporean populations [123].   
 
An association with Z-BMI among the adult Singaporean Chinese at rs1111875 SNP near the 
HHEX gene was novel.  The risk allele for T2D (C allele [184]) was observed to be 
associated with decreased BMI in this study (β = -0.059, corrected meta-analysis p-value = 
0.035, table 5.1).  I re-examined association of rs1111875 with BMI after exclusion of 
diabetic individuals (excluding the SDCS cohorts and removing T2D patients from SP2 and 
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SCES datasets) and detected similar associations among the normal glucose samples (β = -
0.060, meta-analysis p-value = 2.02 x 10
-4
, table 2 in Appendix IV).   Thus, to confirm initial 
results, the rs1111875 association with BMI was followed-up in additional adult datasets that 
were available for analyses (East-Asian and European samples).  
 
Diabetes had been defined as participants with a history of T2D or fasting glucose levels ≥ 
7.0 mmol/l in SP2 (N = 198) or HbA1c levels ≥ 6.5% in non-fasting blood samples in SCES 
(N = 134), according to ADA criteria. 
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Table 5.1: Z-BMI association levels of SNPs tested in SCES, SP2 and SDCS Singaporean adult Chinese datasets and after meta-analysis (fixed-effects).  
Significant data indicated in bold. See table 2 in Appendix IV for full results table. 
      
SCES    
(N=1,861) 
SP2            
(N=2,431) 
SDCS      
(N=1,992) 
Meta-analysis                               
(N=6,284) 
rsid 
Implicated 
gene 
Chr Position Comment 
Test 
allele 
Beta p-value Beta p-value Beta p-value Beta p-value 
Adjusted 
p-value* 
Qp-value 
rs7754840 CDKAL1 6 20769229 typed G 0.073 0.0272 0.005 0.8408 0.135 1.82x10
-5
 0.064 2.10x10
-4
 0.0061 0.073 
rs9939609 FTO 16 52378028 imputed T -0.100 0.0435 -0.078 0.0486 -0.090 0.0401 -0.088 5.24x10
-4
 0.0157 1.000 
rs1111875 HHEX/IDE 10 94452862 typed C -0.029 0.4080 -0.095 6.12x10
-4
 -0.036 0.2798 -0.059 0.0012 0.0355 0.719 
rs1535500 KCNK16 6 39392028 imputed T -0.072 0.0271 -0.013 0.6132 -0.052 0.0898 -0.041 0.0174 0.5217 0.826 
rs6017317 
FITM2/ 
R3HDML/ 
HNF1A 
20 42380380 imputed T 0.097 0.0040 0.018 0.4987 0.018 0.5723 0.038 0.0263 0.7888 0.547 
rs5215 KCNJ11 11 17365206 typed T -0.049 0.1542 -0.042 0.1137 -0.021 0.5090 -0.038 0.0335 1 0.995 
rs7172432 
C2CD4A/ 
C2CD4B 
15 60183681 typed G 0.085 0.0138 0.035 0.1910 -0.004 0.9082 0.037 0.0413 1 0.634 
rs2191349 DGKB 7 15030834 imputed T -0.002 0.9508 -0.028 0.2928 -0.048 0.1571 -0.027 0.1374 1 0.973 
rs1801282 PPARG 3 12368125 typed G 0.147 0.0652 0.048 0.4769 0.071 0.4024 0.069 0.1515 1 0.169 
rs2237892 KCNQ1 11 2796327 typed T 0.012 0.7315 0.027 0.3240 0.030 0.3612 0.024 0.1907 1 0.999 
rs7041847 GLIS3 9 4277466 typed G -0.007 0.8422 0.052 0.0396 -0.001 0.9832 0.021 0.2043 1 0.737 
rs9470794 ZFAND3 6 38214822 typed T 0.077 0.0259 0.022 0.4198 -0.023 0.4719 0.022 0.2096 1 0.487 
rs780094 GCKR 2 27594741 typed T -0.032 0.3392 -0.008 0.7673 -0.029 0.3554 -0.021 0.2234 1 0.995 
rs231362 KCNQ1 11 2648047 imputed G 0.064 0.2694 -0.071 0.1074 -0.051 0.3500 -0.030 0.3077 1 0.602 
rs13266634 SLC30A8 8 118253964 typed T -0.010 0.7666 0.005 0.8330 0.062 0.0498 0.017 0.3117 1 0.722 
rs896854 TP53INP1 8 96029687 typed T -0.027 0.4665 -0.006 0.8305 -0.028 0.4332 -0.018 0.3419 1 0.997 
rs243021 BCL11A 2 60438323 typed G -0.050 0.1540 0.036 0.1863 0.041 0.2233 0.015 0.4070 1 0.457 
rs6780569 UBE2E2 3 23173488 typed G 0.020 0.6255 -0.039 0.2295 -0.012 0.7766 -0.015 0.4899 1 0.942 
rs864745 JAZF1 7 28147081 imputed T 0.029 0.4592 -0.039 0.2019 -0.013 0.7402 -0.013 0.5200 1 0.875 
rs3786897 PEPD 19 38584848 typed G -0.014 0.6797 0.022 0.3900 0.004 0.8935 -0.013 0.5696 1 0.569 
rs1552224 CENTD2 11 72110746 typed C -0.081 0.2235 -0.049 0.3386 0.109 0.1178 -0.018 0.6073 1 0.474 
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rs6467136 
GCC1/  
PAX4 
7 126952194 typed G -0.067 0.1085 0.017 0.5869 0.075 0.0681 0.011 0.6153 1 0.314 
rs1470579 IGF2BP2 3 187011774 typed C 0.056 0.1437 0.005 0.8769 -0.024 0.4912 0.009 0.6285 1 0.786 
rs4430796 TCF2 17 33172153 typed G -0.008 0.8292 -0.021 0.4640 0.013 0.7094 -0.007 0.6898 1 0.988 
rs340874 PROX1 1 212225879 typed T 0.021 0.5247 -0.024 0.3624 0.039 0.2174 0.006 0.7066 1 0.761 
rs831571 PSMD6 3 64023337 typed T -0.042 0.2094 -0.004 0.8649 0.055 0.0852 0.003 0.8423 1 0.485 
rs10906115 
CDC123/ 
CAMK1D 
10 12355003 typed G 0.023 0.4887 0.009 0.7360 -0.024 0.4561 0.003 0.8499 1 0.951 
rs2943641 IRS1 2 226801989 typed T -0.015 0.8091 -0.012 0.8023 0.047 0.4487 0.004 0.9136 1 0.985 
rs7903146 TCF7L2 10 114748339 typed T -0.039 0.7282 -0.023 0.7931 0.048 0.6427 -0.005 0.9284 1 0.995 
rs17584499 PTPRD 9 8869118 typed T -0.019 0.7217 0.040 0.3402 -0.039 0.4451 0.001 0.9798 1 0.899 
Typed: genotyped in at least 1 study. Imputed: imputed SNP. *: Bonferronni correction based on 30 independent tests (30 SNPs meta-analysed). Assessment for SP2 and SDCS performed chip-
wised and subsequently combined to derive overall study results. 
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5.4 Validation of rs1111875 in additional adult East-Asian datasets 
 
Table 5.2 below provides details of association levels for rs1111875 with Z-BMI in 
additional adult East-Asian samples and overall meta-analysis of all datasets.  In the full 
datasets (including T2D patients) used for replication, association levels did not reach 
statistical significance (combined replication cohorts p-value for full datasets = 0.107, table 
5.2).  Nevertheless, direction of effects were observed to be consistent with initial association 
results (SP2, SCES and SDCS adult Singaporean Chinese), for both the SiMES and KARE 
cohorts and overall meta-analysis of all East-Asian datasets improved association 
significance of rs1111875 (overall meta-analysis p-value = 9.36 x 10
-5
). 
 
Re-examination of rs1111875 association after excluding individuals with T2D in the 
replication datasets indicated a statistically significant association (combined replication p-
value for datasets after excluding T2D patients = 0.045, table 5.2).  Overall association of all 
adult East-Asian datasets after excluding T2D patients showed marginally stronger 
associations with Z-BMI than in full datasets (including patients with T2D) (β = -0.037 in all 
full dataset as compared to β = -0.043 in all datasets that had excluded diabetics, table 5.2).  
Diabetes had been defined as participants with a history of T2D or HbA1c levels ≥ 6.5% in 
non-fasting blood samples in SiMES (N = 677) and KARE (N = 1,035).   
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Table 5.2: Individual and meta-analysis Z-BMI associations of rs1111875 in adult East-Asian 
datasets, before and after exclusion of T2D diabetes patients from cohorts.  Initial association from 
adult Singaporean Chinese datasets included data from SCES, SP2 and SDCS. Significant association 
indicated in bold. 
Study N Test allele Beta SE p-value Qp-value 
Association of rs1111875 in full datasets 
    
SiMES 2,541 
C 
-0.050 0.030 0.091 
 
KARE 8,814 -0.015 0.016 0.388 
 
Combined replication cohorts 11,355 -0.023 0.014 0.107 0.303 
Initial association in adult 
Singaporean Chinese 
6,284 -0.059 0.018 0.001 0.719 
Overall meta-analysis 17,639 -0.037 0.012 9.36x10
-5
 0.114 
Association of rs1111875 in datasets after excluding of T2D patients 
  
SiMES 1,864 
C 
-0.055 0.032 0.087 
 
KARE 7,779 -0.024 0.018 0.193 
 
Combined replication cohorts 9,643 -0.031 0.016 0.045 0.398 
Initial association in adult 
Singaporean Chinese 
3,960 -0.060 0.019 0.002 0.698 
Overall meta-analysis 13,603 -0.043 0.012 4.38x10
-5
 0.243 
Diabetes defined as participants with a history of T2D or fasting glucose levels ≥7.0 mmol/l in SP2 or HbA1c levels ≥ 6.5% 
in non-fasting blood samples in SCES, SiMES and KARE. Meta-analysis performed assuming a fixed-effect model. 
 
5.5 Further validation of rs1111875 in additional adult European datasets 
 
Table 5.3, below, provides details of association levels for rs1111875 with Z-BMI in 
additional adult East-Asian samples and overall meta-analysis of all datasets.  In both the full 
as well as datasets after excluding T2D patients, associations in adult Europeans were not 
significant.  Effect directions were observed to be in the opposite direction as compared to the 
East-Asian data (β = 0.019 and p-value in combined European replication datasets = 0.292 
and β = 0.017 and p-value in combined European replication datasets after excluding T2D 
patients = 0.351, table 5.3).  
 
Diabetes was defined as participants with a history of T2D or fasting glucose levels ≥ 7.0 
mmol/l in NFBC96 (N = 232) and BMES (N = 31).   
 
136 
 
Table 5.3: Individual and meta-analysis Z-BMI associations of rs1111875 in BMES and NFBC1966 
adult European datasets, before and after exclusion of T2D diabetes patients from cohorts.  Initial 
association from adult Singaporean Chinese datasets included data from SCES, SP2 and SDCS.  
Significant association indicated in bold. 
Study N Test allele Beta SE p-value Qp-value 
Association of rs1111875 in full datasets 
BMES 2,110 
C 
0.043 0.031 0.162 
 
NFBC1966 4,582 0.008 0.021 0.721 
 
Combined replication cohorts 6,692 0.019 0.018 0.292 0.348 
Initial association in adult 
Singaporean Chinese 
6,284 -0.059 0.018 0.001 0.719 
Overall meta-analysis 12,976 -0.020 0.014 0.130 0.002 
Association of rs1111875 in datasets after excluding of T2D patients 
BMES 1,878 
C 
0.040 0.033 0.162 
 
NFBC1966 4,551 0.007 0.021 0.788 
 
Combined replication cohorts 6,429 0.017 0.018 0.351 0.399 
Initial association in adult 
Singaporean Chinese 
3,960 -0.060 0.019 0.002 0.698 
Overall meta-analysis 10,389 -0.019 0.013 0.138 0.003 
Diabetes defined as participants with a history of T2D or fasting glucose levels ≥7.0 mmol/l in SP2, BMES and NFBC96 or 
HbA1c levels ≥ 6.5% in non-fasting blood samples in SCES. Meta-analysis performed assuming a fixed-effect model. 
 
 
5.6 Assessment for inter-population differences in LD at the HHEX-IDE region  
 
To explain the observed ethnic differences (East-Asians as compared to Europeans) in 
associations between rs1111875 and obesity, I assessed for inter-population variation in LD 
patterns at this genomic region (one Mb region spanning the rs1111875 variant).  The varLD 
programme [170] was used to perform pair-wise comparisons of LD in reference European 
(CEU) and East-Asian (CHS, Chinese and MAS, Malays) populations from HapMap and 
SGVP, respectively.  Pair-wise comparisons with Europeans and East-Asians (CEU-CHS and 
CEU-MAS comparisons) were only marginally greater than the variation levels between 
East-Asian populations (CHS-MAS comparison) at the HHEX region (figure 5.1).  
Furthermore, in all the three comparisons the entire region assessed had normalised Z-score 
values below zero, indicating that LD variation in this region was below the 50
th
 percentile of 
LD variations across the entire genome.    
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Figure 5.1: Inter-population varLD comparison of Singaporean Chinese (CHS), Singaporean Malay 
reference populations from Singapore Genome Variation Project (SGVP) and European population 
(CEU) from HapMap for a1Mb region surrounding the rs1111875 SNP near HHEX on chromosome 
10. Plot indicates position of known genes in the region and red diamond indicates position of 
rs1111875. CEU_CHS: pair-wise comparison of CEU Europeans and CHS Chinese, CEU_MAS: 
pair-wise comparison of CEU Europeans and MAS Malays, CHS_MAS: pair-wise comparison of 
CHS Chinese and MAS Malays. 
 
 
5.7 Assessment for interaction with diet and physical activity at rs1111875  
 
Environmental factors (diet and levels of physical activity) may differ between populations 
and it is possible that these interact with the genetic variant to bring about observed effects.  I 
thus tested the hypothesis that total energy intake or carbohydrate intake or physical activity 
may modulate effects of rs1111875 on BMI, using information available in the SP2 adult 
Singaporean Chinese dataset.   
 
In this dataset, interviewer-based questionnaires were used to estimate total energy intake per 
day (kcal), carbohydrate intake per day (g) and percentage energy from carbohydrates per day 
(%) as well as total activity level per week (METhr/week) (see section 2.1.1.1).  Likelihood-
ratio test (LRT) for interaction of the cross-product terms of these factors and rs1111875 
were however not statistically significant.    
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Table 5.4: Interaction levels between rs1111875 and diet or physical activity levels in the SP2 
Singaporean adult Chinese cohort. Cross-product terms as well as individual terms, were included in 
linear regression models. 
Cross-product term N 
LRT interaction         
p-value 
rs1111875 x Energy intake per day 1,415 0.632 
rs1111875 x Carbohydrate intake per day 1,415 0.591 
rs1111875 x Percentage energy from carbohydrates per day 1,415 0.815 
rs1111875 x Activity level per week 1,415 0.253 
LRT: Likelihood-ratio test.  Assessment performed chip-wise (samples genotyped on 1M, 610 and 550 SNP-chips) and 
subsequently combined in a fixed-effect meta-analysis to derive overall values for SP2 dataset. 
 
5.8 Selection analysis at the HHEX region 
 
The integrated haplotype score (performed by Sim Xueling at the CME) method detected 
evidence of positive selection at the region between 94.8Mb and 95.0 Mb on chromosome 10 
which ranked in the top 0.5 and 0.1 percentile of selection signals in Singaporean Chinese 
(SP2) and Malays (SiMES), respectively (table 5.5).   
 
Table 5.5:  Characteristic of selection signal detected at chromosome 10 identified in Singaporean 
Chinese and Malay populations. 
Genomic region (genes) 
Chromosome 10: 94.8 – 95.0 Mb                                   
(EXOC6, CYP26C1, CYP2A1) 
Study SP2 Chinese SiMES Malay 
Empirical p-value 4.33 x 10
-3
 3.53 x 10
-4
 
Percentile rank of empirical p-value (%) Top 0.5 Top 0.1 
 
 
Using the strongest selected SNP (rs10786074) from this region, we further detected an 
extended haplotype in East-Asians (SP2 Chinese and SiMES Malays from Singapore) that 
was not present in Europeans (CEU HapMap population) using Hapfinder Type 1 [205] 
(figure 5.2).  This extended haplotype contained the T allele (obesity risk allele) of rs1111875 
(figure 5.2).   
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Figure 5.2: Hapfinder Type 1 analysis on the strongest selected SNP (rs10786074, red bar in physical position of SNPs) indicated an extended haplotype in 
SiMES Malays and SP2 Chinese but not in CEU Europeans. Position of T allele of rs1111875 is indicated by the arrow. Green bar: A allele, blue bar: C 
allele, yellow bar: G allele and red bar: T allele. 
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I considered the possibility that the association between rs1111875 and BMI in East-Asians 
might relate to LD between this SNP and a causal SNP that is part of the extended haplotype 
in East Asians.  If this were the case, it might explain the finding that rs1111875 was 
associated with BMI in Asians but not in Europeans (where this extended haplotype is not 
observed).  However, association of common SNPs spanning the region of the identified 
extended haplotype in the East-Asian populations revealed that only variants at the HHEX-
IDE-KIF11 region had strong associations with BMI (figure 5.3A).  Further conditioning 
analysis on the genotypes of rs1111875 indicated that the regional signals were related to the 
rs1111875 variant (figure 5.3B). 
 
Figure 5.3: Regional association of common SNPs with Z-BMI after meta-analysis of Singaporean 
East-Asian datasets (SP2, SCES, SiMES and SDCS). A) Before conditional analysis. B) After 
conditional analysis on genotypes of rs1111875.  Purple diamond indicates position of rs1111875. 
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5.9 SNP selection for validation of HHEX and CDKAL1 loci in SCORM dataset 
 
Three CDKAL1 SNPs and four SNPs near HHEX that had been identified to be associated 
with either BW or childhood obesity in populations of European ancestry [115-117], were 
selected for validation in the SCORM Singaporean Chinese childhood dataset.  Two SNPs 
(one each from CDKAL1 and HHEX) were not genotyped or imputed in SCORM (table 5.6).   
 
The CDKAL1 SNPs identified were in strong LD in East-Asian (CHB and JPT) HapMap 
samples (r
2
 between rs1094639 and rs4712523 = 0.98) and thus only the rs4712523 index 
SNP was brought forward for validation (table 5.6).  Index SNPs near the HHEX locus were 
however in weaker LD among East-Asian (CHB and JPT) HapMap samples and therefore, all 
three SNPs were tested in SCORM (table 5.6).  
 
 
Table 5.6: LD of index SNPs at CDKAL1 and HHEX that have been reported to be associated with 
BW or childhood obesity [115-117]. SNPs brought forward for validation indicated in bold. 
rsid Chr Position 
Commen
t 
Nearest 
gene 
No. of 
SNPs 
selected 
LD (r
2
) in CHB East-Asian 
panels from HapMap 
rs4712523 6 20765543 typed 
CDKAL1 1 0.98 rs1094639 6 20766756 typed 
rs4712526 6 20771015 NA 
rs1111875 10 94452862 typed 
HHEX 3 
0.302 (between rs1111875 
and rs7923837) 
0.563 (between rs1111875 
and rs5015480) 
0.630 (between rs7923837 
and rs5015480) 
rs7923837 10 94471897 typed 
rs5015480 10 94455539 typed 
rs10882102 10 94456476 NA 
Typed: genotyped in Illumina 550 SNP-chip in SCORM. NA: not genotyped or captured after imputation in SCORM. NA: 
not genotyped or imputed in SCORM study. 
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5.10 Association of HHEX and CDKAL1 SNPs with Z-BW and Z-BMI in SCORM  
 
Table 5.7, below, details association levels with Z-BW and Z-BMI (at age 9 years) for 
variants tested in the SCORM childhood dataset.  The G allele of rs7923837 near the HHEX 
gene was observed to be associated with reduced BW in SCORM after multiple test 
corrections (beta= -0.175 and corrected p-value = 0.008, assuming four independent tests).  
Other HHEX SNPs and the CDKAL1 SNP were not associated with Z-BW, and none of the 
SNPs were associated with Z-BMI (at age 9 years) in SCORM. 
 
5.11 Interaction between rs7923837 and birth weight in SCORM 
 
It has been suggested that increased BW may influence association of variants at the HHEX 
locus with BMI at later childhood [115].  As such, I categorically grouped the SCORM 
samples according to percentile BW, low BW (<10
th
 percentile), high BW (>90
th
 percentile) 
and average BW (between 10
th
 and 90
th
 percentile), and tested for interaction with rs7923837 
(which was the only SNP that had a significant association with BW in SCORM).  The cross-
product term of rs7923837xBWgroup was seen to influence Z-BMI at age 9 years in SCORM 
(LRT interaction p-value = 0.028).  Stratifying Z-BMI association of rs7923837 by BW 
groups and genotypes indicated that the G allele of rs7923837 reduced BMI in low BW 
children and increased BMI among those of high BW (table 5.8 and figure 5.4). 
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Table 5.7: Association levels of HHEX and CDKAL1 SNPs with Z-BW and Z-BMI (at age 9) tested in the SCORM dataset. 
      
Z-BW (N=958) Z-BMI (N=1,006) 
rsid Gene Chr Position 
Test 
allele 
AF Beta SE p-value 
Adjusted    
p-value* 
Beta SE p-value 
Adjusted    
p-value* 
rs7923837 HHEX 10 94471897 G 0.197 -0.175 0.057 0.002 0.008 -0.056 0.055 0.309 1 
rs5015480 HHEX 10 94455539 C 0.189 -0.092 0.059 0.118 0.474 -0.054 0.059 0.353 1 
rs1111875 HHEX 10 94452862 C 0.297 -0.025 0.050 0.618 1 -0.050 0.050 0.318 1 
rs4712523 CDKAL1 6 20765543 G 0.381 -0.032 0.046 0.488 1 -0.044 0.046 0.334 1 
* Bonferronni corrected p-value, based on 4 tests. AF: frequency of test allele  
 
 
 
Table 5.8: Birth weight stratified analysis of rs7923837 association with Z-BMI in SCORM.  
Rsid Gene Chr Position 
Test 
allele 
N Beta SE p-value Group 
rs7923837 HHEX 10 94471897 G 
97 -0.316 0.159 0.049 Low birth weight 
766 -0.049 0.063 0.441 Average birth weight 
95 0.386 0.207 0.064 High birth weight 
Group: Low birth weight (<10
th
 percentile birth weight), average birth weight (between 10
th
 and 90
th
 percentile birth weight) and high birth weight (>90
th
 percentile birth 
weight). 
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Figure 5.4: G allele of rs7923837 observed to reduce BMI (at age 9) among SCORM children with 
low BW and to increase BMI among those of high BW. LRT interaction p-value = 0.028. 
 
 
 
5.12 Discussion 
 
In this study I extended findings from an obesity-related trait (T2D) and evaluated the role of 
variants, first identified as T2D susceptibility loci, for adult and childhood obesity in East-
Asian populations.  Data from the adult obesity study identified a possible role for rs1111875, 
upstream of HHEX at chromosome 10, with obesity risk in only East-Asian adults but not 
among adult European samples.  In the second phase of this study I replicated and 
corroborated the role of another variant upstream of HHEX, rs7923837, as a BW and 
childhood obesity locus in Singaporean Chinese children.  Due to the poor LD between these 
two variants, especially among East-Asian samples (r
2
 = 0.302 in CHB HapMap panel), these 
results may represent separate findings in adult and paediatric populations. 
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Non-replications of the rs1111875 variant with obesity in adult populations of European 
ancestry tested in this study were consistent with a larger study of over 30,000 European 
individuals [197].  This could indicate that the association with BMI that I had detected in 
adult East-Asians only may have been a chance finding.  It must be highlighted that 
association levels among full adult East-Asian replication datasets (including individuals with 
T2D) did not reach statistical significance in my study (although effect directions were 
consistent in all datasets) and therefore, further assessments in additional adult East-Asian 
populations would be warranted to firmly confirm (or dismiss) any ethnic-specific obesity 
predisposition at the rs1111875 variant. 
 
Nevertheless, re-examination of the association between rs1111875 and BMI among normal 
glucose East-Asian subjects (after excluding T2D patients) was nominally significant in the 
replication phase of the study.  These analyses further indicated marginally larger effect 
estimates after the exclusion of T2D patients (as compared to effect estimates in full 
datasets).  One possible explanation for these findings may be due to effect modifications of 
T2D therapeutics, such as thiazolidinediones, insulin or sulfonylureas that are known to 
increase body weight [206].  As a result, the inclusion of diabetic patients in the analysis 
using full datasets (including individuals with T2D) may have reduced the ability to detect 
true positive associations in the study. 
 
Interestingly, it has been recently reported that the HHEX gene region has been positively 
selected in East-Asians (as compared to other ethnic populations, including those of 
European ancestry) [207].  In our own analysis for selection signals we detected a region 
upstream of the HHEX locus in the East-Asian Singaporean populations and identified an 
extended haplotype that was not detected among Europeans.  However, I did not identify any 
additional associations for common SNPs with BMI at the region that showed evidence of 
selection, which could have explained the possible ethnic-specific differences in obesity 
risks.   
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It is also recognised that dietary intakes among East-Asians, where rice forms a major staple, 
is higher in carbohydrates and sugars as compared to a Western-diet [208].  This markedly 
varied composition of food intake between East-Asians and Europeans may have contributed 
to differing selection pressures at loci influencing insulin production, such as the HHEX locus 
[207].  However, my interaction analyses with dietary and physical activity data did not 
identify an external variable that modulated effects of the rs1111875 with obesity in the SP2 
Singaporean dataset.  Given the limited sample size (N = 1,415) in this study however, it is 
highly likely that these interaction analyses would have been underpowered to detect such 
associations and therefore, additional follow-up is warranted in larger East-Asian datasets 
with, perhaps, more precise measures of food intake and/or exercise levels.   
 
While T2D is generally associated with increased obesity levels there are instances where 
increased BMI has been identified to be protective for T2D susceptibility.  Variations at the 
PPARγ gene locus are presumed to increase adipocyte deposition and may protect against fat 
accumulation in other important tissues such as the liver and muscle [209]. Furthermore, 
increased circulating adiponectin levels in transgenic mice have also been shown to protect 
against T2D despite increased adiposity [210].  It is, perhaps, possible that the HHEX variant 
may also be involved in similar pathways that enhance efficiency of energy storage in fat 
tissues and thus reduce T2D risks, while increasing obesity levels. 
 
Nevertheless, the results presented herein for obesity associations in adults must be 
considered within the limitations of the study design.  A potential concern was that of bias, 
especially since I had aimed to evaluate BMI associations of T2D risk variants, many of 
which are associated with insulin levels.  Thus, in datasets where effects of insulin production 
may be sufficiently large or reduced, such as cohorts ascertained specifically on diabetic 
status  or ‘abridged’ datasets based on glucose measures, spurious associations with BMI may 
arise.  As such, it remains a possibility that the association of rs1111875 with BMI in only 
glucose normal East-Asian adult samples may have been a biased finding.   
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In the second phase of my study, I detected another variant at the HHEX locus, rs7923837, 
where the T2D risk allele, G allele, was associated with reduced BW in the SCORM Chinese 
children. In line with the foetal insulin hypothesis [211], where insulin secretion modulated 
by foetal genotype is a key growth factor, the HHEX variant may have lasting effects and 
nominal interactions with BW was observed to affect growth later in childhood (BMI at age 
9). 
 
The findings in SCORM children are partially in-line with previous reports of HHEX variants 
detected as childhood obesity loci in children of European ancestry [115-117].  As was 
identified in two of these studies [115, 117] we found a variant at the HHEX locus that was 
marginally associated with reduced BW.  However, when restricting analysis to only 
individuals with higher BW, the study by Winkler and colleagues [115], reported that T2D 
risk alleles at HHEX were associated with lower childhood BMI (at age 8), while we 
observed the opposite trend among the SCORM children.   
 
There may be several reasons for this inconsistency.  Firstly, in the Winkler et al study, the 
paediatric cohort tested was enriched for mothers who were Type 1 diabetic patients and, 
thus, early developmental processes (such as pancreatic development) and programming of 
genes during foetal growth may be differed in their study population as compared to the 
SCORM cohort [212].  Additionally, as maternal genotype information was not available in 
the SCORM study, I was unable to analyse the contribution of maternal genotypes to foetal 
growth patterns in SCORM, which could have totally contrasting effects on the child’s BW 
as compared to the foetal genotype [117].  Furthermore, the variant we detected (rs7923837) 
was not tested in the Winkler et al study and given the moderate LD patterns between these 
SNPs (r
2 
= 0.63 between rs7923837 and rs5015480 (tested by Winkler et al) in HapMap CHB 
population), these may represent separate findings.  
 
In the report by Zhoa et al [116] however, the same SNP that I had tested (rs7923837) was 
analysed and although this study did not identify an association between the HHEX locus and 
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BW, they observed increased childhood BMI associations with the G allele of rs7923837 that 
was consistent in my analysis of SCORM samples with large BW.  In their study, Zhao and 
associates sampled children of a wider age group (2-16 years old) and, therefore, 
developmental factors (such as pubertal stage), may have accounted for some of the 
discrepancies. 
 
The interplay between birth size and subsequent metabolic risks is highly complex [213] and 
in certain populations, such as Pima Indians, both low and high BW increases the risk of later 
T2D development [214].  The results from SCORM indicated that with either excessive or 
restricted foetal growth, defects at the HHEX locus may lead to pathological outcomes.  
Further follow-up of the SCORM children into adulthood with appropriate phenotypic 
measures (such as fasting insulin, fasting glucose, development of T2D, and adiposity levels) 
will allow for better assessment of potential long-term effects of this variation.  
 
To conclude, in this study I have detected two variants near the HHEX locus that were 
nominally associated with reduced BW (rs7923837) and possibly, with reduced BMI 
(rs1111875) in only East-Asian adults. These findings would however, require additional 
follow-up in independent East-Asian datasets and could contribute to the understanding of the 
complex interplay between BW, childhood growth patterns, obesity and T2D risk. 
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6. Evaluation of C-reactive protein (CRP) associated variants in East-Asian populations 
and assessment for causality with vascular disease 
 
6.1 Introduction 
 
The association between inflammation and obesity has been illustrated by increased serum C-
reactive protein (CRP) levels, among overweight and obese individuals [22-23].  Elevated 
CRP is a marker for increased systemic inflammation [215] and is associated with both macro 
[such as stroke and coronary heart disease (CHD)] [216-217] and micro [such as diabetic 
nephropathy and chronic kidney disease (CKD)] [218-219] forms of vascular disease.  CRP 
shows significant heritability [220] and understanding the pathways involved in the 
pathogenesis of elevated serum CRP may improve understanding of disease aetiology.  
Recent large-scale genome-wide association studies (GWAS) have successfully identified 
genetic variants that associate with CRP levels [221-225].  However, the relevance of these 
loci, especially those uncovered after large-scale meta-analysis in only European populations 
[221], among other ethnic groups are not known.   
 
Causality of CRP with vascular diseases is also controversial and it has been suggested that 
elevated CRP may simply be a consequence of inflammatory processes that also lead to 
disease outcomes (and thus an innocent bystander with no pathological role) [226].  While 
there are some evidence for a pro-inflammatory and pro-artherogenic role for CRP [227-228], 
a recent in vivo study provided no indication for atherosclerotic plaque reduction in a CRP 
knock-out mouse model [229].  Furthermore, common genetic variants associated with serum 
CRP levels identified from GWAS, both individually or in combination, were not 
consistently associated with end-stage macro vascular disorders such as myocardial infarction 
(MI) or CHD [221-222].  Nevertheless, a recent study identified that a CRP gene variant was 
associated with CKD [230] and may, highlight a more prominent role for CRP in micro 
vascular forms of disease. 
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In the initial sections of this chapter I provide data from GWAS analyses for serum CRP 
among East-Asian populations living in Singapore [SP2 Chinese adults (N = 2,198) and 
Singaporean Malay adults (N = 2,275)].  Here my aims were to: 
1. Analyse for novel loci associated with serum CRP among East-Asian adults. 
2. Leverage on genome-wide data to determine transferability of recently identified CRP 
risk variants (22 gene loci identified from GWAS studies performed using 
predominantly populations of European ancestry [221-225]) among the East-Asian 
adults. 
3. Identify modification of CRP associations by obesity levels through a genome-wide 
interaction analysis between SNPs and BMI in the two East-Asian populations. 
 
In the second phase of my study, I performed a Mendelian randomisation exercise to evaluate 
if serum CRP is causally associated with vascular disease.   Here I assessed whether the most 
significantly associated variant (for serum CRP association) at the CRP locus was associated 
with changes in retinal micro vascular calibre - central retinal vein equivalent (CRVE) and 
central retinal artery equivalent (CRAE), which are measures of microcirculatory dysfunction 
and intermediate biomarkers for both macro [231] and micro vascular diseases [145] and 
have also been associated with elevated serum CRP [232].  For this study, a total of 24,132 
samples of East-Asian [SiMES (N = 2,230) and SP2 (N = 1,413)], South-Asian [SINDI (N = 
2,390)] and European [CHARGE consortium data (N = 18,722)] [233] ancestry with retinal 
micro vascular calibre phenotype data were utilised. 
 
6.2 GWAS association results for serum CRP in East-Asian adults 
 
Before association analyses, samples with CRP measures greater than 10 mg/L (184 samples 
from SiMES and 44 samples from SP2) that may indicate acute clinical inflammation unlike 
to obesity were excluded, as recommended by the centres for Disease Control and Prevention 
and the American Heart Association [234].  Raw CRP values were normalised to standard 
normal scores (Z-CRP) and used as the dependent variable in regression analyses, adjusted 
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for age and sex.  Results were subsequently adjusted for residual inflation (λ=1.019 in SiMES 
and λ between 1.009 and 1.015 in SP2) 
 
Figure 6.1 shows QQ plots for Z-CRP association in SiMES, SP2 and after meta-analysis 
(fixed effects) of both East-Asian datasets.  In individual datasets as well as after meta-
analysis, significant deviations from expected values were observed for the most strongly 
associated SNPs (figure 6.1 A-C). 
 
Figure 6.1: QQ-plots for Z-CRP association after adjustments for genomic inflation. A) QQ-plot for 
Z-CRP in SiMES (N=2,275, λ=1.019). B) QQ-plot for Z-CRP in SP2 (N=2,198, λ=1.009-1.015).      
C) QQ-plot for Z-CRP after fixed-effect meta-analysis (N=4,473) of SP2 and SiMES. D) QQ-plot for 
Z-CRP association in fixed-effect meta-analysis (N=4,473) of SP2 and SiMES after removal of 
surrounding SNPs from all 22 known CRP gene loci (100 kb upstream and downstream). Associations 
for SP2 performed chip-wise and combined to derive overall study results.  
 
 
 
A) B) 
D) C) 
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Table 6.1, below, provides details of all SNPs that reached genome-wide levels of 
significance (p-value < 5 x 10
-8
) in the meta-analysis of SP2 and SiMES.  These SNPs were 
observed from three gene loci, in or near CRP, apolipoprotein E (APOE) and HNF homeobox 
A (HNF1A).  SNPs that reached genome-wide significance at these three gene loci included 
the same index SNPs (rs11265260, rs7553007 and rs2794520 from CRP, rs2075650 from 
APOE and rs7310409 from HNF1A) reported in recent GWAS studies [221-225] and were 
directionally consistent with the initial studies.  
 
To identify independent associations at these three gene loci (CRP, APOE and HNF1A), I re-
examined associations of SNPs after conditioning analyses on the genotypes of the previously 
identified index SNPs (rs11265260, rs7553007 and rs2794520 from CRP, rs2075650 from 
APOE and rs7310409 from HNF1A).  Conditional probability analyses at these three gene 
loci did not identify additional SNPs with genome-wide levels of significance (figure 6.2).   
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Table 6.1: SNPs that reached genome-wide significance (p-value < 5x10
-8
) for Z-CRP association after meta-analysis of SiMES and SP2. Meta-analysis 
results are presented in the fixed effects model. Significant heterogeneity defined as Qp-value < 0.1. Index SNPs from previous studies indicated in bold. 
      
SP2                               
(N=2,198) 
SiMES                         
(N=2,275) 
Meta-analysis                                  
(N=4,473) 
rsid Chr Position Gene Comment Test allele MAF Beta p-value* MAF Beta p-value* Beta SE p-value  Qp-value 
rs12081252 1 157973137 CRP imputed T 0.179 -0.249 1.13x10-11 0.113 -0.258 1.73x10-8 -0.253 0.029 1.26x10-17 0.799 
rs16842559 1 157942795 CRP imputed T 0.177 -0.249 1.12x10-11 0.116 -0.255 2.04x10-8 -0.251 0.029 1.44x10-17 0.900 
rs16842568 1 157942844 CRP imputed G 0.177 0.249 1.11x10-11 0.116 0.255 2.06x10-8 0.251 0.029 1.45x10-17 0.900 
rs11265260 1 157966663 CRP imputed G 0.175 0.252 7.14x10
-12 0.119 0.250 3.52x10-8 0.251 0.029 1.57x10-17 0.892 
rs16842599 1 157964099 CRP imputed T 0.179 -0.248 1.07x10-11 0.117 -0.252 2.73x10-8 -0.250 0.028 1.83x10-17 0.900 
rs16842502 1 157920487 CRP imputed C 0.177 -0.242 2.91x10-11 0.113 -0.264 9.53x10-9 -0.250 0.029 1.87x10-17 0.887 
rs12081264 1 157973184 CRP imputed T 0.179 -0.249 1.12x10-11 0.113 -0.253 2.88x10-8 -0.251 0.029 2.02x10-17 0.900 
rs12068753 1 157959161 CRP imputed T 0.179 -0.249 9.50x10-12 0.117 -0.248 3.88x10-8 -0.249 0.028 2.28x10-17 0.900 
rs3093075 1 157946537 CRP imputed T 0.180 0.236 7.81x10-11 0.118 0.255 1.70x10-8 0.243 0.028 8.49x10-17 0.891 
rs3093077 1 157946260 CRP imputed C 0.181 0.235 9.45x10-11 0.120 0.255 1.46x10-8 0.243 0.028 8.91x10-17 0.877 
rs12081480 1 157973614 CRP imputed T 0.179 -0.248 1.89x10-11 0.103 -0.252 8.71x10-8 -0.249 0.029 9.81x10-17 0.900 
rs2075650 19 50087459 APOE typed A 0.084 0.222 4.62x10
-6 0.117 0.319 8.39x10-13 0.274 0.033 6.20x10-16 0.543 
rs11265257 1 157935608 CRP imputed T 0.429 -0.132 1.37x10-6 0.486 -0.188 9.92x10-11 -0.159 0.020 1.78x10-15 0.582 
rs2808624 1 157932545 CRP imputed G 0.427 -0.131 1.73x10-6 0.485 -0.189 9.39x10-11 -0.158 0.020 2.44x10-15 0.560 
rs1205 1 157948857 CRP imputed T 0.431 -0.131 1.59x10-6 0.489 -0.186 1.30x10-10 -0.157 0.020 2.89x10-15 0.580 
rs2808628 1 157942635 CRP imputed G 0.428 0.131 1.58x10-6 0.488 0.185 1.64x10-10 0.157 0.020 3.33x10-15 0.603 
rs876537 1 157941557 CRP imputed T 0.435 -0.131 1.67x10-6 0.487 -0.187 1.45x10-10 -0.157 0.020 3.33x10-15 0.583 
rs7553007 1 157965173 CRP imputed G 0.427 0.130 2.17x10
-6 0.486 0.188 1.12x10-10 0.157 0.020 3.55x10-15 0.554 
rs2794520 1 157945440 CRP typed C 0.431 0.127 2.90x10
-6 0.491 0.188 8.94x10-10 0.155 0.020 4.22x10-15 0.506 
rs1470515 1 157920223 CRP imputed T 0.431 -0.130 2.40x10-6 0.490 -0.188 1.23x10-10 -0.157 0.020 4.22x10-15 0.552 
rs2808629 1 157943420 CRP imputed G 0.430 0.129 2.17x10-6 0.489 0.186 1.52x10-10 0.156 0.020 4.66x10-15 0.567 
rs1341665 1 157958183 CRP imputed G 0.406 0.130 2.39x10-6 0.480 0.185 2.57x10-10 0.156 0.020 7.99x10-15 0.596 
rs2027471 1 157956012 CRP imputed T 0.407 0.130 2.32x10-6 0.477 0.185 2.76x10-10 0.156 0.020 8.44x10-15 0.594 
rs2592887 1 157919563 CRP typed T 0.424 -0.115 2.66x10-5 0.500 -0.177 9.37x10-10 -0.144 0.020 4.01x10-13 0.483 
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rs1572970 1 157940209 CRP typed G 0.362 0.110 8.60x10-5 0.381 0.161 8.22x10-10 0.134 0.021 6.55x10-11 0.676 
rs7310409 12 119909244 HNF1A typed G 0.391 0.119 1.99x10
-5 0.321 0.154 5.78x10-7 0.134 0.021 7.21x10-11 0.868 
rs2393791 12 119908339 HNF1A imputed T 0.388 0.117 2.43x10-5 0.320 0.151 8.73x10-7 0.133 0.021 1.28x10-10 0.880 
rs2393775 12 119908957 HNF1A imputed G 0.390 -0.115 3.47x10-5 0.321 -0.150 1.10x10-6 -0.131 0.021 2.30x10-10 0.874 
rs1183910 12 119905190 HNF1A imputed G 0.386 0.119 2.07x10-5 0.286 0.139 1.30x10-5 0.128 0.021 1.24x10-9 0.974 
rs11588887 1 157983786 CRP typed G 0.385 0.086 1.85x10-3 0.489 0.148 3.17x10-7 0.115 0.020 7.56x10-9 0.486 
rs10774579 12 119889593 HNF1A typed T 0.397 -0.098 3.52x10-4 0.355 -0.139 3.45x10-6 -0.117 0.020 8.07x10-9 0.787 
rs12049404 1 157980468 CRP imputed T 0.386 -0.091 1.06x10-3 0.488 -0.142 8.68x10-7 -0.115 0.020 8.13x10-9 0.643 
rs7305618 12 119887315 HNF1A typed T 0.451 0.101 1.88x10-4 0.399 0.129 1.13x10-5 0.114 0.020 1.06x10-8 0.821 
rs10437339 1 157977009 CRP imputed G 0.327 -0.112 1.05x10-4 0.360 -0.127 2.51x10-5 -0.119 0.021 1.08x10-8 0.890 
rs2650000 12 119873345 HNF1A typed C 0.455 0.102 1.57x10-4 0.344 0.130 1.42x10-5 0.114 0.020 1.11x10-8 0.822 
rs2251468 12 119889509 HNF1A imputed C 0.396 -0.098 3.13x10-4 0.313 -0.134 1.53x10-5 -0.114 0.020 2.80x10-8 0.863 
rs2708104 12 119968332 HNF1A typed T 0.400 0.079 4.11 x10-3 0.429 0.145 5.93x10-7 0.110 0.020 3.41x10-8 0.438 
rs1186380 12 119860799 HNF1A typed T 0.404 0.076 6.17x10-3 0.467 0.145 4.88x10-7 0.109 0.020 4.88x10-8 0.385 
* p-value adjusted for genomic inflation, λ=1.002-1.009 in SP2 and λ=1.019 in SiMES . Typed: genotyped in at least 1 dataset; imputed: imputed SNP; MAF: minor allele frequency. 
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Figure 6.2: Regional associations of SNPs at 1Mb regions in A) CRP, B) HNF1A and C) APOE gene 
regions that reached genome-wide levels of association with Z-CRP in the meta-analysis of SP2 and 
SiMES. 1) Shows plots without conditioning for genotypes of index SNPs and 2) indicates association 
levels after conditioning on the genotypes of rs11265260, rs7553007 and rs2794520 from CRP, 
rs2075650 from APOE and rs7310409, rs1183910 and rs1169310 from HNF1A.  
 
 
 
A1) 
B1) B2) 
A2) 
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6.3 Replication of known CRP risk variants in East-Asian adults 
 
35 SNPs from 22 gene loci were identified from previous GWAS studies for serum CRP 
associations [221-225] and table 6.2 details association levels of these SNPs in the two 
datasets.   26 SNP were available (genotyped or imputed and passed QC procedures) in both 
SP2 and SiMES and were combined in a meta-analysis (table 6.2).  Besides CRP, APOE and 
HNF1A gene loci, significant associations for index SNPs at six other gene loci were 
observed at more nominal levels of significance (meta-analyses p-values between 8.42x10
-5
 
and 0.023) – leptin receptor (LEPR, three SNPs), interleukin 6 receptor (IL6R, three SNPs), 
glucokinase regulator (GCKR, one SNP), G protein-coupled receptor, family C, group 6, 
member A (GPRC6A, one SNP), interleukin 6 (IL6, one SNP), protein tyrosine phosphatase 
non-receptor type 2 (PTPN2, one SNP).  Since these were well validated CRP associated 
variants [221-225], a p-value threshold of < 0.05 was used to determine significance. 
 
Two variants, rs6901250 at GPRC6A and rs2847281 at PTPN2, however, had inconsistencies 
in effects directions (as compared to the initial European GWAS [221]) (table 6.2) and 
therefore, only seven (CRP, APOE, HNF1A, LEPR, IL6R, GCKR and IL6) out of 22 known 
CRP-associated loci replicated with consistent effect directions among the Singaporean 
datasets (Binomial-test p-value for over-representation of significant loci < 0.01, α = 0.05).   
C1) C2) 
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Table 6.2: Association results of known CRP loci [221-225] in SP2 and SiMES datasets and after meta-analysis. 26 SNPs were genotyped or imputed and 
passed QC procedures in both SP2 and SiMES datasets and were combined in meta-analyses. Significant results (p-value < 0.05) indicated bold.  
      
SP2                           
(N=2,198) 
SiMES                      
(N=2,275) 
Fixed-effect meta-analysis                                     
(N=4,473) 
rsid Gene Chr Position Comment 
Test 
allele 
MAF Beta p-value MAF Beta p-value Beta p-value Qp-value Beta† p-value† 
rs11265260 CRP 1 157966663 imputed G 0.168 0.252 7.14x10-12 0.119 0.250 3.52x10-8 0.251 1.57x10
-17 0.973 0.273 2.12 x10-18 
rs2075650 APOE 19 50087459 typed A 0.088 0.222 4.62x10-6 0.117 0.319 8.39x10-13 0.274 6.20x10
-16 0.140 0.268 6.45 x10-16 
rs7553007 CRP 1 157965173 imputed G 0.428 0.130 2.17x10-6 0.486 0.188 1.12x10-10 0.157 3.55x10
-15 0.143 0.154 7.23 x10-14 
rs2794520 CRP 1 157945440 typed C 0.435 0.127 2.90x10-6 0.491 0.188 8.94x10-11 0.155 4.22x10
-15 0.124 0.171 4.38 x10-16 
rs7310409 HNF1A 12 119909244 typed G 0.378 0.119 1.99x10-5 0.321 0.154 5.78x10-7 0.135 7.21x10
-11 0.702 0.154 4.44 x10-15 
rs1183910 HNF1A 12 119905190 imputed G 0.374 0.119 2.07x10-5 0.286 0.139 1.30x10-5 0.128 1.24x10
-9 0.221 0.131 7.59 x10-11 
rs1169310 HNF1A 12 119923816 imputed G 0.486 0.098 3.00x10-4 0.398 0.111 1.74x10-4 0.102 1.97x10
-7 0.858 0.122 3.65 x10-9 
rs1892534 LEPR 1 65878532 typed C 0.124 0.085 0.038 0.222 0.119 6.43x10-4 0.105 8.42x10
-5 0.398 0.090 2.04 x10-4 
rs6700896 LEPR 1 65862370 imputed T 0.123 -0.083 0.043 0.219 -0.117 8.98x10-4 -0.103 1.15x10
-4 0.528 -0.097 1.69 x10-4 
rs4420065 LEPR 1 65934049 typed T 0.126 -0.085 0.035 0.224 -0.104 0.003 -0.096 2.67x10
-4 0.721 -0.081 4.13 x10-4 
rs4129267 IL6R 1 152692888 typed C 0.374 0.087 0.002 0.222 0.038 0.264 0.067 0.002 0.266 0.062 0.002 
rs8192284 IL6R 1 152693594 imputed C 0.374 -0.086 0.002 0.222 -0.036 0.282 -0.066 0.002 0.256 -0.063 0.002 
rs4537545 IL6R 1 152685503 typed T 0.370 -0.083 0.004 0.225 -0.038 0.251 -0.064 0.003 0.298 -0.058 0.003 
rs1260326 GCKR 2 27584444 typed T 0.481 0.052 0.055 0.396 0.059 0.043 0.055 0.005 0.860 0.046 0.012 
rs6901250 GPRC6A 6 117220718 imputed G 0.452 0.073 0.007 0.486 0.025 0.399 0.051* 0.011 0.226 0.044 0.019 
rs2097677 IL6 7 22699364 imputed G 0.135 -0.045 0.248 0.099 -0.106 0.024 -0.070 0.019 0.318 -0.076 0.024 
rs2847281 PTPN2 13 12811593 imputed G 0.124 0.082 0.043 0.112 0.052 0.246 0.068* 0.026 0.622 0.071 0.024 
rs780094 GCKR 2 27594741 typed T 0.466 0.029 0.276 0.389 0.044 0.133 0.036 0.068 0.705 - - 
rs6734238 IL1F10 2 113557501 imputed G 0.078 0.037 0.457 0.109 0.051 0.271 0.044 0.190 0.838 - - 
rs2836878 PSMG1 21 39387404 typed G 0.164 0.042 0.247 0.139 0.015 0.707 0.030 0.266 0.621 - - 
rs340029 RORA 15 58682257 typed T 0.097 0.036 0.426 0.135 0.025 0.547 0.030 0.326 0.826 - - 
rs4903031 RGS6 14 72088989 typed G 0.156 0.067 0.074 0.252 -0.022 0.502 0.016 0.511 0.103 - - 
rs13233571 BCL7B 7 72609167 imputed T 0.090 -0.043 0.356 0.115 0.000 0.992 -0.021 0.527 0.521 - - 
rs10778213 - 12 102019281 typed T 0.147 0.035 0.346 0.184 -0.006 0.878 0.015 0.580 0.440 - - 
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rs10745954 ASCL1 12 102007224 imputed G 0.205 -0.025 0.452 0.172 0.017 0.656 -0.007 0.783 0.404 - - 
rs12239046 NLRP3 1 245668218 imputed T 0.382 -0.015 0.586 0.361 0.016 0.585 0.000 0.987 0.104 - - 
rs3093059 CRP 1 157951760 typed G 0.171 0.254 4.18x10-12 NA NA NA NA NA NA - - 
rs12037222 PABPC4 1 39837548 typed G 0.121 0.015 0.713 NA NA NA NA NA NA - - 
rs1800961 HNF4A 20 42475778 typed T 0.014 -0.109 0.053 NA NA NA NA NA NA - - 
rs9987289 PPP1R3B 8 9220768 imputed G NA NA NA 0.046 0.111 0.102 NA NA NA - - 
rs4420638 APOE 19 NA NA NA NA NA NA NA NA NA NA NA NA - - 
rs3091244 CRP 1 NA NA NA NA NA NA NA NA NA NA NA NA - - 
rs769449 APOE 19 NA NA NA NA NA NA NA NA NA NA NA NA - - 
rs10521222 SALL1 16 NA NA NA NA NA NA NA NA NA NA NA NA - - 
rs4705952 IRF1 5 NA NA NA NA NA NA NA NA NA NA NA NA - - 
 Typed: genotyped SNP; imputed: imputed SNP; MAF: minor allele frequency. NA: results of SNPs not genotyped or imputed or failed QC procedures. 
 *: beta in opposite direction after meta-analysis as compared to original study [7], †: Additional adjustment for BMI, LDL-C, HDL-C and diabetes, hypertension and smoking statuses. 
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For SNPs that were significantly associated with Z-CRP after meta-analysis of SP2 and 
SiMES (meta-analysis p-value < 0.05), I assessed whether cardiovascular risk factors known 
to be associated with serum CRP (BMI, LDL-C and HDL-C levels and diabetes, hypertension 
and smoking status [235-236]) affected associations.  Secondary adjustments of these factors 
did not abolish initial associations for these SNPs, including rs6901250 and rs2847281 where 
inconsistencies in beta directions were detected in the East-Asians (meta-analysis p-value 
between 2.12 x 10
-18 
and 0.024, table 6.2).   
 
QQ-plot of meta-analysis results of SP2 and SiMES after removal of SNPs at all 22 
previously identified CRP-associated gene loci (100 kb upstream and downstream of genes) 
did not show an excess of small p-values (figure 6.1D), indicating that this study did not 
identify additional novel loci for Z-CRP association among the East-Asians. 
 
6.4 Further assessment at GPRC6A and PTPN2 gene loci 
 
I tested several hypotheses to understand the opposite directions of the associations observed 
in the East-Asians (as compared to European data [221]) for SNPS at the GPRC6A and 
PTPN2 loci.  I first assessed whether variables known to affect CRP may modify the effects 
of these variants.  Table 6.3 details test of interactions between these two variants and BMI, 
blood glucose or age in SP2 and SiMES.  Nominal significance for the interaction term 
rs2847281 x blood glucose (LRT p-value = 0.046) was detected in the SP2 dataset (assessed 
using fasting glucose levels) but this was not observed in SiMES (assessed with non-fasting 
HbA1c levels) (table 6.3).   
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Table 6.3: Interaction analysis performed for two SNPs, rs6901250 at GPRC6A and rs2847281 at 
PTPN2, which showed directional inconsistencies. Interaction analysis was performed by comparing 
models with and without specified interaction terms in the regression models, using the likelihood 
ratio-test (LRT). Individual terms were also included in the model (as well as age and sex) during 
analyses. Significant LRT results (p-value < 0.05) indicated in bold 
 
SiMES SP2 SiMES SP2 SiMES SP2 
Interaction term rs2847281xBMI rs2847281xblood glucose* rs2847281xage 
N 2,199 2,139 2,205 2,141 2,213 2,141 
Beta -0.003 -0.012 0.012 -0.88 0.001 -0.002 
SE 0.009 0.012 0.029 0.031 0.004 0.004 
LRT p-value 0.7085 0.382 0.434 0.046 0.849 0.509 
Interaction term rs6901250xBMI rs6901250xblood glucose* rs6901250xage 
N 2,155 2,152 2,169 2,154 2,169 2,154 
Beta 0.003 -0.011 -0.023 -0.06 0.002 -0.001 
SE 0.006 0.008 0.021 0.029 0.002 0.014 
LRT p-value 0.651 0.130 0.264 0.092 0.532 0.793 
* Fasting blood glucose measure used in SP2 and non-fasting HbA1c measures used in SiMES. LRT: Likelihood-ratio test. 
 
 
I further examined for variations in LD patterns between East-Asians and Europeans at these 
two loci.  Quantification of inter-population LD at one Mb regions surrounding these two 
variants were performed with the varLD programme [170] and reference European, Chinese 
and Malay populations from HapMap [83] and Singapore Genome Variation Project (SGVP) 
[160].  Normalized varLD scores of comparisons between Europeans (CEU) and East-Asians 
(CHB, CHS or MAS) at these two regions were less than 0.5 standard deviation (SD) 
indicating that LD variation was below the 67
th
 percentile of LD variations across the entire 
genome (figure 6.3).  
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Figure 6.3: Inter-population varLD comparison of Han Chinese population (CHB) and European population (CEU) from HapMap and Singaporean Chinese 
(CHS) and Singaporean Malays (MAS) from SGVP at A) 1Mb region surrounding the rs6901250 SNP at GPRC6A on chromosome 6 and B) 1Mb region 
surrounding the rs2847281 SNP at PTPN2 on chromosome 18. Normalized scores calculated from population specific means and standard deviations. 
Positions of SNPs are indicated by red triangles. 
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6.5 Genome-wide SNP x BMI interaction for Z-CRP association 
 
Figure 6.4 below shows QQ-plots comparing observed SNPxBMI interaction association p-
values with expected association levels in SP2, SiMES and after meta-analysis of both 
datasets (assuming a fixed-effect model).  Top associations in SP2 and after meta-analysis 
showed slight deviations from expected values, although these did not reach robust genome-
wide associations (p-value < 5 x 10
-8
).  Table 6.4 provides details of top hits from the 
interaction analysis (meta-analysis p-value ≤ 10-6). 
 
Leveraging on this genome-wide interaction data, I next examined for interaction with BMI 
for recently identified CRP risk variants [221-225]. Only 16 genotyped SNPs (out of 35 
SNPs) from 12 gene loci were examined as interaction analyses were not performed for 
imputed SNPs. Table 6.4 provides details of BMI interaction associations for these 16 SNPs.  
Nominal associations (meta-analysis p-value between 0.024 and 0.048, table 6.4) were 
detected at SNPs in or near GCKR (two SNPs) and APOE (one SNP).  However, these 
associations were not observed to be significant after adjustments for multiple testing 
(assuming 12 independent tests for 12 gene loci tested) (table 6.5).   
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Figure 6.4: QQ plot of genome-wide BMI interaction p-values for Z-CRP association in A) SiMES (N=2,275, λ=1.021). B) SP2 (N=2,198, λ=1.006-1.018).      
C) fixed-effect meta-analysis (N=4,473) of SP2 and SiMES. 
 
 
 
Table 6.4: Top hits (meta-analysis p-values ≤ 10-6) for SNPxBMI interaction after meta-analysis of SP2 and SiMES. 
     
SP2                           
(N=2,198) 
SiMES                      
(N=2,275) 
Fixed-effect meta-analysis                                     
(N=4,473) 
rsid Chr Position 
Nearest 
gene 
Test 
allele 
Beta SE p-value Beta SE p-value Beta SE p-value Qp-value 
rs10782008 17 75920466 RNF213 A -0.139 0.028 9.07x10
-7
 -0.061 0.029 0.039 -0.102 0.020 6.63x10
-7
 0.300 
rs8074015 17 75920875 RNF213 G -0.141 0.029 8.56x10
-7
 -0.056 0.029 0.057 -0.099 0.020 1.20x10
-6
 0.233 
rs4890010 17 75930774 RNF213 A -0.147 0.029 3.40x10
-7
 -0.050 0.029 0.086 -0.099 0.020 1.39x10
-6
 0.129 
rs293712 20 31404201 CDK5RAP1 A -0.116 0.036 1.15x10
-7
 -0.113 0.032 0.004 -0.114 0.024 1.75x10
-6
 1.000 
rs16861497 3 188214021 ST6GAL1 T -0.111 0.029 1.19x10
-4
 -0.074 0.028 0.009 -0.092 0.020 5.03x10
-6
 0.840 
rs372190 5 94484809 MCTP1 A 0.103 0.028 2.95x10
-4
 0.086 0.032 0.007 0.095 0.021 6.45x10
-6
 0.983 
rs439334 21 46187075 COL6A1 A -0.256 0.066 1.00x10
-4
 -0.246 0.111 0.027 -0.253 0.057 7.72x10
-6
 1.000 
rs7224239 17 75969771 RNF213 G -0.124 0.028 1.28x10
-5
 -0.055 0.030 0.065 -0.091 0.021 9.41x10
-6
 0.420 
C) B) A) 
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Table 6.5: SNPxBMI interaction association levels for 16 recently identified CRP-associated SNPs that were genotyped in the study.  
    
SP2                            
(N=2,198) 
SiMES                       
(N=2,275) 
Fixed-effect meta-analysis                                     
(N=4,473) 
rsid 
Nearest 
gene 
Chr Position Beta SE p-value Beta SE p-value Beta SE p-value p-value* Qp-value 
rs780094 GCKR 2 27594741 0.056 0.028 0.045 0.034 0.029 0.241 0.045 0.020 0.024 0.287 0.960 
rs2075650 APOE 19 50087459 0.031 0.051 0.539 0.102 0.043 0.019 0.072 0.033 0.028 0.338 0.774 
rs1260326 GCKR 2 27584444 0.055 0.027 0.045 0.022 0.029 0.451 0.039 0.020 0.048 0.581 0.875 
rs1892534 LEPR 1 65878532 -0.017 0.041 0.683 -0.070 0.033 0.035 -0.049 0.026 0.057 0.682 0.796 
rs4420065 LEPR 1 65934049 -0.016 0.041 0.701 -0.070 0.033 0.034 -0.047 0.026 0.060 0.720 0.763 
rs7310409 HNF1A 12 119909244 -0.023 0.028 0.415 0.055 0.030 0.069 0.013 0.021 0.525 1 0.311 
rs4129267 IL6R 1 152692888 -0.013 0.030 0.676 -0.012 0.034 0.728 -0.012 0.023 0.587 1 1.000 
rs4537545 IL6R 1 152685503 -0.012 0.031 0.705 -0.011 0.034 0.737 -0.012 0.023 0.613 1 1.000 
rs4903031 RGS6 14 72088989 0.000 0.038 0.994 -0.003 0.032 0.928 -0.010 0.024 0.679 1 0.989 
rs2836878 PSMG1 21 39387404 0.001 0.039 0.978 -0.025 0.041 0.532 -0.011 0.028 0.682 1 0.974 
rs340029 RORA 15 58682257 -0.042 0.045 0.353 0.025 0.043 0.555 -0.007 0.031 0.832 1 0.761 
rs2794520 CRP 1 157945440 0.001 0.028 0.958 -0.007 0.029 0.804 -0.003 0.020 0.893 1 0.997 
rs10778213 - 12 102019281 0.007 0.040 0.860 -0.005 0.037 0.885 0.000 0.027 0.989 1 0.997 
rs3093059 CRP 1 157951760 0.001 0.029 0.976 - - - - - - - - 
rs1800961 HNF4A 20 42475778 0.022 0.024 0.420 - - - - - - - - 
rs12037222 PABPC4 1 39837548 0.002 0.031 0.653 - - - - - - - - 
* Bonferonni adjustment for 12 tests, assuming 12 independent tests at 12 different loci. 
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6.6 Evaluation of CRP risk variant (rs2794520 at CRP gene locus) for association with 
retinal vascular calibre 
 
rs2794520 was identified as the most strongly associated index variant (for Z-CRP 
association in East-Asians as well as Europeans) that was genotyped (as opposed to imputed) 
at the CRP gene locus in this study (tables 6.1 and 6.2).  I thus, assessed associations with 
retinal vascular calibre for only this index variant in all available datasets.  Table 6.6 details 
association levels of rs2794520 with CRVE and CRAE.  As datasets of different ethnic 
groups were utilised in this study and significant between-study heterogeneity was observed, 
meta-analyses were performed in both the random-effect and fixed-effect models.  No 
significant associations were detected for CRAE in any of the datasets (table 6.6).  The CRP 
increasing allele (C allele) of rs2794520 was marginally significant for increased CRVE in 
the three Singaporean datasets (SP2 and SiMES East-Asians and SINDI South-Asian 
datasets, p-value between 0.048 and 0.022) but this association was not replicated among the 
larger CHARGE consortium European populations and overall meta-analyses did not indicate 
a significant association (table 6.6). 
 
Table 6.6: rs2794520 association levels with CRVE and CRAE traits in datasets used in the study. 
 
Ethnicity N 
Test 
allele 
MAF Beta SE p-value Qp-value 
CRVE association 
SP2 East-Asian 1,411 
C 
0.43 1.578 0.778 0.048 
 
SiMES East-Asian 2,230 0.49 1.520 0.716 0.038 
 
SINDI South-Asian 2,390 0.65 1.326 0.610 0.022 
 
CHARGE European 18,101 0.67 -0.006 0.231 0.978 
 
Fixed effect meta-analysis - 24,132  0.360 0.200 0.071 0.018 
Random effect meta-analysis - 24,132  0.955 0.504 0.058 0.018 
CRAE association 
SP2 East-Asian 1,413 
C 
0.43 0.495 0.514 0.335 
 
SiMES East-Asian 2,181 0.49 0.365 0.487 0.454 
 
SINDI South-Asian 2,390 0.65 -0.326 0.447 0.466 
 
CHARGE European 18,722 0.67 -0.086 0.152 0.5744  
Fixed effect meta-analysis - 24,706  -0.034 0.132 0.796 0.517 
Random effect meta-analysis - 24,706  -0.034 0.132 0.796 0.517 
CRVE: central retinal vein equivalent and CRAE: central retinal artery equivalent 
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In SP2 and SiMES East-Asian datasets where both CRP and CRVE phenotype data were 
available, I calculated predicted association levels between rs2794520 and CRVE.  This was 
done by multiplying the increase in beta of Z-CRP (per increase in rs2794520 risk allele) 
with the increase of beta of CRVE per SD increase in CRP (figure 6.5).  In both SP2 and 
SiMES, observed effect sizes for CRVE per increase in risk allele of rs2794520 (C allele) 
were 5 and 3 fold larger than expected, respectively (figure 6.5).   
 
Figure 6.5: Comparison of observed and expected association values for rs2794520 and CRVE in A) 
SiMES dataset and B) SP2 dataset where both CRP and CRVE measures were available and 
association with CRVE was nominally significant (table 6.6). Observed regression values presented in 
black and estimated values presented in grey. Regression models were adjusted for age and sex in SP2 
and age, sex and first 2 principle components in SiMES. 
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6.7 Discussion 
 
In this study I have conducted a GWAS for serum CRP in 4,473 East-Asian individuals 
(SiMES Malays and SP2 Chinese) living in Singapore.  Although no novel loci associated 
with CRP was uncovered in this study, leveraging on GWAS data, I have shown that several 
CRP-associated genetic variants identified in other populations (mainly from studies using 
populations of European ancestry) show similar and statistically significant associations with 
serum CRP in East-Asians populations from Singapore.   
 
The replications of IL6R and LEPR variants for CRP association in East-Asians were novel. 
A recent study has indicated that CRP association at the IL6R locus was independent of IL6 
levels [237] and similarly LEPR SNPs observed to be associated with serum CRP in this 
study were in poor LD with known variants at the LEPR gene locus that were known to be 
associated with circulating leptin [238].  
 
Marginal associations at two loci (rs6901250 at the GPRC6A locus and rs2847281 at the 
PTPN2 locus) were also detected with effect directions that were opposite to those identified 
in populations of European ancestry.  Further examination of inter-ethnic population LD 
differences and interaction analyses did not reveal significant results to explain these 
discrepancies.  Given that these loci with very modest effect sizes were only uncovered in 
European studies after analyses of large number of sample (over 80,000 individuals), my 
study of 4,453 East-Asian individuals would have lacked sufficient power to detect such 
associations.   
 
Using an effect size of 1.35mg/L increase in serum CRP (approximate effect size of 
rs6901250 and rs2847281 in the recent large-scale European GWAS [221]), approximately 
60,000 participants would have been necessary to be at least 80% powered (α = 0.05) to 
detect variants of similar magnitude in the Singaporean Chinese and Malay populations.  As 
such, it was likely that these discrepant findings in my study represent false-positive 
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associations and further large-scale studies in East-Asian populations would be necessary to 
confirm any ethnic-specific results. 
 
Elevated serum CRP has been observed among individuals with higher BMI, suggesting a 
chronic state of low-grade inflammation among overweight and obese patients [22-23].  My 
replication results of known CRP-associated variants in East-Asian populations however, 
revealed associations that were independent of obesity levels as well as other cardiovascular 
risk factors (T2D, hypertension and smoking statuses and cholesterol levels).  It is likely that, 
in the original studies where these variants were first identified, meta-analysis procedures of 
several smaller GWAS would have boosted power to identify variants that lack effect 
modulations due to external factors (such as obesity levels) as these variables may not have 
been adequately represented in all studies that had been combined.   
 
To specifically look for variants that may be modulated by obesity levels, I conducted a 
genome-wide interaction study with BMI levels using the two East-Asian populations.  These 
analyses identified variants in or near five gene loci with association levels that were 
marginally better than expected (by chance) in the study.  Although it would be premature, at 
this stage, to claim that these variants are true associations with definite certainty, some of the 
top hits seemed relevant for both obesity and inflammatory processes.  For example, the top 
hit in this interaction analysis with BMI, ring finger protein 213 gene (RNF213), is highly 
expressed in the human spleen and leukocytes and has been recently identified as 
susceptibility locus for vascular disease (Moyamoya disease) [239-240].  RNF213 is also a 
zinc-binding protein and may have relevance with obesity due to the importance of zinc in 
metabolism and thermoregulatory processes [241].  Therefore, it would be important to 
follow up the top associations from this study in additional datasets to confirm findings and 
subsequently attempt to elucidate the genetic link between obesity and inflammatory 
processes. 
 
Using principles of Mendelian randomisation I have also investigated for a causal link 
between a reproducibly associated index variant (for serum CRP associations) at the CRP 
gene (rs2794520) and retinal vessel calibre.  Due to random assortment of alleles during 
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meiosis in gamete formation, genotypes would not be associated with known and unknown 
confounders of disease and furthermore, SNPs should not be influenced by effects of reverse 
causation effects [242].  Thus detecting an association between a genetic variant associated 
with a trait and disease (in this case CRP and retinal vessel calibre, respectively) would allow 
for a causal inference to be drawn. 
 
Previous large-scales Mendelian randomisation studies have not detected an association 
between CRP variants and CHD or MI [221-222].  Nevertheless, there may have been a 
possibility that the heterogeneous nature of such end-stage disease outcome measures could 
have masked true associations [243]. Furthermore, a recent association of CRP variants with 
CKD [230] warrants the need to assess the role of CRP in micro vascular disease, which has 
not been tested in previous studies.  In my study, I assessed associations for retinal vessel 
calibres which are subclinical phenotypes for end-stage vascular disease to improve 
estimation of disease outcomes.  Furthermore, associations of retinal vessel calibre with both 
macro and micro vascular diseases [217-219], enabled conclusions to be drawn on both forms 
of vascular disease. 
   
This study confirmed the non-causal nature of CRP with macro vascular disease and I did not 
find evidence to support a causal link between CRP and micro vascular disease as well.  It is 
however noteworthy that marginal significance was detected between the CRP variant and 
CRVE in only the Singaporean Asian datasets (SP2 and SiMES East-Asians and SINDI 
South-Asian datasets) but not among the European samples assessed.  Although it may 
suggest ethnic-specific differences, observed CRVE effect sizes far exceeded predicted 
estimates in the two East-Asian populations (predicted estimates were not calculated in 
SINDI South-Asian dataset as CRP measures were not available).  Furthermore, it should be 
noted that in the smaller East-Asian cohorts (SiMES and SP2) power in the study to detect 
estimated effect sizes for rs2794520-CRVE associations (figure 6.5) was poor (23.8% and 
15.6% at α = 0.05 in SiMES and SP2, respectively), and as such these could represent false-
positive findings.  
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In summary, my assessment for CRP association in two East-Asian cohorts living in 
Singapore replicated and corroborated at least seven CRP-associated gene loci (first 
identified in primarily European studies), indicating that common variants involved in 
modulating serum CRP levels are transferable between ethnic groups (at least to East-Asian 
populations).  Nevertheless, discrepancies in effect directions were observed at two loci 
(PTPN2 and GPRC6A) between the East-Asian populations analysed in this study and 
original studies that assessed populations of European ancestry and  further large-scale and 
well-powered studies in East-Asians would be necessary to confirm (or dismiss) these 
findings.    
 
Known CRP-risk variants that replicated in my study were further observed to be 
independent of obesity, highlighting that large-scale meta-analysis studies that combine 
association data from several studies for main effects would not be powered to identify 
modulations of effects.  My genome-wide interaction analysis with BMI to identify such 
specific modifications of serum CRP associations at common variants identified preliminary 
hits which would require validation and further assessment in additional independent 
datasets.  Lastly, I did not find evidence for a causal link between CRP and both micro and 
macro vascular disease in my study, which supports the notion that elevated serum CRP may 
simply be a consequence of inflammatory processes rather than a pathological cause of 
vascular disease. 
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7. Conclusion from study results 
 
This study on the genetics of obesity was primarily focussed on 1) evaluating the role of 
recently identified variants, first detected in populations of European ancestry, among Asian 
populations and 2) unravelling novel obesity loci in East-Asians.  In my study I examined 
Chinese, Malays and Asian-Indian populations, which represent the major portion of 
populations in Asia, where a dramatic increase in obesity and related metabolic health 
complications are expected over the next few decades [136-137].   
 
With prior knowledge from recent GWAS studies for obesity (conducted in populations of 
European ancestry) [91-100, 104-105], my candidate-loci approach in identifying obesity risk 
loci in Asian populations was successful in showing that: 
 
1. Common variants at intron 1 of FTO, the first locus associated with obesity in 
European GWAS, were also associated with BMI in populations of adult East-Asian 
(Chinese and Malay populations) and South-Asian ancestry living in Singapore.  I 
have also corroborated the role of FTO as a childhood obesity locus, using the 
SCORM Singaporean Chinese paediatric cohort.  
2. These obesity associations at common FTO SNPs were observed despite lower risk 
allele frequencies in Asians, especially when comparing East-Asians with European 
populations (approximately 12%, 20% and 40% in Singaporean Chinese, Singaporean 
Malays and Europeans respectively).  Correspondingly, effect estimates were 
marginally smaller in Asian populations as compared to effect estimates from 
European studies.  
3. Evaluation of linkage disequilibrium (LD) structure at the FTO locus among East-
Asians, South-Asians and European populations did not indicate major differences.  
Therefore, it was likely that initial reports of non-replication of the FTO locus for 
obesity risks in Asian populations were either under-powered, as evident in my first 
study of a smaller South-Asian dataset [NHS98 (N = 594) did not indicate obesity 
associations, while the larger SINDI dataset (N = 2,531) showed similar associations] 
or may be affected by modulation of effects.  However, I was unable to detect a 
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statistically significant interaction between the FTO locus and physical activity in the 
NHS98 Chinese, although it should be indicated that this study was underpowered to 
detect such interactions. 
4. A direct association of FTO with T2D (independent of obesity levels) among Asians 
was also detected, which was not seen in European studies.  Nevertheless, the 
association with T2D may have been due to residual confounding, as adjustments for 
BMI in Asians may not have adequately corrected for adiposity levels. 
5. I have further corroborated the role of 12 additional obesity loci (first identified from 
European GWAS) among the Singaporean East-Asian and South-Asian populations.  
Assessing results between the Asian populations, inter-ethnic and age differences in 
allele frequencies and effect estimates were also identified at these loci (i.e. at the near 
MC4R loci stronger effects were observed among South-Asians and paediatric East-
Asian populations as compared to adult East-Asian samples). 
6. The variants that were significantly associated in the Singaporean datasets were those 
for which I had higher power in my study and it may be likely that several other true 
positive variants (with weaker effects and/or lower allele frequencies among Asian 
populations) were not replicated due to the modest sample size of the Singaporean 
datasets.  
7. The over-representation of significant associations among the Singaporean datasets 
for obesity risks, confirms that diverse ethnic groups share some degree of genetic 
predisposition to obesity susceptibility and common variants associated with BMI, 
first detected in Europeans, are transferable across ethnic groups (at least in East-
Asian and South-Asian populations).  Nevertheless all replicating loci, even in 
combination, still explain only a small proportion of BMI variance (less than 2% in 
both European and Asian populations), highlighting that several other genetic risk loci 
remain to be discovered. 
8. I have further corroborated the importance of the central nervous system in common 
obesity by detecting a possible role for the novel MAP2K5 locus in neuronal 
development among Asians.  Moreover, replication of the GIPR locus implicates an 
additional control of appetite by the gut to the brain in the Asian population as well. 
 
To detect novel loci associated with obesity among Asian populations, I have used a 
hypothesis-free GWAS approach.  My initial study for BMI association was performed using 
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only Singaporean East-Asian datasets (7,951 samples in discovery stage) and promising hits 
were further genotyped de novo or assessed in silico (4,981 samples in replication stage) 
using additional independent East-Asian datasets.  The FTO region reached robust genome-
wide significance (p-value < 5 x 10
-8
) in the combined meta-analysis in this study, while 
other promising hits (such as SNPs near the NLN gene region) failed to replicate. These 
findings signified: 
 
1. The importance of validating initial findings from discovery GWAS to exclude false-
positive associations that may have been detected due to chance or multiple testing 
issues. 
2. The lack of robust associations, besides the FTO region, indicates that there may 
remain no additional common variants, with sufficiently large enough effect sizes and 
allele frequencies among East-Asian populations that would have enabled detection in 
a moderately sized study. This however, does not rule out the possibility that other 
rarer genetic variants with modest to large effects exists. 
3. Thus, to detect variants that were likely to have more modest to small effect sizes in 
East-Asian populations there would be a pressing need for substantially larger sample 
sizes to improve power in the study. 
 
This power issue was addressed by the consortia-based GWAS that was convened to detect 
BMI risk loci among populations of East-Asian ancestry.  Collaborating with several groups 
across Asia and the USA, we drastically improved sample sizes in our studies (82,048 and 
62,245 East-Asian samples analysed in total for the AGEN and RIKEN studies, respectively) 
and we were able to show the value of performing GWAS for BMI associations in non-
European samples by: 
 
1. Detecting SNPs in or near four novel gene loci (CDKAL1, PCSK1, GP2 and KLF9) 
associated with increased BMI with robust genome-wide levels of significance (p-
value < 5 x 10
-8
) in East-Asian populations.  The KLF9 locus was further observed to 
be interactive with another gene locus, MSTN, providing the first evidence of epistatic 
interaction for common obesity in a GWAS. 
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2. Expectedly, all four novel loci identified from these consortia-based studies were 
observed to have very modest effect sizes and in combination only identified 
approximately about the same BMI variance explained by the FTO locus alone 
(0.22% of BMI variation in East-Asians).   
3. We showed that three of these novel loci (CDKAL1, PCSK1 and GP2) were 
transferrable to populations of European ancestry.  However, the variance explained 
by these loci in Europeans were smaller than that in East-Asian samples (0.01% - 
0.02% in Europeans as compared to 0.04% - 0.07% in East-Asians) and hence would 
have required even larger sample sizes of European populations to be detected. 
4. The KLF9 locus was however, not replicated in the European samples and thus 
represents an East-Asian specific obesity locus, which would not have been detected 
in GWAS performed in only European populations. 
5. Several of the novel loci identified (especially the CDKAL1 locus) also implicated a 
prominent role for insulin associated processes in common obesity risks. 
6. Leveraging on the larger sample size and genome-wide data, we were also able to 
show robust replication at genome-wide levels for nine loci that were first detected in 
European GWAS (FTO, SEC16B, MC4R, GIPR, ADCY3, BDNF, MAP2K5, GNPDA2 
and TFAP2B), among our East-Asian study.  This firmly corroborated their role as 
obesity risk loci, which were also transferable to the East-Asian populations. 
 
In my next study I expanded on the finding that insulin associated processes may play a 
prominent role in obesity.  I assessed obesity risks for all known variants with an association 
with T2D in adult East-Asian populations and further sought to replicate the role of two gene 
regions (SNPs in or near CDKAL1 and HHEX) as birth weight and childhood obesity 
susceptibility loci.  Results from this study showed: 
 
1. A possible ethnic-specific association with BMI in adult East-Asian populations but 
not in adult European samples for a variant near the HHEX locus (rs1111875).  
2. This association was validated in only adult East-Asian samples that had normal 
blood glucose, perhaps indicating a possibility of effect modulation due to T2D 
therapies.   
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3. The T2D risk allele of this variant was associated with reduced obesity risk, 
highlighting that the HHEX variant may be involved in pathways that enhance 
efficiency of energy storage in fat tissues and thus, reduce T2D risks as seen in other 
gene loci such as PPARγ [209] and ADIPOQ [210]. 
4. These findings are preliminary in nature and warrants further follow-up in large-scale 
East-Asian studies to firmly confirm results and dismiss issues of bias in the study. 
5. I also replicated birth weight associations of another variant near the HHEX locus 
(rs7923837) using the SCORM Singaporean Chinese children cohort.   
6. The association between this variant and extremes in birth weight group was 
interactive in nature and was observed to have lasting effects, modulating BMI levels 
at age nine.  These findings indicate that with either excessive or restricted foetal 
growth, defects at the HHEX locus may lead to obesity or T2D risks and further 
follow-up of the SCORM samples into adulthood would allow for better assessment 
of potential long-term effects. 
 
I my final study, I aimed to assess for inflammation signals in Asian populations and detect 
possible effect modulation due to BMI levels. Results from this study indicated that: 
1. Common variants in at least seven gene loci associated with serum CRP, first 
identified in primarily European GWAS studies, were also significantly associated in 
East-Asian samples living in Singapore. 
2. These variants were independent of obesity levels as well as other cardiovascular risk 
factors (namely T2D, hypertension and smoking statuses and lipid levels), indicating 
that signals detected after large-scale meta-analyses were unlikely to be modulated by 
related exposure variables. 
3. As such, I specifically looked for these interactions by conducting a genome-wide 
interaction analysis with BMI levels among the East-Asian datasets.  Preliminary 
genome-wide interaction results indicated that several other common variants were 
modulated by obesity levels for serum CRP association.  These results however 
require further follow-up in additional independent datasets to confirm results and 
could prove crucial in understanding the role of inflammatory processes in obesity, 
which are believed to be the primary cause of several obesity-related medical 
complications [21,24]. 
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4. I also did not find evidence to support a causal link between CRP and micro or macro 
vascular disease, which supports the notion that elevated serum CRP may simply be a 
consequence of inflammatory processes rather than a pathological cause of vascular 
disease. 
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8. Future direction 
 
My project served to corroborate the role of several recently identified obesity risk loci in 
populations of Asian ancestry, indicating that these common variants are largely transferable 
between different ethnic groups and has also identified novel loci with obesity predisposition 
in East-Asian populations that provides added knowledge on disease aetiology.  Nevertheless, 
all risk loci for common obesity identified thus far, even in combination, explain only a very 
small proportion of variance in BMI in populations of East-Asians as well as in Europeans 
ancestry (less than 2% of overall BMI variation) [99, 244-245]. 
 
This phenomenon is not only seen in obesity but in almost every complex disease analysed 
by GWAS (except some, like age-related macular degeneration where approximately 50% of 
heritability has been explained by a few GWAS hits), leading researchers to query on the 
‘missing heritability’ of disease [246].  It is thus plausible that common variants with modest 
effect sizes have a limited contribution in explaining obesity variation in the population and 
as such, it is expected that many additional mutations exists which are still yet to be 
discovered [65, 68, 69]. 
 
8.1 Importance of other genetic mutations 
 
GWAS is based on looking for associations of SNPs with a disease or a related phenotype.  
While SNPs make up the largest number of mutations in the human genome, other ‘non-SNP’ 
mutations such as structural variants also exist (both common and rare) [247-248].  In fact 
genetic coverage, in terms of number of nucleotides affected, of structural variants far 
exceeds that of SNPs [65].  It is therefore, important to assess the role that structural variants 
could have in disease process. 
 
Some of these structural variants, especially common structural variants, may be tagged by 
SNPs through LD [249] and thus, their contribution to disease may have already been 
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indirectly assessed through GWAS scans [250].  Among the obesity loci identified, it is 
believed that the signal detected at the neuronal growth regulator 1 (NEGR1) loci is due to a 
common deletion just upstream of the gene [97] and another study identified deletions at 
chromosome 16 associated with severe early-onset obesity [251] which, included another 
known loci, SH2B adaptor protein 1 (SH2B1) [97].  Other structural variations have also been 
recently identified, such as the chromosome 16p11.2 deletion causing rare but a highly 
penetrant form of obesity [252] with mirror phenotypes among patients with duplication at 
the same region [253] and a common copy number variation at 10q11.22 was observed to be 
associated with obesity among Han Chinese samples [254] (although this is yet to be 
replicated in additional cohorts).  With continued developments in methodology to detect 
these variants and as better characterisation and cataloguing of structural variations are 
carried out (i.e. Database of Genomic Variants, http://projects.tcag.ca/variation/), it would be 
crucial for studies to determine the contribution of structural variations with obesity risk. 
 
GWAS are powered to detect common variants, those with a MAF of at least 5% and have 
relied on the principle of ‘common disease common variation’ hypothesis [246], which 
suggests that common diseases would involve several common variants each with a nominal 
effect sizes that has enabled the mutations to be sustained in the population due to their less 
severe nature [246].  Less common mutations, variants with MAF between 0.5% and 5% as 
well as rare mutations, variants with MAF less than 0.5% are not sufficiently covered in 
traditional GWAS SNP-chips and are not expected to have large enough effect sizes to have 
been identified through linkage analyses [65, 246].  As such the contributions of these rarer 
variants have not been assessed thoroughly for obesity in GWAS [65, 246]. 
 
Studies indicate that low frequency mutations can explain a higher proportion of heritability 
of a given disease without being truly Mendelian in nature (consisting of multiple rare 
variants) [246, 255].  Even among GWAS hits, such as the melatonin receptor 1B (MTN1RB) 
for T2D risk, multiple rare variants may exist [256].  Studies for obesity association 
examining lower frequency or rarer mutations are limited.  Nevertheless a recent study 
examining the PCSK1 gene has identified rare functional mutations that contribute to human 
obesity [257] and, as highlighted above, rare structural variation at Chr16p11.2 predispose to 
penetrant obesity with substantially larger effect sizes [252-253]. 
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It is also important to note that effect estimates of SNPs detected from GWAS may have been 
underestimated if these in fact tag to a rarer mutation with larger effect size as evident from 
other studies such as those examining lipid traits [258].  It is hoped that with the recent 
availability of the 1000 genomes data [259], which aimed at characterising and cataloguing 
mutations that were at least 1% in several populations and with improvements in sequencing 
technology, the full spectrum of low frequency and rarer mutations for obesity risks would be 
elucidated. 
 
8.2 Determining causative loci 
 
Another important caveat of GWAS is that it is often impossible to pin-point the causal gene 
or variants from initial GWAS alone, as hits identified are often simply surrogates in LD with 
the true causative mutation [260].  Fine-mapping, whereby genotype coverage is increased at 
risk regions, or targeted re-sequencing to determine all variants at a risk region, can be 
adopted to try and narrow down the location of causative mutations and to determine relevant 
causative genes [260].  Determining the precise genomic regions to follow-up in these studies 
are however not straightforward but these strategies could be guided by exploiting differences 
in genetic architecture between ethnic groups (especially from data of African ancestry due to 
higher recombination rates and hence, smaller LD blocks), to further confine chromosomal 
regions to focus on [260].  It would be important to further complement these studies with 
additional work in multiple experimental models such as expression data from relevant 
tissues, in vivo animal studies, in vitro functional assays or chromatin associations [260].  
Only then can firm mechanistic and causal roles of the identified loci be determined [260]. 
 
Although such efforts have led to determining causative mutations in a few other diseases and 
traits such as variants at fibroblast growth factor receptor 2 (FGF2) with breast cancer [261], 
interferon induced with helicase C domain 1 (IFIH1) with Type 1 diabetes [262] and 
MTN1RB in T2D [256], data from obesity studies is however limited.  Studies have 
nevertheless, concentrated on the FTO region as it was observed that an adjacent gene, 
RPGRIP1-like (RPGRIP1), was ubiquitously co-expressed with FTO [263], raising 
180 
 
reservations if FTO was indeed the true causative gene for obesity predisposition detected 
from the GWAS scans. 
 
Nevertheless, a knock-down mouse model of FTO, with RPGRIP1 expression confirmed to 
be unaltered, was observed to protect against obesity [264] establishing the role of FTO in 
obesity predisposition.  Furthermore, recent fine-mapping studies in populations of African 
ancestry have further helped in narrowing the putative causative region at the FTO locus 
[119].  It would therefore, be important to further investigate all obesity-associated loci to 
fully appreciate the genetic contribution to disease aetiology. 
 
8.3 Gene x environment interaction 
 
Common obesity has a strong environmental component and the precise lists of factors 
involved are still highly discussed [265].  Deciphering if obesity risk variants act interactively 
with modifiable environmental factors is of great significance, as this could potentially prove 
valuable in initiating effective public health strategies, especially since it is often believed 
that genetic predisposition to disease cannot be improved by a healthier lifestyle [79]. 
 
During the course of my study, I had evaluated interactions with obesity loci with 
environmental factors (physical activity and dietary intake) in the datasets available to me.  
Although there were some evidence of environmental interactions with genetic variants in my 
studies (such as reduced obesity risk due to FTO among Singaporean Chinese who exercised 
more), due to the modest sample sizes of the datasets available, these studies were largely 
underpowered (less than 40% power to detect exercise interaction with FTO locus,    α = 
0.05). 
 
Sample sizes in studies examining for environmental interaction need to be large to be 
sufficiently powered to detect interactive effects.  Furthermore, these studies are often 
complicated by difficulty in accurately measuring lifestyle exposures for obesity studies 
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(such as physical activity and dietary intake) and the fact that environmental exposures may 
change throughout an individual’s life.  Therefore, there is a need for large-scale prospective 
studies to accurately collect and quantify environmental phenotypes for accurate 
determination of gene x environment interactions. 
 
8.4 Conclusion 
 
Due to the tremendous progress in genetic research, especially with the advent of GWAS, 
scientific research has determined an unprecedented number of risk variants that predispose 
to obesity within a very short period of time.  While researchers are now beginning to better 
elucidate the genetic component leading to common obesity, the variants identified thus far 
are still not clinically useful for accurately predicting obesity risks.  Nevertheless, these 
endeavours have, without doubt, shed new light in disease aetiology and as we gather a better 
appreciation on the pathophysiology of obesity, it could potentially lead to the therapeutic 
developments and better management of obese and overweight individuals.  Continued 
progress is however crucial and initial genetic studies must be coalesced with additional 
analyses (such as functional assays and expression analyses) to translate scientific findings 
into effective clinical care. 
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Appendix I 
1. PCA analysis of SCORM samples genotyped on Illumina 550 and 550duo SNP chips. 
Figure 1:  Principle Component Analysis (PCA) of SCORM Chinese children samples (green dots 
representing samples from 550 chip and brown dots representing samples on 550duo chip) with 
Singapore Genome Variation Project (SGVP) reference panels for Chinese (CHS, red dots), Malay 
(MHS, purple dots) and Asian-Indian samples (INS, blue dots) used to detect outliers with discordant 
ethnic membership from reported ethnicity or admixed samples.  Only first 3 principle components 
are shown below. A) PC 1 vs PC2 and B) PC1 vs PC3. 
 
 
A) 
B) 
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Table 1: 13 SCORM outliers with greater than 8 SD at any one of the top 10 PCs detected by 
Eigenstrat PCA program.  
 
Figure 2: Principle Component Analysis (PCA) of SCORM Chinese children samples (green dots 
representing samples from 550 chip and brown dots representing samples on 550duo chip) with 
Singapore Genome Variation Project (SGVP) reference panels for Chinese (CHS, red dots), Malay 
(MHS, purple dots) and Asian-Indian samples (INS, blue dots) after exclusion of 13 outliers.  Only 
first 3 principle components are shown below.  A) PC1 vs PC2 and B) PC1 vs PC3. 
 
A) 
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2. PCA analysis of SP2 and SDCS samples genotyped on Illumina 1M chips. 
Figure 3:  Principle Component Analysis (PCA) of Chinese adults from  SP2 (turquoise dots) and 
SDCS (pink dots) genotyped on Illumina 1M chips with Singapore Genome Variation Project (SGVP) 
reference panels for Chinese (CHS, red dots), Malay (MAS, blue dots) and Asian-Indian samples 
(INS, green dots) used to detect outliers with discordant ethnic membership from reported ethnicity or 
admixed samples.  Outliers detected are circled in the diagrams. Only first 3 principle components 
(PC) are shown below. A) PC 1 vs PC2 and B) PC1 vs PC3.  
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Figure 4:  Principle Component Analysis (PCA) of Chinese adults from  SP2 (red dots) and SDCS 
(green dots) genotyped on Illumina 1M chips with HapMap reference panels for Europeans  (CEU, 
pink dots), Han Chinese (CHB, yellow dots), Japanese (JPT, turquoise dots) and Yorubans  (YRI, 
black dots) used to detect outliers with discordant ethnic membership from reported ethnicity or 
admixed samples.  Outliers detected are circled in the diagrams. Only first 3 principle components 
(PC) are shown below. A) PC 1 vs PC2 and B) PC2 vs PC3.  
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3. PCA analysis of SP2 and SDCS samples genotyped on Illumina 610 chips. 
Figure 5:  Principle Component Analysis (PCA) of Chinese adults from  SP2 (turquoise dots) and 
SDCS (pink dots) genotyped on Illumina 610 chips with Singapore Genome Variation Project 
(SGVP) reference panels for Chinese (CHS, red dots), Malay (MAS, blue dots) and Asian-Indian 
samples (INS, green dots) used to detect outliers with discordant ethnic membership from reported 
ethnicity or admixed samples.  Outliers detected are circled in the diagrams. Only first 3 principle 
components (PC) are shown below. A) PC 1 vs PC2 and B) PC1 vs PC3.  
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Figure 6:  Principle Component Analysis (PCA) of Chinese adults from  SP2 (red dots) and SDCS 
(green dots) genotyped on Illumina 610 chips with HapMap reference panels for Europeans  (CEU, 
pink dots), Han Chinese (CHB, yellow dots), Japanese (JPT, turquoise dots) and Yorubans  (YRI, 
black dots) used to detect outliers with discordant ethnic membership from reported ethnicity or 
admixed samples.  Outliers detected are circled in the diagrams. Only first 3 principle components 
(PC) are shown below. A) PC 1 vs PC2 and B) PC2 vs PC3.  
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4. PCA analysis of SP2 samples genotyped on Illumina 550 chips. 
Figure 7:  Principle Component Analysis (PCA) of Chinese adults from  SP2 (turquoise dots) 
genotyped on Illumina 550 chips with Singapore Genome Variation Project (SGVP) reference panels 
for Chinese (CHS, red dots), Malay (MAS, blue dots) and Asian-Indian samples (INS, green dots) 
used to detect outliers with discordant ethnic membership from reported ethnicity or admixed 
samples.  Outliers detected are circled in the diagrams. Only first 3 principle components (PC) are 
shown below. A) PC 1 vs PC2 and B) PC1 vs PC3. 
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Figure 8:  Principle Component Analysis (PCA) of Chinese adults from  SP2 (red dots) genotyped on 
Illumina 550 chips with HapMap reference panels for Europeans  (CEU, pink dots), Han Chinese 
(CHB, yellow dots), Japanese (JPT, turquoise dots) and Yorubans  (YRI, black dots) used to detect 
outliers with discordant ethnic membership from reported ethnicity or admixed samples.  Outliers 
detected are circled in the diagrams. Only first 3 principle components (PC) are shown below. A) PC 
1 vs PC2 and B) PC2 vs PC3 
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5. PCA analysis of SCES samples genotyped on Illumina 610 chips. 
Figure 9:  Principle Component Analysis (PCA) of Chinese adults from  SCES (black dots) 
genotyped on Illumina 550 chips with Singapore Genome Variation Project (SGVP) reference panels 
for Chinese (CHS, red dots) and Malay (MAS, green dots) used to detect outliers with discordant 
ethnic membership from reported ethnicity or admixed samples.  Outliers detected are indicated in 
turquoise the diagrams. Only first 3 principle components (PC) are shown below. A) PC 1 vs PC2 and 
B) PC1 vs PC3. 
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Figure 10:  Principle Component Analysis (PCA) of Chinese adults from  SCES (black dots) 
genotyped on Illumina 610 chips with HapMap reference panels for Europeans  (CEU, blue dots), 
Han Chinese (CHB, red dots), Japanese (JPT, green dots) and Yorubans  (YRI, pink dots) used to 
detect outliers with discordant ethnic membership from reported ethnicity or admixed samples.  
Outliers detected are circled in turquoise the diagrams. Only first 4 principle components (PC) are 
shown below. A) PC 1 vs PC2 and B) PC3 vs PC4. 
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6. PCA analysis of SiMES samples genotyped on Illumina 610 chips. 
Figure 11:  Principle Component Analysis (PCA) of Malay adults from  SiMES (black dots) 
genotyped on Illumina 610 chips with Singapore Genome Variation Project (SGVP) reference panels 
for Chinese (CHS, red dots), Malay (MAS, green dots) and Asian-Indian samples (INS, blue dots) 
used to detect outliers with discordant ethnic membership from reported ethnicity or admixed 
samples.  Outliers detected are indicated in pink in the diagrams. Only first 3 principle components 
(PC) are shown below. A) PC 1 vs PC2 and B) PC2 vs PC3.  
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Figure 12:  Principle Component Analysis (PCA) of Malay adults from  SiMES (black dots) 
genotyped on Illumina 610 chips with HapMap reference panels for Europeans  (CEU, red dots), Han 
Chinese (CHB, turquoise dots), Japanese (JPT, blue dots) and Yorubans  (YRI, green dots) used to 
detect outliers with discordant ethnic membership from reported ethnicity or admixed samples.  
Outliers detected are indicated in pink in the diagrams. Only first 3 principle components (PC) are 
shown below. A) PC 1 vs PC2 and B) PC2 vs PC3 
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7. SINDI PCA analyses on samples genotyped on Illumina 610 chips. 
Figure 13:  Principle Component Analysis (PCA) of Asian-Indian adults from  SINDI (black dots) 
genotyped on Illumina 610 chips with Singapore Genome Variation Project (SGVP) reference panels 
for Chinese (CHS, red dots), Malay (MAS, green dots) and Asian-Indian samples (INS, blue dots) 
used to detect outliers with discordant ethnic membership from reported ethnicity or admixed 
samples.  Outliers detected are indicated in pink in the diagrams. Only first 3 principle components 
(PC) are shown below. A) PC 1 vs PC2 and B) PC1 vs PC3.  
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Figure 14:  Principle Component Analysis (PCA) of Asian-Indian adults from  SINDI (black dots) 
genotyped on Illumina 610 chips with HapMap reference panels for Europeans  (red dots), Han 
Chinese (CHB, turquoise dots), Japanese (JPT, blue dots) and Yorubans  (YRI, green dots) used to 
detect outliers with discordant ethnic membership from reported ethnicity or admixed samples.  
Outliers detected are indicated in pink in the diagrams. Only first 3 principle components (PC) are 
shown below. A) PC 1 vs PC2 and B) PC1 vs PC3 
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Appendix II 
 
1) Association levels of 30 index SNPs first detected from European GWAS studies among the Singaporean GWAS datasets. 
 
Table 1: BMI Z-score association levels for obesity loci first detected among Europeans, available in SiMES, SINDI and SCORM datasets. 
     SiMES (N=2,522) SINDI (N=2,538) SCORM (N=1,006) 
rsid chr pos reported gene* 
test 
allele 
P maf beta se pval 
610 
Chip 
P maf beta se pval 
610 
Chip 
P maf beta se pval 
550 
Chip 
SNPs previously detected from GWAS using BMI as a quantitative trait 
rs2815752 1 72585028 NEGRI G 0.09 0.13 -0.04 0.04 3.21E-01 typed 0.16 0.38 -0.01 0.03 6.89E-01 typed 0.08 0.08 -0.02 0.08 7.99E-01 imputed 
rs1555543 1 96717385 PTBP2 C 0.06 0.10 0.00 0.05 9.41E-01 imputed 0.07 0.43 -0.03 0.03 3.11E-01 imputed 0.06 0.11 0.02 0.07 8.34E-01 imputed 
rs10913469 1 176180142 SEC16B T 0.1 0.09 -0.10 0.05 4.88E-02 typed 0.16 0.17 -0.02 0.04 5.26E-01 typed 0.17 0.19 -0.05 0.06 4.16E-01 typed 
rs1514175 1 74764232 TNNI3K G 0.08 0.46 0.01 0.03 7.48E-01 typed 0.08 0.45 -0.01 0.03 8.62E-01 typed 0.08 0.26 -0.08 0.05 1.30E-01 typed 
rs713586 2 25011512 
RBJ, ADCY3, 
POMC 
T 0.16 0.42 0.01 0.03 8.54E-01 imputed 0.02 0.46 -0.03 0.03 3.45E-01 imputed 0.19 0.45 -0.06 0.04 1.64E-01 imputed 
rs2867125 2 612827 TMEM18 T 0.24 0.09 0.02 0.05 6.90E-01 typed 0.45 0.20 -0.09 0.04 8.25E-03 typed 0.25 0.08 -0.12 0.08 1.63E-01 typed 
rs13078807 3 85966840 CADM2 G 0.06 0.04 -0.01 0.08 8.70E-01 typed 0.07 0.09 0.10 0.05 4.18E-02 typed NA NA NA NA NA NA 
rs7647305 3 187316984 
ETV5, SFRS, 
DGKG 
T 0.2 0.14 0.02 0.04 5.42E-01 typed 0.27 0.19 -0.08 0.03 2.41E-02 typed 0.17 0.09 -0.06 0.08 4.34E-01 typed 
rs10938397 4 44877284 GNPDA2 G 0.18 0.23 0.00 0.03 9.60E-01 imputed 0.25 0.38 0.10 0.03 6.87E-04 imputed 0.23 0.26 0.07 0.05 1.74E-01 imputed 
rs2112347 5 75050998 
FLJ35779, 
HMGCR 
T 0.11 0.45 0.02 0.03 5.08E-01 imputed 0.11 0.43 0.02 0.03 5.95E-01 imputed 0.12 0.43 -0.05 0.05 3.30E-01 imputed 
rs206936 6 34410847 NUDT3, HMGA1 G 0.07 0.42 0.03 0.03 2.83E-01 imputed 0.07 0.41 0.03 0.03 2.64E-01 imputed 0.07 0.47 -0.08 0.04 7.07E-02 imputed 
rs987237 6 50911009 TFAP2B G 0.12 0.23 0.04 0.03 2.34E-01 typed 0.2 0.21 0.04 0.03 2.39E-01 typed 0.1 0.13 0.03 0.07 6.60E-01 typed 
rs10968576 9 28404339 LRRN6C G 0.06 0.06 0.07 0.06 2.57E-01 typed 0.96 0.18 -0.06 0.04 1.01E-01 typed 0.1 0.17 -0.01 0.06 8.41E-01 typed 
rs10767664 11 27682562 BDNF T 0.26 0.49 -0.09 0.03 9.57E-04 imputed 0.26 0.31 -0.03 0.03 3.54E-01 imputed 0.31 0.50 -0.02 0.04 7.12E-01 imputed 
rs3817334 11 47607569 
MTCH2, 
NDUFS3, 
CUGBP1 
T 0.06 0.23 0.00 0.03 9.09E-01 imputed 0.07 0.32 0.02 0.03 4.95E-01 imputed 0.07 0.28 0.09 0.05 7.29E-02 imputed 
rs4929949 11 8561169 RPL27A, TUB T NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 
rs7138803 12 48533735 FAIM2 G 0.1 0.17 0.02 0.04 6.68E-01 typed 0.14 0.36 -0.02 0.03 5.46E-01 typed 0.13 0.26 -0.11 0.05 3.10E-02 typed 
rs2241423 15 65873892 MAP2K5, SKOR1 G 0.14 0.37 0.06 0.03 4.12E-02 typed 0.16 0.38 0.00 0.03 9.44E-01 typed 0.17 0.42 0.08 0.05 6.76E-02 typed 
rs1558902 16 52361075 FTO T 0.7 0.30 -0.09 0.03 2.48E-03 imputed 0.78 0.33 -0.07 0.03 1.89E-02 imputed 0.51 0.13 -0.22 0.07 1.03E-03 imputed 
rs7359397 16 28793160 SH2B1, T NA NA NA NA NA NA NA NA NA NA NA NA 0.1 0.09 0.07 0.08 3.29E-01 imputed 
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P: power of study (α=0.05) using reported changes in BMI; maf: minor allele frequency. Typed: genotyped SNP and imputed: Imputed SNP. * reported in original study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APOB48R, 
SULT1A2, 
AC138894.2, 
ATXN2L, TUFM 
rs571312 18 55990749 MC4R C 0.19 0.13 0.04 0.04 3.68E-01 typed 0.36 0.33 -0.10 0.03 6.28E-04 typed 0.26 0.17 -0.17 0.06 3.42E-03 typed 
rs29941 19 39001372 KCTD15 G 0.07 0.35 0.03 0.03 2.78E-01 typed 0.07 0.44 0.01 0.03 7.21E-01 typed 0.07 0.20 -0.04 0.05 4.29E-01 typed 
rs2287019 19 50894012 QPCTL, GIPR T 0.12 0.17 -0.07 0.04 6.63E-02 typed 0.12 0.14 -0.05 0.04 1.84E-01 typed 0.15 0.19 0.03 0.06 6.48E-01 typed 
rs3810291 19 52260843 TMEM160,ZC3H4 G NA NA NA NA NA NA NA NA NA NA NA NA 0.09 0.27 -0.04 0.05 4.86E-01 imputed 
SNPs previously detected from GWAS using Extreme Obese or Early-onset Obese 
rs516175 8 9806983 TNKS, MSRA G - 0.21 0.02 0.03 6.26E-01 imputed - 0.13 0.04 0.04 3.38E-01 imputed - 0.18 0.15 0.06 1.36E-02 imputed 
rs17150703 8 9783208 TNKS, MSRA G NA NA NA NA NA NA NA NA NA NA NA NA - 0.15 0.14 0.06 3.15E-02 imputed 
rs1424233 16 78240252 MAF T - 0.43 0.04 0.03 1.99E-01 typed - 0.30 -0.04 0.03 1.62E-01 typed - 0.34 -0.03 0.05 5.45E-01 typed 
rs1805081 18 19394430 NPC1 T - 0.23 0.02 0.03 6.48E-01 typed - 0.24 0.00 0.03 9.91E-01 typed - 0.24 -0.02 0.05 6.58E-01 typed 
rs10926984 1 241528776 SDCCAG8 T NA NA NA NA NA NA NA NA NA NA NA NA - 0.07 0.04 0.09 6.34E-01 imputed 
rs12145833 1 241550377 SDCCAG8 T - 0.03 0.12 0.08 1.49E-01 imputed NA NA NA NA NA NA - 0.07 0.05 0.09 5.42E-01 imputed 
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Table 2: BMI Z-score associated levels for obesity loci first detected among Europeans, available in SP2 and SDCS datasets. 
 
     SP2 (N=2,431) SDCS (N=1,992) 
rsid chr pos reported gene† 
test 
allele 
P maf* beta se pval 1m chip 
610 
chip 
550 
chip 
P maf* beta se pval 
1M 
chip 
610 
chip 
SNPs previously detected from GWAS using BMI as a quantitative trait 
rs2815752 1 72585028 NEGRI G 0.11 0.09 -0.06 0.05 1.65E-01 typed typed imputed 0.09 0.08 -0.09 0.06 2.86E-01 typed typed 
rs1555543 1 96717385 PTBP2 C 0.06 0.11 -0.01 0.04 8.77E-01 imputed imputed imputed 0.06 0.11 0.13 0.05 1.03E-02 imputed imputed 
rs10913469 1 176180142 SEC16B T 0.24 0.18 0.03 0.03 3.48E-01 typed typed typed 0.2 0.20 -0.11 0.04 3.42E-03 typed typed 
rs1514175 1 74764232 TNNI3K G 0.09 0.25 -0.01 0.03 6.41E-01 typed typed typed 0.08 0.25 -0.03 0.04 4.22E-01 typed typed 
rs713586 2 25011512 
RBJ, ADCY3, 
POMC 
T 0.26 0.46 0.00 0.03 9.95E-01 imputed imputed imputed 0.21 0.46 -0.03 0.03 3.00E-01 imputed imputed 
rs2867125 2 612827 TMEM18 T 0.35 0.08 -0.08 0.05 1.17E-01 typed typed typed 0.24 0.07 -0.09 0.06 1.36E-01 typed typed 
rs13078807 3 85966840 CADM2 G NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 
rs7647305 3 187316984 
ETV5, SFRS, 
DGKG 
T 0.25 0.09 -0.13 0.04 3.47E-03 typed typed typed 0.19 0.09 0.01 0.05 8.47E-01 typed typed 
rs10938397 4 44877284 GNPDA2 G 0.32 0.26 0.07 0.03 1.51E-02 imputed imputed imputed 0.26 0.28 0.02 0.03 5.36E-01 imputed imputed 
rs2112347 5 75050998 FLJ35779, HMGCR T 0.15 0.43 0.04 0.03 1.30E-01 imputed imputed imputed 0.13 0.44 0.04 0.03 2.53E-01 imputed imputed 
rs206936 6 34410847 NUDT3, HMGA1 G 0.09 0.46 0.01 0.03 5.91E-01 typed imputed imputed 0.08 0.46 0.04 0.03 1.52E-01 typed imputed 
rs987237 6 50911009 TFAP2B G 0.13 0.13 0.01 0.04 8.21E-01 typed typed typed 0.11 0.13 0.02 0.05 6.49E-01 typed typed 
rs10968576 9 28404339 LRRN6C G 0.12 0.17 0.02 0.03 5.43E-01 typed typed typed 0.1 0.17 -0.01 0.04 8.10E-01 typed typed 
rs10767664 11 27682562 BDNF T 0.43 0.48 -0.04 0.03 9.95E-02 imputed imputed imputed 0.34 0.49 0.01 0.03 7.40E-01 imputed imputed 
rs3817334 11 47607569 
MTCH2, NDUFS3, 
CUGBP1 
T 0.08 0.28 0.01 0.03 8.66E-01 typed imputed imputed 0.07 0.29 -0.03 0.03 4.24E-01 typed imputed 
rs4929949 11 8561169 RPL27A, TUB T NA NA NA NA NA NA NA NA 0.08 0.43 0.02 0.03 5.45E-01 imputed imputed 
rs7138803 12 48533735 FAIM2 G 0.17 0.26 0.03 0.03 3.20E-01 typed typed typed 0.14 0.27 -0.08 0.04 2.50E-02 typed typed 
rs2241423 15 65873892 MAP2K5, SKOR1 G 0.23 0.41 0.02 0.03 4.32E-01 typed typed typed 0.18 0.42 0.02 0.03 4.94E-01 typed typed 
rs1558902 16 52361075 FTO T 0.68 0.12 -0.08 0.04 4.87E-02 imputed imputed imputed 0.61 0.14 -0.09 0.04 4.20E-02 imputed imputed 
rs7359397 16 28793160 
SH2B1, APOB48R, 
SULT1A2, 
AC138894.2, 
ATXN2L, TUFM 
T 0.12 0.09 0.04 0.05 4.27E-01 typed imputed imputed 0.1 0.07 -0.06 0.06 3.03E-01 typed imputed 
rs571312 18 55990749 MC4R C 0.36 0.17 -0.02 0.03 4.79E-01 typed typed typed 0.3 0.17 -0.04 0.04 3.34E-01 typed typed 
rs29941 19 39001372 KCTD15 G 0.07 0.20 0.00 0.03 9.60E-01 typed typed typed 0.07 0.21 0.03 0.04 4.55E-01 typed typed 
rs2287019 19 50894012 QPCTL, GIPR T 0.21 0.20 -0.07 0.03 2.43E-02 typed typed typed 0.16 0.19 -0.04 0.04 3.08E-01 typed typed 
rs3810291 19 52260843 TMEM160,ZC3H4 G NA NA NA NA NA NA NA NA 0.1 0.27 0.03 0.04 4.82E-01 typed imputed 
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SNPs previously detected from GWAS using Extreme Obese or Early-onset Obese 
rs4712652 6 22186594 PRL G - 0.11 0.00 0.04 9.67E-01 typed typed typed - 0.12 -0.02 0.05 7.15E-01 typed typed 
rs516175 8 9806983 TNKS, MSRA G - 0.19 0.02 0.03 4.83E-01 imputed imputed imputed - 0.18 0.08 0.04 5.97E-02 imputed imputed 
rs17150703 8 9783208 TNKS, MSRA G - 0.17 0.04 0.03 2.06E-01 typed imputed imputed - 0.16 0.06 0.04 1.48E-01 typed imputed 
rs1424233 16 78240252 MAF T - 0.37 0.05 0.03 6.37E-02 typed typed typed - 0.36 0.00 0.03 9.80E-01 typed typed 
rs1805081 18 19394430 NPC1 T - 0.26 0.00 0.03 9.98E-01 typed typed typed - 0.24 0.01 0.04 8.04E-01 typed typed 
rs10926984 1 241528776 SDCCAG8 T - 0.06 -0.02 0.05 7.52E-01 imputed imputed imputed - 0.06 -0.04 0.07 5.71E-01 imputed imputed 
rs12145833 1 241550377 SDCCAG8 T - 0.06 -0.01 0.05 8.51E-01 imputed imputed imputed - 0.06 -0.04 0.07 5.50E-01 imputed imputed 
P: power of study (α=0.05) using reported changes in BMI; maf: minor allele frequency. Typed: genotyped SNP and imputed: Imputed SNP. * Average minor allele frequency from 2 and 3 SNP 
arrays used for genotyping in SDCS and SP2 respectively. †: reported in original study. 
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2) Association levels of regional SNPs where index SNP was not examined 
Figure1: Regional plots of 9 previously detected obesity loci which did not have index SNP 
information in any of the Singaporean datasets, using Z-BMI association p-values after meta-analysis. 
All plots plotted to include reported SNP (purple diamonds) in between 2 recombination peaks of at 
least 20Cm/Mb. Index SNPs have been included in plots with dummy -log10(p-value)=0 as reference. 
A) rs4771122 at chromosome 13. B) rs13107325 at chromosome 4. C) rs10150332 at chromosome 
14. D) rs12444979 at chromosome 16. E) rs2890652 at chromosome 2. F) rs4836133 at chromosome 
5. G) rs11847697 at chromosome 14. H) rs887912 at chromosome 2. I) rs10508503 at chromosome 
10. Estimated LD for regional proxy SNPs are derived from East-Asians (CHB+JPT) from 
International HapMap. Gene annotations from the RefSeq track of the UCSC Gene Browser 
(LocusZoom http://csg.sph.umich.edu/locuszoom/). 
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3) Comparison of meta-analyses data for Z-BMI association after exclusion of SCORM and SDCS datasets. 
 
Table 3: BMI Z-score meta-analysis of Singaporean GWAS datasets after exclusion of SDCS diabetic cohort, SCORM childhood cohort and with all datasets 
(SDCS, SCORM, SP2, SiMES, SINDI) included.  Significant associations are highlighted in bold.                
 
 
Meta-analysis – Excluding SDCS diabetics  
(N=8,490) 
Meta-analysi – Excluding SCORM 
children (N=9,476) 
Meta-analysis – All datasets                        
(N=10,482) 
rsid chr pos gene beta se pval Q Qpval beta se pval Q Qpval beta se pval Q Qpval 
rs1558902 16 52361075 FTO -0.090 0.018 5.82E-07 4.374 0.497 -0.081 0.017 2.29E-06 0.365 0.996 -0.090 0.017 1.44E-07 4.400 0.736 
rs10938397 4 44877284 GNPDA2 0.061 0.016 1.75E-04 5.328 0.377 0.052 0.015 6.45E-04 6.327 0.276 0.054 0.015 3.58E-04 6.500 0.487 
rs571312 18 55990749 MC4R -0.058 0.019 1.58E-03 12.110 0.033 -0.045 0.018 1.14E-02 7.938 0.160 -0.054 0.017 1.79E-03 12.300 0.092 
rs2867125 2 612827 TMEM18 -0.063 0.023 6.70E-03 4.234 0.516 -0.063 0.023 5.18E-03 4.076 0.538 -0.067 0.022 2.80E-03 4.400 0.729 
rs2287019 19 50894012 QPCTL,GIPR -0.054 0.019 4.77E-03 2.507 0.776 -0.060 0.018 9.97E-04 0.461 0.993 -0.052 0.018 3.46E-03 2.600 0.920 
rs10767664 11 27682562 BDNF -0.050 0.015 8.74E-04 3.322 0.651 -0.041 0.014 4.02E-03 6.090 0.298 -0.039 0.014 4.95E-03 6.300 0.501 
rs516175 8 9806983 TNKS,MSRA 0.037 0.019 4.99E-02 3.975 0.553 0.035 0.018 5.58E-02 1.497 0.913 0.044 0.018 1.28E-02 4.700 0.691 
rs7647305 3 187316984 ETV5 -0.058 0.021 6.64E-03 7.323 0.198 -0.048 0.021 2.02E-02 8.707 0.121 -0.049 0.020 1.67E-02 8.700 0.272 
rs2241423 15 65873892 MAP2K5,SKOR1 0.031 0.015 4.01E-02 3.778 0.582 0.024 0.014 9.11E-02 2.348 0.799 0.029 0.014 3.43E-02 3.800 0.798 
rs10913469 1 176180142 SEC16B -0.018 0.021 2.23E-01 4.998 0.416 -0.038 0.019 4.75E-02 9.747 0.103 -0.039 0.018 3.71E-02 9.800 0.203 
rs2815752 1 72585028 NEGRI -0.030 0.020 1.45E-01 1.002 0.962 -0.034 0.020 8.55E-02 1.242 0.941 -0.033 0.020 9.18E-02 1.300 0.989 
rs987237 6 50911009 TFAP2B 0.031 0.019 1.09E-01 0.465 0.993 0.029 0.018 1.11E-01 0.505 0.992 0.029 0.018 1.06E-01 0.500 0.999 
rs2112347 5 75050998 FLJ35779, HMGCR 0.018 0.015 2.21E-01 2.593 0.762 0.027 0.014 5.05E-02 0.586 0.989 0.021 0.014 1.22E-01 2.800 0.900 
rs206936 6 34410847 NUDT3, HMGA1 0.013 0.015 3.84E-01 5.147 0.398 0.029 0.014 4.79E-02 0.585 0.989 0.019 0.014 1.67E-01 6.000 0.544 
rs713586 2 25011512 RBJ, ADCY3,POMC -0.013 0.015 3.77E-01 2.166 0.826 -0.012 0.014 3.93E-01 1.306 0.934 -0.016 0.014 2.37E-01 2.500 0.926 
rs7138803 12 48533735 FAIM2 -0.005 0.017 7.62E-01 6.217 0.286 -0.010 0.016 5.40E-01 6.224 0.285 -0.019 0.016 2.37E-01 9.800 0.203 
rs1514175 1 74764232 TNNI3K -0.010 0.016 5.22E-01 2.237 0.815 -0.007 0.015 6.15E-01 0.761 0.979 -0.013 0.015 3.88E-01 2.500 0.929 
rs29941 19 39001372 KCTD15 0.010 0.016 5.37E-01 1.601 0.901 0.018 0.016 2.61E-01 0.643 0.986 0.013 0.015 4.06E-01 1.800 0.970 
rs1424233 16 78240252 MAF 0.013 0.015 3.95E-01 6.675 0.246 0.015 0.015 3.18E-01 6.044 0.302 0.011 0.014 4.44E-01 6.800 0.451 
rs3817334 11 47607569 
MTCH2, 
NDUFS3,CUGBP1 
0.019 0.016 2.53E-01 2.440 0.786 0.003 0.015 8.69E-01 1.135 0.951 0.010 0.015 5.09E-01 3.900 0.792 
rs10968576 9 28404339 LRRN6C -0.006 0.021 7.67E-01 4.357 0.499 -0.007 0.020 7.44E-01 4.355 0.500 -0.006 0.019 7.45E-01 4.400 0.737 
rs1555543 1 96717385 PTBP2 -0.015 0.020 4.44E-01 0.485 0.993 0.004 0.019 8.56E-01 7.570 0.182 0.004 0.019 8.40E-01 7.500 0.377 
rs1805081 18 19394430 NPC1 0.002 0.017 9.13E-01 0.396 0.995 0.006 0.016 7.32E-01 0.164 0.999 0.003 0.016 8.55E-01 0.400 1.000 
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Appendix III 
 
1) Details of 75 SNPs that had meta-analysis p-value ≤ 10-5 after combination of all four Singapore GWAS datasets. 
 
Table 1:  Association results from individual studies and meta-analysis summary statistics for all 75 SNPs (58 genotyped and 17 imputed) selected from 
discovery GWAS of four Singaporean datasets (SCORM, SP2, SDCS, SiMES) brought forward to the replication stage.  
 
SCORM (N=1,006) SP2 (N=2,431) SiMES (N=2,531) SDCS (N=1,992) Meta-analysis (N=7,951) 
 
SNP Chr Position 
Test 
Allele Ref MAF Beta p-value MAF+ Beta p-value MAF Beta p-value MAF+ Beta p-value Beta p-value Q Q pvalue Genes 
rs7185735 16 52380152 G imp 0.125 0.220 1.17E-03 0.123 0.090 3.93E-02 0.293 0.101 8.56E-04 0.147 0.082 5.97E-02 0.105 3.15E-07 3.28 3.50E-01 FTO 
rs8050136 16 52373776 C typed 0.126 -0.221 1.08E-03 0.123 -0.089 4.05E-02 0.297 -0.101 8.54E-04 0.144 -0.080 6.89E-02 -0.105 3.66E-07 3.43 3.28E-01 FTO 
rs7711329 5 65161785 T typed 0.188 0.169 3.48E-03 0.186 0.095 8.08E-03 0.327 0.085 3.88E-03 0.198 0.071 7.09E-02 0.093 5.61E-07 2.12 5.49E-01 NLN 
rs10085083 5 65160171 T imp 0.187 0.176 2.40E-03 0.185 0.092 1.03E-02 0.325 0.085 4.24E-03 0.203 0.070 7.37E-02 0.093 6.60E-07 2.45 4.85E-01 NLN 
rs9291848 5 65155783 G typed 0.185 -0.143 1.31E-02 0.184 -0.088 1.44E-02 0.321 -0.083 5.36E-03 0.196 -0.074 5.87E-02 -0.089 2.19E-06 1.07 7.85E-01 NLN 
rs11221723 11 128860611 G imp 0.416 0.098 3.30E-02 0.414 0.069 1.61E-02 0.472 0.062 2.29E-02 0.405 0.081 1.16E-02 0.073 3.82E-06 0.53 9.11E-01 
 rs16894435 5 65168686 G typed 0.188 -0.169 2.94E-03 0.190 -0.065 6.65E-02 0.311 -0.090 2.52E-03 0.201 -0.062 1.08E-01 -0.085 4.52E-06 2.88 4.10E-01 NLN 
rs11221724 11 128865609 G imp 0.409 0.096 3.67E-02 0.410 0.072 1.09E-02 0.468 0.058 3.15E-02 0.402 0.079 1.36E-02 0.072 4.60E-06 0.56 9.06E-01 
 rs11221725 11 128868289 G typed 0.409 0.097 3.45E-02 0.411 0.073 1.03E-02 0.482 0.056 3.64E-02 0.404 0.077 1.56E-02 0.071 5.52E-06 0.64 8.87E-01 
 rs777294 2 195844481 G typed 0.270 0.068 1.84E-01 0.256 0.123 1.23E-04 0.112 0.067 1.22E-01 0.249 0.067 5.89E-02 0.088 5.81E-06 1.92 5.88E-01 
 rs2341849 2 151632344 T typed 0.246 -0.087 9.20E-02 0.249 -0.025 4.44E-01 0.265 -0.089 4.32E-03 0.245 -0.138 1.76E-04 -0.081 6.83E-06 5.39 1.45E-01 
 rs573264 11 113597792 G typed 0.308 0.064 1.78E-01 0.300 0.084 6.51E-03 0.439 0.069 1.09E-02 0.303 0.066 5.39E-02 0.072 1.18E-05 0.23 9.74E-01 ZBTB16 
rs422084 9 107030743 T typed 0.111 -0.158 2.80E-02 0.113 -0.106 1.38E-02 0.110 -0.103 1.94E-02 0.103 -0.092 6.56E-02 -0.108 1.21E-05 0.60 8.97E-01 
 rs651748 11 113597363 C imp 0.308 -0.064 1.78E-01 0.300 -0.084 6.60E-03 0.431 -0.069 1.15E-02 0.306 -0.064 5.80E-02 -0.072 1.36E-05 0.24 9.71E-01 ZBTB16 
rs7502947 17 54584498 G typed 0.328 -0.033 5.01E-01 0.320 -0.064 3.44E-02 0.370 -0.068 1.64E-02 0.314 -0.103 1.70E-03 -0.072 1.36E-05 1.61 6.58E-01 PRR11 
rs328008 9 107079355 G imp 0.111 0.158 2.78E-02 0.113 0.107 1.28E-02 0.115 0.098 2.44E-02 0.104 0.093 6.41E-02 0.107 1.37E-05 0.63 8.90E-01 SLC44A1 
rs3778812 7 137097938 G typed 0.321 -0.082 8.66E-02 0.331 -0.112 1.44E-04 0.304 -0.057 5.83E-02 0.326 -0.036 2.70E-01 -0.072 1.37E-05 3.28 3.50E-01 DGKI 
rs328010 9 107078234 G imp 0.111 -0.158 2.78E-02 0.113 -0.107 1.28E-02 0.115 -0.097 2.61E-02 0.104 -0.094 6.00E-02 -0.107 1.38E-05 0.62 8.91E-01 SLC44A1 
rs8067682 17 54574173 G typed 0.328 0.030 5.37E-01 0.320 0.062 3.96E-02 0.362 0.072 1.15E-02 0.313 0.101 2.10E-03 0.072 1.41E-05 1.61 6.58E-01 
 rs7136193 12 57603148 T typed 0.055 -0.211 2.94E-02 0.055 -0.194 1.57E-03 0.061 -0.074 2.02E-01 0.050 -0.161 2.45E-02 -0.148 1.45E-05 2.61 4.53E-01 LRIG3 
rs327983 9 107093881 G typed 0.111 -0.142 4.78E-02 0.114 -0.107 1.28E-02 0.114 -0.102 1.76E-02 0.103 -0.092 6.61E-02 -0.106 1.46E-05 0.33 9.53E-01 SLC44A1 
rs446641 9 107028018 T typed 0.111 0.158 2.76E-02 0.113 0.106 1.38E-02 0.112 0.095 2.81E-02 0.103 0.095 5.89E-02 0.106 1.56E-05 0.64 8.88E-01 
 rs4923728 15 32741576 T typed 0.459 0.032 4.86E-01 0.476 0.048 8.71E-02 0.319 0.108 2.46E-04 0.474 0.066 3.22E-02 0.068 1.74E-05 2.98 3.92E-01 
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rs7564469 2 144974915 T typed 0.367 0.078 8.73E-02 0.360 0.093 1.26E-03 0.397 0.072 8.27E-03 0.382 0.026 4.09E-01 0.068 1.74E-05 2.53 4.70E-01 ZEB2 
rs328018 9 107073397 T typed 0.110 0.154 3.30E-02 0.113 0.107 1.26E-02 0.112 0.096 2.75E-02 0.103 0.092 6.60E-02 0.105 1.76E-05 0.57 9.02E-01 SLC44A1 
rs327992 9 107099123 T typed 0.110 0.144 4.71E-02 0.113 0.106 1.42E-02 0.114 0.102 1.81E-02 0.104 0.089 7.53E-02 0.105 1.87E-05 0.39 9.42E-01 SLC44A1 
rs328012 9 107077538 C typed 0.124 0.145 3.67E-02 0.131 0.104 1.05E-02 0.154 0.093 1.53E-02 0.118 0.071 1.32E-01 0.097 1.93E-05 0.81 8.46E-01 SLC44A1 
rs10061096 5 65134468 G typed 0.134 -0.143 2.92E-02 0.126 -0.051 2.20E-01 0.270 -0.084 6.90E-03 0.135 -0.116 1.03E-02 -0.088 1.94E-05 1.89 5.95E-01 NLN 
rs327967 9 107040928 T typed 0.111 0.158 2.76E-02 0.113 0.106 1.38E-02 0.112 0.089 3.97E-02 0.103 0.095 5.83E-02 0.104 2.19E-05 0.71 8.69E-01 
 rs889869 7 137156581 G typed 0.152 0.016 7.92E-01 0.157 -0.070 6.86E-02 0.240 -0.093 4.14E-03 0.160 -0.141 9.39E-04 -0.086 2.22E-05 4.55 2.07E-01 DGKI 
rs1881731 10 80177803 G typed 0.255 -0.034 5.10E-01 0.272 -0.043 1.75E-01 0.163 -0.104 5.29E-03 0.256 -0.125 5.26E-04 -0.079 2.32E-05 4.17 2.44E-01 
 rs6894548 5 147327341 C imp 0.386 0.052 2.68E-01 0.392 0.092 1.26E-03 0.404 0.083 3.63E-03 0.388 0.023 4.69E-01 0.067 2.87E-05 3.11 3.74E-01 
 rs1598260 8 83324170 T imp 0.289 -0.034 4.86E-01 0.293 -0.063 4.47E-02 0.305 -0.085 4.28E-03 0.301 -0.081 1.77E-02 -0.071 3.15E-05 0.98 8.07E-01 
 rs8077052 17 54563703 T typed 0.327 -0.022 6.56E-01 0.321 -0.056 6.17E-02 0.355 -0.069 1.60E-02 0.316 -0.104 1.50E-03 -0.069 3.18E-05 2.27 5.18E-01 
 rs4507392 4 41157169 T typed 0.104 0.161 3.04E-02 0.095 0.084 7.48E-02 0.170 0.061 9.56E-02 0.089 0.179 1.08E-03 0.100 3.21E-05 4.02 2.58E-01 LIMCH1 
rs979753 8 83316723 G typed 0.289 -0.034 4.86E-01 0.293 -0.063 4.43E-02 0.305 -0.084 4.45E-03 0.302 -0.081 1.77E-02 -0.071 3.22E-05 0.96 8.10E-01 
 rs7812812 8 116971648 G typed 0.062 -0.298 1.59E-03 0.059 -0.076 1.97E-01 0.121 -0.133 1.48E-03 0.061 -0.055 3.92E-01 -0.120 3.27E-05 5.21 1.57E-01 
 rs17681747 5 132613427 T typed 0.195 -0.038 4.95E-01 0.200 -0.035 3.02E-01 0.177 -0.127 3.75E-04 0.198 -0.106 6.19E-03 -0.081 3.34E-05 4.44 2.15E-01 FSTL4 
rs994669 8 83345690 T typed 0.289 -0.033 5.00E-01 0.291 -0.062 4.97E-02 0.304 -0.084 5.08E-03 0.302 -0.083 1.50E-02 -0.071 3.64E-05 1.02 7.97E-01 
 rs1382614 8 83361328 G imp 0.289 0.032 5.06E-01 0.291 0.062 4.77E-02 0.304 0.083 5.32E-03 0.300 0.083 1.56E-02 0.071 3.78E-05 1.00 8.01E-01 
 rs10515600 5 147316068 C typed 0.387 0.047 3.13E-01 0.392 0.093 1.11E-03 0.407 0.080 4.77E-03 0.391 0.022 4.80E-01 0.066 3.88E-05 3.19 3.63E-01 
 rs11671664 19 50864118 G typed 0.409 0.104 2.34E-02 0.383 0.032 2.69E-01 0.254 0.085 6.31E-03 0.403 0.075 1.96E-02 0.067 4.36E-05 2.55 4.65E-01 GIPR 
rs1351207 8 83383887 T typed 0.292 0.042 3.89E-01 0.290 0.063 4.47E-02 0.306 0.078 8.16E-03 0.303 0.080 1.91E-02 0.070 4.38E-05 0.56 9.05E-01 
 rs10930471 2 151738844 T typed 0.295 0.111 2.82E-02 0.290 0.019 5.35E-01 0.348 0.106 2.39E-04 0.281 0.060 8.08E-02 0.069 4.39E-05 5.03 1.68E-01 
 rs1037550 8 83314011 T typed 0.287 -0.039 4.26E-01 0.290 -0.062 4.76E-02 0.306 -0.084 4.53E-03 0.299 -0.075 2.88E-02 -0.070 4.48E-05 0.73 8.65E-01 
 rs3899106 19 38755459 G imp 0.052 -0.192 6.21E-02 0.057 -0.108 7.40E-02 0.096 -0.105 2.61E-02 0.055 -0.164 1.46E-02 -0.126 4.71E-05 1.02 7.96E-01 
 rs7711077 5 65122383 T typed 0.125 -0.180 7.54E-03 0.112 -0.058 1.76E-01 0.225 -0.081 1.37E-02 0.114 -0.096 4.81E-02 -0.088 4.76E-05 2.41 4.91E-01 NLN 
rs6899444 6 56313447 T imp 0.176 0.054 3.65E-01 0.161 0.108 4.45E-03 0.129 0.081 5.28E-02 0.164 0.087 3.58E-02 0.088 4.98E-05 0.61 8.93E-01 COL21A1 
rs2167065 8 76723009 T typed 0.339 0.091 5.66E-02 0.341 0.069 1.72E-02 0.357 0.026 3.67E-01 0.340 0.104 1.66E-03 0.066 4.98E-05 3.54 3.13E-01 
 rs6447084 4 41226161 T typed 0.096 0.117 1.20E-01 0.093 0.017 7.15E-01 0.133 0.114 4.79E-03 0.100 0.173 8.67E-04 0.101 4.99E-05 5.14 1.61E-01 LIMCH1 
rs2038143 6 56312934 T imp 0.176 0.054 3.64E-01 0.161 0.108 4.29E-03 0.129 0.080 5.33E-02 0.164 0.086 3.71E-02 0.087 5.03E-05 0.63 8.90E-01 COL21A1 
rs6715902 2 151909715 C typed 0.403 0.102 2.57E-02 0.410 0.022 4.41E-01 0.450 0.085 1.93E-03 0.396 0.069 2.94E-02 0.063 5.17E-05 3.53 3.15E-01 
 rs10267498 7 25848251 C imp 0.412 -0.004 9.31E-01 0.397 -0.067 1.62E-02 0.315 -0.068 2.16E-02 0.393 -0.086 6.62E-03 -0.065 5.44E-05 2.15 5.42E-01 
 rs10225976 7 25836218 T imp 0.422 0.003 9.53E-01 0.411 0.070 1.19E-02 0.343 0.064 2.80E-02 0.409 0.086 6.56E-03 0.064 5.45E-05 2.25 5.21E-01 
 rs891036 19 38752711 C typed 0.052 0.197 5.44E-02 0.059 0.105 7.87E-02 0.102 0.099 3.13E-02 0.058 0.165 1.34E-02 0.123 5.52E-05 1.28 7.33E-01 
 rs10238703 7 25848699 T imp 0.411 -0.004 9.28E-01 0.397 -0.067 1.65E-02 0.315 -0.067 2.39E-02 0.393 -0.086 6.55E-03 -0.065 5.98E-05 2.14 5.44E-01 
 rs1026330 18 13370824 T typed 0.168 0.112 5.67E-02 0.168 0.070 5.88E-02 0.169 0.055 1.34E-01 0.173 0.122 3.62E-03 0.083 6.03E-05 1.82 6.10E-01 C18orf1 
rs1868086 2 46433179 T typed 0.092 0.169 3.47E-02 0.084 0.072 1.42E-01 0.065 0.121 2.97E-02 0.081 0.142 1.26E-02 0.115 6.04E-05 1.48 6.87E-01 EPAS1 
rs1055144 7 25837634 T typed 0.408 -0.001 9.83E-01 0.393 -0.066 1.84E-02 0.307 -0.067 2.24E-02 0.392 -0.088 5.41E-03 -0.064 6.09E-05 2.43 4.87E-01 
 rs7814835 8 116984146 G typed 0.062 0.293 1.80E-03 0.058 0.073 2.15E-01 0.120 0.127 2.56E-03 0.061 0.055 3.91E-01 0.115 6.11E-05 5.03 1.69E-01 
 rs722333 1 6333801 G typed 0.141 0.086 2.07E-01 0.124 0.086 3.99E-02 0.109 0.101 2.34E-02 0.124 0.106 2.43E-02 0.095 6.70E-05 0.13 9.88E-01 ACOT7 
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rs2834497 21 34783587 G typed 0.274 0.106 3.41E-02 0.280 0.064 3.90E-02 0.277 0.075 1.44E-02 0.280 0.049 1.49E-01 0.069 6.75E-05 0.94 8.15E-01 KCNE1 
rs10282436 7 25839635 T typed 0.408 0.000 9.97E-01 0.393 -0.063 2.28E-02 0.307 -0.068 2.01E-02 0.392 -0.088 5.31E-03 -0.064 6.88E-05 2.51 4.73E-01 
 rs2038144 6 56312739 G typed 0.178 -0.051 3.97E-01 0.164 -0.106 4.37E-03 0.129 -0.075 6.66E-02 0.167 -0.086 3.73E-02 -0.085 6.96E-05 0.72 8.69E-01 COL21A1 
rs11193560 10 109362066 G typed 0.033 -0.272 3.08E-02 0.025 -0.050 5.72E-01 0.064 -0.155 5.75E-03 0.031 -0.213 1.56E-02 -0.157 7.18E-05 2.69 4.41E-01 
 rs9969635 8 10369046 C typed 0.403 0.101 2.67E-02 0.411 0.100 5.55E-04 0.494 0.046 9.39E-02 0.416 0.023 4.70E-01 0.062 7.30E-05 4.43 2.18E-01 
 rs1729788 13 94606004 G typed 0.234 0.031 5.61E-01 0.262 0.116 2.82E-04 0.219 0.049 1.32E-01 0.255 0.059 9.09E-02 0.071 8.31E-05 3.15 3.68E-01 ABCC4 
rs4890330 18 42372917 T typed 0.370 0.097 3.84E-02 0.386 0.038 1.94E-01 0.378 0.080 4.78E-03 0.392 0.057 7.26E-02 0.063 8.49E-05 1.71 6.35E-01 LOXHD1 
rs7798431 7 25827337 G typed 0.427 0.003 9.48E-01 0.413 0.063 2.32E-02 0.338 0.065 2.43E-02 0.412 0.085 6.54E-03 0.062 8.56E-05 2.19 5.33E-01 
 rs3808153 7 126119537 T imp 0.329 0.067 1.55E-01 0.311 0.067 2.50E-02 0.206 0.070 4.27E-02 0.325 0.067 4.02E-02 0.068 8.88E-05 0.01 1.00E+00 GRM8 
rs1008905 7 126117199 T typed 0.328 -0.068 1.51E-01 0.312 -0.068 2.23E-02 0.204 -0.067 4.97E-02 0.329 -0.067 4.00E-02 -0.067 8.92E-05 0.00 1.00E+00 GRM8  
rs3891660 10 32549666 G typed 0.093 -0.260 8.81E-04 0.079 -0.077 1.35E-01 0.030 -0.105 2.02E-01 0.083 -0.118 3.80E-02 -0.124 8.99E-05 3.89 2.74E-01 
 
rs9849092 3 101293099 G typed 0.034 -0.312 1.13E-02 0.042 -0.062 3.95E-01 0.057 -0.153 9.59E-03 0.031 -0.203 2.50E-02 -0.152 9.15E-05 3.56 3.13E-01 
C3orf26, 
FILIP1L  
rs3784390 15 37658372 G typed 0.193 0.052 3.56E-01 0.198 0.090 1.06E-02 0.117 0.104 1.47E-02 0.206 0.063 9.50E-02 0.080 9.33E-05 0.85 8.36E-01 THBS1  
rs12526579 6 108922246 G typed 0.299 0.087 7.12E-02 0.291 0.072 1.80E-02 0.378 0.054 4.95E-02 0.291 0.060 8.27E-02 0.065 9.89E-05 0.45 9.30E-01 LACE1 
typed: SNP genotyped in at least 1 SNP-chip; imp: SNP not genotyped in any SNP-chip; MAF: minor allele frequency. 
+
 Average MAF for SP2 and SDCS derived from data from 3 and 2 SNP-chips used for genotyping, respectively.  
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2) Details of MAF, call-rates and HWE p-values for 75 SNPs that were de novo genotyped in additional East-Asian datasets. 
 
Table 2:  Minor-allele frequencies (MAF), missingness (call-rate) and Hardy-Weinberg equilibrium deviation p-values for 75 SNPs that were de novo 
genotyped in additional East-Asian datasets.  10 SNPs that failed QC missingness > 0.10 (call-rate < 0.90) and HWE p-value < 0.05 indicated in red. 
   MAF Missingnes HWE p-value 
rsid Chr Position 
SP2 
Malays 
MEC 
Malays 
SCCS2 
Malays 
SCCS2 
Chinese 
Da Qing 
Chinese* 
SP2 
Malays 
MEC 
Malays 
SCCS2 
Malays 
SCCS2 
Chinese 
Da Qing 
Chinese* 
SP2 
Malays 
MEC 
Malays 
SCCS2 
Malays 
SCCS2 
Chinese 
Da Qing 
Chinese* 
N 721 1,200 197 582 420 721 1,200 197 582 420 721 1,200 197 582 420 
rs7814835 8 116984146 0.136 0.120 0.104 0.047 0.060 0.003 0.034 0.000 0.000 0.008 0.753 0.405 1.000 1.000 0.021 
rs4923728 15 32741576 0.350 0.332 0.332 0.441 0.455 0.003 0.117 0.005 0.007 0.025 0.414 < 0.0001 0.424 0.178 0.350 
rs573264 11 113597792 0.406 0.427 0.439 0.291 0.246 0.003 0.039 0.000 0.000 0.019 0.013 0.510 < 0.0001 0.229 0.708 
rs11221725 11 128868289 0.493 0.467 0.477 0.397 0.402 0.004 0.035 0.010 0.007 0.027 0.073 0.860 0.015 0.931 0.385 
rs8077052 17 54563703 0.347 0.393 0.336 0.316 0.346 0.006 0.134 0.010 0.147 0.118 0.805 0.400 0.338 0.022 0.451 
rs6715902 2 151909715 0.480 0.435 0.430 0.393 0.372 0.007 0.004 0.015 0.043 0.013 0.369 0.008 0.079 0.535 0.622 
rs2341849 2 151632344 0.250 0.202 0.216 0.220 0.227 0.035 0.137 0.061 0.039 0.023 0.026 0.848 0.663 0.389 0.018 
rs11671664 19 50864118 0.392 0.411 0.396 0.389 0.290 0.040 0.103 0.071 0.036 0.032 < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 
rs10930471 2 151738844 0.340 0.324 0.285 0.297 0.254 0.083 0.041 0.162 0.000 0.040 0.119 0.947 0.035 0.843 0.388 
rs651748 11 113597363 0.498 0.496 0.493 0.499 0.499 0.159 0.203 0.264 0.082 0.074 < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 
rs9291848 5 65155783 0.343 0.315 0.306 0.188 0.197 0.003 0.002 0.005 0.024 0.015 1.000 0.045 0.239 1.000 0.465 
rs3778812 7 137097938 0.284 0.321 0.343 0.337 0.308 0.000 0.009 0.000 0.000 0.019 0.410 0.895 0.874 0.781 0.129 
rs7564469 2 144974915 0.392 0.390 0.353 0.362 0.317 0.001 0.011 0.000 0.002 0.021 0.242 0.059 0.755 0.060 0.830 
rs7812812 8 116971648 0.137 0.122 0.107 0.047 0.058 0.001 0.007 0.000 0.000 0.008 0.753 0.280 1.000 1.000 0.064 
rs16894435 5 65168686 0.322 0.313 0.292 0.199 0.210 0.001 0.007 0.000 0.000 0.019 0.552 0.094 0.490 1.000 0.071 
rs7136193 12 57603148 0.058 0.051 0.043 0.045 0.073 0.001 0.009 0.005 0.000 0.017 0.504 1.000 1.000 0.624 0.085 
rs1881731 10 80177803 0.178 0.158 0.137 0.254 0.359 0.001 0.008 0.000 0.000 0.021 0.201 0.513 1.000 0.275 0.087 
rs1008905 7 126117199 0.212 0.218 0.201 0.301 0.286 0.001 0.008 0.000 0.000 0.015 0.316 0.800 0.117 0.168 0.089 
rs12526579 6 108922246 0.364 0.393 0.386 0.285 0.208 0.001 0.009 0.000 0.000 0.011 0.470 0.717 0.765 0.310 0.124 
rs7711077 5 65122383 0.239 0.232 0.236 0.120 0.126 0.001 0.009 0.000 0.000 0.013 0.683 0.871 0.693 0.844 0.139 
rs3899106 19 38755459 0.112 0.103 0.096 0.060 0.057 0.001 0.008 0.000 0.000 0.011 1.000 0.640 1.000 1.000 0.189 
rs1026330 18 13370824 0.178 0.160 0.168 0.163 0.210 0.001 0.038 0.000 0.000 0.013 0.704 0.744 0.203 0.648 0.213 
rs1351207 8 83383887 0.307 0.325 0.338 0.285 0.270 0.001 0.007 0.000 0.000 0.021 0.861 0.645 0.427 0.085 0.290 
rs7711329 5 65161785 0.345 0.321 0.322 0.190 0.193 0.001 0.008 0.000 0.000 0.019 0.934 0.165 0.143 1.000 0.297 
rs11193560 10 109362066 0.070 0.072 0.069 0.033 0.031 0.001 0.036 0.000 0.000 0.008 1.000 0.192 0.221 1.000 0.358 
rs11221723 11 128860611 0.482 0.452 0.464 0.396 0.401 0.001 0.008 0.000 0.000 0.011 0.264 0.243 0.117 0.931 0.503 
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rs6447084 4 41226161 0.154 0.125 0.145 0.100 0.122 0.001 0.040 0.005 0.000 0.025 0.775 0.424 1.000 0.064 0.519 
rs10085083 5 65160171 0.347 0.321 0.327 0.189 0.191 0.001 0.008 0.000 0.000 0.019 0.869 0.127 0.109 1.000 0.548 
rs2834497 21 34783587 0.279 0.268 0.266 0.307 0.277 0.001 0.033 0.000 0.000 0.021 0.853 1.000 0.276 0.627 0.565 
rs327983 9 107093881 0.141 0.116 0.119 0.108 0.108 0.001 0.006 0.000 0.002 0.011 0.760 0.202 0.490 0.525 0.810 
rs327967 9 107040928 0.137 0.112 0.112 0.109 0.112 0.001 0.009 0.000 0.002 0.021 1.000 0.309 0.715 0.667 0.818 
rs2038144 6 56312739 0.139 0.148 0.132 0.160 0.229 0.001 0.034 0.000 0.000 0.019 0.877 0.561 1.000 0.878 0.896 
rs2167065 8 76723009 0.360 0.376 0.371 0.342 0.330 0.001 0.008 0.000 0.000 0.021 0.808 0.176 0.879 0.782 1.000 
rs10515600 5 147316068 0.405 0.397 0.402 0.408 0.368 0.003 0.036 0.015 0.005 0.032 0.122 0.199 0.456 0.441 0.057 
rs4507392 4 41157169 0.189 0.164 0.162 0.082 0.134 0.003 0.004 0.000 0.029 0.006 0.330 0.916 1.000 0.413 0.059 
rs6894548 5 147327341 0.406 0.397 0.403 0.408 0.365 0.003 0.038 0.005 0.002 0.023 0.105 0.327 0.373 0.393 0.089 
rs17681747 5 132613427 0.185 0.205 0.162 0.205 0.185 0.003 0.007 0.000 0.000 0.032 0.323 0.860 0.792 0.165 0.354 
rs4890330 18 42372917 0.398 0.394 0.390 0.396 0.380 0.003 0.034 0.005 0.002 0.027 0.312 0.624 0.653 0.863 0.375 
rs979753 8 83316723 0.308 0.324 0.343 0.292 0.268 0.003 0.002 0.000 0.022 0.008 0.930 0.693 0.347 0.069 0.412 
rs11221724 11 128865609 0.473 0.450 0.462 0.389 0.396 0.003 0.039 0.000 0.005 0.029 0.654 0.192 0.154 0.930 0.437 
rs327992 9 107099123 0.141 0.116 0.119 0.109 0.117 0.003 0.004 0.000 0.022 0.013 0.760 0.161 0.490 0.665 0.500 
rs328010 9 107078234 0.140 0.113 0.112 0.110 0.118 0.003 0.035 0.005 0.000 0.017 0.756 0.188 0.716 0.674 0.501 
rs10061096 5 65134468 0.275 0.267 0.270 0.130 0.137 0.003 0.006 0.005 0.029 0.027 0.926 0.461 0.587 0.852 0.559 
rs777294 2 195844481 0.121 0.117 0.102 0.269 0.286 0.003 0.002 0.000 0.024 0.008 0.219 0.781 1.000 0.241 0.575 
rs722333 1 6333801 0.101 0.125 0.114 0.117 0.168 0.003 0.002 0.000 0.021 0.008 0.299 0.512 0.723 0.684 0.621 
rs1382614 8 83361328 0.306 0.324 0.338 0.288 0.263 0.003 0.007 0.000 0.031 0.021 0.793 0.598 0.427 0.065 0.635 
rs328018 9 107073397 0.140 0.114 0.114 0.112 0.113 0.003 0.004 0.000 0.026 0.011 0.756 0.775 0.290 0.672 0.642 
rs3784390 15 37658372 0.116 0.100 0.095 0.230 0.214 0.003 0.012 0.010 0.002 0.029 0.587 0.873 1.000 0.482 0.678 
rs8067682 17 54574173 0.351 0.375 0.335 0.330 0.342 0.003 0.004 0.000 0.024 0.019 1.000 0.580 0.342 0.570 0.681 
rs1868086 2 46433179 0.085 0.064 0.092 0.071 0.131 0.003 0.035 0.005 0.003 0.015 0.467 0.465 1.000 0.523 0.685 
rs7798431 7 25827337 0.335 0.362 0.376 0.434 0.408 0.003 0.002 0.000 0.022 0.019 0.802 0.901 0.362 1.000 0.701 
rs889869 7 137156581 0.222 0.238 0.264 0.172 0.180 0.003 0.002 0.000 0.024 0.015 0.333 0.578 0.587 0.884 0.756 
rs2038143 6 56312934 0.138 0.148 0.132 0.160 0.232 0.003 0.033 0.000 0.000 0.025 1.000 0.562 1.000 0.878 0.794 
rs10225976 7 25836218 0.340 0.355 0.380 0.441 0.414 0.003 0.070 0.005 0.003 0.023 0.868 0.328 0.172 1.000 0.848 
rs1598260 8 83324170 0.309 0.324 0.343 0.293 0.269 0.003 0.004 0.000 0.033 0.008 0.861 0.645 0.347 0.054 0.907 
rs7502947 17 54584498 0.366 0.391 0.350 0.329 0.356 0.003 0.003 0.000 0.026 0.017 0.872 1.000 0.433 0.635 1.000 
rs9849092 3 101293099 0.060 0.067 0.033 0.038 0.017 0.003 0.002 0.000 0.026 0.008 0.735 0.358 1.000 1.000 1.000 
rs3808153 7 126119537 0.209 0.216 0.201 0.301 0.283 0.004 0.008 0.000 0.000 0.013 0.216 1.000 0.117 0.117 0.068 
rs891036 19 38752711 0.112 0.105 0.097 0.063 0.058 0.004 0.007 0.010 0.022 0.017 1.000 0.758 1.000 1.000 0.191 
rs422084 9 107030743 0.140 0.117 0.117 0.113 0.115 0.004 0.003 0.000 0.031 0.019 0.877 0.264 0.310 0.677 0.363 
rs9969635 8 10369046 0.486 0.491 0.497 0.401 0.408 0.004 0.003 0.000 0.026 0.040 0.233 0.205 0.776 1.000 0.440 
rs1055144 7 25837634 0.302 0.321 0.342 0.424 0.401 0.004 0.037 0.005 0.002 0.008 0.791 0.946 0.751 0.800 0.445 
rs10267498 7 25848251 0.297 0.318 0.342 0.420 0.397 0.004 0.041 0.005 0.007 0.023 0.655 0.456 0.751 0.610 0.498 
rs994669 8 83345690 0.307 0.322 0.342 0.286 0.255 0.004 0.015 0.005 0.033 0.042 0.793 0.466 0.526 0.060 0.540 
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rs328008 9 107079355 0.139 0.114 0.112 0.112 0.113 0.004 0.005 0.005 0.033 0.019 0.755 0.251 0.716 0.670 0.644 
rs328012 9 107077538 0.175 0.164 0.154 0.122 0.122 0.004 0.003 0.010 0.029 0.017 0.300 0.529 0.175 0.843 0.664 
rs6899444 6 56313447 0.139 0.149 0.132 0.163 0.224 0.004 0.004 0.000 0.022 0.011 0.877 0.426 1.000 0.878 0.692 
rs1729788 13 94606004 0.225 0.219 0.228 0.248 0.264 0.004 0.009 0.000 0.000 0.015 0.831 0.499 0.155 0.376 0.723 
rs8050136 16 52373776 0.295 0.290 0.279 0.126 0.127 0.004 0.005 0.000 0.024 0.006 0.244 0.363 0.725 0.256 0.836 
rs3891660 10 32549666 0.024 0.032 0.036 0.094 0.111 0.006 0.047 0.005 0.003 0.023 0.061 1.000 1.000 0.058 0.099 
rs1037550 8 83314011 0.308 0.321 0.342 0.286 0.272 0.006 0.034 0.005 0.002 0.029 0.930 0.502 0.342 0.156 0.289 
rs10238703 7 25848699 0.298 0.321 0.342 0.423 0.403 0.006 0.036 0.005 0.002 0.008 0.721 0.737 0.751 0.735 0.390 
rs7185735 16 52380152 0.295 0.289 0.277 0.125 0.129 0.006 0.003 0.010 0.027 0.013 0.243 0.262 0.592 0.247 0.543 
rs10282436 7 25839635 0.302 0.323 0.342 0.419 0.402 0.007 0.007 0.020 0.045 0.023 0.790 0.742 0.634 0.931 0.288 
rs446641 9 107028018 0.139 0.112 0.113 0.110 0.110 0.007 0.040 0.015 0.007 0.025 0.877 0.235 0.717 0.671 0.812 
* Da Qing Chinese from China while all other datasets were Singaporean Chinese and Malay samples. 
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3) Association levels for Z-BMI in replication datasets. 
 
Table 3:  Association levels for 64 SNPs (that passed QC) with Z-BMI in replication stage of GWAS. SNPs with p-value < 0.05 and consistent beta direction 
(with initial discovery GWAS stage) indicated in bold. 
    SP2 Malays MEC Malays SCCS2 Malays SCCS2 Chinese Da Qing Chinese* SCES Chinese Combined replication 
N 721 1,200 197 582 420 1,861 4,981 
rsid Chr Position 
Test 
allele 
Beta p-value Beta p-value Beta p-value Beta p-value Beta p-value Beta 
p-
value 
Beta p-value Qp-value 
rs7185735 16 52380152 G 0.038 0.498 0.087 0.046 0.196 0.083 0.028 0.751 0.076 0.452 0.099 0.044 0.080 0.002 0.825 
rs8050136 16 52373776 C -0.038 0.496 -0.080 0.065 -0.204 0.066 -0.032 0.713 -0.074 0.468 -0.095 0.056 -0.077 0.002 0.820 
rs4507392 4 41157169 T 0.046 0.497 0.117 0.031 -0.091 0.494 0.117 0.274 0.207 0.056 0.090 0.105 0.091 0.002 0.586 
rs2167065 8 76723009 T 0.100 0.062 0.115 0.006 -0.230 0.027 -0.110 0.076 0.039 0.594 0.099 0.005 0.060 0.004 0.002 
rs7136193
†
 12 57603148 T 0.102 0.363 0.227 0.013 -0.141 0.562 -0.029 0.839 0.283 0.025 0.072 0.323 0.121 0.006 0.332 
rs328012 9 107077538 C 0.068 0.308 0.070 0.202 0.165 0.210 0.053 0.556 0.181 0.079 0.049 0.322 0.074 0.009 0.866 
rs12526579 6 108922246 G 0.011 0.832 0.047 0.258 0.149 0.150 -0.020 0.762 0.120 0.143 0.060 0.087 0.048 0.023 0.638 
rs6447084 4 41226161 T -0.040 0.570 0.118 0.053 0.088 0.528 0.010 0.917 0.074 0.487 0.088 0.113 0.062 0.046 0.622 
rs328018 9 107073397 T 0.016 0.828 0.107 0.092 0.220 0.140 -0.002 0.984 0.168 0.116 0.027 0.603 0.061 0.048 0.563 
rs2038143 6 56312934 T 0.153 0.042 0.017 0.764 0.121 0.404 -0.013 0.871 0.072 0.369 0.044 0.307 0.051 0.057 0.674 
rs327967 9 107040928 T -0.001 0.989 0.098 0.128 0.201 0.190 0.000 0.999 0.199 0.070 0.029 0.587 0.058 0.066 0.517 
rs2038144 6 56312739 G -0.148 0.049 -0.017 0.769 -0.121 0.404 0.013 0.871 -0.064 0.424 -0.043 0.314 -0.049 0.066 0.705 
rs328008 9 107079355 G 0.016 0.833 0.095 0.141 0.204 0.184 0.008 0.929 0.176 0.099 0.022 0.672 0.057 0.067 0.620 
rs6899444 6 56313447 T 0.153 0.043 0.005 0.930 0.121 0.404 -0.017 0.827 0.083 0.309 0.044 0.308 0.049 0.070 0.602 
rs422084 9 107030743 T 0.003 0.963 -0.104 0.100 -0.231 0.119 0.011 0.907 -0.154 0.144 -0.026 0.627 -0.056 0.074 0.504 
rs328010 9 107078234 G -0.010 0.894 -0.109 0.098 -0.202 0.189 0.019 0.834 -0.170 0.105 -0.022 0.674 -0.055 0.077 0.519 
rs7711077 5 65122383 T -0.023 0.709 -0.053 0.261 -0.018 0.871 -0.079 0.373 0.027 0.786 -0.069 0.170 -0.046 0.080 0.952 
rs446641 9 107028018 T 0.001 0.992 0.106 0.110 0.202 0.189 -0.003 0.975 0.165 0.135 0.026 0.616 0.055 0.081 0.591 
rs4890330 18 42372917 T -0.022 0.683 -0.061 0.144 -0.108 0.293 -0.008 0.898 -0.031 0.682 -0.026 0.431 -0.035 0.085 0.941 
rs1868086 2 46433179 T -0.095 0.319 0.185 0.027 -0.351 0.046 -0.049 0.658 -0.103 0.314 -0.127 0.030 -0.061 0.092 0.024 
rs11193560 10 109362066 G -0.083 0.416 -0.088 0.255 -0.230 0.221 -0.086 0.605 -0.322 0.096 0.059 0.573 -0.080 0.092 0.552 
rs1881731 10 80177803 G 0.046 0.484 -0.054 0.320 0.071 0.619 0.028 0.669 0.054 0.442 0.078 0.036 0.039 0.098 0.524 
rs8067682 17 54574173 G -0.163 0.003 -0.001 0.990 0.105 0.297 -0.068 0.271 0.030 0.680 -0.021 0.549 -0.032 0.125 0.097 
rs327992 9 107099123 T 0.006 0.932 0.071 0.264 0.253 0.087 -0.002 0.984 0.157 0.133 0.014 0.790 0.047 0.125 0.526 
rs327983 9 107093881 G 0.006 0.935 -0.074 0.245 -0.253 0.087 0.006 0.944 -0.186 0.091 -0.014 0.791 -0.047 0.133 0.421 
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rs7502947 17 54584498 G 0.166 0.002 0.005 0.894 -0.118 0.238 0.069 0.271 -0.027 0.709 0.014 0.704 0.031 0.143 0.077 
rs10061096 5 65134468 G 0.005 0.928 -0.073 0.102 0.037 0.730 -0.050 0.565 0.035 0.722 -0.030 0.529 -0.031 0.225 0.823 
rs11221723 11 128860611 G 0.116 0.023 -0.038 0.355 -0.119 0.202 -0.061 0.304 0.082 0.256 -0.073 0.029 -0.024 0.237 0.020 
rs11221724 11 128865609 G 0.090 0.080 -0.027 0.525 -0.131 0.162 -0.024 0.690 0.049 0.503 -0.068 0.039 -0.023 0.255 0.108 
rs6894548 5 147327341 C -0.052 0.311 0.000 0.999 0.070 0.467 -0.059 0.327 0.000 0.996 -0.012 0.714 -0.017 0.420 0.850 
rs10515600 5 147316068 C -0.055 0.284 0.007 0.872 0.058 0.551 -0.057 0.340 0.007 0.926 -0.014 0.678 -0.016 0.436 0.847 
rs994669 8 83345690 T -0.124 0.027 0.024 0.578 -0.160 0.115 0.107 0.090 -0.167 0.042 0.008 0.832 -0.016 0.466 0.014 
rs3778812 7 137097938 G -0.060 0.289 -0.024 0.574 0.017 0.869 0.077 0.206 0.047 0.542 0.042 0.230 0.015 0.486 0.494 
rs1382614 8 83361328 G 0.124 0.027 -0.026 0.534 0.145 0.149 -0.099 0.117 0.151 0.062 -0.007 0.842 0.015 0.490 0.024 
rs10267498 7 25848251 C -0.082 0.148 0.040 0.374 0.072 0.480 -0.049 0.410 -0.126 0.069 0.007 0.824 -0.014 0.501 0.223 
rs1598260 8 83324170 T -0.119 0.034 0.027 0.520 -0.121 0.223 0.098 0.120 -0.171 0.029 0.009 0.800 -0.014 0.503 0.022 
rs1351207 8 83383887 T 0.122 0.030 -0.032 0.455 0.145 0.149 -0.107 0.088 0.174 0.031 -0.005 0.890 0.014 0.508 0.013 
rs979753 8 83316723 G -0.123 0.029 0.029 0.494 -0.121 0.223 0.097 0.123 -0.170 0.033 0.009 0.800 -0.014 0.523 0.021 
rs17681747 5 132613427 T 0.010 0.884 -0.029 0.563 0.106 0.442 0.167 0.025 0.092 0.282 -0.022 0.596 0.016 0.525 0.222 
rs10282436 7 25839635 T -0.070 0.217 0.045 0.295 0.054 0.590 -0.070 0.248 -0.109 0.107 0.007 0.845 -0.012 0.548 0.259 
rs7812812 8 116971648 G -0.132 0.084 -0.122 0.042 0.098 0.542 0.082 0.553 -0.023 0.871 0.169 0.017 -0.021 0.564 0.022 
rs9849092 3 101293099 G -0.176 0.105 -0.133 0.102 -0.008 0.977 0.160 0.311 0.179 0.489 0.097 0.243 -0.027 0.568 0.165 
rs1037550 8 83314011 T -0.118 0.036 0.026 0.550 -0.122 0.222 0.102 0.104 -0.161 0.046 0.011 0.769 -0.012 0.571 0.027 
rs722333 1 6333801 G 0.009 0.916 -0.020 0.736 0.207 0.176 -0.032 0.724 0.090 0.324 -0.070 0.145 -0.017 0.577 0.432 
rs7564469 2 144974915 T -0.015 0.780 -0.001 0.981 0.047 0.650 -0.006 0.917 -0.022 0.759 -0.023 0.503 -0.011 0.582 0.991 
rs1055144 7 25837634 T -0.080 0.158 0.050 0.254 0.072 0.480 -0.054 0.359 -0.112 0.100 0.007 0.842 -0.011 0.593 0.214 
rs777294 2 195844481 G 0.041 0.594 0.175 0.005 0.174 0.279 0.043 0.503 -0.071 0.346 -0.049 0.194 0.013 0.595 0.035 
rs10225976 7 25836218 T 0.093 0.093 -0.056 0.191 -0.025 0.793 0.060 0.307 0.096 0.166 -0.012 0.728 0.010 0.615 0.190 
rs10238703 7 25848699 T -0.071 0.206 0.047 0.284 0.072 0.480 -0.050 0.398 -0.119 0.081 0.008 0.815 -0.010 0.618 0.235 
rs2834497 21 34783587 G -0.074 0.199 -0.011 0.805 -0.097 0.358 0.019 0.766 0.211 0.008 -0.031 0.404 -0.010 0.639 0.072 
rs3899106 19 38755459 G 0.121 0.143 0.008 0.903 -0.185 0.277 -0.100 0.418 0.082 0.560 -0.104 0.137 -0.014 0.702 0.269 
rs16894435 5 65168686 G 0.084 0.125 -0.055 0.195 0.079 0.447 -0.023 0.755 0.045 0.568 0.014 0.739 0.008 0.724 0.414 
rs891036 19 38752711 C -0.117 0.155 -0.004 0.952 0.187 0.275 0.072 0.555 -0.090 0.520 0.097 0.153 0.013 0.727 0.316 
rs889869 7 137156581 G 0.068 0.266 -0.021 0.648 -0.076 0.501 0.107 0.173 -0.081 0.358 -0.040 0.360 -0.007 0.770 0.375 
rs1008905 7 126117199 T -0.085 0.174 -0.028 0.564 0.246 0.062 0.024 0.695 -0.018 0.810 0.036 0.303 0.006 0.773 0.231 
rs7798431 7 25827337 G 0.085 0.124 -0.055 0.184 -0.033 0.729 0.058 0.328 0.089 0.193 -0.016 0.625 0.005 0.788 0.215 
rs3808153 7 126119537 T 0.089 0.154 0.035 0.474 -0.246 0.062 -0.032 0.600 0.018 0.808 -0.034 0.330 -0.005 0.832 0.201 
rs1026330 18 13370824 T 0.105 0.126 0.076 0.176 -0.250 0.049 0.045 0.568 0.010 0.904 -0.082 0.052 -0.004 0.868 0.033 
rs9969635 8 10369046 C 0.029 0.565 -0.004 0.909 -0.034 0.722 -0.014 0.820 0.070 0.310 -0.009 0.784 0.003 0.883 0.900 
rs1729788 13 94606004 G 0.001 0.988 -0.071 0.146 0.001 0.994 0.050 0.446 -0.023 0.770 0.024 0.520 -0.002 0.920 0.672 
rs10085083 5 65160171 T -0.034 0.529 0.066 0.113 -0.024 0.803 0.019 0.801 -0.100 0.236 -0.017 0.694 0.002 0.930 0.469 
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rs7711329 5 65161785 T -0.043 0.433 0.064 0.125 -0.059 0.550 0.015 0.835 -0.102 0.217 -0.013 0.765 -0.002 0.944 0.419 
rs3784390 15 37658372 G -0.016 0.846 -0.040 0.554 0.114 0.501 0.001 0.986 -0.011 0.895 0.017 0.683 0.001 0.970 0.961 
rs3891660 10 32549666 G 0.129 0.427 -0.106 0.363 0.264 0.327 0.085 0.413 -0.086 0.453 -0.009 0.887 -0.001 0.989 0.598 
* Da Qing Chinese from China while all other datasets were Singaporean Chinese and Malay samples. † SNP with opposite effect direction as compared to discovery stage of GWAS. 
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4) Details of MAF, call-rates and HWE p-values for 75 SNPs that were de novo 
genotyped in Singaporean early-onset and extreme obesity cohorts. 
 
Table 4:  Minor-allele frequencies (MAF), missingness (call-rate) and Hardy-Weinberg equilibrium 
deviation p-values for 75 SNPs that were de novo genotyped in Singaporean early-onset and extreme 
obese cases and controls.  6 SNPs that failed QC missingness > 0.10 (call-rate < 0.90) and HWE p-
value < 0.05 indicated in red. MAF and HWE p-value based on control samples only. 
   
141 Chinese early-onset obese cases       
and 332 controls 
97 Malay early-onset obese cases           
and 227 controls 
rsid Chr Position MAF Missing HWE p-value MAF Missing HWE p-value 
rs11671664 19 50864118 0.415 0.051 < 0.001 0.359 0.071 < 0.001 
rs651748 11 113597363 0.493 0.108 < 0.001 0.447 0.216 < 0.001 
rs1729788 13 94606004 0.231 0.002 0.443 0.217 0.009 0.046 
rs6894548 5 147327341 0.377 0.006 0.483 0.385 0.015 0.048 
rs12526579 6 108922246 0.311 0.004 0.039 0.416 0.003 0.217 
rs16894435 5 65168686 0.195 0.004 0.022 0.302 0.000 0.752 
rs328012 9 107077538 0.103 0.004 0.553 0.148 0.006 0.059 
rs11221725 11 128868289 0.410 0.002 0.910 0.498 0.019 0.059 
rs10515600 5 147316068 0.378 0.006 0.559 0.385 0.025 0.087 
rs1037550 8 83314011 0.302 0.004 0.194 0.353 0.019 0.107 
rs7502947 17 54584498 0.340 0.008 0.389 0.416 0.003 0.133 
rs979753 8 83316723 0.305 0.002 0.244 0.357 0.003 0.149 
rs1598260 8 83324170 0.308 0.002 0.303 0.357 0.003 0.149 
rs1351207 8 83383887 0.308 0.004 0.198 0.361 0.003 0.195 
rs8077052 17 54563703 0.335 0.015 0.455 0.384 0.025 0.201 
rs1868086 2 46433179 0.097 0.006 0.211 0.086 0.019 0.204 
rs8067682 17 54574173 0.337 0.002 0.218 0.394 0.003 0.211 
rs1055144 7 25837634 0.385 0.004 0.908 0.267 0.012 0.231 
rs10282436 7 25839635 0.386 0.000 1.000 0.264 0.003 0.233 
rs1382614 8 83361328 0.306 0.004 0.244 0.357 0.003 0.248 
rs2167065 8 76723009 0.329 0.004 0.901 0.363 0.000 0.253 
rs2038143 6 56312934 0.190 0.004 1.000 0.141 0.009 0.268 
rs2038144 6 56312739 0.191 0.002 1.000 0.141 0.009 0.268 
rs6899444 6 56313447 0.190 0.002 1.000 0.139 0.006 0.268 
rs573264 11 113597792 0.274 0.011 0.680 0.444 0.012 0.279 
rs889869 7 137156581 0.177 0.002 0.184 0.248 0.006 0.284 
rs7798431 7 25827337 0.406 0.002 0.571 0.326 0.003 0.289 
rs9969635 8 10369046 0.363 0.008 0.550 0.498 0.003 0.290 
rs4923728 15 32741576 0.471 0.015 0.122 0.358 0.031 0.303 
rs994669 8 83345690 0.307 0.015 0.244 0.359 0.006 0.312 
rs9849092 3 101293099 0.027 0.002 1.000 0.044 0.003 0.354 
rs7136193 12 57603148 0.068 0.002 0.382 0.075 0.000 0.357 
rs777294 2 195844481 0.267 0.004 0.398 0.088 0.003 0.392 
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rs722333 1 6333801 0.147 0.006 0.080 0.142 0.006 0.411 
rs3778812 7 137097938 0.325 0.006 0.381 0.280 0.000 0.414 
rs328018 9 107073397 0.093 0.000 0.335 0.093 0.006 0.417 
rs422084 9 107030743 0.093 0.000 0.335 0.095 0.006 0.432 
rs328008 9 107079355 0.092 0.002 0.336 0.095 0.006 0.432 
rs328010 9 107078234 0.092 0.004 0.336 0.096 0.009 0.435 
rs10225976 7 25836218 0.406 0.006 0.571 0.322 0.015 0.442 
rs1008905 7 126117199 0.302 0.008 0.432 0.226 0.003 0.446 
rs10930471 2 151738844 0.227 0.004 0.532 0.334 0.003 0.454 
rs4507392 4 41157169 0.094 0.004 0.753 0.168 0.006 0.473 
rs10238703 7 25848699 0.382 0.004 1.000 0.266 0.015 0.491 
rs10267498 7 25848251 0.382 0.006 0.907 0.271 0.012 0.499 
rs11221724 11 128865609 0.397 0.006 1.000 0.475 0.019 0.503 
rs7812812 8 116971648 0.051 0.002 1.000 0.132 0.000 0.560 
rs3808153 7 126119537 0.298 0.002 0.357 0.219 0.003 0.563 
rs7814835 8 116984146 0.050 0.006 1.000 0.134 0.009 0.563 
rs6715902 2 151909715 0.369 0.002 0.125 0.438 0.006 0.589 
rs11221723 11 128860611 0.400 0.004 0.819 0.474 0.000 0.595 
rs2834497 21 34783587 0.287 0.004 1.000 0.270 0.009 0.611 
rs10061096 5 65134468 0.133 0.002 0.480 0.270 0.006 0.613 
rs327983 9 107093881 0.088 0.004 0.155 0.088 0.003 0.686 
rs327967 9 107040928 0.091 0.002 0.091 0.089 0.006 0.687 
rs327992 9 107099123 0.092 0.000 0.336 0.091 0.006 0.700 
rs891036 19 38752711 0.053 0.004 0.053 0.095 0.006 0.701 
rs7711077 5 65122383 0.106 0.004 0.557 0.238 0.000 0.714 
rs3784390 15 37658372 0.165 0.011 0.421 0.123 0.000 0.756 
rs9291848 5 65155783 0.189 0.004 0.106 0.316 0.006 0.758 
rs7711329 5 65161785 0.195 0.004 0.159 0.332 0.003 0.764 
rs1026330 18 13370824 0.156 0.004 1.000 0.174 0.009 0.820 
rs2341849 2 151632344 0.205 0.019 0.867 0.219 0.074 0.840 
rs10085083 5 65160171 0.195 0.004 0.292 0.335 0.000 0.882 
rs7564469 2 144974915 0.349 0.011 0.088 0.372 0.003 0.887 
rs3891660 10 32549666 0.111 0.011 0.574 0.036 0.022 1.000 
rs6447084 4 41226161 0.088 0.004 0.491 0.131 0.022 1.000 
rs446641 9 107028018 0.093 0.004 0.335 0.093 0.019 1.000 
rs4890330 18 42372917 0.354 0.011 0.337 0.354 0.015 1.000 
rs11193560 10 109362066 0.033 0.002 0.302 0.069 0.009 1.000 
rs8050136 16 52373776 0.088 0.006 0.491 0.312 0.006 1.000 
rs7185735 16 52380152 0.089 0.006 0.493 0.311 0.003 1.000 
rs3899106 19 38755459 0.053 0.000 0.053 0.099 0.000 1.000 
rs1881731 10 80177803 0.272 0.002 0.212 0.128 0.000 1.000 
rs17681747 5 132613427 0.201 0.008 1.000 0.181 0.000 1.000 
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5) Association results of top hits from discovery GWAS in Singaporean early-onset and 
extreme obesity cohorts. 
 
Table 5:  Logistic regression association results of top hits Singaporean early-onset and extreme 
obese cohorts. Among the significant SNPs (p-value < 0.05 in either datasets), several OR were 
observed to be in opposite direction between the ethnic groups (including the FTO positive control 
SNPs) and thus individual cohort results were not combined in a meta-analysis. 
    
141 Chinese early-onset obese cases       
and 332 controls 
97 Malay early-onset obese cases           
and 227 controls 
rsid Chr Position 
Test 
allele 
OR 
OR 95% 
lower 
OR 95% 
upper 
p-value OR 
OR 95% 
lower 
OR 95% 
upper 
p-value 
rs8050136* 16 52373776 C 0.32 0.22 0.47 3.72E-09 1.29 0.88 1.88 0.200 
rs7185735* 16 52380152 G 3.08 2.09 4.53 9.35E-09 0.78 0.54 1.14 0.213 
rs7814835* 8 116984146 G 2.45 1.48 4.07 3.43E-04 0.66 0.38 1.15 0.161 
rs7812812* 8 116971648 G 0.42 0.26 0.70 5.76E-04 1.49 0.85 2.60 0.179 
rs3891660* 10 32549666 G 0.46 0.26 0.81 0.004 1.80 0.84 3.89 0.113 
rs777294* 2 195844481 G 1.54 1.09 2.16 0.013 0.54 0.33 0.91 0.023 
rs11193560 10 109362066 G 2.00 1.06 3.80 0.030 1.05 0.54 2.01 0.955 
rs2834497 21 34783587 G 0.69 0.50 0.96 0.058 0.86 0.59 1.28 0.406 
rs10061096 5 65134468 G 0.74 0.50 1.08 0.087 1.50 0.99 2.26 0.068 
rs9969635 8 10369046 C 1.26 0.95 1.68 0.104 1.03 0.74 1.44 0.908 
rs573264 11 113597792 G 0.75 0.55 1.01 0.130 1.41 1.00 2.00 0.057 
rs1881731* 10 80177803 G 1.30 0.93 1.80 0.146 0.46 0.30 0.70 4.65E-04 
rs11221723 11 128860611 G 0.84 0.63 1.11 0.163 0.98 0.70 1.37 0.878 
rs2341849 2 151632344 T 0.76 0.53 1.11 0.169 0.77 0.49 1.20 0.258 
rs1008905 7 126117199 T 0.78 0.57 1.07 0.192 1.22 0.83 1.80 0.266 
rs11221724 11 128865609 G 0.85 0.64 1.13 0.212 0.97 0.69 1.36 0.814 
rs11221725 11 128868289 G 0.86 0.65 1.14 0.216 0.99 0.71 1.39 0.942 
rs3808153 7 126119537 T 1.26 0.92 1.73 0.232 0.77 0.52 1.13 0.155 
rs9291848 5 65155783 G 0.81 0.58 1.14 0.235 1.31 0.90 1.92 0.165 
rs1868086 2 46433179 T 1.33 0.86 2.06 0.246 0.89 0.48 1.66 0.726 
rs4890330 18 42372917 T 1.16 0.86 1.57 0.252 0.74 0.52 1.04 0.072 
rs7711077 5 65122383 T 0.79 0.51 1.20 0.259 1.52 0.99 2.35 0.070 
rs2167065 8 76723009 T 1.21 0.91 1.62 0.271 0.99 0.70 1.40 0.955 
rs7711329 5 65161785 T 1.21 0.86 1.70 0.276 0.78 0.54 1.12 0.201 
rs10930471 2 151738844 T 0.86 0.62 1.19 0.280 1.07 0.75 1.53 0.715 
rs9849092 3 101293099 G 0.63 0.30 1.32 0.285 1.06 0.46 2.45 0.931 
rs7564469 2 144974915 T 0.85 0.64 1.13 0.312 1.10 0.77 1.56 0.578 
rs4923728 15 32741576 T 1.18 0.89 1.57 0.327 0.78 0.55 1.10 0.151 
rs10085083 5 65160171 T 1.18 0.84 1.66 0.344 0.75 0.52 1.08 0.139 
rs1055144 7 25837634 T 0.85 0.63 1.13 0.345 1.12 0.77 1.62 0.504 
rs10515600 5 147316068 C 0.87 0.66 1.16 0.389 0.79 0.56 1.11 0.213 
rs1026330 18 13370824 T 1.21 0.84 1.75 0.399 1.16 0.75 1.78 0.480 
rs10282436 7 25839635 T 0.86 0.65 1.15 0.400 1.09 0.75 1.59 0.585 
rs10267498 7 25848251 C 0.87 0.65 1.16 0.402 1.12 0.77 1.62 0.487 
rs7136193 12 57603148 T 1.30 0.71 2.37 0.418 1.88 0.85 4.14 0.114 
rs891036 19 38752711 C 0.73 0.41 1.28 0.432 1.16 0.63 2.11 0.647 
rs10238703 7 25848699 T 0.87 0.65 1.16 0.436 1.15 0.79 1.67 0.408 
rs3899106 19 38755459 G 1.37 0.78 2.42 0.440 0.82 0.45 1.48 0.503 
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rs3778812 7 137097938 G 0.88 0.65 1.18 0.454 0.72 0.50 1.03 0.075 
rs4507392 4 41157169 T 1.19 0.76 1.88 0.474 0.74 0.45 1.21 0.268 
rs3784390 15 37658372 G 0.92 0.63 1.33 0.510 0.66 0.42 1.05 0.077 
rs327983 9 107093881 G 0.87 0.54 1.40 0.519 1.01 0.56 1.83 0.977 
rs7798431 7 25827337 G 1.12 0.84 1.49 0.520 1.17 0.81 1.70 0.413 
rs10225976 7 25836218 T 1.11 0.83 1.48 0.556 1.09 0.75 1.57 0.700 
rs2038144 6 56312739 G 0.90 0.62 1.29 0.561 1.30 0.82 2.05 0.284 
rs2038143 6 56312934 T 1.11 0.77 1.60 0.579 0.77 0.49 1.21 0.284 
rs328008 9 107079355 G 1.10 0.69 1.76 0.624 0.92 0.51 1.66 0.832 
rs328012 9 107077538 C 1.08 0.69 1.69 0.630 0.98 0.61 1.58 0.930 
rs6899444 6 56313447 T 1.09 0.76 1.57 0.631 0.78 0.49 1.24 0.315 
rs327992 9 107099123 T 1.09 0.68 1.74 0.654 0.97 0.54 1.76 0.969 
rs6715902 2 151909715 C 0.95 0.71 1.26 0.696 0.90 0.64 1.27 0.614 
rs328018 9 107073397 T 1.07 0.67 1.71 0.697 0.95 0.53 1.71 0.893 
rs327967 9 107040928 T 1.06 0.66 1.71 0.736 0.98 0.54 1.78 0.994 
rs8077052 17 54563703 T 0.95 0.71 1.27 0.746 1.11 0.78 1.58 0.596 
rs328010 9 107078234 G 0.95 0.59 1.53 0.766 1.11 0.61 1.99 0.768 
rs446641 9 107028018 T 1.04 0.65 1.68 0.767 0.94 0.52 1.70 0.863 
rs889869 7 137156581 G 0.93 0.65 1.33 0.768 1.25 0.83 1.88 0.245 
rs422084 9 107030743 T 0.97 0.60 1.56 0.822 1.08 0.60 1.95 0.819 
rs6447084 4 41226161 T 1.07 0.66 1.73 0.831 0.73 0.42 1.26 0.242 
rs722333 1 6333801 G 0.98 0.66 1.46 0.839 1.04 0.64 1.67 0.771 
rs7502947 17 54584498 G 0.97 0.72 1.30 0.848 1.22 0.86 1.72 0.324 
rs994669 8 83345690 T 0.97 0.71 1.31 0.879 0.78 0.55 1.13 0.213 
rs1351207 8 83383887 T 1.03 0.76 1.39 0.906 1.29 0.90 1.85 0.195 
rs8067682 17 54574173 G 1.02 0.76 1.36 0.922 0.84 0.59 1.20 0.382 
rs1382614 8 83361328 G 1.02 0.75 1.38 0.934 1.25 0.87 1.80 0.250 
rs1037550 8 83314011 T 1.01 0.74 1.36 0.943 0.84 0.59 1.21 0.390 
rs1598260 8 83324170 T 0.99 0.73 1.33 0.959 0.84 0.59 1.20 0.377 
rs17681747 5 132613427 T 1.03 0.73 1.45 0.969 1.07 0.70 1.64 0.758 
rs979753 8 83316723 G 1.00 0.74 1.35 0.984 0.84 0.59 1.20 0.377 
* significant SNPs with directional inconsistencies between Chinese and Malay datasets. 
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6) Association results of top hits from WHR and WC associations in Singaporean adult females of SP2 dataset. 
 
Table 6:  Top SNPs (p-value ≤ 10-7) after linear regression analysis in females of SP2 Singaporean adult Chinese dataset for Z-WHR (before and after 
adjustment for BMI) and Z-WC associations. 
       
SP2 1M Chip 
(N=344) 
SP2 610 Chip 
(N=874) 
SP2 550 Chip 
(N=80) 
SP2 Combined dataset                    
(N=1,298) 
rsid comment Chr Position Gene* 
Test 
allele 
MAF Beta p-value Beta p-value Beta p-value Beta SE p-value Qp-value 
Z-WHR association  
rs12819069 typed 12 31281817 
 
T 0.018 -0.982 6.72E-03 -0.728 1.43E-05 -0.456 2.67E-01 -0.734 0.142 2.67E-07 0.628 
rs12816652 imputed 12 31281363 
 
T 0.018 1.048 6.47E-03 0.728 1.39E-05 0.442 2.77E-01 0.737 0.143 2.92E-07 0.555 
rs9563982 typed 13 62256173 
 
G 0.148 0.424 1.38E-04 0.190 9.99E-04 0.338 8.61E-02 0.246 0.049 7.07E-07 0.157 
rs9563981 typed 13 62255930 
 
G 0.149 -0.424 1.38E-04 -0.192 9.14E-04 -0.288 1.33E-01 -0.244 0.049 8.27E-07 0.175 
rs1335690 imputed 13 62260430 
 
T 0.149 -0.424 1.38E-04 -0.190 9.98E-04 -0.288 1.33E-01 -0.243 0.049 9.21E-07 0.171 
Z-WHR association with additional adjustment for BMI 
rs12565939 imputed 1 161807403 NUF2 T 0.135 -0.238 2.95E-02 -0.232 4.00E-05 -0.593 1.19E-03 -0.259 0.048 9.27E-08 0.166 
rs1934526 imputed 1 161824269 NUF2 T 0.133 0.238 2.91E-02 0.228 5.09E-05 0.616 8.90E-04 0.256 0.048 1.11E-07 0.133 
rs2494215 imputed 1 161799919 NUF2 G 0.133 -0.239 2.95E-02 -0.230 4.55E-05 -0.592 1.33E-03 -0.256 0.048 1.15E-07 0.168 
rs2486833 imputed 1 161800534 NUF2 C 0.133 -0.238 3.00E-02 -0.230 4.62E-05 -0.593 1.31E-03 -0.256 0.048 1.18E-07 0.167 
rs9923860 imputed 16 60700604 CDH8 G 0.059 0.227 1.02E-01 0.368 2.99E-05 1.044 6.09E-04 0.368 0.072 3.63E-07 0.051 
rs12447477 imputed 16 60704051 CDH8 G 0.059 -0.224 1.05E-01 -0.368 2.97E-05 -1.042 6.09E-04 -0.367 0.072 3.75E-07 0.050 
rs11075455 imputed 16 60709028 CDH8 T 0.059 -0.224 1.05E-01 -0.368 2.97E-05 -1.029 6.90E-04 -0.366 0.072 3.89E-07 0.054 
rs7499818 typed 16 60709933 CDH8 T 0.059 0.224 1.05E-01 0.368 2.97E-05 1.025 7.16E-04 0.366 0.072 3.92E-07 0.056 
rs10852401 imputed 16 60754124 CDH8 T 0.058 0.227 1.04E-01 0.384 1.63E-05 0.765 8.06E-03 0.366 0.072 4.89E-07 0.231 
rs7499790 imputed 16 60725325 CDH8 G 0.060 0.224 1.05E-01 0.368 2.97E-05 0.916 1.77E-03 0.362 0.072 5.00E-07 0.102 
rs7500962 typed 16 60705514 CDH8 G 0.055 0.220 1.17E-01 0.384 2.42E-05 1.018 1.38E-03 0.373 0.074 5.12E-07 0.071 
rs7499443 imputed 16 60721701 CDH8 G 0.055 0.220 1.17E-01 0.384 2.42E-05 0.920 2.97E-03 0.369 0.074 6.36E-07 0.116 
rs4580183 typed 16 60740638 CDH8 G 0.061 0.224 1.05E-01 0.369 2.87E-05 0.786 4.86E-03 0.357 0.071 6.51E-07 0.192 
rs12103387 imputed 16 60739510 CDH8 G 0.061 0.224 1.05E-01 0.369 2.90E-05 0.785 4.84E-03 0.357 0.071 6.53E-07 0.192 
rs9933487 imputed 16 60740101 CDH8 T 0.061 0.224 1.05E-01 0.369 2.90E-05 0.786 4.85E-03 0.357 0.071 6.54E-07 0.192 
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rs16964271 imputed 16 60738450 CDH8 T 0.061 0.224 1.05E-01 0.368 2.94E-05 0.784 4.82E-03 0.357 0.071 6.59E-07 0.193 
rs11864696 typed 16 60737691 CDH8 G 0.061 0.224 1.05E-01 0.368 2.97E-05 0.784 4.81E-03 0.357 0.071 6.62E-07 0.193 
rs16964343 imputed 16 60781951 CDH8 G 0.057 -0.225 1.17E-01 -0.391 2.24E-05 -0.754 1.05E-02 -0.369 0.075 8.68E-07 0.251 
rs8046248 imputed 16 60736475 CDH8 T 0.057 -0.220 1.17E-01 -0.384 2.42E-05 -0.744 9.94E-03 -0.362 0.073 9.13E-07 0.243 
rs16964272 imputed 16 60748488 CDH8 T 0.057 0.220 1.17E-01 0.384 2.42E-05 0.744 9.94E-03 0.362 0.073 9.15E-07 0.243 
Z-WC association with additional adjustment for BMI 
rs12307610 typed 12 8753428 FAM80B G 0.013 -0.574 9.00E-04 -0.413 6.08E-05 -0.367 2.28E-01 -0.448 0.084 1.32E-07 0.699 
rs12311861 imputed 12 8752419 FAM80B G 0.013 0.574 9.00E-04 0.413 6.08E-05 0.367 2.28E-01 0.448 0.084 1.32E-07 0.699 
rs11046900 typed 12 8759944 FAM80B G 0.013 -0.574 9.00E-04 -0.413 6.10E-05 -0.367 2.28E-01 -0.448 0.084 1.32E-07 0.698 
rs12312128 imputed 12 8759474 FAM80B T 0.013 -0.574 9.00E-04 -0.413 6.10E-05 -0.367 2.28E-01 -0.448 0.084 1.32E-07 0.698 
rs12318215 imputed 12 8763759 FAM80B T 0.013 0.574 9.00E-04 0.412 6.12E-05 0.367 2.28E-01 0.448 0.084 1.33E-07 0.698 
rs7313614 imputed 12 8766675 FAM80B T 0.013 -0.574 9.00E-04 -0.412 6.12E-05 -0.367 2.28E-01 -0.448 0.084 1.33E-07 0.698 
rs2159889 typed 12 8823377 FAM80B T 0.013 -0.574 9.00E-04 -0.417 6.16E-05 -0.365 2.31E-01 -0.451 0.085 1.33E-07 0.708 
rs12297411 imputed 12 8767514 FAM80B G 0.013 -0.574 9.00E-04 -0.412 6.14E-05 -0.367 2.28E-01 -0.448 0.084 1.33E-07 0.698 
rs7303757 imputed 12 8768080 FAM80B G 0.013 -0.574 9.00E-04 -0.412 6.18E-05 -0.367 2.28E-01 -0.447 0.084 1.34E-07 0.697 
rs6487347 imputed 12 8770150 FAM80B C 0.013 -0.574 9.00E-04 -0.412 6.18E-05 -0.367 2.28E-01 -0.447 0.084 1.34E-07 0.697 
rs7316051 imputed 12 8770628 FAM80B G 0.013 -0.574 9.00E-04 -0.412 6.18E-05 -0.367 2.28E-01 -0.447 0.084 1.34E-07 0.697 
rs7960582 imputed 12 8774597 FAM80B G 0.013 -0.574 9.00E-04 -0.412 6.18E-05 -0.367 2.28E-01 -0.447 0.084 1.34E-07 0.697 
rs1476902 imputed 12 8819729 FAM80B G 0.013 0.574 9.00E-04 0.415 6.22E-05 0.365 2.31E-01 0.450 0.085 1.35E-07 0.704 
rs12311263 imputed 12 8815372 FAM80B G 0.013 -0.574 9.00E-04 -0.413 6.29E-05 -0.367 2.28E-01 -0.448 0.085 1.36E-07 0.700 
rs12314822 imputed 12 8786598 FAM80B T 0.013 0.574 9.00E-04 0.411 6.34E-05 0.367 2.28E-01 0.447 0.084 1.38E-07 0.694 
rs16917739 imputed 12 8789260 FAM80B G 0.013 0.574 9.00E-04 0.411 6.34E-05 0.367 2.28E-01 0.447 0.084 1.38E-07 0.694 
rs11047042 imputed 12 8791188 FAM80B G 0.013 0.574 9.00E-04 0.411 6.34E-05 0.367 2.28E-01 0.447 0.084 1.38E-07 0.694 
rs16917746 typed 12 8795751 FAM80B T 0.013 -0.574 9.00E-04 -0.411 6.35E-05 -0.367 2.28E-01 -0.447 0.084 1.39E-07 0.695 
rs7139182 imputed 12 8812178 FAM80B G 0.013 0.574 9.00E-04 0.411 6.42E-05 0.367 2.28E-01 0.447 0.084 1.40E-07 0.695 
rs11046858 typed 12 8745992 FAM80B G 0.013 0.574 9.00E-04 0.410 6.74E-05 0.367 2.28E-01 0.446 0.084 1.48E-07 0.692 
rs10128818 imputed 12 8726098 FAM80B G 0.013 0.595 6.92E-04 0.352 4.09E-04 0.367 2.28E-01 0.408 0.083 9.74E-07 0.479 
* nearest gene (500kb region) from identified SNP. MAF: average MAF of 3 SNP-chips used in study. Typed: genotyped in at least 1 SNP chip, imputed: not genotyped in any chip. 
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7) Association results in AGEN study after exclusion of patients with chronic disease and in dichotomous obesity study. 
 
Table 7:  Association in AGEN study after excluding samples with chronic disease (cancer and diabetes patients) and dichotomous obesity case-control 
association for 4 novel loci identified in study. 
    
Association after exclusion of patients 
with diabetes                              
(N=69,512) 
Association after exclusion of patients 
with chronic disease                    
(N=59,958) 
8,230 cases and 32,480 controls           
from Stage 1 and 2 
Nearest 
gene 
Chr rsid 
Test 
allele 
Beta (SE) Meta-analysis p-value* Beta (SE) Meta-analysis p-value* OR Meta-analysis p-value† 
CDKAL1 6 rs9356744 T 2.95 (0.54) 4.01x10
-8
 2.99 (0.54) 5.00x10
-7
 1.10 (1.06-1.13) 4.21x10
-9
 
PCSK1 5 rs261967 C 2.87 (0.55) 1.53x10
-7
 2.67 (0.60) 8.65x10
-6
 1.05 (1.02-1.08) 3.11x10
-3
 
GP2 16 rs12597579 C 3.36 (0.66) 3.06x10
-7
 3.10 (0.73) 2.10x10
-5
 1.06 (1.02-1.10) 1.17x10
-3
 
PAX6 11 rs652722 C 2.60 (0.55) 2.29x10
-6
 2.95 (0.30) 9.37x10
-7
 1.05 (1.02-1.08) 1.78x10
-3
 
*meta-analysis of all 3 stages of study. † meta-analysis of stage 1 datasets (excluding SCORM childhood dataset). Obese cases defined as BMI ≥ 27.5 kg/m
2 
and controls defined as BMI < 27.5 
kg/m
2
. 
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8) QQ plots comparing gene-gene interaction associations for 7 landmark SNPs in the 
RIKEN study. 
 
Figure 1: QQ plots comparing p-values in the gene–gene interaction analysis. Genome-wide      
gene–gene interaction analyses were conducted between the landmark SNP of the each of the BMI-
associated loci (SEC16B, CDKAL1, KLF9, BDNF, FTO, MC4R, and GIPR loci) and genome-wide 
SNPs (2,178,018 SNPs).  Diagonal represents expected interaction p-values and black dots represent 
observed interaction p-values. 
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Appendix IV 
 
1) Details of MAF, call-rates and HWE p-values for 33 SNPs that were selected for in silico assessment of Z-BMI in East-Asians 
 
Table1: Minor-allele frequencies (MAF), missingness (call-rate) and Hardy-Weinberg equilibrium deviation p-values for 34 SNPs that were in silico 
assessment in SP2, SDCS and SCES adult Singaporean Chinese GWAS dataset.  None of the selected SNPs failed QC procedures. 
     
MAF Missingness HWE p-value 
rsid Gene Chr Position Comment SCES 
SP2 
1M 
SP2 
610 
SP2 
550 
SDCS 
1M 
SDCS 
610 
SCES 
SP2 
1M 
SP2 
610 
SP2 
550 
SDCS 
1M 
SDCS 
610 
SCES 
SP2 
1M 
SP2 
610 
SP2 
550 
SDCS 
1M 
SDCS 
610 
rs340874 PROX1 1 212225879 typed 0.399 0.402 0.399 0.391 0.388 0.425 0.001 0.000 0.000 0.000 0.001 0.000 0.337 0.736 0.758 0.360 1.000 0.756 
rs2943641 IRS1 2 226801989 typed 0.073 0.076 0.070 0.058 0.061 0.072 0.000 0.000 0.000 0.000 0.000 0.000 0.731 1.000 0.819 1.000 1.000 1.000 
rs243021 BCL11A 2 60438323 typed 0.338 0.340 0.339 0.306 0.319 0.331 0.001 0.001 0.000 0.000 0.000 0.000 0.089 0.194 0.844 0.898 0.940 0.784 
rs780094 GCKR 2 27594741 typed 0.479 0.481 0.445 0.467 0.457 0.459 0.000 0.000 0.000 0.000 0.000 0.000 0.249 0.650 0.370 0.442 0.052 0.142 
rs1801282 PPARG 3 12368125 typed 0.044 0.033 0.041 0.036 0.037 0.033 0.002 0.000 0.000 0.000 0.000 0.001 0.399 1.000 0.126 1.000 0.630 0.105 
rs6780569 UBE2E2 3 23173488 typed 0.188 0.197 0.182 0.201 0.178 0.172 0.000 0.000 0.000 0.000 0.000 0.000 0.408 0.609 0.488 0.866 1.000 0.240 
rs1470579 IGF2BP2 3 187011774 typed 0.244 0.240 0.238 0.248 0.260 0.275 0.001 0.001 0.000 0.009 0.002 0.000 0.574 0.657 0.073 0.769 0.495 0.079 
rs831571 PSMD6 3 64023337 typed 0.375 0.383 0.396 0.367 0.365 0.373 0.001 0.000 0.000 0.000 0.000 0.001 0.961 0.681 0.711 0.483 0.724 0.218 
rs6815464 MAEA 4 1299901 imputed 0.449 - - - 0.436 0.433 0.037 - - - 0.027 0.049 0.256 - - - 0.276 0.227 
rs9470794 ZFAND3 6 38214822 typed 0.337 0.338 0.321 0.331 0.355 0.366 0.001 0.000 0.001 0.000 0.000 0.000 0.719 0.169 0.415 0.805 0.055 0.394 
rs7754840 CDKAL1 6 20769229 typed 0.389 0.349 0.350 0.357 0.387 0.392 0.001 0.000 0.000 0.000 0.000 0.000 0.287 0.669 0.697 1.000 0.534 0.053 
rs1535500 KCNK16 6 39392028 imputed 0.473 0.478 0.473 0.475 0.492 0.498 0.001 0.000 0.000 0.000 0.000 0.000 0.854 0.845 0.057 1.000 0.692 0.855 
rs6467136 
GCC1/  
PAX4 
7 126952194 typed 0.201 0.208 0.199 0.203 0.180 0.176 0.000 0.000 0.000 0.021 0.000 0.000 0.051 0.278 0.711 0.733 0.739 0.916 
rs864745 JAZF1 7 28147081 imputed 0.218 0.217 0.205 0.218 0.211 0.211 0.014 0.018 0.018 0.012 0.014 0.024 0.946 0.334 0.584 0.195 0.920 0.229 
rs2191349 DGKB 7 15030834 imputed 0.306 0.322 0.308 0.272 0.308 0.295 0.001 0.000 0.000 0.000 0.000 0.000 0.516 0.503 0.072 0.782 0.938 0.272 
rs896854 TP53INP1 8 96029687 typed 0.263 0.251 0.259 0.254 0.255 0.270 0.001 0.000 0.001 0.003 0.000 0.000 0.906 0.168 0.701 0.474 1.000 1.000 
rs13266634 SLC30A8 8 118253964 typed 0.447 0.463 0.457 0.484 0.435 0.456 0.001 0.001 0.003 0.000 0.001 0.002 0.136 0.515 0.812 1.000 0.841 0.270 
rs17584499 PTPRD 9 8869118 typed 0.104 0.112 0.096 0.107 0.101 0.106 0.001 0.001 0.005 0.000 0.000 0.000 0.107 0.626 0.863 1.000 0.719 0.520 
rs10811661 CDKN2A/B 9 22124095 imputed - 0.406 0.383 0.392 - - - 0.049 0.049 0.048 - - - 0.783 0.405 0.815 - - 
rs7041847 GLIS3 9 4277466 typed 0.476 0.488 0.489 0.479 0.494 0.486 0.000 0.000 0.000 0.000 0.000 0.001 0.580 0.560 0.124 0.913 1.000 0.181 
rs7903146 TCF7L2 10 114748339 typed 0.021 0.023 0.019 0.025 0.022 0.026 0.000 0.000 0.000 0.000 0.000 0.000 1.000 1.000 0.343 1.000 1.000 1.000 
rs1111875 HHEX/ IDE 10 94452862 typed 0.305 0.294 0.287 0.334 0.310 0.312 0.000 0.000 0.001 0.000 0.000 0.000 0.664 0.533 0.829 0.540 0.092 0.436 
254 
 
rs10906115 
CDC123/ 
CAMK1D 
10 12355003 typed 0.395 0.383 0.391 0.383 0.387 0.371 0.000 0.000 0.000 0.003 0.000 0.000 0.923 1.000 1.000 0.645 0.166 0.297 
rs12779790 
CDC123/ 
CAMK1D 
10 12368017 - - - - - - - - - - - - - - - - - - - 
rs1552224 CENTD2 11 72110746 typed 0.066 0.069 0.068 0.069 0.060 0.049 0.000 0.001 0.000 0.000 0.000 0.001 0.060 0.615 0.161 0.384 0.246 1.000 
rs231362 KCNQ1 11 2648047 imputed 0.092 0.090 0.090 0.116 0.093 0.090 0.025 0.004 0.009 0.021 0.017 0.012 0.263 0.425 0.719 0.595 0.692 0.851 
rs2237892 KCNQ1 11 2796327 typed 0.330 0.315 0.308 0.318 0.300 0.324 0.000 0.000 0.000 0.000 0.000 0.000 0.054 0.707 0.044 0.801 0.532 0.165 
rs5215 KCNJ11 11 17365206 typed 0.363 0.363 0.343 0.366 0.370 0.377 0.001 0.002 0.000 0.000 0.000 0.001 0.252 0.575 0.896 0.480 0.291 1.000 
rs7172432 
C2CD4A/ 
C2CD4B 
15 60183681 typed 0.337 0.354 0.331 0.325 0.314 0.315 0.000 0.000 0.000 0.000 0.000 0.000 0.719 0.777 0.689 0.619 0.148 0.778 
rs8042680 PRC1 15 89322342 - - - - - - - - - - - - - - - - - - - 
rs9939609 FTO 16 52378028 imputed 0.122 0.113 0.121 0.135 0.138 0.150 0.000 0.000 0.000 0.003 0.000 0.001 0.197 0.417 0.070 0.639 0.889 0.402 
rs4430796 TCF2 17 33172153 typed 0.279 0.274 0.277 0.276 0.299 0.295 0.008 0.000 0.001 0.012 0.001 0.000 0.647 0.329 1.000 0.336 0.695 1.000 
rs3786897 PEPD 19 38584848 typed 0.431 0.449 0.429 0.416 0.414 0.402 0.040 0.000 0.031 0.039 0.000 0.024 0.416 0.695 0.358 0.251 0.250 0.304 
rs6017317 
FITM2/ 
R3HDML/ 
HNF1A 
20 42380380 imputed 0.423 0.425 0.412 0.400 0.436 0.448 0.006 0.016 0.009 0.012 0.007 0.009 0.539 0.082 0.807 0.648 0.590 0.173 
1M: SP2 and SDCS samples genotyped on the Illumina 1M chip, 610: SP2 and SDCS samples genotyped on the Illumina 610 chip, 550: SP2 samples genotyped on the Illumina 55 chip. 
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2) Z-BMI association results of all SNPs in adult Singaporean GWAS datasets and after meta-analyses 
 
Table 2: Z-BMI association levels of SNPs tested in SCES, SP2 and SDCS Singaporean adult Chinese datasets and after fixed-effect meta-analyses (full 
datasets and after excluding patients with T2D).  Re-analysis after excluding diabetic patients performed only at rs1111875. Significant data indicated in bold.  
      
SCES                 
(N=1,861) 
SP2                    
(N=2,431) 
SDCS                    
(N=1,992) 
Meta-analysis                               
(N=6,284) 
Meta-analysis*                               
(N=3,960) 
rsid 
Implicated 
gene 
Chr Position Comment 
Test 
allele 
Beta SE P Beta SE P Beta SE P Beta SE P 
Adjusted 
P† 
Beta SE P 
rs7754840 CDKAL1 6 20769229 typed G 0.073 0.033 0.0272 0.005 0.027 0.8408 0.135 0.031 2.1x10-4 0.064 0.017 0.0002 0.0061 - - - 
rs9939609 FTO 16 52378028 imputed T -0.100 0.049 0.0435 -0.078 0.040 0.0486 -0.090 0.044 0.0401 -0.088 0.025 0.0005 0.0157 - - - 
rs1111875 HHEX/ IDE 10 94452862 typed C -0.029 0.035 0.4080 -0.095 0.028 0.0006 -0.036 0.033 0.2798 -0.059 0.018 0.0012 0.0355 -0.060 0.019 0.002 
rs1535500 KCNK16 6 39392028 imputed T -0.072 0.033 0.0271 -0.013 0.026 0.6132 -0.052 0.031 0.0898 -0.041 0.017 0.0174 0.5217 - - - 
rs6017317 
FITM2/ 
R3HDML/ 
HNF1A 
20 42380380 imputed T 0.097 0.034 0.0040 0.018 0.026 0.4987 0.018 0.031 0.5723 0.038 0.017 0.0263 0.7888 - - - 
rs5215 KCNJ11 11 17365206 typed T -0.049 0.034 0.1542 -0.042 0.027 0.1137 -0.021 0.032 0.5090 -0.038 0.018 0.0335 1 - - - 
rs7172432 
C2CD4A/ 
C2CD4B 
15 60183681 typed G 0.085 0.035 0.0138 0.035 0.027 0.1910 -0.004 0.033 0.9082 0.037 0.018 0.0413 1 - - - 
rs2191349 DGKB 7 15030834 imputed T -0.002 0.036 0.9508 -0.028 0.027 0.2928 -0.048 0.034 0.1571 -0.027 0.018 0.1374 1 - - - 
rs1801282 PPARG 3 12368125 typed G 0.147 0.080 0.0652 0.048 0.067 0.4769 0.071 0.084 0.4024 0.069 0.033 0.1515 1 - - - 
rs2237892 KCNQ1 11 2796327 typed T 0.012 0.034 0.7315 0.027 0.028 0.3240 0.030 0.033 0.3612 0.024 0.018 0.1907 1 - - - 
rs7041847 GLIS3 9 4277466 typed G -0.007 0.033 0.8422 0.052 0.025 0.0396 -0.001 0.031 0.9832 0.021 0.017 0.2043 1 - - - 
rs9470794 ZFAND3 6 38214822 typed T 0.077 0.035 0.0259 0.022 0.027 0.4198 -0.023 0.032 0.4719 0.022 0.018 0.2096 1 - - - 
rs780094 GCKR 2 27594741 typed T -0.032 0.033 0.3392 -0.008 0.026 0.7673 -0.029 0.031 0.3554 -0.021 0.017 0.2234 1 - - - 
rs231362 KCNQ1 11 2648047 imputed G 0.064 0.058 0.2694 -0.071 0.044 0.1074 -0.051 0.055 0.3500 -0.030 0.030 0.3077 1 - - - 
rs13266634 SLC30A8 8 118253964 typed T -0.010 0.033 0.7666 0.005 0.026 0.8330 0.062 0.032 0.0498 0.017 0.017 0.3117 1 - - - 
rs896854 TP53INP1 8 96029687 typed T -0.027 0.037 0.4665 -0.006 0.029 0.8305 -0.028 0.035 0.4332 -0.018 0.019 0.3419 1 - - - 
rs243021 BCL11A 2 60438323 typed G -0.050 0.035 0.1540 0.036 0.027 0.1863 0.041 0.033 0.2233 0.015 0.018 0.4070 1 - - - 
rs6780569 UBE2E2 3 23173488 typed G 0.020 0.042 0.6255 -0.039 0.033 0.2295 -0.012 0.042 0.7766 -0.015 0.022 0.4899 1 - - - 
rs864745 JAZF1 7 28147081 imputed T 0.029 0.040 0.4592 -0.039 0.031 0.2019 -0.013 0.039 0.7402 -0.013 0.021 0.5200 1 - - - 
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rs3786897 PEPD 19 38584848 typed G -0.014 0.033 0.6797 0.022 0.025 0.3900 0.004 0.032 0.8935 -0.013 0.022 0.5696 1 - - - 
rs1552224 CENTD2 11 72110746 typed C -0.081 0.067 0.2235 -0.049 0.051 0.3386 0.109 0.070 0.1178 -0.018 0.035 0.6073 1 - - - 
rs6467136 
GCC1/  
PAX4 
7 126952194 typed G -0.067 0.042 0.1085 0.017 0.032 0.5869 0.075 0.041 0.0681 0.011 0.022 0.6153 1 - - - 
rs1470579 IGF2BP2 3 187011774 typed C 0.056 0.038 0.1437 0.005 0.029 0.8769 -0.024 0.035 0.4912 0.009 0.019 0.6285 1 - - - 
rs4430796 TCF2 17 33172153 typed G -0.008 0.037 0.8292 -0.021 0.028 0.4640 0.013 0.034 0.7094 -0.007 0.019 0.6898 1 - - - 
rs340874 PROX1 1 212225879 typed T 0.021 0.033 0.5247 -0.024 0.026 0.3624 0.039 0.032 0.2174 0.006 0.017 0.7066 1 - - - 
rs831571 PSMD6 3 64023337 typed T -0.042 0.034 0.2094 -0.004 0.026 0.8649 0.055 0.032 0.0852 0.003 0.017 0.8423 1 - - - 
rs10906115 
CDC123/ 
CAMK1D 
10 12355003 typed G 0.023 0.033 0.4887 0.009 0.026 0.7360 -0.024 0.032 0.4561 0.003 0.017 0.8499 1 - - - 
rs2943641 IRS1 2 226801989 typed T -0.015 0.063 0.8091 -0.012 0.050 0.8023 0.047 0.063 0.4487 0.004 0.033 0.9136 1 - - - 
rs7903146 TCF7L2 10 114748339 typed T -0.039 0.113 0.7282 -0.023 0.087 0.7931 0.048 0.103 0.6427 -0.005 0.057 0.9284 1 - - - 
rs17584499 PTPRD 9 8869118 typed T -0.019 0.053 0.7217 0.040 0.042 0.3402 -0.039 0.051 0.4451 0.001 0.028 0.9798 1 - - - 
rs6815464 MAEA 4 1299901 imputed G 0.049 0.034 0.1430 - - - 0.020 0.031 0.5120 - - - - - - - 
rs10811661 CDKN2A/B 9 22124095 imputed - - - - 0.023 0.026 0.3873 - - - - - - - - - - 
rs8042680 PRC1 15 89322342 - - - - - - - - - - - - - - - - - - 
* After exclusion of SDCS diabetic cohort and 198 and 134 T2D patients from SP2 and SCES respectively.  Diabetes defined as participants with a history of T2D or fasting glucose levels ≥7.0 
mmol/l in SP2 or HbA1c levels ≥ 6.5% in non-fasting blood samples in SCES.  
P: p-value, † Bonferronni correction based on 30 independent tests (30 SNPs meta-analysed). 
 
 
 
 
 
 
 
 
 
 
 
 
257 
 
3) Association of rs1111875 with fasting insulin and fasting glucose measures in SP2 
 
Table 3: Fasting insulin Z-score and fasting glucose Z-score associations for rs1111875 in the SP2 
dataset (after exclusion of T2D patients). 
rsid Gene Chr Position Test allele Study N Beta SE p-value 
Fasting insulin Z-score 
rs1111875 HHEX 10 94452862 C SP2 2,249 0.015 0.022 0.239 
Fasting glucose Z-score 
rs1111875 HHEX 10 94452862 C SP2 2,232 0.026 0.022 0.198 
 
 
 
 
